: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

Vaccines

Free Subscription

Articles published in Vaccine
Retrieve available abstracts of 2387 articles:
HTML format

Single Articles

April 2024

WANG Y, Xu F, Yuan C, Zhang Y, et al
Comparison of immune effects of porcine circovirus type 2d (PCV2d) capsid protein expressed by Escherichia coli and baculovirus-insect cells.
Vaccine. 2024;42:2848-2857.
PubMed Abstract available

MOHANTY S, Done N, Liu Q, Song Y, et al
Incidence of pneumococcal disease in children
Vaccine. 2024;42:2758-2769.
PubMed Abstract available

INGRAO F, Ngabirano E, Rauw F, Dauphin G, et al
Immunogenicity and protective efficacy of a multivalent herpesvirus vectored vaccine against H9N2 low pathogenic avian influenza in chicken.
Vaccine. 2024 Apr 18:S0264-410X(24)00452-3. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

WON H, Kim JA, Jeong NY, Choi NK, et al
Safety of concomitant administration of 23-valent polysaccharide pneumococcal vaccine and influenza vaccine among the elderly.
Vaccine. 2024 Apr 18:S0264-410X(24)00400-6. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

RICKE IJ, Spaulding AB, Rajtar NN, Benton EM, et al
Predictors of willingness to receive updated 2023-2024 COVID-19 booster vaccines among a convenience sample in Minnesota.
Vaccine. 2024 Apr 18:S0264-410X(24)00480-8. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

ORANGZEB S, Desalegn A, Trinh NTH, Zhao J, et al
COVID-19 vaccine uptake among children and adolescents in Norway: A comprehensive registry-based cohort study of over 800,000 individuals.
Vaccine. 2024 Apr 18:S0264-410X(24)00464-X. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

GAJEWSKA M, Lewtak K, Gorynski P, Piotrowicz M, et al
Effect of the PCV 10 vaccination on community-acquired pneumonia hospitalisations after four years of its introduction into the Polish National Immunisation Programme: Follow-up study.
Vaccine. 2024 Apr 18:S0264-410X(24)00433-X. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

BEITARI S, Yi S, Sharma S, Yung R, et al
Exploring COVID-19 vaccine uptake and hesitancy among vulnerable populations in inner city Vancouver, Canada: Insights into characteristics and clinical outcomes.
Vaccine. 2024 Apr 17:S0264-410X(24)00477-8. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

MUTSAERTS EAML, van Cranenbroek B, Madhi SA, Simonetti E, et al
Impact of nutritional status on vaccine-induced immunity in children living in South Africa: Investigating the B-cell repertoire and metabolic hormones.
Vaccine. 2024 Apr 17:S0264-410X(24)00448-1. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

MATUR RV, Thuluva S, Gunneri S, Yerroju V, et al
Immunogenicity and safety of a 14-valent pneumococcal polysaccharide conjugate vaccine (PNEUBEVAX 14) administered to 6-8 weeks old healthy Indian Infants: A single blind, randomized, active-controlled, Phase-III study.
Vaccine. 2024 Apr 17:S0264-410X(24)00362-1. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

VAN DER POL S, Zeevat F, Postma MJ, Boersma C, et al
Cost-effectiveness of high-dose influenza vaccination in the Netherlands: Incorporating the impact on both respiratory and cardiovascular hospitalizations.
Vaccine. 2024 Apr 17:S0264-410X(24)00465-1. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

JI Y, Sui X, Miao W, Wang C, et al
Erratum to "Immunogenicity of an adenovirus-vectored bivalent vaccine against wild type SARS-CoV-2 and Omicron variants in a murine model" [Vaccine 42(6) (2024) 1292-1299].
Vaccine. 2024 Apr 16:S0264-410X(24)00386-4. doi: 10.1016/j.vaccine.2024.
PubMed

PEREIRA ET, Iasulaitis S, Greco BC
Analysis of causal relations between vaccine hesitancy for COVID-19 vaccines and ideological orientations in Brazil.
Vaccine. 2024 Apr 16:S0264-410X(24)00436-5. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

GEE J, Shimabukuro TT, Su JR, Shay D, et al
Overview of U.S. COVID-19 vaccine safety surveillance systems.
Vaccine. 2024 Apr 16:S0264-410X(24)00224-X. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

LEE N, Hong Y, Kirkpatrick CE, Hu S, et al
COVID-19 vaccination communication: Effects of vaccine conspiracy beliefs and message framing among black and white participants.
Vaccine. 2024 Apr 16:S0264-410X(24)00402-X. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

DEAL A, Crawshaw AF, Salloum M, Hayward SE, et al
Understanding the views of adult migrants around catch-up vaccination for missed routine immunisations to define strategies to improve coverage: A UK in-depth interview study.
Vaccine. 2024 Apr 16:S0264-410X(24)00406-7. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

SHEFFER R, Bucris E, Amitai Z, Indenbaum V, et al
Measles outbreak associated with a preschool setting among partially vaccinated children in the Tel Aviv District, Israel, October 2023.
Vaccine. 2024 Apr 15:S0264-410X(24)00427-4. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

MELNIKOW J, Padovani A, Zhang J, Miller M, et al
Patient concerns and physician strategies for addressing COVID-19 vaccine hesitancy.
Vaccine. 2024 Apr 15:S0264-410X(24)00437-7. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

WONG IOL, Wong C, Mak N, Dai A, et al
Assessment of the impact of the vaccine pass policy on COVID-19 vaccine hesitancy and uptake among Chinese adults in Hong Kong.
Vaccine. 2024 Apr 15:S0264-410X(24)00449-3. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

DAVIS BM, Blake I, Panicker G, Meites E, et al
Immunogenicity of quadrivalent human papillomavirus vaccine among Alaska Native children aged 9-14 years at 5 years after vaccination.
Vaccine. 2024 Apr 15:S0264-410X(24)00447-X. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

YAGI A, Ueda Y, Kimura T
HPV Vaccine Issues in Japan: A review of our attempts to promote the HPV vaccine and to provide effective evaluation of the problem through social-medical and behavioral-economic perspectives.
Vaccine. 2024 Apr 13:S0264-410X(24)00407-9. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

SUKIK L, Chemaitelly H, Ayoub HH, Coyle P, et al
Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradient.
Vaccine. 2024 Apr 13:S0264-410X(24)00440-7. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

BAKER J, Aliabadi N, Munjal I, Jiang Q, et al
Equivalent immunogenicity across three RSVpreF vaccine lots in healthy adults 18-49 years of age: Results of a randomized phase 3 study.
Vaccine. 2024 Apr 13:S0264-410X(24)00387-6. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

NASKAR S, Harsukhbhai Chandpa H, Agarwal S, Meena J, et al
Super epitope dengue vaccine instigated serotype independent immune protection in-silico.
Vaccine. 2024 Apr 13:S0264-410X(24)00423-7. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

YONEKAWA M, Watanabe T, Kogawara O, Yoshii C, et al
Phase 3 immunogenicity and safety study of a tick-borne encephalitis vaccine in healthy Japanese participants 1 year of age and older.
Vaccine. 2024 Apr 12:S0264-410X(24)00388-8. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

LEE JS, Choi H, Shin SH, Hwang MJ, et al
Characterization of Brighton Collaboration criteria for myocarditis and pericarditis following COVID-19 vaccine in Korean adolescents.
Vaccine. 2024 Apr 11:S0264-410X(24)00446-8. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

NOLAN MB, Chrenka E, Walker P, Steiner A, et al
COVID-19 vaccine uptake among non-US-born populations in the United States, 2020-2022.
Vaccine. 2024 Apr 11:S0264-410X(24)00443-2. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

KAINTH MK, Sembajwe GN, Ahn H, Qian M, et al
Despite mandated primary series, health care personnel still hesitant about COVID-19 vaccine and immunizing children.
Vaccine. 2024 Apr 11:S0264-410X(24)00442-0. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

AHERN S, Browne J, Murphy A, Teljeur C, et al
An economic evaluation and incremental analysis of the cost effectiveness of three universal childhood varicella vaccination strategies for Ireland.
Vaccine. 2024 Apr 11:S0264-410X(24)00441-9. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

OWUSU-EDUSEI K, Favre-Bulle A, Tsoumani E, Mutschler T, et al
Evaluating the health and economic outcomes of a PCV15 vaccination program for adults aged 65 years-and-above in Switzerland.
Vaccine. 2024 Apr 11:S0264-410X(24)00431-6. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

PITTS PJ, Poland GA
Addressing vaccine hesitancy: Learning from the successes and failures of the COVID-19 pandemic.
Vaccine. 2024 Apr 10:S0264-410X(24)00396-7. doi: 10.1016/j.vaccine.2024.
PubMed

HUSETH-ZOSEL AL, Fuller H, Hicks A, Carson PJ, et al
Reliance on sources of immunization information and vaccine uptake among older adults in a rural state: The mediating role of trust.
Vaccine. 2024 Apr 10:S0264-410X(24)00444-4. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

BLAKE JM, Thompson J, HogenEsch H, Ekenstedt KJ, et al
Heritability and genome-wide association study of vaccine-induced immune response in Beagles: A pilot study.
Vaccine. 2024 Apr 10:S0264-410X(24)00398-0. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

THAI H, Audet EC, Koestner R
Motivation for COVID-19 Vaccination: Applying a Self-Determination Theory Perspective to a Global Health Crisis.
Vaccine. 2024 Apr 9:S0264-410X(24)00439-0. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

AKMATOVA R, Ebama MS, Temirbekov S, Alymkulova V, et al
A comparative analysis of knowledge, attitude, and practice (KAP) towards influenza and influenza vaccination among healthcare workers in Kyrgyzstan prior to and during the COVID-19 pandemic.
Vaccine. 2024 Apr 9:S0264-410X(24)00420-1. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

EL BUSHRA HE, Haroun AAA, Dauod Altaf M, Gardiwal H, et al
Early use of oral cholera vaccines as a prime control measure during outbreaks: Necessary but not sufficient.
Vaccine. 2024 Apr 8:S0264-410X(24)00332-3. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

KONERU A, Wells K, Amanda Carnes C, Drumhiller K, et al
A survey of state and local practices encouraging pediatric COVID-19 vaccination of children ages 6 months through 11 years.
Vaccine. 2024 Apr 8:S0264-410X(24)00369-4. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

ARCHER H, McCoy SI, Sears D, Kwan A, et al
Indirect vaccine effectiveness in an outbreak of Alpha B.1.1.7 variant in a California state Prison, May 2021.
Vaccine. 2024 Apr 6:S0264-410X(24)00368-2. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

CUMMINGS JF, Polhemus ME, Kester KE, Ockenhouse CF, et al
A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naive adults.
Vaccine. 2024 Apr 6:S0264-410X(24)00389-X. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

CHONG CY, Kam KQ, Zhang J, Bertoletti A, et al
Immunogenicity and safety of Sinovac-CoronaVac booster vaccinations in 12-17- year-olds with clinically significant reactions from Pfizer-BNT162b2 vaccination.
Vaccine. 2024 Apr 6:S0264-410X(24)00425-0. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

BINTE HOSSAIN F, Muscatello D, Jayasinghe S, Jonnagaddala J, et al
Uptake of pneumococcal vaccines in older Australian adults before and after universal public funding of PCV13.
Vaccine. 2024 Apr 6:S0264-410X(24)00426-2. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

CHARD AN, Machingaidze C, Loayza S, Gharpure R, et al
Estimating averted illnesses from influenza vaccination for children and pregnant women - El Salvador, Panama, and Peru, 2011-2018.
Vaccine. 2024 Apr 6:S0264-410X(24)00419-5. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

SCHULTZE A, Martin I, Messina D, Bots S, et al
A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases.
Vaccine. 2024 Apr 5:S0264-410X(24)00330-X. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

STEFANIZZI P, Moscara L, Palmieri C, Martinelli A, et al
Safety profile of recombinant adjuvanted anti-herpes zoster vaccine (RZV) in high-risk groups: Data from active surveillance program. Puglia (Italy), 2021-23.
Vaccine. 2024 Apr 5:S0264-410X(24)00311-6. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

NYBRU GLEDITSCH R, Skogset Ofitserova T, Aubrey White R, Karoline Raberg Kjollesdal M, et al
Vaccine coverage among children born to immigrant parents in Norway, 2000-2020.
Vaccine. 2024 Apr 5:S0264-410X(24)00395-5. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

NAKANO T, Hasegawa M, Endo M, Matsuda K, et al
Immunogenicity and safety of adsorbed diphtheria-purified pertussis-tetanus-inactivated polio (Sabin strain)-Haemophilus type b conjugate combined vaccine (DPT-IPV-Hib) in healthy Japanese Infants >/= 2 and < 43 months of Age: A phase III, multicenter
Vaccine. 2024 Apr 5:S0264-410X(24)00394-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BAUM HE, Thirard R, Halliday A, Baos S, et al
Detection of SARS-CoV-2-specific mucosal antibodies in saliva following concomitant COVID-19 and influenza vaccination in the ComFluCOV trial.
Vaccine. 2024 Apr 4:S0264-410X(24)00367-0. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

ALTAWALBEH SM, Wateska AR, Nowalk MP, Lin CJ, et al
Cost-effectiveness of an in-development adult-formulated 21-valent pneumococcal conjugate vaccine in US adults aged 50 years or older.
Vaccine. 2024 Apr 4:S0264-410X(24)00404-3. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

HEISLER-MACKINNON JA, Queen T, Yi Kong W, Kennedy KL, et al
Identifying effective vaccine champions: Findings from a national survey of primary care professionals.
Vaccine. 2024 Apr 3:S0264-410X(24)00403-1. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

NURDIN A, Movieta Nency Y, Maddeppungeng M, Sekartini R, et al
Immunogenicity and safety of SARS-CoV-2 recombinant protein subunit vaccine (IndoVac) adjuvanted with alum and CpG 1018 in Indonesian adults: A phase 3, randomized, active-controlled, multicenter trial.
Vaccine. 2024 Apr 3:S0264-410X(24)00399-2. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

TEMBO G, Mayuni M, Kamng'ona R, Chimgoneko L, et al
Poor association between 13-valent pneumococcal conjugate vaccine-induced serum and mucosal antibody responses with experimental Streptococcus pneumoniae serotype 6B colonisation.
Vaccine. 2024 Apr 2:S0264-410X(24)00360-8. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

WU CY, Kao SE, Tseng YC, Hou JT, et al
Pilot-scale production of a highly efficacious and stable monoglycosylated influenza split virus vaccine.
Vaccine. 2024;42:2220-2228.
PubMed Abstract available

LIU J, Qi Q, Liu Y, Ni P, et al
A paired measles-rubella catch-up campaign in Sichuan China to stop an outbreak and strengthen local immunization programs.
Vaccine. 2024;42:2155-2160.
PubMed Abstract available

SU L, Zhou X, Peng W, Luo J, et al
Investigation on the correlation factors of positive Streptococcus pneumoniae antibody and IgG antibody level of Streptococcus pneumoniae in the elderly over 60 years old in Shenzhen.
Vaccine. 2024;42:2448-2454.
PubMed Abstract available

HUBER A, Kovacs E, Horvath A, Sahin-Toth J, et al
Prevalence, serogroup distribution and risk factors of Neisseria meningitidis carriage in high school and university students in Hungary.
Vaccine. 2024;42:2271-2277.
PubMed Abstract available

KIMBUGWE G, Vatrinet R, Mwanga JA, Kakuru R, et al
Perceptions, attitudes, and willingness of healthcare and frontline workers to participate in an Ebola vaccine trial in Uganda.
Vaccine. 2024 Apr 1:S0264-410X(24)00358-X. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

March 2024

GONG JD, Barnboym E, O'Mara M, Gurevich N, et al
Self-reported determinants of COVID-19 vaccine acceptance among persons with and without autoimmune disease.
Vaccine. 2024 Mar 30:S0264-410X(24)00373-6. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

MALTEZOU HC, Kontogianni S, Michailidou E, Vergadi E, et al
Effectiveness of COVID-19 vaccination against school absenteeism in children and adolescents hospitalized with COVID-19.
Vaccine. 2024 Mar 30:S0264-410X(24)00397-9. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

PADENIYA TN, Hui BB, Wood JG, Regan DG, et al
Review of mathematical models of Neisseria gonorrhoeae vaccine impact: Implications for vaccine development.
Vaccine. 2024 Mar 30:S0264-410X(24)00380-3. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

HUF SW, Grailey K, Crespo RF, Woldmann L, et al
Testing the impact of differing behavioural science informed text message content in COVID-19 vaccination invitations on vaccine uptake: A randomised clinical trial.
Vaccine. 2024 Mar 28:S0264-410X(24)00365-7. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

FUKUDA Y, Suzuki T, Iwata KI, Haruta K, et al
Nanopore sequencing in distinguishing between wild-type and vaccine strains of Varicella-Zoster virus.
Vaccine. 2024 Mar 27:S0264-410X(24)00333-5. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

BRUUN N, Laursen MF, Carmelo R, Christensen E, et al
Novel nucleotide-packaging vaccine delivers antigen and poly(I:C) to dendritic cells and generate a potent antibody response in vivo.
Vaccine. 2024 Mar 26:S0264-410X(24)00364-5. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

PARISI A, Nunez O, Lopez-Perea N, Masa-Calles J, et al
Reduced pertussis disease severity in infants following the introduction of pertussis vaccination of pregnant women in Spain, 2015-2019.
Vaccine. 2024 Mar 25:S0264-410X(24)00315-3. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

WEYANT C, Hooda Y, Munira SJ, Lo NC, et al
Cost-effectiveness and public health impact of typhoid conjugate vaccine introduction strategies in Bangladesh.
Vaccine. 2024 Mar 25:S0264-410X(24)00322-0. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

DALEY MF, Reifler LM, Shoup JA, Glanz JM, et al
Influenza vaccination accuracy among adults: Self-report compared with electronic health record data.
Vaccine. 2024 Mar 25:S0264-410X(24)00339-6. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

BIEGUS J, Szenborn L, Zymlinski R, Zakliczynski M, et al
The early safety profile of simultaneous vaccination against influenza and Respiratory Syncytial Virus (RSV) in patients with high-risk heart failure.
Vaccine. 2024 Mar 25:S0264-410X(24)00366-9. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

VOLKMANN AM, Goldin S, McMurren B, Gapare C, et al
Leveraging seasonal influenza health worker vaccination programmes for COVID-19 vaccine Introduction: A global qualitative analysis.
Vaccine. 2024 Mar 25:S0264-410X(23)01490-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DAHL BA, Tritter B, Butryn D, Dahlke M, et al
Global VAX: A U.S. contribution to global COVID-19 vaccination efforts, 2021-2023.
Vaccine. 2024 Mar 23:S0264-410X(24)00359-1. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

PONNE S, Kumar R, Vanmathi SM, Brilhante RSN, et al
Reverse engineering protection: A comprehensive survey of reverse vaccinology-based vaccines targeting viral pathogens.
Vaccine. 2024 Mar 23:S0264-410X(24)00265-2. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

MORGAN G, Casalino S, Chowdhary S, Frangione E, et al
COVID-19 vaccine reactogenicity among participants enrolled in the GENCOV study.
Vaccine. 2024 Mar 22:S0264-410X(24)00317-7. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

STUREBORG R, Nichols J, Dhingra B, Yang J, et al
Development and validation of VaxConcerns: A taxonomy of vaccine concerns and misinformation with Crowdsource-Viability.
Vaccine. 2024 Mar 22:S0264-410X(24)00255-X. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

CONDIE J, Northstone K, Major-Smith D, Halstead I, et al
Exploring associations between the Big Five personality traits and cognitive ability with COVID-19 vaccination hesitancy and uptake among mothers and offspring in a UK prospective cohort study.
Vaccine. 2024 Mar 22:S0264-410X(24)00305-0. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

COMES JDG, Doets K, Zegers T, Kessler M, et al
Evaluation of bird-adapted self-amplifying mRNA vaccine formulations in chickens.
Vaccine. 2024 Mar 22:S0264-410X(24)00319-0. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

PRICE O, Dietze P, Maher L, Dore GJ, et al
High COVID-19 vaccine uptake following initial hesitancy among people in Australia who inject drugs.
Vaccine. 2024 Mar 21:S0264-410X(24)00337-2. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

HIRTH J, Ostovar-Kermani T, Gutierrez JA, Thompson EL, et al
Effect of age at initiation of the human papillomavirus vaccine on the association between race/ethnicity and completion of the vaccine series.
Vaccine. 2024 Mar 21:S0264-410X(24)00336-0. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

ZHANG Y, Wang Y, Li G, Zhao X, et al
A randomized, blind, parallel controlled phase I clinical trial to evaluate the safety and preliminary immunogenicity of 23-valent pneumococcal polysaccharide vaccine in healthy people aged 2 years and older.
Vaccine. 2024 Mar 21:S0264-410X(24)00331-1. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

KLUWER B, Gleditsch R, Rydland KM, Mamelund SE, et al
Higher educational attainment associated with higher confidence in influenza vaccination in Norway.
Vaccine. 2024 Mar 21:S0264-410X(24)00338-4. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

ZHAO Z, Meng Q, Sun TZ, Zhu B, et al
Mannose modified targeted immersion vaccine delivery system improves protective immunity against Infectious spleen and kidney necrosis virus in mandarin fish (Siniperca chuatsi).
Vaccine. 2024 Mar 21:S0264-410X(24)00335-9. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

MOFFETT KW, Seserman K, Margolis KA, Kranzler EC, et al
Differences in social media use by COVID-19 vaccination status.
Vaccine. 2024 Mar 20:S0264-410X(24)00318-9. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

SASI A, Dandotiya J, Kaushal J, Ganguly S, et al
Humoral and cellular immunity to SARS-CoV-2 following vaccination with non-mRNA vaccines in adolescent/young adults with cancer: A prospective cohort study.
Vaccine. 2024 Mar 20:S0264-410X(24)00329-3. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

BROOKS SP, Sidhu K, Cooper E, Michelle Driedger S, et al
The influence of health service interactions and local policies on vaccination decision-making in immigrant women: A multi-site Canadian qualitative study.
Vaccine. 2024 Mar 20:S0264-410X(24)00299-8. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

CRISTINA MARTINI RODRIGUES C, Caroline Ribeiro Sales A, Marli Christovam Sartori A, de Souza Azevedo A, et al
Yellow fever neutralizing antibody seroprevalence proportion and titers in previously vaccinated adults with chronic kidney disease.
Vaccine. 2024 Mar 20:S0264-410X(24)00316-5. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

ARTIGAS-JERONIMO S, Villar M, Estrada-Pena A, Alberdi P, et al
Subolesin knockdown in tick cells provides insights into vaccine protective mechanisms.
Vaccine. 2024 Mar 19:S0264-410X(24)00278-0. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

CHENG Y, Shen R, Liu F, Li Y, et al
Humoral and cellular immune responses induced by serogroup W135 meningococcal conjugate and polysaccharide vaccines.
Vaccine. 2024 Mar 19:S0264-410X(24)00326-8. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

KRASILNIKOV I, Isaev A, Djonovic M, Ivanov A, et al
Transformative vaccination: A pentavalent shield against COVID-19 and influenza with betulin-based adjuvant for enhanced immunity.
Vaccine. 2024 Mar 19:S0264-410X(23)01421-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GEHRT L, Englund H, Laake I, Nieminen H, et al
Is vaccination against measles, mumps, and rubella associated with reduced rates of antibiotic treatments among children below the age of 2 years? Nationwide register-based study from Denmark, Finland, Norway, and Sweden.
Vaccine. 2024 Mar 19:S0264-410X(24)00313-X. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

ANWARI P, Burnett E, Chavers TP, Samsor A, et al
Post-marketing surveillance of intussusception after Rotarix administration in Afghanistan, 2018-2022.
Vaccine. 2024;42:2059-2064.
PubMed Abstract available

LLOYD PC, Lufkin B, Moll K, Ogilvie RP, et al
Incidence rates of thrombosis with thrombocytopenia syndrome (TTS) among adults in United States commercial and Medicare claims databases, 2017-2020.
Vaccine. 2024;42:2004-2010.
PubMed Abstract available

SOVIK WLM, Madsen AMR, Aaby P, Nielsen S, et al
The association between BCG scars and self-reported chronic diseases: A cross-sectional observational study within an RCT of Danish health care workers.
Vaccine. 2024;42:1966-1972.
PubMed Abstract available

KWON KW, Choi HG, Choi HH, Choi E, et al
Immunogenicity and protective efficacy of RipA, a peptidoglycan hydrolase, against Mycobacterium tuberculosis Beijing outbreak strains.
Vaccine. 2024;42:1941-1952.
PubMed Abstract available

HILL-BATORSKI L, Bowen R, Bielefeldt-Ohmann H, Moser MJ, et al
Mucosal immunization with dual influenza/COVID-19 single-replication virus vector protects hamsters from SARS-CoV-2 challenge.
Vaccine. 2024 Mar 19:S0264-410X(24)00327-X. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

SANCHEZ-MARTINEZ ZV, Alpuche-Lazcano SP, Stuible M, Durocher Y, et al
CHO cells for virus-like particle and subunit vaccine manufacturing.
Vaccine. 2024 Mar 18:S0264-410X(24)00321-9. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

WU J, Jiang L, Shao Q, Liu J, et al
Comparison of the safety and efficacy of the wild-type and lpxL/lpxM mutant inactivated vaccine against the avian pathogenic Escherichia coli O1, O2, and O78 challenge.
Vaccine. 2024 Mar 18:S0264-410X(24)00325-6. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

MEDENI V, Altiner OT, Medeni I
Measles vaccination coverage and immunization status of nurses: An interventional study in Turkiye.
Vaccine. 2024 Mar 18:S0264-410X(24)00324-4. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

DANGOR Z, Benson N, Berkley JA, Bielicki J, et al
Vaccine value profile for Klebsiella pneumoniae.
Vaccine. 2024 Mar 18:S0264-410X(24)00248-2. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

OPMEER L, Gazzoli I, Ballmann M, Willemsen M, et al
High throughput AS LNA qPCR method for the detection of a specific mutation in poliovirus vaccine strains.
Vaccine. 2024 Mar 18:S0264-410X(24)00130-0. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

CAMPAGNA R, Dominelli F, Zingaropoli MA, Ciurluini F, et al
COVID-19 vaccination in cancer patients: Immune responses one year after the third dose.
Vaccine. 2024 Mar 17:S0264-410X(24)00304-9. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

FIERRO C, Weidenthaler H, Vidojkovic S, Schmidt D, et al
Safety and immunogenicity of a novel trivalent recombinant MVA-based equine encephalitis virus vaccine: A Phase 1 clinical trial.
Vaccine. 2024 Mar 16:S0264-410X(24)00296-2. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

HARTMEIER PR, Ostrowski SM, Busch EE, Empey KM, et al
Lymphatic distribution considerations for subunit vaccine design and development.
Vaccine. 2024 Mar 16:S0264-410X(24)00320-7. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

FIX J, Christopher Mast T, Smith K, Baker N, et al
Benefit-risk assessment for the Novavax COVID-19 vaccine (NVX-CoV2373).
Vaccine. 2024 Mar 16:S0264-410X(24)00323-2. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

COTTON SA, Subramanian A, Hughes TD, Huang Y, et al
The effect of SARS-COV-2 variant on non-respiratory features and mortality among vaccinated and non-fully vaccinated patients.
Vaccine. 2024 Mar 14:S0264-410X(24)00195-6. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

JUNEAU C, Fall E, Bros J, Le Duc-Banaszuk AS, et al
Do boys have the same intentions to get the HPV vaccine as girls? Knowledge, attitudes, and intentions in France.
Vaccine. 2024 Mar 14:S0264-410X(24)00256-1. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

CAMERON DB, Grage L, Van Wyck R, Edwards A, et al
Identifying trusted local sources and predicting behavior change pathways according to COVID-19 vaccination status: Results of a 2022 statewide survey of Alaskan adults.
Vaccine. 2024 Mar 14:S0264-410X(24)00314-1. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

MACKENZIE GA, Hossain I, Salaudeen R, Badji H, et al
Impact of pneumococcal conjugate vaccination on pneumococcal nasopharyngeal carriage in the Gambia: Population-based cross-sectional surveys.
Vaccine. 2024 Mar 14:S0264-410X(24)00225-1. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

EL SALIBI N, Abdulrahim S, El Haddad M, Abi Zeid B, et al
Predicting intention to vaccinate against COVID-19 in older Syrian refugees in Lebanon: Findings from a multi-wave study.
Vaccine. 2024 Mar 13:S0264-410X(24)00213-5. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

MCCOSKER LK, Ware RS, Seale H, Hooshmand D, et al
The effect of a financial incentive on COVID-19 vaccination uptake, and predictors of uptake, in people experiencing homelessness: A randomized controlled trial.
Vaccine. 2024 Mar 13:S0264-410X(24)00307-4. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

SAKAUE T, Sugawara T, Mukasa K, Nohara M, et al
Varicella outbreak at nursery school under routine immunization in Japan in 2017 and 2018 and vaccine effectiveness.
Vaccine. 2024 Mar 12:S0264-410X(24)00250-0. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

CHEUNG DH, Chen S, Fang Y, Sun F, et al
Influences of mpox disease perceptions, sources and contents of information exposure on mpox vaccine uptake among gay, bisexual, and other men who have sex with men in Hong Kong, China.
Vaccine. 2024 Mar 12:S0264-410X(24)00259-7. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

SHERMAN SM, Allerton-Price C, Lingley-Heath N, Lai J, et al
UK healthcare professionals' attitudes towards the introduction of varicella vaccine into the routine childhood vaccination schedule and their preferences for administration.
Vaccine. 2024 Mar 12:S0264-410X(24)00274-3. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

RUSS S, Myers C, Licherdell E, Bowden A, et al
Sociodemographic and Occupational Characteristics Associated with Early and Continued COVID-19 Vaccine Uptake Among Healthcare Personnel: Monroe County, NY.
Vaccine. 2024 Mar 12:S0264-410X(24)00306-2. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

MERDRIGNAC L, Ait El Belghiti F, Pandolfi E, Acosta L, et al
Effectiveness of one and two doses of acellular pertussis vaccines against laboratory-confirmed pertussis requiring hospitalisation in infants: Results of the PERTINENT sentinel surveillance system in six EU/EEA countries, December 2015 - December 201
Vaccine. 2024 Mar 11:S0264-410X(24)00272-X. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

SHIJIA YAN A, Jay Sehgal N
Partisan divide and Racial/Ethnic disparities in COVID-19 vaccine hesitancy among Parents/Guardians and vaccine uptake among children in the U.S.
Vaccine. 2024 Mar 11:S0264-410X(24)00309-8. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

SENPUKU K, Kataoka-Nakamura C, Kunishima Y, Hirai T, et al
An inactivated whole-virion vaccine for Enterovirus D68 adjuvanted with CpG ODN or AddaVax elicits potent protective immunity in mice.
Vaccine. 2024 Mar 11:S0264-410X(24)00303-7. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

MORO PL, Carlock G, Fifadara N, Habenicht T, et al
Safety monitoring of bivalent mRNA COVID-19 vaccine among pregnant persons in the vaccine adverse event reporting System - United States, September 1, 2022 - March 31, 2023.
Vaccine. 2024 Mar 9:S0264-410X(24)00262-7. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

HARRELL JE, Roy CJ, Gunn JS, McLachlan JB, et al
Current vaccine strategies and novel approaches to combatting Francisella infection.
Vaccine. 2024 Mar 8:S0264-410X(24)00264-0. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

SU YW, Qiu YZ, Wang YH, Xu Y, et al
Safety and immunogenicity of heterologous boosting with a bivalent SARS-CoV-2 mRNA vaccine (XBB.1.5/BQ.1) in Chinese participants aged 18 years or more: A randomised, double-blinded, active-controlled phase 1 trial.
Vaccine. 2024 Mar 8:S0264-410X(24)00277-9. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

LUISI M, Geana MV, Pei J
Pandemic antecedents - Exploring predictivity and relationships between COVID-19 vaccine uptake and influenza, shingles, and HPV vaccination.
Vaccine. 2024 Mar 8:S0264-410X(24)00275-5. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

BROUSSEAU N, Angers-Goulet ME, Bastien R, Ye L, et al
Vaccination during pregnancy and modulation of IgG response to pertussis vaccines in infants: The impact of different vaccine formulations.
Vaccine. 2024 Mar 8:S0264-410X(24)00300-1. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

ST-LOUIS P, Martin C, Khatri V, Bourgault S, et al
Intranasal delivery of a self-adjuvanted nanovaccine composed of the curli filaments and the highly conserved M2e epitope confers protection against influenza a virus in mice.
Vaccine. 2024 Mar 8:S0264-410X(24)00222-6. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

GHASEMIFAR S, Chabak O, Piri-Gharaghie T, Doosti A, et al
PIRES2-EGFP/CTB-UreI vaccination activated a mixed Th1/Th2/Th17 immune system defense towards Helicobacter pylori infection in the BALB/c mice model.
Vaccine. 2024 Mar 7:S0264-410X(24)00209-3. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

Expression of Concern: "Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccine" [Vaccine [33/1], 1 January 2015, Pages 108-116].
Vaccine. 2024;42:1851.
PubMed

Expression of Concern: "Human COBRA 2 vaccine contains two major epitopes that are responsible for eliciting neutralizing antibody responses against heterologous clades of viruses" [Vaccine Volume 38, Issue 4, 22 January 2020, Pages 830-839].
Vaccine. 2024;42:1850.
PubMed

DE WAELE A, Hendrickx G, Valckx S, Dominguez A, et al
The Vaccine Training Barometer: Assessing healthcare providers' confidence to answer vaccine-related questions and their training needs.
Vaccine. 2024 Mar 7:S0264-410X(24)00254-8. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

SIREK G, Ulysse S, Jacques Toussaint M, Nosamiefan C, et al
A community-engaged approach to translate a Vaccine Hesitancy Scale into Haitian Creole.
Vaccine. 2024 Mar 7:S0264-410X(24)00257-3. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

GILBERT PB, Fong Y, Hejazi NS, Kenny A, et al
Four statistical frameworks for assessing an immune correlate of protection (surrogate endpoint) from a randomized, controlled, vaccine efficacy trial.
Vaccine. 2024 Mar 7:S0264-410X(24)00247-0. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

MALDONADO I, Rodriguez Nino N, Valencia CF, Ortiz D, et al
Evaluation of the safety profile of the quadrivalent vaccine against human papillomavirus in the risk of developing autoimmune, neurological, and hematological diseases in adolescent women in Colombia.
Vaccine. 2024 Mar 7:S0264-410X(24)00263-9. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

ZIBOLENOVA J, Malobicka E, Ulbrichtova R, Novak M, et al
Probability of exposure to the wild measles virus in adult population - Estimation from seroepidemiology and historical data.
Vaccine. 2024;42:1648-1655.
PubMed Abstract available

HYAMS C, Lahuerta M, Theilacker C, King J, et al
Surveillance of pneumococcal serotypes in adults hospitalised with acute lower respiratory tract infection in Bristol, UK.
Vaccine. 2024;42:1599-1607.
PubMed Abstract available

MENG L, Harris L, Shaw L, Lymon H, et al
Social and demographic factors associated with receipt of a COVID-19 vaccine initial booster dose and with interval between primary series completion and initial booster dose uptake among persons aged >/= 12 years, United States, August 2021-October 2
Vaccine. 2024 Mar 6:S0264-410X(24)00271-8. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

KARRAS J, Harrison M, Steffens M, Abdi I, et al
"COVID is a huge jigsaw puzzle that I am trying to make sense of myself": Exploring the perceptions towards the COVID-19 vaccine communication strategy in Australia amongst unvaccinated Australian adults.
Vaccine. 2024 Mar 6:S0264-410X(24)00276-7. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

WONG WHS, Leung DL, Yip KM, So HK, et al
Effectiveness of inactivated COVID-19 vaccine CoronaVac in children aged less than 3 years old during Omicron wave in Hong Kong.
Vaccine. 2024 Mar 6:S0264-410X(24)00226-3. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

RAETHKE M, van Hunsel F, Luxi N, Lieber T, et al
Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring study.
Vaccine. 2024 Mar 6:S0264-410X(24)00273-1. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

CHEN D, Cowling BJ, Ainslie KEC, Lin Y, et al
Association of COVID-19 vaccination with duration of hospitalization in older adults in Hong Kong.
Vaccine. 2024 Mar 5:S0264-410X(24)00252-4. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

MARQUES RF, Gimenez AM, Caballero O, Simpson A, et al
Non-clinical toxicity and immunogenicity evaluation of a Plasmodium vivax malaria vaccine using Poly-ICLC (Hiltonol(R)) as adjuvant.
Vaccine. 2024 Mar 5:S0264-410X(24)00229-9. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

BEAVIS AC, Dienger-Stambaugh K, Briggs K, Chen Z, et al
A J Paramyxovirus-vectored HIV vaccine induces humoral and cellular responses in mice.
Vaccine. 2024 Mar 4:S0264-410X(24)00227-5. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

DUAN X, Zhang L, Ding L, Zhang C, et al
Effectiveness of enterovirus A71 vaccine against pediatric HFMD and disease profile of post-vaccination infection.
Vaccine. 2024 Mar 2:S0264-410X(24)00172-5. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

ZAMAN K, Schuind AE, Adjei S, Antony K, et al
Safety and immunogenicity of Innovax bivalent human papillomavirus vaccine in girls 9-14 years of age: Interim analysis from a phase 3 clinical trial.
Vaccine. 2024 Mar 1:S0264-410X(24)00251-2. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

YASHAR-GERSHMAN SG, Rosenberg AT, Sawhney M, Fernanda Machicao M, et al
Developing a novel screening tool to address pediatric COVID-19 vaccine hesitancy at point of care.
Vaccine. 2024 Mar 1:S0264-410X(24)00228-7. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

February 2024

YADEGARYNIA D, Keyvanfar A, Keyvani H, Tehrani S, et al
Immunogenicity and safety of a quadrivalent recombinant influenza vaccine manufactured in Iran (FluGuard) in volunteers aged 18-60 years: A double-blind, non-inferiority, randomized controlled trial.
Vaccine. 2024 Feb 29:S0264-410X(24)00249-4. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

KOHLI M, Maschio M, Lee A, Igarashi A, et al
Projections of the incidence of COVID-19 in Japan and the potential impact of a Fall 2023 COVID-19 vaccine.
Vaccine. 2024 Feb 29:S0264-410X(24)00117-8. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

CHATHAM-STEPHENS K, Carter RJ, Duggar C, Woodworth KR, et al
An overview of the COVID-19 pediatric vaccine program - The U.S. experience vaccinating children ages 6 months through 17 years.
Vaccine. 2024 Feb 29:S0264-410X(24)00166-X. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

LEVIN MJ, Ginde AA, Schmid DS, Lang N, et al
Effect of high dose vitamin D supplementation on subsequent immune responses to administration of the live herpes zoster vaccine to long-term care residents.
Vaccine. 2024 Feb 28:S0264-410X(24)00214-7. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

MARINDA E, Mathentamo Q, Coulson N, Parker S, et al
Impact evaluation of a youth led intervention to increase COVID-19 vaccine uptake in Kwazulu-Natal, South Africa.
Vaccine. 2024 Feb 28:S0264-410X(24)00211-1. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

OMAR ALI S, Dessart C, Parikh R
Co-administration of the adjuvanted recombinant zoster vaccine with other adult vaccines: An overview.
Vaccine. 2024 Feb 28:S0264-410X(24)00194-4. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

GUO J, Chen X, Guo Y, Liu M, et al
Real-world effectiveness of seasonal influenza vaccination and age as effect modifier: A systematic review, meta-analysis and meta-regression of test-negative design studies.
Vaccine. 2024 Feb 28:S0264-410X(24)00218-4. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

ZHOU W, Guo X, Lu J, Lu X, et al
Parental willingness to accept and pay human papillomavirus vaccine for boys aged 9-14 in a metropolis area of China: Evidence for developing a vaccination strategy.
Vaccine. 2024 Feb 28:S0264-410X(24)00253-6. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

JACKSON S, Kabir Z, Comiskey C
Retrospective cohort study exploring the impact of universal Tuberculosis (TB) vaccination cessation on the epidemiology of paediatric TB in Ireland, 2011-2021.
Vaccine. 2024 Feb 28:S0264-410X(24)00220-2. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

JABBAR F, Kadhim KA, Alhilfi RA, Chitheer A, et al
Intensification of integrated immunization services to recover routine vaccination coverage and bring COVID-19 vaccine to the population of Iraq in 2022.
Vaccine. 2024 Feb 27:S0264-410X(24)00197-X. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

TANAKA M, Okubo R, Hoshi SL, Kondo M, et al
Cost-effectiveness analysis of pertussis booster vaccination for adolescents in Japan.
Vaccine. 2024 Feb 27:S0264-410X(24)00199-3. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

GIDENGIL C, Scherer AM, Parker AM, Gedlinske A, et al
Lyme disease vaccine attitudes and intentions among parents of children aged 5-18 years in the United States.
Vaccine. 2024 Feb 27:S0264-410X(24)00105-1. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

YANG XY, Liu T, Jiang SC, Zhang ZW, et al
Antibodies against SARS-CoV-2 non-structural protein 3 cross-react with human muscle cells and neuroglial cells.
Vaccine. 2024;42:1259-1267.
PubMed Abstract available

MUNDO ORTIZ A, Nasri B
Socio-demographic determinants of COVID-19 vaccine uptake in Ontario: Exploring differences across the Health Region model.
Vaccine. 2024 Feb 26:S0264-410X(24)00204-4. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

KEGELE LIGNANI L, de Vasconcellos Carvalhaes de Oliveira R, Matos Dos Santos E, Antonio Bastos Camacho L, et al
Neutralizing antibody titers against D8 genotype and persistence of measles humoral and cell-mediated immunity eight years after the first dose of measles, mumps, and rubella vaccine in Brazilian children.
Vaccine. 2024 Feb 26:S0264-410X(24)00219-6. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

TOLENTINO JUNIOR DS, Vasconcelos Marques MS, de Oliveira RC
Rabies vaccination of the Maxakali indigenous population.
Vaccine. 2024 Feb 26:S0264-410X(23)01542-6. doi: 10.1016/j.vaccine.2023.
PubMed

KRISTINSDOTTIR I, Haraldsson A, Thors V
Influenza vaccination in pregnant women in Iceland 2010-2020 and the burden of influenza in pregnant women and their infants.
Vaccine. 2024 Feb 26:S0264-410X(24)00205-6. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

NEWALL AT, Nazareno AL, Muscatello DJ, Boettiger D, et al
The association between influenza vaccination uptake and influenza and pneumonia-associated deaths in the United States.
Vaccine. 2024 Feb 24:S0264-410X(24)00113-0. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

BIJUKCHHE SM, Gurung M, Pokhrel B, Shakya M, et al
Immune responses to typhoid conjugate vaccine in a two dose schedule among Nepalese children <2 years of age.
Vaccine. 2024 Feb 22:S0264-410X(24)00156-7. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

MURPHY C, Kwan MYW, Chan ELY, Wong JSC, et al
Influenza vaccine effectiveness against hospitalizations associated with influenza A(H3N2) in Hong Kong children aged 9 months to 17 years, June-November 2023.
Vaccine. 2024 Feb 22:S0264-410X(24)00215-9. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

SHETTY AN, Morgan HJ, Phuong LK, Mallard J, et al
Audiovestibular adverse events following COVID-19 vaccinations.
Vaccine. 2024 Feb 22:S0264-410X(24)00210-X. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

XU S, Sy LS, Hong V, Farrington P, et al
Mortality risk after COVID-19 vaccination: A self-controlled case series study.
Vaccine. 2024 Feb 21:S0264-410X(24)00191-9. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

PLIESKATT J, Bang P, Wood GK, Naghizadeh M, et al
Clinical formulation development of Plasmodium falciparum malaria vaccine candidates based on Pfs48/45, Pfs230, and PfCSP.
Vaccine. 2024 Feb 21:S0264-410X(24)00202-0. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

BOTTCHER J, Bauer BU, Ambros C, Alex M, et al
The immune response to a Coxiella burnetii vaccine in sheep varies according to their natural pre-exposure.
Vaccine. 2024 Feb 21:S0264-410X(24)00207-X. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

YIN Q, Zheng Y, Ying Z, Li J, et al
Immunogenicity and lot-to-lot consistency of booster shot with Sabin inactivated poliomyelitis vaccine in Chinese children aged 18-24 Months: A phase ? clinical trial.
Vaccine. 2024 Feb 21:S0264-410X(24)00201-9. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

KABORE L, Pecenka C, Hausdorff WP
Lassa fever vaccine use cases and demand: Perspectives from select West African experts.
Vaccine. 2024 Feb 17:S0264-410X(24)00203-2. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

BRUEL S, Rakotomampionona Z, Gignon M, Agrinier N, et al
The intentions of French health university students to recommend and to receive the HPV vaccine are mainly influenced by vaccine knowledge, confidence in vaccines and personal HPV vaccination.
Vaccine. 2024 Feb 17:S0264-410X(24)00192-0. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

SHOUKAT A, Bawden CE, Rost G, LeBlanc JJ, et al
Impact and cost-effectiveness analyses of vaccination for prevention of respiratory syncytial virus disease among older adults in Ontario: A Canadian Immunization Research Network (CIRN) study.
Vaccine. 2024 Feb 16:S0264-410X(24)00200-7. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

PIKE J, Lueken J, Zajac J, Tippins A, et al
2022 Polio outbreak, Rockland County, NY: Cost evaluation of strategies to prevent future outbreaks of vaccine-preventable diseases.
Vaccine. 2024 Feb 16:S0264-410X(24)00171-3. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

FABER BW, Yeoh LM, Kurtovic L, Mol WEM, et al
A Diversity Covering (DiCo) Plasmodium vivax apical membrane antigen-1 vaccine adjuvanted with RFASE/RSL10 yields high levels of growth-inhibitory antibodies.
Vaccine. 2024 Feb 16:S0264-410X(24)00175-0. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

KOCHHAR S, Assis DN, Mack C, Izurieta HS, et al
Autoimmune hepatitis: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunisation safety data.
Vaccine. 2024 Feb 16:S0264-410X(24)00021-5. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

POLAND GA, Raina MacIntyre C
Celebrating vaccines: The 2023 Nobel prize in medicine or physiology.
Vaccine. 2024 Feb 15:S0264-410X(23)01258-6. doi: 10.1016/j.vaccine.2023.
PubMed

JIN F, Qiu Y, Wu Z, Wang YH, et al
Immunogenicity and safety of a SARS-CoV-2 mRNA vaccine (SYS6006) in healthy Chinese participants: A randomized, observer-blinded, placebo-controlled phase 2 clinical trial.
Vaccine. 2024 Feb 15:S0264-410X(24)00124-5. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

MZIOU E, Hchaichi A, Letaief H, Dhaouadi S, et al
Vaccine effectiveness against COVID-19: A test negative case-control study in Tunisia, August 2021.
Vaccine. 2024 Feb 15:S0264-410X(24)00174-9. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

TOBACK S, Marchese AM, Warren B, Ayman S, et al
Safety and immunogenicity of the NVX-CoV2373 vaccine as a booster in adults previously vaccinated with the BBIBP-CorV vaccine.
Vaccine. 2024 Feb 15:S0264-410X(24)00196-8. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

THIAUCOURT F, Exbrayat A, Loire E, Boissiere A, et al
Deep sequencing and variant frequency analysis for the quality control of a live bacterial vaccine against contagious bovine pleuropneumonia, strain T1.
Vaccine. 2024 Feb 15:S0264-410X(24)00177-4. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

ROCKSON ADJEI M, Longsignikuu A, Saeed Iddris I, Nang Suuri T, et al
Trend of measles-rubella vaccination coverage and impact on measles epidemiology in the Savannah Region, Ghana; 2018-2022: A secondary data analysis.
Vaccine. 2024 Feb 15:S0264-410X(24)00170-1. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

KIM HK, Park SK, Choe SA, Gwak ES, et al
Risk of SARS-CoV-2 breakthrough infection following NVX-CoV2373 and BNT162b2 vaccinations in Korean Adults: A population-based observational study.
Vaccine. 2024 Feb 15:S0264-410X(24)00168-3. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

KUTER BJ, Brien K, Anderson S, Bass SB, et al
COVID-19 vaccine perspectives and uptake among university students three years into the pandemic.
Vaccine. 2024 Feb 15:S0264-410X(24)00162-2. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

DREYFUS J, Munnangi S, Bengtsson C, Correia B, et al
Background incidence rates of health outcomes in populations at risk for Lyme disease using US administrative claims data.
Vaccine. 2024;42:1094-1107.
PubMed Abstract available

PREVOT-MONSACRE P, Hamaide-Defrocourt F, Guyonvarch O, Masse S, et al
What is the relevancy of a surveillance of mumps without a systematic laboratory confirmation in highly immunized populations? Epidemiology of suspected and biologically confirmed mumps cases seen in general practice in France between 2014 and 2020.
Vaccine. 2024;42:1065-1070.
PubMed Abstract available

ROWLEY F, Cottrell S, Howard C, Meredith N, et al
Use of invitations and reminders are associated with higher levels of Herpes zoster (shingles) vaccination uptake. A cross-sectional survey of general practices in Wales, and ecological analysis of uptake data, 2022.
Vaccine. 2024 Feb 14:S0264-410X(24)00193-2. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

ACEVES-SANCHEZ MJ, Barrios-Payan JA, Segura-Cerda CA, Flores-Valdez MA, et al
Erratum to "BCGDeltaBCG1419c and BCG differ in induction of autophagy, c-di-GMP content, proteome, and progression of lung pathology in Mycobacterium tuberculosis HN878-infected male BALB/c mice" [Vaccine 41(26) (2023) 3824-3835].
Vaccine. 2024 Feb 14:S0264-410X(24)00176-2. doi: 10.1016/j.vaccine.2024.
PubMed

DUGGAR C, Santoli JM, Noblit C, Moore LB, et al
U.S. COVID-19 vaccine distribution strategies, systems, performance, and lessons learned, December 2020 - May 2023.
Vaccine. 2024 Feb 14:S0264-410X(24)00167-1. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

BORYS D, Rupp R, Smulders R, Chichili GR, et al
Safety, tolerability and immunogenicity of a novel 24-valent pneumococcal vaccine in toddlers: A phase 1 randomized controlled trial.
Vaccine. 2024 Feb 14:S0264-410X(24)00145-2. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

BATHEJA A, Balkrishnan R
Rhode Island as a model for promoting flu vaccination in the United States.
Vaccine. 2024 Feb 14:S0264-410X(24)00161-0. doi: 10.1016/j.vaccine.2024.
PubMed

OKOLI GN, Righolt CH, Zhang G, Van Caeseele P, et al
A population-based, province-wide, record-linkage interrupted time series analysis of impact of the universal seasonal influenza vaccination policy on seasonal influenza vaccine uptake among 5-64-year-olds in the province of Manitoba, Canada.
Vaccine. 2024 Feb 14:S0264-410X(24)00104-X. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

KLASSEN AC, Lee G, Chiang S, Murray R, et al
Did the COVID-19 experience change U.S. parents' attitudes towards HPV vaccination? Results from a national survey.
Vaccine. 2024 Feb 14:S0264-410X(24)00142-7. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

DONATO F, Pilotto A, Foca E, Tresoldi M, et al
The impact of time since SARS-Cov-2 vaccination, age, sex and comorbidities on COVID-19 outcome in hospitalized patients with SARS-CoV-2 infection.
Vaccine. 2024 Feb 13:S0264-410X(24)00147-6. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

HEARN EB, Kehinde G, Sambamoorthi U
Food insecurity and COVID-19 vaccine hesitancy among adults in the United States (US).
Vaccine. 2024 Feb 13:S0264-410X(24)00102-6. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

MCDERMID P, Blazek K, Mougin N, Thomson A, et al
Attitudes and behaviors of maternal Tdap vaccination in Panama, Peru, and Colombia: An international cross-sectional study.
Vaccine. 2024 Feb 13:S0264-410X(24)00143-9. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

LI Y, Sun X, Fu Y, You X, et al
Literature review to identify evidence of secondary transmission of pentavalent human-bovine reassortant rotavirus vaccine (RV5) strains to unvaccinated subjects.
Vaccine. 2024 Feb 13:S0264-410X(24)00107-5. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

BHARUCHA T, Gangadharan B, Clarke R, Fernandez LG, et al
Repurposing rapid diagnostic tests to detect falsified vaccines in supply chains.
Vaccine. 2024 Feb 13:S0264-410X(24)00019-7. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

MORGAN HJ, Clothier HJ, Sepulveda Kattan G, Boyd JH, et al
Acute disseminated encephalomyelitis and transverse myelitis following COVID-19 vaccination - A self-controlled case series analysis.
Vaccine. 2024 Feb 12:S0264-410X(24)00126-9. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

MABALE MAA, Tejero LMS, Montes LA, Collante MTM, et al
Implications of information heard about Dengvaxia on Filipinos' perception on vaccination.
Vaccine. 2024 Feb 12:S0264-410X(24)00123-3. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

AMDISEN L, Pedersen L, Abildgaard N, Benn CS, et al
The coverage of influenza vaccination and predictors of influenza non-vaccination in Danish cancer patients: A nationwide register-based cohort study.
Vaccine. 2024 Feb 12:S0264-410X(24)00155-5. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

FAKSOVA K, Walsh D, Jiang Y, Griffin J, et al
COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals.
Vaccine. 2024 Feb 12:S0264-410X(24)00127-0. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

MANNING J, Manna S, Dunne EM, Bongcaron V, et al
Immunization with a whole cell vaccine reduces pneumococcal nasopharyngeal density and shedding, and middle ear infection in mice.
Vaccine. 2024 Feb 12:S0264-410X(24)00131-2. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

VALENTIN J, Ingrao F, Rauw F, Lambrecht B, et al
Protection conferred by an H5 DNA vaccine against highly pathogenic avian influenza in chickens: The effect of vaccination schedules.
Vaccine. 2024 Feb 12:S0264-410X(23)01422-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DE WALS P, Desjardins M
Minimal interval for the administration of a pneumococcal polysaccharide vaccine following the administration of a pneumococcal conjugate vaccine.
Vaccine. 2024 Feb 12:S0264-410X(24)00163-4. doi: 10.1016/j.vaccine.2024.
PubMed

LIJESKIC O, Bauman N, Markovic M, Srbljanovic J, et al
SARS-CoV-2 specific antibody response after an mRNA vaccine as the third dose: Homologous versus heterologous boost.
Vaccine. 2024 Feb 10:S0264-410X(24)00110-5. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

WHITAKER HJ, Hassell K, Hoschler K, Power L, et al
Influenza vaccination during the 2021/22 season: A data-linkage test-negative case-control study of effectiveness against influenza requiring emergency care in England and serological analysis of primary care patients.
Vaccine. 2024 Feb 10:S0264-410X(24)00150-6. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

MARKOWITZ LE, Hopkins RH Jr, Broder KR, Lee GM, et al
COVID-19 Vaccine Safety Technical (VaST) Work Group: Enhancing vaccine safety monitoring during the pandemic.
Vaccine. 2024 Feb 9:S0264-410X(23)01505-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WEI J, Tan TC, Moa AM, MacIntyre CR, et al
Cost-benefit of influenza vaccination in preventing sudden cardiac arrest amongst Australian adults.
Vaccine. 2024 Feb 9:S0264-410X(24)00154-3. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

NGUYEN KH, Chen S, Zhao R, Vasudevan L, et al
Vaccination patterns and up-to-date status of children 19-35 months, 2011-2021.
Vaccine. 2024 Feb 9:S0264-410X(24)00122-1. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

FORTUNATO F, Musco A, Iannelli G, Meola M, et al
Effectiveness of the combined MMRV Priorix-Tetra vaccine against varicella in a large Italian region: A case-control study.
Vaccine. 2024 Feb 9:S0264-410X(24)00146-4. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

BUEKENS P, Berrueta M, Ciapponi A, Bardach A, et al
Safe in pregnancy: A global living systematic review and meta-analysis of COVID-19 vaccines in pregnancy.
Vaccine. 2024 Feb 9:S0264-410X(24)00158-0. doi: 10.1016/j.vaccine.2024.
PubMed

WADAPURKAR R, Singh S, Singh A
Leveraging the immunoinformatics approach for designing the SARS-CoV-2 omicron-specific antigenic cassette of mRNA vaccine.
Vaccine. 2024 Feb 8:S0264-410X(24)00111-7. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

SERRANO-MAYORGA CC, Ibanez-Prada ED, Restrepo-Martinez JM, Garcia-Gallo E, et al
The potential impact of PCV-13, PCV-15 and PCV-20 vaccines in Colombia.
Vaccine. 2024 Feb 8:S0264-410X(24)00109-9. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

AMINZADEH A, Hilgers L, Paul Platenburg P, Riou M, et al
Immunogenicity and safety in rabbits of a Clostridioides difficile vaccine combining novel toxoids and a novel adjuvant.
Vaccine. 2024 Feb 8:S0264-410X(24)00101-4. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

WELDEGEBRIEL GG, Okot C, Majingo N, Oumer NJ, et al
Resurgent rotavirus diarrhoea outbreak five years after introduction of rotavirus vaccine in Botswana, 2018.
Vaccine. 2024 Feb 7:S0264-410X(24)00108-7. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

CHEN M, Feng X, Liu J, Wang J, et al
Prokaryote-derived phosphorylated Tau epitope vaccine is immunogenic and non-T-cell activated in the mice model.
Vaccine. 2024 Feb 7:S0264-410X(23)01517-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KOLANDAI K, Milne B, von Randow M, Bullen C, et al
Public opinion on global COVID-19 vaccine procurement and distribution policies: A nationally representative survey in Aotearoa New Zealand 2022.
Vaccine. 2024 Feb 6:S0264-410X(24)00115-4. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

LAMBACH P, Orenstein W, Silal S, Sbarra AN, et al
Report from the World Health Organization's immunization and vaccines related implementation research advisory committee (IVIR-AC) meeting, Geneva, 11-13 September 2023.
Vaccine. 2024 Feb 6:S0264-410X(24)00160-9. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

SOBLE A, Ko M, Gilchrist S, Malvolti S, et al
A review of potential use cases for measles-rubella, measles-mumps-rubella, and typhoid-conjugate vaccines presented on microarray patches.
Vaccine. 2024 Feb 6:S0264-410X(23)01493-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KOHLI K, Jain B, Dee EC, Ho BL, et al
Addressing cultural and political drivers of vaccine hesitancy: Considerations for the African and Asian contexts.
Vaccine. 2024 Feb 6:S0264-410X(24)00159-2. doi: 10.1016/j.vaccine.2024.
PubMed

SMITH TC, Gorski DH
Infertility: A common target of antivaccine misinformation campaigns.
Vaccine. 2024;42:924-929.
PubMed Abstract available

PENG Y, Yan H, Zhang J, Peng R, et al
Potent immune responses against thermostable Foot-and-Mouth disease virus VP1 nanovaccine adjuvanted with polymeric thermostable scaffold.
Vaccine. 2024;42:732-737.
PubMed Abstract available

MAEDA M, Murata F, Fukuda H
The age-specific impact of COVID-19 vaccination on medical expenditures and hospitalization duration after breakthrough infection: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) Study.
Vaccine. 2024 Feb 5:S0264-410X(24)00106-3. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

KIM NE, Kim MJ, Park BJ, Kwon JW, et al
A DNA vaccine against GII.4 human norovirus VP1 induces blocking antibody production and T cell responses.
Vaccine. 2024 Feb 5:S0264-410X(24)00114-2. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

HOUY N, Flaig J
Value of information dynamics in Disease X vaccine clinical trials.
Vaccine. 2024 Feb 3:S0264-410X(24)00075-6. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

RIVERS P, Porter C, LeClair LB, Jeddy Z, et al
Longitudinal parental perception of COVID-19 vaccines for children in a multi-site, cohort study.
Vaccine. 2024 Feb 2:S0264-410X(24)00010-0. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

HWANG YH, Byeon Y, Ahn SH, Kim MY, et al
Live attenuated smallpox vaccine candidate (KVAC103) efficiently induces protective immune responses in mice.
Vaccine. 2024 Feb 2:S0264-410X(24)00076-8. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

KURIYAMA K, Murakami K, Sugiura K, Sakui S, et al
One-year follow-up of the immunogenicity and safety of a primary series of the NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults: Final report of a phase I/II randomized controlled trial.
Vaccine. 2024 Feb 2:S0264-410X(24)00068-9. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

LI D, Han M, Cao Y, Du J, et al
Protective effect against toxoplasmosis in BALB/C mice vaccinated with recombinant Toxoplasma gondii CDPK3, GRA35, and ROP46 protein cocktail vaccine.
Vaccine. 2024 Feb 2:S0264-410X(24)00062-8. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

WANG ZJ, Zhang RR, Wu M, Zhao H, et al
Development of a live-attenuated chimeric vaccine against the emerging Usutu virus.
Vaccine. 2024 Feb 2:S0264-410X(24)00098-7. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

MIYAMOTO S, Suzuki T
Infection-mediated immune response in SARS-CoV-2 breakthrough infection and implications for next-generation COVID-19 vaccine development.
Vaccine. 2024 Feb 2:S0264-410X(24)00112-9. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

SUMNER T, Clark RA, Mukandavire C, Portnoy A, et al
Modelling the health and economic impacts ofM72/AS01(E) vaccination and BCG-revaccination: Estimates for South Africa.
Vaccine. 2024 Feb 1:S0264-410X(24)00096-3. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

BENNETT JC, Luiten KG, O'Hanlon J, Han PD, et al
Utilizing a university testing program to estimate relative effectiveness of monovalent COVID-19 mRNA booster vaccine versus two-dose primary series against symptomatic SARS-CoV-2 infection.
Vaccine. 2024 Feb 1:S0264-410X(24)00103-8. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

DE DEUS N, Chissaque A, Bauhofer A, Barata A, et al
Safety of incidental exposure to the novel oral poliovirus vaccine type 2 in pregnancy: A longitudinal observational study in Mozambique, 2022-2023.
Vaccine. 2024 Feb 1:S0264-410X(24)00095-1. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

DATTA S, Vattiato G, Maclaren OJ, Hua N, et al
The impact of Covid-19 vaccination in Aotearoa New Zealand: A modelling study.
Vaccine. 2024 Feb 1:S0264-410X(24)00128-2. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

January 2024

SCHONBORN L, Pavord S, Chen VMY, Pai M, et al
Thrombosis with thrombocytopenia syndrome (TTS) and vaccine-induced immune thrombocytopenia and thrombosis (VITT): Brighton Collaboration case definitions and guidelines for data collection, analysis, and presentation of immunisation safety data.
Vaccine. 2024 Jan 31:S0264-410X(24)00057-4. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

SLAVKOVSKY R, Callen E, Pecenka C, Mvundura M, et al
Costs of human papillomavirus vaccine delivery in low- and middle-income countries: A systematic review.
Vaccine. 2024 Jan 31:S0264-410X(24)00118-X. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

SOOD S, Matar MM, Kim J, Kinsella M, et al
Strong immunogenicity & protection in mice with PlaCCine: A COVID-19 DNA vaccine formulated with a functional polymer.
Vaccine. 2024 Jan 31:S0264-410X(24)00077-X. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

JI Y, Sui X, Miao W, Wang C, et al
Immunogenicity of an adenovirus-vectored bivalent vaccine against wild type SARS-CoV-2 and Omicron variants in a murine model.
Vaccine. 2024 Jan 30:S0264-410X(24)00097-5. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

KOFF WC, Anandkumar A, Poland GA
AI and the future of vaccine development.
Vaccine. 2024 Jan 30:S0264-410X(24)00071-9. doi: 10.1016/j.vaccine.2024.
PubMed

POLAND GA, Black S
Cryptic vaccine-associated adverse events: The critical need for a new vaccine safety surveillance paradigm to improve public trust in vaccines.
Vaccine. 2024 Jan 30:S0264-410X(24)00070-7. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

BURNS KE, Dube E, Nascimento HG, Meyer SB, et al
Erratum to "Examining vaccine hesitancy among a diverse sample of Canadian adults" [Vaccine 42(2) (2024) 129-135].
Vaccine. 2024 Jan 30:S0264-410X(24)00061-6. doi: 10.1016/j.vaccine.2024.
PubMed

HUANG Y, Shi H, Forgacs D, Ross TM, et al
Flu-COVID combo recombinant protein vaccines elicited protective immune responses against both influenza and SARS-CoV-2 viruses infection.
Vaccine. 2024 Jan 30:S0264-410X(23)01543-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

XIAOFEI L, Yudan LI, Qinghui C, Jiaming S, et al
Effectiveness of 13-valent pneumococcal conjugate vaccine against vaccine-serotype community acquired pneumococcal diseases among children in China: A test-negative case-control study.
Vaccine. 2024 Jan 30:S0264-410X(24)00080-X. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

SHAPIRO BEN DAVID S, Baruch Gez S, Adler L, Kovatch R, et al
Short term safety of BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine among children aged 5-11 years, a nationwide parental survey.
Vaccine. 2024 Jan 27:S0264-410X(24)00067-7. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

BALSELLS E, Vicente M, Reyes S, Figueroa M, et al
Impact of the 'Health on Wheels' (HoW) strategy on COVID-19 vaccination coverage in hard-to-reach communities in Alta Verapaz, Guatemala, 2022.
Vaccine. 2024 Jan 27:S0264-410X(24)00033-1. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

VIDLUND J, Gelalcha BD, Gillespie BE, Agga GE, et al
Efficacy of novel staphylococcal surface associated protein vaccines against Staphylococcus aureus and non-aureus staphylococcal mastitis in dairy cows.
Vaccine. 2024 Jan 27:S0264-410X(24)00079-3. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

MURATA F, Maeda M, Ono R, Fukuda H, et al
Association between regular physical activity and pneumonia-related hospitalization according to pneumococcal vaccination status: The VENUS study.
Vaccine. 2024 Jan 27:S0264-410X(24)00072-0. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

OKPANI AI, Adu P, Paetkau T, Lockhart K, et al
Are COVID-19 vaccination mandates for healthcare workers effective? A systematic review of the impact of mandates on increasing vaccination, alleviating staff shortages and decreasing staff illness.
Vaccine. 2024 Jan 27:S0264-410X(24)00052-5. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

HALL E, Mahon BE, Peacock G
The U.S. COVID-19 vaccination program: A look back and future directions.
Vaccine. 2024 Jan 26:S0264-410X(24)00065-3. doi: 10.1016/j.vaccine.2024.
PubMed

LEVIN A, Yeung KHT, Hutubessy R
Systematic review of cost projections of new vaccine introduction.
Vaccine. 2024 Jan 25:S0264-410X(24)00024-0. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

TAKALANI A, Robinson M, Jonas P, Bodenstein A, et al
Safety of a second homologous Ad26.COV2.S vaccine among healthcare workers in the phase 3b implementation Sisonke study in South Africa.
Vaccine. 2024 Jan 25:S0264-410X(24)00078-1. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

FILIPAS DK, Labban M, Beatrici E, Stone BV, et al
Exploring preventive care practices among unvaccinated individuals in the United States during the COVID-19 pandemic.
Vaccine. 2024;42:441-447.
PubMed Abstract available

FERRERAS-COLINO E, Contreras M, Risalde MA, Sevilla IA, et al
Heat-inactivated mycobacteria activate the toll-like receptor 2 and 4 pathways in the zebrafish model of tuberculosis.
Vaccine. 2024;42:403-409.
PubMed Abstract available

KHAN A, Hussain I, Rhoda DA, Umer M, et al
Determinants of immunization in polio super high-risk union councils of Pakistan.
Vaccine. 2024;42:583-590.
PubMed Abstract available

RUSS S, Bennett N, van Wijngaarden E, Hill E, et al
Influence of Community Determinants on Barriers and Facilitators to COVID-19 Vaccine Uptake: Regional Stakeholders' Perspectives.
Vaccine. 2024 Jan 24:S0264-410X(24)00051-3. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

RATTAY K, Thierry JM, Yeargin-Allsopp M, Griffin-Blake S, et al
Lessons learned: COVID-19 vaccinations and people with disabilities.
Vaccine. 2024 Jan 23:S0264-410X(24)00028-8. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

WANG CP, Lin YT, Du YZ, Zhang T, et al
Impact of innovative immunization strategy on PCV13 vaccination coverage among children under 5 years in Weifang city, China: A retrospective study.
Vaccine. 2024 Jan 23:S0264-410X(24)00030-6. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

LIU R, Fan Y, Patel A, Liu H, et al
The association between influenza vaccination, cardiovascular mortality and hospitalization: A living systematic review and prospective meta-analysis.
Vaccine. 2024 Jan 23:S0264-410X(24)00053-7. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

HARANAKA M, Young Song J, Huang KC, de Solom R, et al
A phase 3 randomized trial of the safety and immunogenicity of 20-valent pneumococcal conjugate vaccine in adults?>/=?60 years of age in Japan, South Korea, and Taiwan.
Vaccine. 2024 Jan 23:S0264-410X(24)00008-2. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

ABAD N, Bonner KE, Kolis J, Brookmeyer KA, et al
Strengthening COVID-19 vaccine confidence & demand during the US COVID-19 emergency response.
Vaccine. 2024 Jan 23:S0264-410X(24)00029-X. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

HADLER SC, Shefer AM, Cavallaro KF, Ebama M, et al
Supporting National Immunization Technical Advisory Groups (NITAGs) in development of evidence-based vaccine recommendations and NITAG assessments - New tools and approaches.
Vaccine. 2024 Jan 23:S0264-410X(24)00035-5. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

CLOTHIER HJ, Shetty AN, Mesfin Y, Mackie M, et al
What would have happened anyway? Population data source considerations when estimating background incident rates of adverse events following immunisation to inform vaccine safety.
Vaccine. 2024 Jan 22:S0264-410X(24)00025-2. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

CAO H, Li H, Luan N, Zhang H, et al
A rabies mRNA vaccine with H270P mutation in its glycoprotein induces strong cellular and humoral immunity.
Vaccine. 2024 Jan 22:S0264-410X(24)00069-0. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

HAMAD SAIED M, van Straalen JW, de Roock S, Verduyn Lunel FM, et al
Humoral and cellular immunogenicity, effectiveness and safety of COVID-19 mRNA vaccination in patients with pediatric rheumatic diseases: A prospective cohort study.
Vaccine. 2024 Jan 22:S0264-410X(24)00059-8. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

PAL R, Ferrari MG, Honda-Okubo Y, Wattay L, et al
Study of immunogenicity and efficacy against Omicron BA.5 of recombinant protein-based COVID-19 vaccine delivered by intramuscular and mucosal routes in nonhuman primates.
Vaccine. 2024 Jan 22:S0264-410X(24)00034-3. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

CATALDI JR, Suresh K, Brewer SE, Perreira C, et al
Boot Camp Translation using Community-Engaged messaging for adolescent Vaccination: A Cluster-Randomized trial.
Vaccine. 2024 Jan 21:S0264-410X(24)00054-9. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

SANTORO PE, Paladini A, Borrelli I, Amantea C, et al
Vaccine-preventable diseases: Immune response in a large population of healthcare students.
Vaccine. 2024 Jan 20:S0264-410X(24)00049-5. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

HILL PL, Morstead T, Pfund GN, Burrow AL, et al
Examining changes in sense of purpose before, during, and after COVID-19 vaccination.
Vaccine. 2024 Jan 20:S0264-410X(24)00027-6. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

KUMWICHAR P, Chongsuvivatwong V, Vasoppakarn S, Atthakul N, et al
Incidence rates of myocarditis and pericarditis within 30 days following homologous and heterologous BNT162b2 vaccinations in individuals 5-40 years of age.
Vaccine. 2024 Jan 20:S0264-410X(24)00026-4. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

GEINITZ H, Silberberger E, Spiegl K, Feichtinger J, et al
SARS-CoV-2 vaccination willingness and humoral vaccination response in radiation oncology patients.
Vaccine. 2024 Jan 20:S0264-410X(24)00004-5. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

MITCHELL MM, Klott A, Scholtes J, Braden BB, et al
Mixed-methods examination of attitudes and behaviors related to COVID-19 vaccines among parents of children with autism and autistic adults.
Vaccine. 2024 Jan 19:S0264-410X(24)00013-6. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

MEMEDOVICH A, Orr T, Hollis A, Salmon C, et al
Social network risk factors and COVID-19 vaccination: A cross-sectional survey study.
Vaccine. 2024 Jan 18:S0264-410X(24)00005-7. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

MUNKWASE G
Implications of vaccine non-specific effects on licensure of new vaccines.
Vaccine. 2024 Jan 18:S0264-410X(24)00060-4. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

CHRISTOPH R, Giovanni A, Arne S, Sebastian V, et al
Immunogenicity of tick-borne-encephalitis-virus-(TBEV)-vaccination and impact of age on humoral and cellular TBEV-specific immune responses in patients with rheumatoid arthritis.
Vaccine. 2024 Jan 18:S0264-410X(24)00022-7. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

HICKEN A, Jones P, Menon A, Rozek LS, et al
Can endorsement by religious leaders move the needle on vaccine hesitancy?
Vaccine. 2024 Jan 18:S0264-410X(24)00006-9. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

FIEBELKORN AP, Adelsberg S, Anthony R, Ashenafi S, et al
The role of funded partnerships in working towards decreasing COVID-19 vaccination disparities, United States, March 2021-December 2022.
Vaccine. 2024 Jan 17:S0264-410X(23)01507-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LEMMER Y, Chapman R, Abolnik C, Smith T, et al
Protective efficacy of a plant-produced beta variant rSARS-CoV-2 VLP vaccine in golden Syrian hamsters.
Vaccine. 2024 Jan 17:S0264-410X(24)00036-7. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

GRIMA AA, Kwong JC, Richard L, Reid J, et al
The safety of seasonal influenza vaccination among adults prescribed immune checkpoint inhibitors: A self-controlled case series study using administrative data.
Vaccine. 2024 Jan 17:S0264-410X(24)00023-9. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

FAN J, Song Y, Cong S, Millman AJ, et al
Assessing interventions to encourage primary care health workers to recommend influenza vaccination and the impact on vaccination uptake for persons with Non-Communicable diseases in China.
Vaccine. 2024 Jan 16:S0264-410X(24)00011-2. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

HARALAMBIEVA IH, Monroe JM, Ovsyannikova IG, Warner ND, et al
Restricted Omicron-specific cross-variant memory B-cell immunity after a 3rd dose/booster of monovalent Wuhan-Hu-1-containing COVID-19 mRNA vaccine.
Vaccine. 2024 Jan 16:S0264-410X(24)00032-X. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

TIAN X, Wang J, Chen H, Ding M, et al
In vivo functional immunoprotection correlates for vaccines against invasive bacteria.
Vaccine. 2024 Jan 16:S0264-410X(24)00018-5. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

KING ML
How manufacturing won or lost the COVID-19 vaccine race.
Vaccine. 2024 Jan 15:S0264-410X(23)01477-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KANG DW, Kim CR, Song JY, Park SK, et al
Cost-effectiveness of the 20-valent pneumococcal conjugate vaccine versus the 23-valent pneumococcal polysaccharide vaccine for older adults in South Korea.
Vaccine. 2024 Jan 14:S0264-410X(24)00031-8. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

MCADAM E, Hayashi K, Barker B, Reddon H, et al
COVID-19 vaccination among young people who use drugs in Vancouver, Canada.
Vaccine. 2024 Jan 14:S0264-410X(24)00009-4. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

BEARSON SMD, Monson MS, Bearson BL, Whelan SJ, et al
Commercial vaccine provides cross-protection by reducing colonization of Salmonella enterica serovars Infantis and Hadar in turkeys.
Vaccine. 2024 Jan 13:S0264-410X(23)01500-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GUO W, Wang C, Song X, Xu H, et al
Immunogenicity and protective efficacy of a trimeric full-length S protein subunit vaccine for porcine epidemic diarrhea virus.
Vaccine. 2024 Jan 13:S0264-410X(24)00020-3. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

NAUTA J
Estimand for non-inferiority influenza vaccine immunogenicity trials.
Vaccine. 2024 Jan 13:S0264-410X(24)00014-8. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

RATISHVILI T, Quach HQ, Haralambieva IH, Suryawanshi YR, et al
A multifaceted approach for identification, validation, and immunogenicity of naturally processed and in silico-predicted highly conserved SARS-CoV-2 peptides.
Vaccine. 2024;42:162-174.
PubMed Abstract available

VAN ROEKEL C, Labuschagne L, Pijpers J, van Roon A, et al
Factors associated with COVID-19 autumn 2022 booster uptake in the Netherlands among older adults aged >/= 60 years and younger adults with chronic conditions.
Vaccine. 2024;42:146-155.
PubMed Abstract available

KURATA T, Kaida Y, Kanbayashi D, Motomura K, et al
Achieving measles elimination and emerging modified measles: Longitudinal measles epidemiology from 1982 to 2021 in Osaka Prefecture, Japan.
Vaccine. 2024;42:271-286.
PubMed Abstract available

SMITH CL, Richardson B, Rubsamen M, Cameron MJ, et al
Adjuvant AS01 activates human monocytes for costimulation and systemic inflammation.
Vaccine. 2024;42:229-238.
PubMed Abstract available

THOMPSON KM, Kalkowska DA, Kidd SE, Burns CC, et al
Trade-offs of different poliovirus vaccine options for outbreak response in the United States and other countries that only use inactivated poliovirus vaccine (IPV) in routine immunization.
Vaccine. 2024 Jan 12:S0264-410X(23)01541-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KNIJFF M, van Lier A, Boer M, de Vries M, et al
Parental intention, attitudes, beliefs, trust and deliberation towards childhood vaccination in the Netherlands in 2022: Indications of change compared to 2013.
Vaccine. 2024 Jan 11:S0264-410X(23)01539-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GOLDIN S, Moen A, Moss WJ, Nuzzo J, et al
Assessing the relationship between existing childhood, adolescent and adult immunization programmes and national COVID-19 vaccination capacities in 2021.
Vaccine. 2024 Jan 11:S0264-410X(23)01484-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

JOACHIM GE, Wagner AL, Naseem M, Boulton ML, et al
Trends in childhood vaccination in Pakistan and associated factors; 2006-2018.
Vaccine. 2024 Jan 10:S0264-410X(24)00015-X. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

SHARP M, Lozano P, Southworth A, Peters A, et al
Mixed methods approach to understanding COVID-19 vaccine hesitancy among immigrants in the Chicago.
Vaccine. 2024 Jan 9:S0264-410X(23)01508-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LIN HH, Wu YS, Chang MT, Shyur LF, et al
Plant-derived galactolipids enhance specific antibody production and induce class-switch as vaccine adjuvant.
Vaccine. 2024 Jan 9:S0264-410X(24)00002-1. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

HINSON-ENSLIN AM, Espinoza LE
The mental health symptoms of individuals with sensory disabilities and the reasons that lead to COVID-19 vaccine refusal and hesitancy.
Vaccine. 2024 Jan 9:S0264-410X(24)00012-4. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

MULLER MP, Navarro C, Wilson SE, Shulha HP, et al
Prospective monitoring of adverse events following vaccination with Modified vaccinia Ankara - Bavarian Nordic (MVA-BN) administered to a Canadian population at risk of Mpox: A Canadian Immunization Research Network study.
Vaccine. 2024 Jan 9:S0264-410X(23)01514-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

OKUMOTO A, Nomura Y, Okuda S, Shikano M, et al
Issues with infectious disease vaccine introduction into routine vaccination in Japan, and considerations for accelerating the process.
Vaccine. 2024 Jan 9:S0264-410X(23)01504-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

QURESHI NS, Miller LG, Judge SP, Tran NDT, et al
Characterizing predictors of COVID-19 vaccine refusal in an urban southern California jail population.
Vaccine. 2024 Jan 9:S0264-410X(24)00017-3. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

CARROLL JC, Herbert SMC, Nguyen TQ, Schork CJ, et al
Vaccination equity and the role of community pharmacy in the United States: A qualitative study.
Vaccine. 2024 Jan 8:S0264-410X(23)01509-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ROZENBAUM MH, Huang L, Perdrizet J, Cane A, et al
Cost-effectiveness of 20-valent pneumococcal conjugate vaccine in US infants.
Vaccine. 2024 Jan 7:S0264-410X(23)01503-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

COSTA M, Mansilla F, Manuel Sala J, Saravia A, et al
Fasciola hepatica infection modifies IgG1 specific immune response to foot-and-mouse disease virus induced by vaccination.
Vaccine. 2024 Jan 6:S0264-410X(23)01513-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

STELETOU E, Giannouchos T, Dimitriou G, Karatza A, et al
Parental concerns and vaccine hesitancy against COVID-19 vaccination for children in Greece: A cross-sectional survey.
Vaccine. 2024 Jan 6:S0264-410X(24)00003-3. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

DOBROVOLSKIENE N, Balevicius R, Mlynska A, Zilionyte K, et al
Immunomodulatory properties of bacteriophage derived dsRNA of different size and their use as anticancer vaccine adjuvants.
Vaccine. 2024 Jan 5:S0264-410X(23)01518-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

STONE ND, Parker Fiebelkorn A, Guo A, Mothershed E, et al
Challenges and opportunities during the COVID-19 vaccination efforts in long-term care.
Vaccine. 2024 Jan 5:S0264-410X(23)01510-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

REIS JN, Azevedo J, de Oliveira AML, Menezes APO, et al
Long-term surveillance of invasive pneumococcal disease: The impact of 10-valent pneumococcal conjugate vaccine in the metropolitan region of Salvador, Brazil.
Vaccine. 2024 Jan 5:S0264-410X(23)01501-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ENYINNAYA JC, Anderson AA, Kelp NC, Long M, et al
The Social Ecology of Health Beliefs and Misinformation Framework: Examining the impact of misinformation on vaccine uptake through individual and sociological factors.
Vaccine. 2024 Jan 5:S0264-410X(24)00001-X. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available

KRANZLER EC, Ihongbe TO, Marshall MC, Denison B, et al
Racial and ethnic differences in COVID-19 vaccine readiness among adults in the United States, January 2021-April 2023.
Vaccine. 2024 Jan 4:S0264-410X(23)01537-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BUHL C, Jacobsen R, Almarsdottir AB, Abtahi S, et al
Public's perspective on COVID-19 adenovirus vector vaccines after thrombosis with thrombocytopenia syndrome (TTS) reports and associated regulatory actions - A cross-sectional study in six EU member states.
Vaccine. 2024 Jan 4:S0264-410X(23)01511-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ALVAREZ CA, Hall RG 2nd, Lin S, Perkins AR, et al
Compliance with recommended pneumococcal vaccination schedule in patients treated for rheumatoid arthritis: A retrospective cohort study in the Veterans Affairs population.
Vaccine. 2024 Jan 3:S0264-410X(23)01532-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CHARPIGNON ML, Gupta S, Shahnaz Majumder M
Massachusetts companion program bolsters COVID-19 vaccine rates among seniors.
Vaccine. 2024 Jan 3:S0264-410X(23)01494-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DAVIDSON AM, Burns S, White LA, Perlman M, et al
"I shall not poison my child with your human experiment": Investigating predictors of parents' hesitancy about vaccinating younger children (<12) in Canada.
Vaccine. 2024 Jan 2:S0264-410X(23)01519-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

YAEGASHI M, Matsui H, Yoshida A, Ban H, et al
A retrospective cohort study evaluating the incidence of herpes zoster and postherpetic neuralgia after a live attenuated Oka-strain herpes zoster vaccine in a real-world setting in Japan.
Vaccine. 2024 Jan 2:S0264-410X(23)01540-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HUSSEIN I, Vanska S, Sivela J, Leino T, et al
Factors associated with parental Human Papillomavirus (HPV) vaccination intention of daughter: A national survey in Finland.
Vaccine. 2024 Jan 2:S0264-410X(23)01473-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

AGASSE E, Rodriguez GF, Vilarino V, Galli JH, et al
Social determinants of health and vaccine uptake in pregnancy: Disparities in a diverse, predominately foreign-born population.
Vaccine. 2024 Jan 2:S0264-410X(23)01515-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DE PINHO RB, Barbosa TN, Dall'Agno L, da Rocha Fonseca B, et al
Mycobacterium bovis BCG expressing the proteins CP40 or CP09720 of Corynebacterium pseudotuberculosis promotes protection in mice after challenge.
Vaccine. 2024;42:33-39.
PubMed Abstract available

VASHI MD, Watkins M
Missed opportunities: Reducing zero dose children amongthe urban poor after COVID, Mumbai India, 2022.
Vaccine. 2024;42:59-63.
PubMed Abstract available

December 2023

ZOLA MATUVANGA T, Lariviere Y, Lemey G, Isekah Osang'ir B, et al
Longitudinal assessment of an Ebola vaccine trial understanding among healthcare providers in the Democratic Republic of the Congo.
Vaccine. 2023 Dec 31:S0264-410X(23)01530-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ROMANO IG, Core SB, Lee NR, Mowry C, et al
A bacteriophage virus-like particle vaccine against oxycodone elicits high-titer and long-lasting antibodies that sequester drug in the blood.
Vaccine. 2023 Dec 29:S0264-410X(23)01533-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TO A, Wong TAS, Ball AH, Lieberman MM, et al
Thermostable bivalent filovirus vaccine protects against severe and lethal Sudan ebolavirus and marburgvirus infection.
Vaccine. 2023 Dec 28:S0264-410X(23)01499-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BARZEN G, Rieber F, Stangl K, Hahn K, et al
mRNA vaccines for COVID-19 are safe and clinically effective in patients with cardiac amyloidosis.
Vaccine. 2023 Dec 28:S0264-410X(23)01487-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

RUBIO-CASILLAS A, Rodriguez-Quintero CM, Redwan EM, Gupta MN, et al
Do vaccines increase or decrease susceptibility to diseases other than those they protect against?
Vaccine. 2023 Dec 28:S0264-410X(23)01506-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

OLIVER SE, Wallace M, Twentyman E, Moulia DL, et al
Development of COVID-19 vaccine policy - United States, 2020-2023.
Vaccine. 2023 Dec 28:S0264-410X(23)01466-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SURTEES TC, Granade CJ, Wells C, Banks M, et al
CDC COVID-19 vaccination program: Healthcare provider compliance with COVID-19 vaccine requirements and recommendations.
Vaccine. 2023 Dec 27:S0264-410X(23)01467-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GHARPURE R, Akumu AO, Dawa J, Gobin S, et al
Costs of seasonal influenza vaccine delivery in a pediatric demonstration project for children aged 6-23 months - Nakuru and Mombasa Counties, Kenya, 2019-2021.
Vaccine. 2023 Dec 27:S0264-410X(23)01475-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SHENTON P, Schrader S, Smith J, Alafaci A, et al
Long term follow up and outcomes of Covid-19 vaccine associated myocarditis in Victoria, Australia: A clinical surveillance study.
Vaccine. 2023 Dec 27:S0264-410X(23)01516-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FONSECA HAR, Zimerman A, Monfardini F, Guimaraes HP, et al
In-Hospital influenza vaccination to prevent cardiorespiratory events in the first 45 days after acute coronary syndrome: A prespecified analysis of the VIP-ACS trial.
Vaccine. 2023 Dec 27:S0264-410X(23)01531-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MIRANDA MCR, Nunes CM, Santos LF, da Silva LB, et al
Ordered mesoporous silicas for potential applications in solid vaccine formulations.
Vaccine. 2023 Dec 24:S0264-410X(23)01478-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SEESKIN ZH, Ganesh N, Maitra P, Herman P, et al
Estimating county-level vaccination coverage using small area estimation with the National Immunization Survey-Child.
Vaccine. 2023 Dec 23:S0264-410X(23)01492-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

NGUYEN KH, Coy KC, Black CL, Scanlon P, et al
Comparison of adult hesitancy towards COVID-19 vaccines and vaccines in general in the USA.
Vaccine. 2023 Dec 23:S0264-410X(23)01488-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MAHMOOD S, Skinner P, Warren CJ, Mayers J, et al
In vivo challenge studies on vaccinated chickens indicate a virus genotype mismatched vaccine still offers significant protection against NDV.
Vaccine. 2023 Dec 23:S0264-410X(23)01483-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KACHKO A, Selvaraj P, Liu S, Kim J, et al
Vaccine-associated respiratory pathology correlates with viral clearance and protective immunity after immunization with self-amplifying RNA expressing the spike (S) protein of SARS-CoV-2 in mouse models.
Vaccine. 2023 Dec 22:S0264-410X(23)01498-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SEPPALA E, Dahl J, Veneti L, Rydland KM, et al
Covid-19 and influenza vaccine effectiveness against associated hospital admission and death among individuals over 65 years in Norway: A population-based cohort study, 3 October 2022 to 20 June 2023.
Vaccine. 2023 Dec 22:S0264-410X(23)01496-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LANGLEY JM, Gantt S, Halperin SA, Ward B, et al
An enveloped virus-like particle alum-adjuvanted cytomegalovirus vaccine is safe and immunogenic: A first-in-humans Canadian Immunization Research Network (CIRN) study.
Vaccine. 2023 Dec 22:S0264-410X(23)01452-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LO E, Brousseau N, Defay F, Fortin E, et al
Neighborhood-level vaccine impact on COVID-19 infection and hospital admission in Quebec, Canada, during the Delta and early Omicron periods.
Vaccine. 2023 Dec 22:S0264-410X(23)01489-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LEVITAN B, Hadler SC, Hurst W, Izurieta HS, et al
The Brighton collaboration standardized module for vaccine benefit-risk assessment.
Vaccine. 2023 Dec 21:S0264-410X(23)01109-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

JORDAN Z, Rowland E
Parental perceptions of chickenpox and the varicella vaccine: A qualitative systematic review.
Vaccine. 2023 Dec 20:S0264-410X(23)01491-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KURIYAMA K, Murakami K, Sugiura K, Sakui S, et al
Immunogenicity and safety of a second heterologous booster dose of NVX-CoV2373 (TAK-019) in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: Interim analysis report of a phase 3 open-label trial.
Vaccine. 2023 Dec 20:S0264-410X(23)01482-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LINK-GELLES R, Britton A, Fleming-Dutra KE
Building the U.S. COVID-19 vaccine effectiveness program: Past successes and future directions.
Vaccine. 2023 Dec 20:S0264-410X(23)01435-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WOLFF M, Charpentier P, Canals A, Vial C, et al
Humoral immune response in people living with HIV after administration of SARS-CoV-2 vaccine CoronaVac or BNT162b2 or CoronaVac/BNT162b2 booster sequence: A cross-sectional study.
Vaccine. 2023 Dec 19:S0264-410X(23)01481-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

STUMPF J, Anders L, Siepmann T, Schwobel J, et al
9-Month observational Dia-Vacc study of vaccine type influence on SARS-CoV-2 immunity in dialysis and kidney transplant patients.
Vaccine. 2023 Dec 18:S0264-410X(23)01479-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ARASHIRO T, Miwa M, Nakagawa H, Takamatsu J, et al
COVID-19 vaccine effectiveness against severe COVID-19 requiring oxygen therapy, invasive mechanical ventilation, and death in Japan: A multicenter case-control study (MOTIVATE study).
Vaccine. 2023 Dec 18:S0264-410X(23)01480-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PILIOU S, Farman TA, Marini A, Manoharan S, et al
Commensal Neisseria cinerea outer membrane vesicles as a platform for the delivery of meningococcal and gonococcal antigens to the immune system.
Vaccine. 2023;41:7671-7681.
PubMed Abstract available

DAWA J, Jalang'o R, Mirieri H, Kalani R, et al
Comparing performance of year-round and campaign-mode influenza vaccination strategies among children aged 6-23 months in Kenya: 2019-2021.
Vaccine. 2023 Dec 16:S0264-410X(23)01380-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PICHON S, Moureau A, Petit C, Kirstein JL, et al
Safety and immunogenicity of a serum-free purified Vero rabies vaccine in comparison with the rabies human diploid cell vaccine (HDCV; Imovax(R) Rabies) administered in a simulated rabies post-exposure regimen in healthy adults.
Vaccine. 2023 Dec 16:S0264-410X(23)01398-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

JACKSON LA, Stapleton JT, Walter EB, Chen WH, et al
Immunogenicity and safety of varying dosages of a fifth-wave influenza A/H7N9 inactivated vaccine given with and without AS03 adjuvant in healthy adults.
Vaccine. 2023 Dec 16:S0264-410X(23)01434-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ZHAN XY, Chen Y, Zhang X, Shi Q, et al
Characterization of SARS-CoV-2-specific humoral immunity and associated factors in the healthy population post-vaccination.
Vaccine. 2023 Dec 15:S0264-410X(23)01465-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BAJRACHARYA D, Jansen RJ
Observations of COVID-19 vaccine coverage and vaccine hesitancy on COVID-19 outbreak: An American ecological study.
Vaccine. 2023 Dec 15:S0264-410X(23)01441-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

JIANG W, Lu C, Yan X, Tucker JD, et al
Vaccine confidence mediates the association between a pro-social pay-it-forward intervention and improved influenza vaccine uptake in China: A mediation analysis.
Vaccine. 2023 Dec 15:S0264-410X(23)01392-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BURNS KE, Dube E, Godinho Nascimento H, Meyer SB, et al
Examining vaccine hesitancy among a diverse sample of Canadian adults.
Vaccine. 2023 Dec 15:S0264-410X(23)01476-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DONG C, Ma Y, Zhu W, Wang Y, et al
Influenza immune imprinting synergizes PEI-HA/CpG nanoparticle vaccine protection against heterosubtypic infection in mice.
Vaccine. 2023 Dec 14:S0264-410X(23)01485-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FERRONI E, Gennaro N, Maifredi G, Leoni O, et al
Access to SARS-CoV-2 vaccination in immigrants in Italy, by geographical area of origin.
Vaccine. 2023 Dec 13:S0264-410X(23)01387-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CAO Z, Yu R, Yuan Q, Ji W, et al
Impact of the COVID-19 pandemic on routine vaccination coverage under varying prevalence Conditions: A cohort study in Beijing, China.
Vaccine. 2023 Dec 13:S0264-410X(23)01447-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SCHARF LG, Adeniyi K, Augustini E, Boyd D, et al
Monitoring and reporting the US COVID-19 vaccination effort.
Vaccine. 2023 Dec 13:S0264-410X(23)01438-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LYU Y, Choong A, Chow EPF, Seib KL, et al
Vaccine value profile for Neisseria gonorrhoeae.
Vaccine. 2023 Dec 13:S0264-410X(23)00086-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

O'NEIL SS, Pendl-Robinson EL, Carosella EA, Sullivan BD, et al
The importance of community-specific survey data in understanding behavioral and social drivers of COVID-19 vaccination: Lessons learned from urban neighborhoods in four United States cities.
Vaccine. 2023 Dec 12:S0264-410X(23)01450-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

OPRIESSNIG T, Gauger PC, Filippsen Favaro P, Rawal G, et al
An experimental universal swine influenza a virus (IAV) vaccine candidate based on the M2 ectodomain (M2e) peptide does not provide protection against H1N1 IAV challenge in pigs.
Vaccine. 2023 Dec 11:S0264-410X(23)01445-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

YAMADA N, Nakatsuka K, Tezuka M, Murata F, et al
Pneumococcal vaccination coverage and vaccination-related factors among older adults in Japan: LIFE Study.
Vaccine. 2023 Dec 11:S0264-410X(23)01442-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

YANG X, Shi N, Liu C, Zhang J, et al
Relationship between vaccine hesitancy and vaccination behaviors: Systematic review and meta-analysis of observational studies.
Vaccine. 2023 Dec 11:S0264-410X(23)01397-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LYTRAS T, Di Gregorio AAA, Apostolopoulos D, Naziris D, et al
Effectiveness of COVID-19 vaccine mandates in raising vaccination rates among the elderly and general population in Europe: Controlled interrupted time series analysis.
Vaccine. 2023 Dec 11:S0264-410X(23)01472-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LO VECCHIO A, Scarano SM, Palladino R, Del Bene M, et al
Co-administration with Men-B vaccine increases Rotavirus vaccination coverage: A 5-year regionwide retrospective cohort study (STORM study).
Vaccine. 2023 Dec 9:S0264-410X(23)01436-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SKIRROW H, Foley K, Bedford H, Lewis C, et al
Impact of pregnancy vaccine uptake and socio-demographic determinants on subsequent childhood Measles, Mumps and Rubella vaccine uptake: A UK birth cohort study.
Vaccine. 2023 Dec 9:S0264-410X(23)01431-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MESIDOR M, Liu Y, Talbot D, Skowronski DM, et al
Test negative design for vaccine effectiveness estimation in the context of the COVID-19 pandemic: A systematic methodology review.
Vaccine. 2023 Dec 9:S0264-410X(23)01446-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

AKMATOVA R, Dzhangaziev B, Ebama MS, Otorbaeva D, et al
Knowledge, attitudes, and practices (KAP) towards seasonal influenza and influenza vaccine among pregnant women in Kyrgyzstan: A cross-sectional study.
Vaccine. 2023 Dec 9:S0264-410X(23)01453-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BJERKHAUG AU, Ramalingham S, Mboizi R, Le Doare K, et al
The immunogenicity and safety of Group B Streptococcal maternal vaccines: A systematic review.
Vaccine. 2023 Dec 9:S0264-410X(23)01420-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

JONGEN VW, Groot Bruinderink ML, Boyd A, Koole JCD, et al
What determines mpox vaccination uptake? Assessing the effect of intent-to-vaccinate versus other determinants among men who have sex with men.
Vaccine. 2023 Dec 9:S0264-410X(23)01449-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SUI Y, Andersen H, Li J, Hoang T, et al
SARS-CoV-2 mucosal vaccine protects against clinical disease with sex bias in efficacy.
Vaccine. 2023 Dec 8:S0264-410X(23)01426-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DI CHIARA C, Cantarutti A, Raffaella Petrara M, Bonfante F, et al
Stronger and durable SARS-CoV-2 immune response to mRNA vaccines in 5-11 years old children with prior COVID-19.
Vaccine. 2023 Dec 8:S0264-410X(23)01439-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MALAKER R, Hasanuzzaman M, Hooda Y, Rahman H, et al
Effectiveness of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease among children <2 years old: A prospective population-based study in rural Bangladesh.
Vaccine. 2023 Dec 8:S0264-410X(23)01440-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LI J, Ding J, Chen K, Xu X, et al
Protective effects of a novel chimeric virus-like particle vaccine against virulent NDV and IBDV challenge.
Vaccine. 2023 Dec 8:S0264-410X(23)01430-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CHENG DR, Reimer H, Le D, Crawford NW, et al
Analyzing an immunization resource website: User browsing trends.
Vaccine. 2023;41:7498-7502.
PubMed Abstract available

REEF SE, Icenogle JP, Plotkin SA
The path to eradication of rubella.
Vaccine. 2023;41:7525-7531.
PubMed Abstract available

LESCOP J, Pennes B, Epaulard O
Mind the gap: Concordance between perceptions regarding vaccination as declared by patients and their evaluation by their general practitioner.
Vaccine. 2023 Dec 7:S0264-410X(23)01433-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

YU Y, Zhang X, Lau MMC, Lau JTF, et al
The intention to get COVID-19 booster vaccination and its association with cognitive and emotional factors: A survey of Chinese COVID-19 infected people in Hong Kong.
Vaccine. 2023 Dec 7:S0264-410X(23)01448-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GRAMACHO W, Turgeon M, Santos Mundim P, Pereira I, et al
Why did Brazil fail to vaccinate children against COVID-19 during the pandemic? An assessment of attitudinal and behavioral determinants.
Vaccine. 2023 Dec 6:S0264-410X(23)01432-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CHOKEPHAIBULKIT K, Puthanakit T, Chaithongwongwatthana S, Bhat N, et al
Effective and safe transfer of maternal antibodies persisting two months postpartum following maternal immunization with different doses of recombinant pertussis-containing vaccines.
Vaccine. 2023 Dec 6:S0264-410X(23)01386-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HUANG L, Chen Z, Song Y, Tan J, et al
Immunogenicity and safety of a live-attenuated varicella vaccine in a healthy population aged 13 years and older: A randomized, double-blind, controlled study.
Vaccine. 2023 Dec 5:S0264-410X(23)01212-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MADNI SA, Sharma AJ, Zauche LH, Waters AV, et al
CDC COVID-19 Vaccine Pregnancy Registry: Design, data collection, response rates, and cohort description.
Vaccine. 2023 Dec 5:S0264-410X(23)01423-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ENUL H, Uzar S, Satir E, Sarac F, et al
Humoral immune response profile of a cattle herd vaccinated with 5- and 10-times Bakirkoy strain sheep pox vaccine under field conditions.
Vaccine. 2023 Dec 5:S0264-410X(23)01388-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CANEVARI JT, Cheng AC, Wu L, Rowe SL, et al
The relative effectiveness of three and four doses of COVID-19 vaccine in Victoria, Australia: A data linkage study.
Vaccine. 2023 Dec 5:S0264-410X(23)01393-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DIONNE M, Sauvageau C, Kiely M, Dahhou M, et al
School-based vaccination program against HPV and Hepatitis B: A longitudinal analysis of vaccine coverage between 2015 and 2021 in Quebec.
Vaccine. 2023 Dec 2:S0264-410X(23)01419-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SATO S, Katsuta T, Kawazoe Y, Takahashi M, et al
Immune thrombocytopenic purpura and Guillain-Barre syndrome after 23-valent pneumococcal polysaccharide vaccination in Japan: The vaccine effectiveness, networking, and universal safety (VENUS) study.
Vaccine. 2023 Dec 2:S0264-410X(23)01399-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PRASERT K, Praphasiri P, Lerdsamran H, Nakphook S, et al
Safety and immunogenicity of locally produced trivalent inactivated influenza vaccine (Tri Fluvac) in healthy Thai adults aged 18-64 years in Nakhon Phanom: A Phase III double blinded, three-arm, randomized, controlled trial.
Vaccine. 2023 Dec 1:S0264-410X(23)01396-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

JENNINGS MC, Sauer M, Manchester C, Soeters HM, et al
Supporting evidence-based rotavirus vaccine introduction decision-making and implementation: Lessons from 8 Gavi-eligible countries.
Vaccine. 2023 Dec 1:S0264-410X(23)01379-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

November 2023

BAQAR S, Bonavia A, Louis Bourgeois A, Campo JJ, et al
The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of breakout workshops.
Vaccine. 2023 Nov 29:S0264-410X(23)01391-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BANERJEE S, Barry EM, Baqar S, Louis Bourgeois A, et al
The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of abstract-based presentations.
Vaccine. 2023 Nov 28:S0264-410X(23)01364-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WANG Y, Hu Y, Ma Y, Li P, et al
RBD class 1 and 2 antibody epitopes elicit around 70% neutralizing capacity against SARS-CoV-2 virus following boosting with inactivated virus vaccine.
Vaccine. 2023 Nov 27:S0264-410X(23)01381-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

NISHIYAMA T, Miyamatsu Y, Park H, Nakamura N, et al
Modeling COVID-19 vaccine booster-elicited antibody response and impact of infection history.
Vaccine. 2023 Nov 25:S0264-410X(23)01384-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TANAKA T, Kakiuchi S, Tashiro M, Fujita A, et al
Adherence to recommended vaccination policies for pre- and post-solid organ transplantation patients: A national questionnaire survey in Japan.
Vaccine. 2023 Nov 24:S0264-410X(23)01377-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MOITA D, Nunes-Cabaco H, Rola C, Franke-Fayard B, et al
Variable long-term protection by radiation-, chemo-, and genetically-attenuated Plasmodium berghei sporozoite vaccines.
Vaccine. 2023 Nov 24:S0264-410X(23)01335-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DUCASA N, Benencio P, Mauro E, Anders M, et al
Evaluation of the humoral response to the third dose of SARS-COV-2 vaccines in liver transplant recipients.
Vaccine. 2023 Nov 24:S0264-410X(23)01383-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PAYNE AB, Ciesla AA, Rowley EAK, Weber ZA, et al
Impact of accounting for correlation between COVID-19 and influenza vaccination in a COVID-19 vaccine effectiveness evaluation using a test-negative design.
Vaccine. 2023 Nov 23:S0264-410X(23)01337-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SOWE A, Namatovu F, Cham B, Gustafsson PE, et al
Missed opportunities for vaccination at point of care and their impact on coverage and urban-rural coverage inequity in the Gambia.
Vaccine. 2023 Nov 22:S0264-410X(23)01385-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WANG B, McDonough J, Chen G, Ong JJ, et al
Sociodemographic factors and attitudes associated with Australian parental acceptance of paediatric COVID-19 vaccination.
Vaccine. 2023 Nov 22:S0264-410X(23)01336-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

NEELY SR, Hao F
Breakthrough COVID-19 infections and perceived vaccine effectiveness.
Vaccine. 2023 Nov 22:S0264-410X(23)01365-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ECONOMIDOU EC, Soteriades ES
Excess mortality in Cyprus during the COVID-19 vaccination campaign.
Vaccine. 2023 Nov 22:S0264-410X(23)01361-0. doi: 10.1016/j.vaccine.2023.
PubMed

KAUR R, Gonzalez E, Pham M, Pichichero M, et al
Naturally-induced serum antibody levels in children to pneumococcal polysaccharide 15B that correlate with protection from nasopharyngeal colonization but anti-serotype 15B antibody has low functional cross-reactivity with serotype 15C.
Vaccine. 2023;41:7265-7273.
PubMed Abstract available

NEUHANN JM, Stemler J, Carcas AJ, Frias-Iniesta J, et al
Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: A randomised VACCELERATE trial in adults >/=75 years (EU-COVAT-1).
Vaccine. 2023;41:7166-7175.
PubMed Abstract available

ZURCHER SJ, Signorell A, Lechot-Huser A, Aebi C, et al
Childhood vaccination coverage and regional differences in Swiss birth cohorts 2012-2021: Are we on track?
Vaccine. 2023;41:7226-7233.
PubMed Abstract available

LARIVIERE Y, Matuvanga TZ, Lemey G, Osang'ir BI, et al
Conducting an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo: Challenges, mitigations, and lessons learned.
Vaccine. 2023 Nov 21:S0264-410X(23)01363-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LAW AW, Judy J, Atwell JE, Willis S, et al
Maternal Tdap and influenza vaccination uptake 2017-2021 in the United States: Implications for maternal RSV vaccine uptake in the future.
Vaccine. 2023 Nov 21:S0264-410X(23)01307-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

NAUGLE D, Tibbels N, Dosso A, Benie W, et al
"I'd do it for my baby": Lessons learned from qualitative research on COVID-19 vaccination among pregnant women in Cote d'Ivoire.
Vaccine. 2023 Nov 19:S0264-410X(23)01333-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MAN-LIK CHOI E, Abu-Baker Mustapher G, Omosa-Manyonyi G, Foster J, et al
Safety and immunogenicity of an Ad26.ZEBOV booster vaccine in Human Immunodeficiency Virus positive (HIV+) adults previously vaccinated with the Ad26.ZEBOV, MVA-BN-Filo vaccine regimen against Ebola: A single-arm, open-label Phase II clinical trial in
Vaccine. 2023 Nov 17:S0264-410X(23)01257-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SHRESTHA AC, Field E, Rajmokan M, Lambert SB, et al
Assessing the impact of chickenpox and shingles vaccination using intermittent enhanced surveillance in Queensland, Australia.
Vaccine. 2023 Nov 16:S0264-410X(23)01327-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CHANDPA HH, Panda AK, Meena CL, Meena J, et al
Beyond the polysaccharide and glycoconjugate vaccines for Streptococcus pneumoniae: Does protein/peptide nanovaccines hold promises?
Vaccine. 2023 Nov 16:S0264-410X(23)01332-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

YU Z, Keskinocak P, Orenstein WA, Toktay LB, et al
A mixed integer programming model for vaccine pricing within a group purchasing organization.
Vaccine. 2023 Nov 15:S0264-410X(23)01223-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ANRAAD C, van Empelen P, Ruiter RAC, van Keulen H, et al
Effects of an online tailored decision aid to promote informed decision making about maternal pertussis vaccination in the Netherlands: A randomized controlled trial.
Vaccine. 2023 Nov 15:S0264-410X(23)01281-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CHRISTENSEN S, Bouguermouh S, Ilangovan K, Pride MW, et al
A phase 3 study evaluating the lot consistency, immunogenicity, safety, and tolerability of a Clostridioides difficile vaccine in healthy adults 65 to 85 years of age.
Vaccine. 2023 Nov 15:S0264-410X(23)01296-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HAEDER SF
Assessing parental intention to vaccinate against COVID-19, influenza, and RSV in the United States in late 2023.
Vaccine. 2023 Nov 15:S0264-410X(23)01303-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CHOI Y, Park S, Lee J, Kim Y, et al
Who gets COVID-19 booster vaccination? Trust in public health institutions and promotion strategies post-pandemic in the Republic of Korea.
Vaccine. 2023 Nov 15:S0264-410X(23)01294-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

AMITAI N, Wertheimer R, Prais D, Wertheimer KO, et al
Influenza vaccination in children with pulmonary disease during the COVID-19 pandemic.
Vaccine. 2023 Nov 15:S0264-410X(23)01338-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PLUMB ID, Briggs Hagen M, Wiegand R, Dumyati G, et al
Effectiveness of a bivalent mRNA vaccine dose against symptomatic SARS-CoV-2 infection among U.S. Healthcare personnel, September 2022-May 2023.
Vaccine. 2023 Nov 14:S0264-410X(23)01287-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CHOE S, Park GN, Kim KS, Shin J, et al
Efficacy of an orally administered classical swine fever live marker vaccine (Flc-LOM-BE(rns) strain) in pigs.
Vaccine. 2023 Nov 14:S0264-410X(23)01286-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SARAFIAN JT, Eucker SA, Gillman M, DeLaroche AM, et al
Impact of a hypothetical COVID-19 vaccine mandate on parental likelihood to vaccinate children: Exploring school-related concerns and vaccination decision-making.
Vaccine. 2023 Nov 14:S0264-410X(23)01334-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GUBERNOT D, Menis M, Whitaker B
Background rates for severe cutaneous reactions in the US: Contextual support for safety assessment of COVID-19 vaccines and novel biologics.
Vaccine. 2023;41:6922-6929.
PubMed Abstract available

CUBIZOLLES C, Barjat T, Chauleur C, Bruel S, et al
Evaluation of intentions to get vaccinated against influenza, COVID 19, pertussis and to get a future vaccine against respiratory syncytial virus in pregnant women.
Vaccine. 2023 Nov 12:S0264-410X(23)01280-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

JIANG X, Wang J, Li C, Yeoh EK, et al
Impact of the surge of COVID-19 Omicron outbreak on the intention of seasonal influenza vaccination in Hong Kong: A cross-sectional study.
Vaccine. 2023 Nov 11:S0264-410X(23)01304-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HERZIG VAN WEES S, Stalgren M, Viberg N, Puranen B, et al
"Who is Anders Tegnell?" Unanswered questions hamper COVID-19 vaccine uptake: A qualitative study among ethnic minorities in Sweden.
Vaccine. 2023 Nov 10:S0264-410X(23)01328-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LIU YY, Xu YQ, Zhong Y, Wei F, et al
Pathogenicity of novel hantavirus isolate and antigenicity and immunogenicity of novel strain-based inactivated vaccine.
Vaccine. 2023 Nov 10:S0264-410X(23)01329-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GRABENSTEIN JD, Ferrara P, Mantovani LG, McGovern I, et al
Evaluating risk of bias using ROBINS-I tool in nonrandomized studies of adjuvanted influenza vaccine.
Vaccine. 2023 Nov 10:S0264-410X(23)01302-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BRUXVOORT KJ, Sy LS, Hong V, Lewin B, et al
Factors associated with uptake of bivalent mRNA COVID-19 vaccines in a large US health care system.
Vaccine. 2023 Nov 10:S0264-410X(23)01324-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DUDLEY MZ, Schwartz B, Brewer J, Kan L, et al
COVID-19 vaccination attitudes, values, intentions: US parents for their children, September 2021.
Vaccine. 2023 Nov 9:S0264-410X(23)01295-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ANDERSON EC, Blair PS, Finn A, Ingram J, et al
Maternal vaccination provision in NHS maternity trusts across England.
Vaccine. 2023 Nov 9:S0264-410X(23)01284-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WIDDERSHOVEN V, Reijs RP, Eskes A, Verhaegh-Haasnoot A, et al
Maternal pertussis vaccination behavior: Psychosocial, attitudinal and organizational factors.
Vaccine. 2023 Nov 9:S0264-410X(23)01325-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TECHAKRIENGKRAI N, Aryuman S, Vanlarat K, Karnchanapraphas C, et al
Impacts of shelter management on canine rabies immune status.
Vaccine. 2023 Nov 9:S0264-410X(23)01330-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

YANG C, Zheng Z, Zheng P, Chen J, et al
Inactivated COVID-19 vaccines in peri-pregnancy period: Evaluation of safety for both pregnant women and neonates.
Vaccine. 2023 Nov 8:S0264-410X(23)01322-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TSAI SA, Lu CY, Chen TI, Huang SP, et al
Adverse events from HPV vaccination in Taiwan.
Vaccine. 2023 Nov 8:S0264-410X(23)01321-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TAMIR TT, Kassie AT, Zegeye AF
Prevalence and determinants of two or more doses of tetanus toxoid-containing vaccine immunization among pregnant women in sub-Saharan Africa: Evidence from recent demographic and health survey data.
Vaccine. 2023 Nov 8:S0264-410X(23)01305-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MVUNDURA M, Slavkovsky R, Debellut F, Naddumba T, et al
Cost and operational context for national human papillomavirus (HPV) vaccine delivery in six low- and middle-income countries.
Vaccine. 2023 Nov 8:S0264-410X(23)01306-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GSELL PS, Giersing B, Gottlieb S, Wilder-Smith A, et al
Key considerations for the development of novel mRNA candidate vaccines in LMICs: A WHO/MPP mRNA Technology Transfer Programme meeting report.
Vaccine. 2023 Nov 8:S0264-410X(23)01210-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

COOPER LV, Stuart JM, Okot C, Asiedu-Bekoe F, et al
Corrigendum to "Reactive vaccination as a control strategy for pneumococcal meningitis outbreaks in the African meningitis belt: Analysis of outbreak data from Ghana" [Vaccine 37(37) (2019) 5657-5663].
Vaccine. 2023 Nov 7:S0264-410X(23)01293-8. doi: 10.1016/j.vaccine.2023.
PubMed

INOUE Y, Li Y, Yamamoto S, Fukunaga A, et al
The association between antipyretic analgesics use and SARS-CoV-2 antibody titers following the second dose of the BNT162b2 mRNA vaccine: An observational study.
Vaccine. 2023 Nov 7:S0264-410X(23)01220-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FLANDES X, Hansen CA, Palani S, Abbas K, et al
Vaccine value profile for Chikungunya.
Vaccine. 2023 Nov 7:S0264-410X(23)00915-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HAEDER SF
Assessing vaccine hesitancy and support for vaccination requirements for pets and potential Spillovers from humans.
Vaccine. 2023 Nov 5:S0264-410X(23)01263-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HANSEN LG, Larsen LE, Rasmussen TB, Miar Y, et al
Investigation of the SARS-CoV-2 post-vaccination antibody response in Canadian farmed mink.
Vaccine. 2023 Nov 4:S0264-410X(23)01288-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

JONES G, Perry M, Bailey R, Arumugam S, et al
Dimensions of equality in uptake of COVID-19 vaccination in Wales, UK: A multivariable linked data population analysis.
Vaccine. 2023 Nov 4:S0264-410X(23)01279-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SPACKMAN E, Suarez DL, Lee CW, Pantin-Jackwood MJ, et al
Efficacy of inactivated and RNA particle vaccines against a North American Clade 2.3.4.4b H5 highly pathogenic avian influenza virus in chickens.
Vaccine. 2023 Nov 4:S0264-410X(23)01285-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KHALIL I, Anderson JD, Bagamian KH, Baqar S, et al
Vaccine value profile for enterotoxigenic Escherichia coli (ETEC).
Vaccine. 2023;41 Suppl 2:S95-S113.
PubMed Abstract available

TROTTER CL, Alderson M, Dangor Z, Ip M, et al
Vaccine value profile for Group B streptococcus.
Vaccine. 2023;41 Suppl 2:S41-S52.
PubMed Abstract available

KAYE PM, Matlashewski G, Mohan S, Le Rutte E, et al
Vaccine value profile for leishmaniasis.
Vaccine. 2023;41 Suppl 2:S153-S175.
PubMed Abstract available

ARMAH G, Lopman BA, Vinje J, O'Ryan M, et al
Vaccine value profile for norovirus.
Vaccine. 2023;41 Suppl 2:S134-S152.
PubMed Abstract available

MARTIN LB, Khanam F, Qadri F, Khalil I, et al
Vaccine value profile for Salmonella enterica serovar Paratyphi A.
Vaccine. 2023;41 Suppl 2:S114-S133.
PubMed Abstract available

HOTEZ PJ, Bottazzi ME, Kaye PM, Lee BY, et al
Neglected tropical disease vaccines: hookworm, leishmaniasis, and schistosomiasis.
Vaccine. 2023;41 Suppl 2.
PubMed

HOLDER T, Coad M, Allan G, Hogarth PJ, et al
Vaccination of calves with Bacillus Calmette-Guerin Danish strain 1331 results in a duration of immunity of at least 52 weeks.
Vaccine. 2023 Nov 2:S0264-410X(23)01262-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CHEN GL, Yu XY, Luo LP, Zhang F, et al
Phase I study of a non-S2P SARS-CoV-2 mRNA vaccine LVRNA009 in Chinese adults.
Vaccine. 2023 Nov 2:S0264-410X(23)01278-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

AKHTAR Z, Gotberg M, Erlinge D, Christiansen EH, et al
Optimal timing of influenza vaccination among patients with acute myocardial infarction - Findings from the IAMI trial.
Vaccine. 2023 Nov 2:S0264-410X(23)01211-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

JAMES WG, Stanberry LR, LaRussa PS, Grodman MD, et al
Vaccines and global health: COVID-19 vaccine development, strategy, and implementation symposium - Summary of the meeting at Vagelos College of Physicians and Surgeons (February 22-26, 2021, New York).
Vaccine. 2023 Nov 1:S0264-410X(23)01254-9. doi: 10.1016/j.vaccine.2023.
PubMed

GREYSON D, Goh G
Education components of school vaccine mandates: An environmental scan.
Vaccine. 2023 Nov 1:S0264-410X(23)01155-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ALIZADEH M, Raj S, Shojadoost B, Matsuyama-Kato A, et al
In ovo administration of retinoic acid enhances cell-mediated immune responses against an inactivated H9N2 avian influenza virus vaccine.
Vaccine. 2023 Nov 1:S0264-410X(23)01261-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

October 2023

SALLOUM M, Paviotti A, Bastiaens H, Van Geertruyden JP, et al
The inclusion of pregnant women in vaccine clinical trials: An overview of late-stage clinical trials' records between 2018 and 2023.
Vaccine. 2023 Oct 28:S0264-410X(23)01259-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

RAMSAY JA, Jones M, Vande More AM, Hunt SL, et al
A single blinded, phase IV, adaptive randomised control trial to evaluate the safety of coadministration of seasonal influenza and COVID-19 vaccines (The FluVID study).
Vaccine. 2023 Oct 28:S0264-410X(23)01250-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LIU Y, Sanchez-Ovando S, Carolan L, Dowson L, et al
Superior immunogenicity of mRNA over adenoviral vectored COVID-19 vaccines reflects B cell dynamics independent of anti-vector immunity: Implications for future pandemic vaccines.
Vaccine. 2023 Oct 28:S0264-410X(23)01217-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TANI N, Ikematsu H, Goto T, Kondo S, et al
Correlation between specific antibody response to wild-type BNT162b2 booster and the risk of breakthrough infection with omicron variants: Impact of household exposure in hospital healthcare workers.
Vaccine. 2023;41:6672-6678.
PubMed Abstract available

STEFANIZZI P, Di Lorenzo A, Martinelli A, Moscara L, et al
Adverse events following immunization (AEFIs) with anti-meningococcus type B vaccine (4CMenB): Data of post-marketing active surveillance program. Apulia Region (Italy), 2019-2023.
Vaccine. 2023 Oct 26:S0264-410X(23)01158-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CENAT JM, Moshirian Farahi SMM, Broussard C, Dalexis RD, et al
The state of COVID-19 vaccine confidence and need in Black individuals in Canada: Understanding the role of sociodemographic factors, health literacy, conspiracy theories, traumatic stressors and racial discrimination.
Vaccine. 2023 Oct 25:S0264-410X(23)01246-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WALLIAR T, Khan B, Newstead S, Al-Assadi G, et al
"Fighting the pandemic!" Western Australian pharmacists' perspectives on COVID-19 vaccines: A qualitative study.
Vaccine. 2023 Oct 25:S0264-410X(23)01243-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ANASTASSOPOULOU C, Boufidou F, Hatziantoniou S, Vasileiou K, et al
Adverse events of acute nephrotoxicity reported to EudraVigilance and VAERS after COVID-19 vaccination.
Vaccine. 2023 Oct 25:S0264-410X(23)01214-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BURNETT E, Riaz A, Anwari P, Myat TW, et al
Intussusception risk following oral monovalent rotavirus vaccination in 3 Asian countries: A self-control case series evaluation.
Vaccine. 2023 Oct 24:S0264-410X(23)01225-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TRICOU V, Winkle PJ, Tharenos LM, Rauscher M, et al
Consistency of immunogenicity in three consecutive lots of a tetravalent dengue vaccine candidate (TAK-003): A randomized placebo-controlled trial in US adults.
Vaccine. 2023 Oct 24:S0264-410X(23)01132-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FLOR N, Garcia MI, Molineri A, Bottasso O, et al
Antibodies to SARS-CoV2 induced by vaccination and infection correlate with protection against the infection.
Vaccine. 2023 Oct 24:S0264-410X(23)01221-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KITIKOON P, Knetter SM, Mogler MA, Morgan CL, et al
Quadrivalent neuraminidase RNA particle vaccine protects pigs against homologous and heterologous strains of swine influenza virus infection.
Vaccine. 2023 Oct 24:S0264-410X(23)01175-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SHARIF H, Ghani H, Ahmad L, Bagol S, et al
Heterologous prime-boost with mRNA-1273 stimulates persistent neutralising antibodies in BBIBP-CorV-vaccinated individuals.
Vaccine. 2023 Oct 23:S0264-410X(23)01227-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DI GIUSEPPE G, Pelullo CP, Napoli A, Napolitano F, et al
Willingness to receive Herpes Zoster vaccination among adults and older people: A cross sectional study in Italy.
Vaccine. 2023 Oct 23:S0264-410X(23)01247-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LOONEY MM, Hatherill M, Musvosvi M, Flynn J, et al
Conference report: WHO meeting report on mRNA-based tuberculosis vaccine development.
Vaccine. 2023 Oct 21:S0264-410X(23)01209-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BRESEE J, Koh M, Chadwick C, Jit M, et al
The need and ongoing efforts to understand the full value of improved influenza vaccines.
Vaccine. 2023 Oct 21:S0264-410X(23)01245-8. doi: 10.1016/j.vaccine.2023.
PubMed

TERADA M, Shimazu T, Saito J, Odawara M, et al
Age, gender and socioeconomic disparities in human papillomavirus (HPV) awareness and knowledge among Japanese adults after a 7-year suspension of proactive recommendation for the HPV vaccine: A nationally representative cross-sectional survey.
Vaccine. 2023 Oct 20:S0264-410X(23)01207-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MORI Y, Uchida N, Wake A, Miyawaki K, et al
Impact of a third dose of anti-SARS-CoV-2 vaccine in hematopoietic cell transplant recipients: A Japanese multicenter observational study.
Vaccine. 2023 Oct 20:S0264-410X(23)01022-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WANGCHUK S, Prabhakaran AO, Dhakal GP, Zangmo C, et al
Introducing seasonal influenza vaccine in Bhutan: Country experience and achievements.
Vaccine. 2023 Oct 20:S0264-410X(23)01255-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PUTRI WCWS, Sawitri AAS, Yuliyatni PCD, Ariawan IMD, et al
Cost-effectiveness analysis of Japanese Encephalitis (JE) vaccination program in Bali Province, Indonesia.
Vaccine. 2023 Oct 20:S0264-410X(23)01177-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

IRVING SA, Groom HC, Belongia EA, Crane B, et al
Influenza vaccination coverage among persons ages six months and older in the Vaccine Safety Datalink in the 2017-18 through 2022-23 influenza seasons.
Vaccine. 2023 Oct 20:S0264-410X(23)01206-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

VERMA N, Gupta P, Pandey AK, Awasthi S, et al
Nasopharyngeal carriage of Streptococcus pneumoniae serotypes among sick and healthy children in northern India: A case-control study.
Vaccine. 2023;41:6619-6624.
PubMed Abstract available

HONGTU Q, BoLi L, Jianguo C, Shusheng P, et al
Immunogenicity of rabies virus G mRNA formulated with lipid nanoparticles and nucleic acid immunostimulators in mice.
Vaccine. 2023 Oct 20:S0264-410X(23)01191-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MULLER T, Wallace RM, Freuling CM
Rabies importation in dogs and reduction of waiting period - The fear for scientifically justified changes.
Vaccine. 2023 Oct 20:S0264-410X(23)01043-5. doi: 10.1016/j.vaccine.2023.
PubMed

HART R, Feygin Y, Kluthe T, Quinn KG, et al
Emergency departments: An underutilized resource to address pediatric influenza vaccine coverage.
Vaccine. 2023 Oct 19:S0264-410X(23)01222-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MCCLYMONT E, Atkinson A, Albert A, Av-Gay G, et al
Reactogenicity, pregnancy outcomes, and SARS-CoV-2 infection following COVID-19 vaccination during pregnancy in Canada: A national prospective cohort study.
Vaccine. 2023 Oct 19:S0264-410X(23)01215-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PUCHNER KP, Bottazzi ME, Periago V, Grobusch M, et al
Vaccine value profile for Hookworm.
Vaccine. 2023 Oct 18:S0264-410X(23)00540-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KWAK HW, Park HJ, Jung SY, Oh EY, et al
Corrigendum to "Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants" [Vaccine 41(11) (2023) 1892-1901].
Vaccine. 2023 Oct 18:S0264-410X(23)01216-1. doi: 10.1016/j.vaccine.2023.
PubMed

HONDA-OKUBO Y, Bowen R, Barker M, Bielefeldt-Ohmann H, et al
Advax-CpG55.2-adjuvanted monovalent or trivalent SARS-CoV-2 recombinant spike protein vaccine protects hamsters against heterologous infection with Beta or Delta variants.
Vaccine. 2023 Oct 18:S0264-410X(23)01190-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

RIEFOLO F, Castillo-Cano B, Martin-Perez M, Messina D, et al
Effectiveness of homologous/heterologous booster COVID-19 vaccination schedules against severe illness in general population and clinical subgroups in three European countries.
Vaccine. 2023 Oct 17:S0264-410X(23)01181-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ANGULO FJ, Zhang P, Halsby K, Kelly P, et al
A systematic literature review of the effectiveness of tick-borne encephalitis vaccines in Europe.
Vaccine. 2023 Oct 17:S0264-410X(23)01184-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CHOPRA A, Rodriguez A, Prakash A, Raskar R, et al
Using neural networks to calibrate agent based models enables improved regional evidence for vaccine strategy and policy.
Vaccine. 2023 Oct 17:S0264-410X(23)01016-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HAEDER SF
U.S. public support and opposition to vaccination mandates in K-12 education in light of the COVID-19 pandemic.
Vaccine. 2023 Oct 17:S0264-410X(23)01188-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

YANG H, Wang Z, Zhang Y, Xu M, et al
Effectiveness of inactivated COVID-19 vaccines against SARS-CoV-2 Omicron subvariant BF.7 among outpatients in Beijing, China.
Vaccine. 2023 Oct 17:S0264-410X(23)01219-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PLATENBURG PPLI, Deschamps F, Jung J, Leonard C, et al
Carbohydrate fatty acid monosulphate ester is a potent adjuvant for low-dose seasonal influenza vaccines.
Vaccine. 2023 Oct 16:S0264-410X(23)01189-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WRIGHT J, Science M, Osman S, Arnold C, et al
Uptake of pertussis immunization in pregnancy and determinants of vaccination in Toronto, Canada.
Vaccine. 2023 Oct 14:S0264-410X(23)01192-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MUKASA K, Sugawara T, Okutomi Y
Susceptibility of nursery teachers to measles, rubella, varicella and mumps in Japan.
Vaccine. 2023;41:6530-6534.
PubMed Abstract available

ARASHIRO T, Arima Y, Kuramochi J, Muraoka H, et al
Immune escape and waning immunity of COVID-19 monovalent mRNA vaccines against symptomatic infection with BA.1/BA.2 and BA.5 in Japan.
Vaccine. 2023 Oct 13:S0264-410X(23)01194-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MOSCA S, Lin Q, Stokes R, Bharucha T, et al
Innovative method for rapid detection of falsified COVID-19 vaccines through unopened vials using handheld Spatially Offset Raman Spectroscopy (SORS).
Vaccine. 2023 Oct 13:S0264-410X(23)01182-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

VAN EWIJK CE, Smit C, Bavalia R, Ainslie K, et al
Acceptance and timeliness of post-exposure vaccination against mpox in high-risk contacts, Amsterdam, the Netherlands, May-July 2022.
Vaccine. 2023 Oct 12:S0264-410X(23)01183-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SUKWA N, Mubanga C, Hatyoka LM, Chilyabanyama ON, et al
Safety, tolerability, and immunogenicity of an oral inactivated ETEC vaccine (ETVAX(R)) with dmLT adjuvant in healthy adults and children in Zambia: An age descending randomised, placebo-controlled trial.
Vaccine. 2023 Oct 12:S0264-410X(23)01138-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

RODRIGUEZ VJ, Kozlova S, LaBarrie DL, Liu Q, et al
Parental anxiety and pediatric vaccine refusal in a US national sample of parents.
Vaccine. 2023 Oct 11:S0264-410X(23)01187-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

NAND KN, Jordan TB, Yuan X, Basore DA, et al
Bacterial production of recombinant contraceptive vaccine antigen from CatSper displayed on a human papilloma virus-like particle.
Vaccine. 2023 Oct 11:S0264-410X(23)01114-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HAUSDORFF WP, Anderson JD 4th, Bagamian KH, Bourgeois AL, et al
Vaccine value profile for Shigella.
Vaccine. 2023 Oct 10:S0264-410X(22)01562-6. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

AYDIN I, May M, Pisano F, Mpofu-Maetzig N, et al
Safety and immunogenicity of SIIPL Tdap, a new tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, in healthy subjects 4-65 years of age: A Phase II/III randomized, observer-blinded, active controlled, multicenter clinical study
Vaccine. 2023 Oct 10:S0264-410X(23)01157-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

YAO X, Peng J, Ma Y, Fu M, et al
Development of a vaccine hesitancy scale for childhood immunization in China.
Vaccine. 2023 Oct 9:S0264-410X(23)01154-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

YU P, Liu Y, Tao X, He Y, et al
Potential option for rabies post-exposure prophylaxis: New vaccine with PIKA adjuvant against diverse Chinese rabies strains.
Vaccine. 2023 Oct 9:S0264-410X(23)01161-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PARK H, Jang MS, Choi JA, Kim W, et al
Nonclinical safety assessment and immunogenicity of rVSVInd(GML)-mspSGtc vaccine for SARS-CoV-2 in rabbits.
Vaccine. 2023 Oct 9:S0264-410X(23)01178-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CHECCHI M, Mesher D, Panwar K, Anderson A, et al
The impact of over ten years of HPV vaccination in England: Surveillance of type-specific HPV in young sexually active females.
Vaccine. 2023 Oct 9:S0264-410X(23)01162-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MO C, Li X, Wu Q, Fan Y, et al
SARS-CoV-2 mRNA vaccine requires signal peptide to induce antibody responses.
Vaccine. 2023 Oct 9:S0264-410X(23)01156-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SATHE N, Shaikh S, Bhavsar M, Parte L, et al
Safety, immunogenicity and efficacy of Relcovax(R), a dual receptor binding domain (RBD) and nucleocapsid (N) subunit protein vaccine candidate against SARS-CoV-2 virus.
Vaccine. 2023 Oct 8:S0264-410X(23)01176-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FEBRIANI Y, Mansour T, Sadarangani M, Ulanova M, et al
Tdap vaccine in pregnancy and immunogenicity of pertussis and pneumococcal vaccines in children: What is the impact of different immunization schedules?
Vaccine. 2023 Oct 8:S0264-410X(23)01160-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BOPPANA SB, van Boven M, Britt WJ, Gantt S, et al
Vaccine value profile for cytomegalovirus.
Vaccine. 2023 Oct 6:S0264-410X(23)00670-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PROCTER TD, Ogasawara H, Spruin S, Wijayasri S, et al
Thrombosis with thrombocytopenia syndrome (TTS) following adenovirus vector COVID-19 vaccination in Canada.
Vaccine. 2023 Oct 6:S0264-410X(23)01159-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LOPEZ-ZAMBRANO MA, Pita CC, Escribano MF, Galan Melendez IM, et al
Factors associated to influenza vaccination among hospital's healthcare workers in the Autonomous Community of Madrid, Spain 2021-2022.
Vaccine. 2023 Oct 6:S0264-410X(23)01117-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PAPACHRISTIDOU S, Lapea V, Charisi M, Kourkouni E, et al
A multicenter study on the epidemiology of complicated parapneumonic effusion in the era of currently available pneumococcal conjugate vaccines.
Vaccine. 2023 Oct 5:S0264-410X(23)01164-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CAVIT L, Charania NA
Exploring factors that influence vaccination uptake for children with refugee backgrounds: An interpretive description study of primary healthcare providers' perspectives.
Vaccine. 2023 Oct 4:S0264-410X(23)01141-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

OZAWA S, Schuh HB, Nakamura T, Yemeke TT, et al
How to increase and maintain high immunization coverage: Vaccination Demand Resilience (VDR) framework.
Vaccine. 2023 Oct 3:S0264-410X(23)01097-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BEERENS D, Poland GA
Latest developments in vaccine research: Selected papers from the 16th annual vaccine congress.
Vaccine. 2023 Oct 3:S0264-410X(23)01153-2. doi: 10.1016/j.vaccine.2023.
PubMed

KANEVSKY I, Surendran N, McElwee K, Lei L, et al
Comparison of pneumococcal immunogenicity elicited by the PCV13 and PCV15 vaccines in adults 18 through 49 years of age.
Vaccine. 2023 Oct 3:S0264-410X(23)01113-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ZACHRESON C, Tobin R, Szanyi J, Walker C, et al
Individual variation in vaccine immune response can produce bimodal distributions of protection.
Vaccine. 2023 Oct 2:S0264-410X(23)01095-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

September 2023

OKOLI GN, Righolt CH, Zhang G, Alessi-Severini S, et al
Impact of the universal seasonal influenza vaccination policy in the province of Manitoba, Canada: A population-based, province-wide record-linkage study.
Vaccine. 2023 Sep 29:S0264-410X(23)01133-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

OVSYANNIKOVA IG, Haralambieva IH, Schaid DJ, Warner ND, et al
Genome-wide determinants of cellular immune responses to mumps vaccine.
Vaccine. 2023 Sep 29:S0264-410X(23)01055-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MIAO X, Zhang L, Zhou P, Yu R, et al
Adenovirus-vectored PDCoV vaccines induce potent humoral and cellular immune responses in mice.
Vaccine. 2023 Sep 29:S0264-410X(23)01139-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DE COUVREUR LA, Cobo MJ, Kennedy PJ, Ellis JT, et al
Bibliometric analysis of parasite vaccine research from 1990 to 2019.
Vaccine. 2023 Sep 28:S0264-410X(23)01105-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KOCHHAR S, Okomo U, Nkereuwem O, Shaum A, et al
Establishing vaccine pregnancy registries and active surveillance studies in low-and middle-income countries: Experience from an observational cohort surveillance project in The Gambia.
Vaccine. 2023 Sep 28:S0264-410X(23)01111-8. doi: 10.1016/j.vaccine.2023.
PubMed

DIONNE M, Sauvageau C, Kiely M, Rathwell M, et al
"The problem is not lack of information": A qualitative study of parents and school nurses' perceptions of barriers and potential solutions for HPV vaccination in schools.
Vaccine. 2023 Sep 28:S0264-410X(23)01140-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TSIRIGOTAKI M, Galanakis E
Impact of vaccines on Staphylococcus aureus colonization: A systematic review and meta-analysis.
Vaccine. 2023 Sep 28:S0264-410X(23)01104-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

NUSSBAUM J, Cao X, Railkar RA, Sachs JR, et al
Evaluation of a stabilized RSV pre-fusion F mRNA vaccine: Preclinical studies and Phase 1 clinical testing in healthy adults.
Vaccine. 2023 Sep 28:S0264-410X(23)00623-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HARBOE ZB, Hald A, Ekenberg C, Ete Wareham N, et al
Implementation of a vaccination clinic for adult solid organ transplant candidates: A single-center experience.
Vaccine. 2023 Sep 27:S0264-410X(23)01106-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LAVELL AHA, Schramade AE, Sikkens JJ, van der Straten K, et al
25-Hydroxyvitamin D concentrations do not affect the humoral or cellular immune response following SARS-CoV-2 mRNA vaccinations.
Vaccine. 2023 Sep 27:S0264-410X(23)00957-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SHEN X, Hao Y, Wang S, Li D, et al
Sequential heterologous immunization with COVID-19 vaccines induces broader neutralizing responses against SARS-CoV-2 variants in comparison with homologous boosters.
Vaccine. 2023 Sep 26:S0264-410X(23)01100-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CASSARINO N, Ahnger-Pier KK, Wurcel A
Trends in COVID-19 and influenza vaccine ordering and distribution in Massachusetts jails.
Vaccine. 2023 Sep 25:S0264-410X(23)01115-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SANA S, Merkelbach I, Magnee T, Kollmann J, et al
Identifying barriers to vaccination intention at walk-in vaccination facilities in deprived neighbourhoods: A cross-sectional survey.
Vaccine. 2023 Sep 25:S0264-410X(23)01038-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GOLOVKINA MI, Ertz SC, Lechnir SS, Hayney MS, et al
Providing influenza vaccines at endoscopy visits increases influenza vaccine uptake.
Vaccine. 2023 Sep 23:S0264-410X(23)01108-8. doi: 10.1016/j.vaccine.2023.
PubMed

SALO H, Perala J, Hannila-Handelberg T, Sarvikivi E, et al
Decline in varicella cases contacting primary health care after introduction of varicella vaccination in Finland - A population-based register study.
Vaccine. 2023 Sep 22:S0264-410X(23)01094-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MATHUR I, Church R, Ruisch A, Noyes K, et al
Insights to COVID-19 vaccine delivery: Results from a survey of 27 countries.
Vaccine. 2023 Sep 22:S0264-410X(23)01053-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

NGAMCHALIEW P, Kaewkuea N, Nonthasorn N, Vonnasrichan T, et al
Acceptance of COVID-19 vaccination and vaccine confidence levels in Thailand: A cross-sectional study.
Vaccine. 2023 Sep 22:S0264-410X(23)01088-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

RAISER F, Davis M, Adelglass J, Cai MR, et al
Immunogenicity and safety of NVX-CoV2373 as a booster: A phase 3 randomized clinical trial in adults.
Vaccine. 2023;41:5965-5973.
PubMed Abstract available

HOMAIRA N, He WQ, McRae J, Macartney K, et al
Coverage and predictors of influenza and pertussis vaccination during pregnancy: a whole of population-based study.
Vaccine. 2023 Sep 21:S0264-410X(23)01062-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FU Y, Wu K, Wang Z, Yang H, et al
Effectiveness of various COVID-19 vaccine regimens among 10.4 million patients from the National COVID Cohort Collaborative during Pre-Delta to Omicron periods - United States, 11 December 2020 to 30 June 2022.
Vaccine. 2023 Sep 21:S0264-410X(23)01025-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KIM DR, You YA, Ahn HS, Park EL, et al
Statistical considerations on real time and extended controlled temperature conditions (ECTC) stability data analysis of vaccines.
Vaccine. 2023 Sep 21:S0264-410X(23)00944-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WILKINSON B, Patel KS, Smith K, Walker R, et al
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Novavax COVID-19 Vaccine (NVX-CoV2373), a recombinant spike protein vaccine with Matrix-M adjuvant to prevent disease caused by SARS-CoV-2 vir
Vaccine. 2023 Sep 20:S0264-410X(23)00871-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DEPEW CE, McSorley SJ
The role of tissue resident memory CD4 T cells in Salmonella infection: Implications for future vaccines.
Vaccine. 2023 Sep 20:S0264-410X(23)01066-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ALHARBI HS
Review: Factors influencing parents' decisions to vaccinate children against COVID-19.
Vaccine. 2023 Sep 19:S0264-410X(23)01090-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SCHMITZ KS, Comvalius AD, Nieuwkoop NJ, Geers D, et al
A measles virus-based vaccine induces robust chikungunya virus-specific CD4(+) T-cell responses in a phase II clinical trial.
Vaccine. 2023 Sep 17:S0264-410X(23)01092-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HAN C, Zhao ZZ, Chan P, Li F, et al
A large survey on COVID-19 vaccination in patients with Parkinson's disease and healthy population.
Vaccine. 2023 Sep 17:S0264-410X(23)01056-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LASSAUNIERE R, Polacek C, Linnea Tingstedt J, Fomsgaard A, et al
Preclinical evaluation of a SARS-CoV-2 variant B.1.351-based candidate DNA vaccine.
Vaccine. 2023 Sep 17:S0264-410X(23)01091-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WANG Y, Ji W, Li D, Sun T, et al
Active inoculation with an inactivated Coxsackievirus A2 vaccine induces neutralizing antibodies and protects mice against lethal infection.
Vaccine. 2023 Sep 15:S0264-410X(23)01049-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SHAVER N, Katz M, Darko Asamoah G, Linkins LA, et al
Protocol for a living evidence synthesis on variants of concern and COVID-19 vaccine effectiveness.
Vaccine. 2023 Sep 15:S0264-410X(23)01065-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

IRALA S, Hamid S, Penayo E, Michel F, et al
COVID-19 vaccine effectiveness against hospitalizations in Paraguay, May 2021-April 2022: A test-negative design.
Vaccine. 2023 Sep 14:S0264-410X(23)01069-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SALAT J, Hunady M, Svoboda P, Strelcova L, et al
Efficacy and immunogenicity of a veterinary vaccine candidate against tick-borne encephalitis in dogs.
Vaccine. 2023 Sep 14:S0264-410X(23)01089-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LUGELO A, Hampson K, McElhinney LM, Lankester F, et al
Evaluation of an iELISA for detection and quantification of rabies antibodies in domestic dog sera.
Vaccine. 2023 Sep 14:S0264-410X(23)01058-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

REID MC, Mittler JE, Murphy JT, Stansfield SE, et al
Evolution of HIV virulence in response to disease-modifying vaccines: A modeling study.
Vaccine. 2023 Sep 13:S0264-410X(23)01027-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

JI WY, Liu DL, Yu R, Miao L, et al
Vaccination coverage survey of children aged 1-3 years in Beijing, China, 2005-2021.
Vaccine. 2023 Sep 12:S0264-410X(23)00946-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MEERAUS W, Stuurman AL, Durukal I, Conde-Sousa E, et al
COVID-19 vaccine booster doses provide increased protection against COVID-19 hospitalization compared with previously vaccinated individuals: Interim findings from the REFORCO-Brazil real-world effectiveness study during Delta and Omicron.
Vaccine. 2023 Sep 11:S0264-410X(23)01051-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

REUSCHENBACH M, Doorbar J, Del Pino M, Joura EA, et al
Prophylactic HPV vaccines in patients with HPV-associated diseases and cancer.
Vaccine. 2023 Sep 11:S0264-410X(23)00990-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SU F, Xue Y, Ye S, Yu B, et al
Integrative transcriptomic and metabolomic analysis in mice reveals the mechanism by which ginseng stem-leaf saponins enhance mucosal immunity induced by a porcine epidemic diarrhea virus vaccination.
Vaccine. 2023 Sep 11:S0264-410X(23)01085-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SURYAWANSHI YR
An overview of protein-based SARS-CoV-2 vaccines.
Vaccine. 2023 Sep 10:S0264-410X(23)01067-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ROY VL, Majumder PP
Genomic associations with antibody response to an oral cholera vaccine.
Vaccine. 2023 Sep 10:S0264-410X(23)01084-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FULLER HR, Huseth-Zosel A, Vleet BV, Hajdar M, et al
Vaccine attitudes and acceptance among older adults in North Dakota: Understanding demographic characteristic variability.
Vaccine. 2023 Sep 9:S0264-410X(23)01059-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

POTT H, Andrew MK, Shaffelburg Z, Nichols MK, et al
Vaccine Effectiveness of non-adjuvanted and adjuvanted trivalent inactivated influenza vaccines in the prevention of influenza-related hospitalization in older adults: A pooled analysis from the Serious Outcomes Surveillance (SOS) Network of the Canad
Vaccine. 2023 Sep 9:S0264-410X(23)01026-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MCCARTY JM, Bedell L, Mendy J, Coates EE, et al
Chikungunya virus virus-like particle vaccine is well tolerated and immunogenic in chikungunya seropositive individuals.
Vaccine. 2023 Sep 8:S0264-410X(23)01052-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

YU J, Sreenivasan C, Sheng Z, Zhai SL, et al
A recombinant chimeric influenza virus vaccine expressing the consensus H3 hemagglutinin elicits broad hemagglutination inhibition antibodies against divergent swine H3N2 influenza viruses.
Vaccine. 2023 Sep 7:S0264-410X(23)01060-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PANDEY MK, Rajukumar K, Senthilkumar D, Kombiah S, et al
Evaluation of dynamics of immune responses and protective efficacy in piglets immunized with an inactivated porcine reproductive and respiratory syndrome vaccine candidate.
Vaccine. 2023 Sep 7:S0264-410X(23)01047-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MONTEIRO HS, Lima Neto AS, Kahn R, Sousa GS, et al
Impact of CoronaVac on Covid-19 outcomes of elderly adults in a large and socially unequal Brazilian city: A target trial emulation study.
Vaccine. 2023;41:5742-5751.
PubMed Abstract available

LI P, Jia WY, Zhang X, Wang DB, et al
Effect of enterovirus 71 vaccine on epidemiological characteristics of hand, foot and mouth disease: An 8-year retrospective intermittent time series analysis.
Vaccine. 2023 Sep 6:S0264-410X(23)01061-7. doi: 10.1016/j.vaccine.2023.
PubMed

CHILDS K, Harvey Y, Waters R, Woma T, et al
Development of a quadrivalent foot-and-mouth disease vaccine candidate for use in East Africa.
Vaccine. 2023 Sep 5:S0264-410X(23)01054-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PATERNINA-CAICEDO A, Quevedo DS, Rios DS, Moyano D, et al
Comparative effectiveness and duration of protection of ChAdOx1, CoronaVac, BNT162b2, mRNA-1273, and Ad26.COV2.S COVID-19 vaccines for symptomatic and hospitalized Mu, Delta, and Omicron: A test-negative case-control study.
Vaccine. 2023 Sep 5:S0264-410X(23)01028-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

YUE PHR, Lau HPB, Ng SM, Chan LWC, et al
When to be vaccinated? What to consider? Modelling decision-making and time preference for COVID-19 vaccine through a conjoint experiment.
Vaccine. 2023 Sep 5:S0264-410X(23)01024-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TIEU HV, Karuna S, Huang Y, Sobieszczyk ME, et al
Safety and immunogenicity of a recombinant oligomeric gp145 subtype C Env protein (gp145 C.6980) HIV vaccine candidate in healthy, HIV-1-uninfected adult participants in the US.
Vaccine. 2023 Sep 5:S0264-410X(23)00877-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PHILLIPS A, Jiang Y, Walsh D, Andrews N, et al
Background rates of adverse events of special interest for COVID-19 vaccines: A multinational Global Vaccine Data Network (GVDN) analysis.
Vaccine. 2023 Sep 5:S0264-410X(23)01045-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

VAUX S, Gautier A, Nassany O, Bonmarin I, et al
Vaccination acceptability in the French general population and related determinants, 2000-2021.
Vaccine. 2023 Sep 4:S0264-410X(23)01018-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

YASUGI M, Nakagama Y, Kaku N, Nitahara Y, et al
Characteristics of epitope dominance pattern and cross-variant neutralisation in 16 SARS-CoV-2 mRNA vaccine sera.
Vaccine. 2023 Sep 4:S0264-410X(23)01040-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ALSAIF F, Twigg M, Scott S, Blyth A, et al
A systematic review of barriers and enablers associated with uptake of influenza vaccine among care home staff.
Vaccine. 2023 Sep 4:S0264-410X(23)01048-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CLAESSENS T, Krouwer S, Vandebosch H, Poels K, et al
Pathways to informed choices: The impact of freedom of choice and two-sided messages on psychological reactance and vaccination intentions among individuals who express concerns.
Vaccine. 2023 Sep 3:S0264-410X(23)00948-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BIRNBAUM JA, Guttman D, Parulekar M, Omarufilo F, et al
Eliminating hepatitis B vaccination disparities for West African immigrants.
Vaccine. 2023 Sep 3:S0264-410X(23)01012-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ZHOU G, Ma Q, Li Q, Wang S, et al
The disruption of LPS in Salmonella Typhimurium provides partial protection against Salmonella Choleraesuis as a live attenuated vaccine.
Vaccine. 2023 Sep 2:S0264-410X(23)01044-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WILLIS DE, Moore R, Andersen JA, Li J, et al
Correlates of COVID-19 vaccine coverage in Arkansas: Results from a weighted random sample survey.
Vaccine. 2023 Sep 1:S0264-410X(23)01039-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SUSARLA SK, Gupta M, Uttam KG, Palkar S, et al
Immunogenicity and safety of Havisure(TM) vaccine developed by Human Biologicals Institute in healthy subjects of 12 months to 49 years of age: A phase II/III, randomized, single blind, non-inferiority study.
Vaccine. 2023 Sep 1:S0264-410X(23)01050-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DA PENHA GOMES GOUVEA M, Lira Machado KLL, de Oliveira YGP, Moulaz IR, et al
Timeline kinetics of protective immunity to SARS-CoV-2 upon primary vaccination and humoral response to variants after booster dose.
Vaccine. 2023 Sep 1:S0264-410X(23)00954-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SANCHEZ-GONZALEZ G, Luna-Casas G, Mascarenas C, Macina D, et al
Pertussis in Mexico from 2000 to 2019: A real-world study of incidence, vaccination coverage, and vaccine effectiveness.
Vaccine. 2023 Sep 1:S0264-410X(23)00989-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PORRAS-RAMIREZ A, Sanchez-Paris R, Lopez-Devia W, Moreno-Perilla Z, et al
Confirmed cases of COVID-19 after vaccination against COVID in health personnel in Bogota, Colombia.
Vaccine. 2023 Sep 1:S0264-410X(23)00924-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PALMER M, Katanoda K, Saito E, Acuti Martellucci C, et al
Corrigendum to "Genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: A systematic review and meta-analysis" [Vaccine 40(41) (2022) 5971-5996].
Vaccine. 2023 Sep 1:S0264-410X(23)00787-9. doi: 10.1016/j.vaccine.2023.
PubMed

August 2023

FLOOD T, McLaughlin M, Hughes CM, Wilson IM, et al
Applying the COM-B behaviour model to understand factors which impact school immunisation nurses' attitudes towards designing and delivering a HPV educational intervention in post-primary schools for 15-17 year old students in Northern Ireland, UK.
Vaccine. 2023;41:5630-5639.
PubMed Abstract available

GRILLS LA, Wagner AL
The impact of the COVID-19 pandemic on parental vaccine hesitancy: A cross-sectional survey.
Vaccine. 2023 Aug 31:S0264-410X(23)00977-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SAKALA IG, Honda-Okubo Y, Petrovsky N
Developmental and reproductive safety of Advax-CpG55.2 adjuvanted COVID-19 and influenza vaccines in mice.
Vaccine. 2023 Aug 31:S0264-410X(23)01007-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DUDLEY HM, O'Mara M, Auma A, Gong J, et al
Rheumatoid arthritis and older age are associated with lower humoral and cellular immune response to primary series COVID-19 mRNA vaccine.
Vaccine. 2023 Aug 31:S0264-410X(23)00965-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

REGAN AK, Fell DB, Wise LA, Vazquez-Benitez G, et al
Challenges & opportunities for the epidemiological evaluation of the effects of COVID-19 vaccination on reproduction and pregnancy.
Vaccine. 2023 Aug 31:S0264-410X(23)00964-7. doi: 10.1016/j.vaccine.2023.
PubMed

KRISHNA SUSARLA S, Jahagirdar R, Ghosh Uttam K, Srikanth Bhatt S, et al
Immunogenicity and safety of Mebella vaccine developed by Human Biologicals Institute in a Phase II/III, randomized, multicentric, non-inferiority study.
Vaccine. 2023 Aug 31:S0264-410X(23)01021-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SNIDER CJ, Zaman K, Wilkinson AL, Binte Aziz A, et al
Poliovirus type 1 systemic humoral and intestinal mucosal immunity induced by monovalent oral poliovirus vaccine, fractional inactivated poliovirus vaccine, and bivalent oral poliovirus vaccine: A randomized controlled trial.
Vaccine. 2023 Aug 29:S0264-410X(23)01009-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PUNCHHI G, Negus R, Saif H, Pritchard S, et al
Real-world challenges in eligibility for MMR vaccination two years after autologous and allogeneic HSCT.
Vaccine. 2023 Aug 29:S0264-410X(23)00778-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

YESKENDIR A, Gusmanov A, Zhussupov B
Parental attitudes, beliefs and behaviors toward childhood and COVID-19 vaccines: A countrywide survey conducted in Kazakhstan examining vaccine refusal and hesitancy.
Vaccine. 2023 Aug 29:S0264-410X(23)01019-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

YI EJ, Kim YI, Song JH, Ko HJ, et al
Potential of a bivalent vaccine for broad protection against enterovirus 71 and coxsackie virus 16 infections causing hand, foot, and mouth disease.
Vaccine. 2023 Aug 28:S0264-410X(23)00961-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HACKER E, Baker B, Lake T, Ross C, et al
Vaccine microarray patch self-administration: An innovative approach to improve pandemic and routine vaccination rates.
Vaccine. 2023 Aug 27:S0264-410X(23)00959-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PHIRIYASART F, Aimyong N, Jirapongsuwan A, Roseh N, et al
COVID-19 vaccine hesitancy among older adult Thai Muslim people: A case-control study.
Vaccine. 2023 Aug 27:S0264-410X(23)00994-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

NYGARD S, Nygard M, Orumaa M, Hansen BT, et al
Erratum to "Quadrivalent HPV vaccine effectiveness against anogenital warts: A registry-based study of 2,2 million individuals" [Vaccine 41(37) (2023) 5469-5476].
Vaccine. 2023 Aug 26:S0264-410X(23)01010-1. doi: 10.1016/j.vaccine.2023.
PubMed

UGAI S, Ugai T, Kanayama T, Kamiya H, et al
Mumps vaccine hesitancy: Current evidence and an evidence-based campaign in Japan.
Vaccine. 2023 Aug 26:S0264-410X(23)00976-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

YANG J, Li B, Yang D, Wu J, et al
The immunogenicity of Alum+CpG adjuvant SARS-CoV-2 inactivated vaccine in mice.
Vaccine. 2023 Aug 26:S0264-410X(23)01017-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MOTTA M, Motta G, Stecula D
Sick as a dog? The prevalence, politicization, and health policy consequences of canine vaccine hesitancy (CVH).
Vaccine. 2023 Aug 26:S0264-410X(23)01015-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

JANSSEN ERC, van Montfoort AZ, Hollman F, Lambers Heerspink FO, et al
The prevalence and clinical course of shoulder injury related to vaccine administration (SIRVA) after COVID-19 vaccines in Dutch hospital workers.
Vaccine. 2023 Aug 25:S0264-410X(23)00975-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CHIBA S, Halfmann PJ, Iida S, Hirata Y, et al
Recombinant spike protein vaccines coupled with adjuvants that have different modes of action induce protective immunity against SARS-CoV-2.
Vaccine. 2023 Aug 25:S0264-410X(23)01008-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CHEUVART B, Callegaro A, Rosillon D, Meyer N, et al
Effectiveness of maternal immunisation with a three-component acellular pertussis vaccine at preventing pertussis in infants in the United States: Post-hoc analysis of a case-control study using Bayesian dynamic borrowing.
Vaccine. 2023 Aug 25:S0264-410X(23)00888-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CHEN IR, Wang GJ, Hsueh PR, Chou CH, et al
Immune responses and safety of COVID-19 vaccination in atypical hemolytic uremic syndrome patients in Taiwan.
Vaccine. 2023 Aug 25:S0264-410X(23)00952-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DENG L, Tapper K, Thosar D, Goeman E, et al
Use of adrenaline to manage suspected anaphylaxis following COVID-19 vaccination: An Australian retrospective cohort study.
Vaccine. 2023 Aug 24:S0264-410X(23)00956-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GOULD S, Wrzesinski C, Stebbings R, Segal L, et al
Report from an ICT 2022 workshop on toxicology for Covid19 vaccines: Industry, regulatory and CRO perspectives.
Vaccine. 2023 Aug 24:S0264-410X(23)00972-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MOHAMMED IS, Widome R, Searle KM
COVID-19 vaccine decision-making among Black women: A qualitative study.
Vaccine. 2023 Aug 24:S0264-410X(23)00920-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WATERLOW NR, Procter SR, van Leeuwen E, Radhakrishnan S, et al
The potential cost-effectiveness of next generation influenza vaccines in England and Wales: A modelling analysis.
Vaccine. 2023 Aug 24:S0264-410X(23)00963-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

STRUYF F, Hardt K, Van Rampelbergh R, Shukarev G, et al
Thrombosis with thrombocytopenia syndrome: A database review of clinical trial and post-marketing experience with Ad26.COV2.S.
Vaccine. 2023;41:5351-5359.
PubMed Abstract available

TIAN J, Zheng B, Yang L, Guan Y, et al
Effectiveness of 13-valent pneumococcal conjugate vaccine on all-cause pneumonia in children under 5 years in Shanghai, China: An observational study.
Vaccine. 2023 Aug 23:S0264-410X(23)00973-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HALDER P, Maiti S, Banerjee S, Das S, et al
Bacterial ghost cell based bivalent candidate vaccine against Salmonella Typhi and Salmonella Paratyphi A: A prophylactic study in BALB/c mice.
Vaccine. 2023 Aug 23:S0264-410X(23)00992-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SHAPIRO JR, Andreani G, Dube C, Berube M, et al
Development and characterization of a plant-derived norovirus-like particle vaccine.
Vaccine. 2023 Aug 23:S0264-410X(23)00968-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HOMAIRA N, Strachan R, Quinn H, Beggs S, et al
Erratum to "Real world impact of 13vPCV in preventing invasive pneumococcal pneumonia in Australian children: A national study" [Vaccine 41(1) (2023) 85-91].
Vaccine. 2023 Aug 23:S0264-410X(23)00870-8. doi: 10.1016/j.vaccine.2023.
PubMed

KUMRU OS, Sanyal M, Friedland N, Hickey JM, et al
Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 spike ferritin nanoparticle vaccine antigen produced from two different cell lines.
Vaccine. 2023 Aug 22:S0264-410X(23)00969-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MAKI Y, Edo N, Mizuguchi M, Ikeda M, et al
Impact of frequency and duration of freeze-dried inactivated tissue culture hepatitis A vaccine (Aimmugen(R)) vaccination on antibody titers; a japanese cross-sectional study.
Vaccine. 2023 Aug 22:S0264-410X(23)00962-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

YAO T, Guo Y, Xu X, Zhang X, et al
Predictors of immune persistence induced by two-dose BBIBP-CorV vaccine in high-risk occupational population.
Vaccine. 2023 Aug 19:S0264-410X(23)00974-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SU Y, Guo Z, Gu X, Sun S, et al
Influenza vaccine effectiveness against influenza A during the delayed 2022/23 epidemic in Shihezi, China.
Vaccine. 2023 Aug 19:S0264-410X(23)00971-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CHAIWONG W, Takheaw N, Pata S, Laopajon W, et al
Neutralizing antibody and T-cell responses against SARS-CoV-2 variants by heterologous CoronaVac/ChAdOx-1 vaccination in elderly subjects with chronic obstructive pulmonary disease.
Vaccine. 2023 Aug 18:S0264-410X(23)00966-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ENUJIOKE SC, Shedd-Steele R, Daggy J, Burney HN, et al
County-level correlates of completed HPV vaccination in Indiana.
Vaccine. 2023 Aug 18:S0264-410X(23)00875-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KENIGSBERG TA, Goddard K, Hanson KE, Lewis N, et al
Simultaneous administration of mRNA COVID-19 bivalent booster and influenza vaccines.
Vaccine. 2023 Aug 18:S0264-410X(23)00955-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MORRISON K, Cullen L, James AB, Chua V, et al
Predictors of incomplete COVID-19 vaccine schedule among adults in Scotland: Two retrospective cohort analyses of the primary schedule and third dose.
Vaccine. 2023 Aug 17:S0264-410X(23)00916-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PALACHE A, Billingsley JK, MacLaren K, Morgan L, et al
Lessons learned from the COVID-19 pandemic for improved influenza control.
Vaccine. 2023 Aug 17:S0264-410X(23)00960-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DALE JB, Aranha MP, Penfound TA, Salehi S, et al
Structure-guided design of a broadly cross-reactive multivalent group a streptococcal vaccine.
Vaccine. 2023 Aug 16:S0264-410X(23)00958-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ZUR M, Shelef L, Glassberg E, Fink N, et al
Are intelligent people more likely to get vaccinated? The association between COVID-19 vaccine adherence and cognitive profiles.
Vaccine. 2023 Aug 15:S0264-410X(23)00951-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FILARDO TD, Prasad N, Waddell CJ, Persad N, et al
Mpox vaccine acceptability among people experiencing homelessness in San Francisco - October-November 2022.
Vaccine. 2023 Aug 15:S0264-410X(23)00914-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

REIFFERSCHEID L, Kiely MS, Lin MSN, Libon J, et al
Effectiveness of hospital-based strategies for improving childhood immunization coverage: A systematic review.
Vaccine. 2023;41:5233-5244.
PubMed Abstract available

TOYAMA K, Eto T, Takazawa K, Shimizu S, et al
DS-5670a, a novel mRNA-encapsulated lipid nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2: Results from a phase 2 clinical study.
Vaccine. 2023 Aug 14:S0264-410X(23)00824-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WITTAWATMONGKOL O, Bunjoungmanee P, Kosalaraksa P, Laoprasopwattana K, et al
Immunogenicity and reactogenicity of fractional, heterologous primary COVID-19 vaccination schedules with BNT162b2 boosters in 5-11-year-old Thai children: A multicenter, prospective, double-blind, randomized control trial.
Vaccine. 2023 Aug 14:S0264-410X(23)00953-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FRANCONERI L, Antona D, Cauchemez S, Levy-Bruhl D, et al
Two-dose measles vaccine effectiveness remains high over time: A French observational study, 2017-2019.
Vaccine. 2023 Aug 14:S0264-410X(23)00950-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

YIN MZ, Gu YY, Shu JT, Zhang B, et al
Cost-effectiveness of cytomegalovirus vaccination for females in China: A decision-analytical Markov study.
Vaccine. 2023 Aug 12:S0264-410X(23)00943-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BERTHELEMY C, Bouche P, Lamiral Z, Boivin JM, et al
Parental acceptability of vaccinating young children against influenza and COVID-19.
Vaccine. 2023 Aug 12:S0264-410X(23)00929-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MALIRAT V, Caldevilla C, Cardillo S, Espinoza AM, et al
Broad immunogenic spectrum of monovalent and trivalent foot-and-mouth disease virus vaccines containing O(1) campos, A24 cruzeiro and A Argentina 2001 strains against circulating viral lineages in cattle and pigs.
Vaccine. 2023 Aug 11:S0264-410X(23)00939-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SUFFEL AM, Walker JL, Williamson E, McDonald HI, et al
Timeliness of childhood vaccination in England: A population-based cohort study.
Vaccine. 2023 Aug 11:S0264-410X(23)00926-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BUMATAY S, Dickinson C, Larsen R, Stock I, et al
A comparison of electronic health records and the Oregon state immunization registry for human papilloma virus vaccine delivery (2005-2022).
Vaccine. 2023 Aug 10:S0264-410X(23)00949-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

EIFFERT SR, Sturmer T, Thorpe CT, Traub R, et al
Vaccine patterns among patients diagnosed with Guillain-Barre Syndrome and matched counterparts in a Medicare supplemental population, 2000-2020.
Vaccine. 2023 Aug 10:S0264-410X(23)00947-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CARDONA RSB, Weckx LY, de Moraes-Pinto MI, Ramos BCF, et al
Pertussis antibodies and vaccination coverage among healthcare professionals in Brazil is inadequate: A cross-sectional serological study.
Vaccine. 2023 Aug 10:S0264-410X(23)00940-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HONDA-OKUBO Y, Bart Tarbet E, Hurst BL, Petrovsky N, et al
An Advax-CpG adjuvanted recombinant H5 hemagglutinin vaccine protects mice against lethal influenza infection.
Vaccine. 2023 Aug 9:S0264-410X(23)00941-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BAGLIVO F, Magri M, De Angelis L, Aprile V, et al
Performance comparison between heterologous and homologous COVID19 vaccine schedules on Omicron variant incidence: A real-world retrospective cohort study in Southern Italy.
Vaccine. 2023 Aug 9:S0264-410X(23)00886-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WARIRI O, Utazi CE, Okomo U, Metcalf CJE, et al
Mapping the timeliness of routine childhood vaccination in The Gambia: A spatial modelling study.
Vaccine. 2023 Aug 8:S0264-410X(23)00928-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SHEARS MJ, Watson FN, Stone BC, Cruz Talavera I, et al
Preliminary studies on the immunogenicity of a prime-and-trap malaria vaccine in nonhuman primates.
Vaccine. 2023 Aug 8:S0264-410X(23)00913-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KOCHHAR S, Izurieta HS, Chandler RE, Hacker A, et al
Benefit-risk assessment of vaccines.
Vaccine. 2023 Aug 8:S0264-410X(23)00872-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PITTS PJ, Poland GA
Trust and science: Public health's home field advantage in addressing vaccine hesitancy and improving immunization rates.
Vaccine. 2023 Aug 6:S0264-410X(23)00927-1. doi: 10.1016/j.vaccine.2023.
PubMed

VERJOVSKY M, Barreto MP, Carmo I, Coutinho B, et al
Political quarrel overshadows vaccination advocacy: How the vaccine debate on Brazilian Twitter was framed by anti-vaxxers during Bolsonaro administration.
Vaccine. 2023 Aug 5:S0264-410X(23)00921-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CAMPBELL J, Kaur A, Gamino D, Benoit E, et al
Individual and structural determinants of COVID-19 vaccine uptake in a marginalized community in the United States.
Vaccine. 2023 Aug 5:S0264-410X(23)00923-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SIMMS AJ, King KD, Tsui N, Edwards SA, et al
COVID-19 vaccine behaviour among citizens of the Metis Nation of Ontario: A qualitative study.
Vaccine. 2023 Aug 5:S0264-410X(23)00891-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

IZULLA P, Wagai JN, Akelo V, Ombeva A, et al
Vaccine safety surveillance in Kenya using GAIA standards: A feasibility assessment of existing national and subnational research and program systems.
Vaccine. 2023 Aug 5:S0264-410X(23)00906-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CHICOYE A, Crepey P, Nguyen VH, Marquez-Pelaez S, et al
Contributions of cost-effectiveness analyses (CEA) to influenza vaccination policy for older adults in Europe.
Vaccine. 2023 Aug 5:S0264-410X(23)00919-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MOSCARA L, Venerito V, Martinelli A, Di Lorenzo A, et al
Safety profile and SARS-CoV-2 breakthrough infections among HCWs receiving anti-SARS-CoV-2 and influenza vaccines simultaneously: an Italian observational study.
Vaccine. 2023 Aug 4:S0264-410X(23)00874-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

XU S, Yu H, Cheng X, Wu J, et al
Inactivated SARS-CoV-2 vaccination does not disturb the clinical course of Graves' disease: An observational cohort study.
Vaccine. 2023 Aug 4:S0264-410X(23)00884-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GRANT LR, Slack MPE, Theilacker C, Vojicic J, et al
Distribution of serotypes causing invasive pneumococcal disease in older adults from high-income countries and impact of pediatric and adult vaccination policies.
Vaccine. 2023 Aug 4:S0264-410X(23)00925-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

AUVIGNE V, Tamandjou Tchuem CR, Schaeffer J, Vaux S, et al
Protection against symptomatic SARS-CoV-2 infection conferred by the Pfizer-BioNTech Original/BA.4-5 bivalent vaccine compared to the mRNA Original monovalent vaccines - A matched cohort study in France.
Vaccine. 2023 Aug 2:S0264-410X(23)00917-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SINGER D, Salem A, Stempniewicz N, Ma S, et al
The potential impact of increased recombinant zoster vaccine coverage on the burden of herpes zoster among adults aged 50-59 years.
Vaccine. 2023 Aug 2:S0264-410X(23)00837-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CARTER A, Msemburi W, Sim SY, Gaythorpe KAM, et al
Modeling the impact of vaccination for the immunization Agenda 2030: Deaths averted due to vaccination against 14 pathogens in 194 countries from 2021 to 2030.
Vaccine. 2023 Aug 1:S0264-410X(23)00854-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MO J, Spackman E, Swayne DE
Prediction of highly pathogenic avian influenza vaccine efficacy in chickens by comparison of in vitro and in vivo data: A meta-analysis and systematic review.
Vaccine. 2023 Aug 1:S0264-410X(23)00922-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

July 2023

AMAI M, Nojima M, Yuki Y, Kiyono H, et al
A review of criteria strictness in "Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials".
Vaccine. 2023 Jul 31:S0264-410X(23)00918-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GUNALE B, Farinola N, Yeolekar L, Shrivastava S, et al
A Phase 1, double-blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of a tetravalent live attenuated dengue vaccine in adults.
Vaccine. 2023 Jul 31:S0264-410X(23)00876-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HONDA-OKUBO Y, Sakala IG, Andre G, Tarbet EB, et al
An Advax-CpG55.2 adjuvanted recombinant hemagglutinin vaccine provides immunity against H7N9 influenza in adult and neonatal mice.
Vaccine. 2023 Jul 31:S0264-410X(23)00892-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WALLACE M, Rosenblum HG, Moulia DL, Broder KR, et al
A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United States.
Vaccine. 2023 Jul 30:S0264-410X(23)00868-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

VAN WALSTIJN C, Verweij S, Care R, Rigsby P, et al
Variability of in vivo potency assays of whole-cell pertussis, inactivated polio, and meningococcal B vaccines.
Vaccine. 2023 Jul 30:S0264-410X(23)00885-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LIU B, Stepien S, Qian J, Gidding H, et al
Comparative effectiveness of four COVID-19 vaccines, BNT162b2 mRNA, mRNA-1273, ChAdOx1 nCov-19 and NVX-CoV2373 against SARS-CoV-2 B.1.1.529 (Omicron) infection.
Vaccine. 2023 Jul 29:S0264-410X(23)00881-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

AMANI A, Njoh AA, Atuhebwe P, Ndoula S, et al
Beyond the numbers: An in-depth look at Cameroon's fifth national COVID-19 vaccination campaign through geographical and gender lenses.
Vaccine. 2023 Jul 29:S0264-410X(23)00905-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DECEUNINCK G, Brousseau N, Lefebvre B, Quach C, et al
Effectiveness of thirteen-valent pneumococcal conjugate vaccine to prevent serotype 3 invasive pneumococcal disease in Quebec in children, Canada.
Vaccine. 2023 Jul 29:S0264-410X(23)00880-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GREEN-MCKENZIE J, Shofer FS, Kruse G, Momplaisir F, et al
COVID-19 vaccine uptake before and after a vaccine mandate at a major academic hospital: Trends by race/ethnicity and level of patient contact.
Vaccine. 2023 Jul 28:S0264-410X(23)00853-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LENTSCH V, Aslani S, Echtermann T, Preet S, et al
"EvoVax" - A rationally designed inactivated Salmonella Typhimurium vaccine induces strong and long-lasting immune responses in pigs.
Vaccine. 2023 Jul 28:S0264-410X(23)00890-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KIM SY, Lee KM, Kim KH
Differences between DNA vaccine and single-cycle viral vaccine in the ability of cross-protection against viral hemorrhagic septicemia virus (VHSV) and infectious hematopoietic necrosis virus (IHNV).
Vaccine. 2023 Jul 28:S0264-410X(23)00889-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PADENIYA TN, Hui BB, Wood JG, Seib KL, et al
The potential impact of a vaccine on Neisseria gonorrhoeae prevalence among heterosexuals living in a high prevalence setting.
Vaccine. 2023 Jul 28:S0264-410X(23)00879-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HAMAD SAIED M, van Straalen JW, de Roock S, de Joode-Smink GCJ, et al
Long-term immunoprotection after live attenuated measles-mumps-rubella booster vaccination in children with juvenile idiopathic arthritis.
Vaccine. 2023 Jul 27:S0264-410X(23)00883-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LAVENDER B, Hooker C, Frampton C, Williams M, et al
Robust immunogenicity of a third BNT162b2 vaccination against SARS-CoV-2 Omicron variant in a naive New Zealand cohort.
Vaccine. 2023 Jul 27:S0264-410X(23)00882-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

JIANG XY, Gong MQ, Zhang HJ, Peng AQ, et al
The safety and immunogenicity of a recombinant five-antigen Staphylococcus aureus vaccine among patients undergoing elective surgery for closed fractures: A randomized, double-blind, placebo-controlled, multicenter phase 2 clinical trial.
Vaccine. 2023 Jul 27:S0264-410X(23)00878-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

NYGARD S, Nygard M, Orumaa M, Hansen BT, et al
Quadrivalent HPV vaccine effectiveness against anogenital warts: A registry-based study of 2,2 million individuals.
Vaccine. 2023 Jul 27:S0264-410X(23)00852-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ROSA RG, Falavigna M, Manfio JL, de Araujo CLP, et al
BNT162b2 mRNA COVID-19 against symptomatic Omicron infection following a mass vaccination campaign in southern Brazil: A prospective test-negative design study.
Vaccine. 2023 Jul 26:S0264-410X(23)00869-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KABIR A, Randall D, Newall AT, Moore HC, et al
Incremental effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia hospitalisation among Australian Indigenous children: A record linkage study.
Vaccine. 2023 Jul 26:S0264-410X(23)00873-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KIM DH, Lee J, Youk S, Jeong JH, et al
Intramuscular administration of recombinant Newcastle disease virus expressing SARS-CoV-2 spike protein protects hACE-2 TG mice against SARS-CoV-2 infection.
Vaccine. 2023;41:4787-4797.
PubMed Abstract available

MARTINI M, Orsini D
The ghost of polio haunts us once again. The appeal of the scientific community is clear: "Vaccinate your kids today!".
Vaccine. 2023 Jul 24:S0264-410X(23)00850-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TAMADA Y, Takeuchi K, Kusama T, Maeda M, et al
Effectiveness of COVID-19 vaccines against infection in Japan: A test-negative study from the VENUS study.
Vaccine. 2023 Jul 22:S0264-410X(23)00856-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GHAZY RM, Ibrahim SA, Taha SHN, Elshabrawy A, et al
Attitudes of parents towards influenza vaccine in the Eastern Mediterranean Region: A multilevel analysis.
Vaccine. 2023 Jul 20:S0264-410X(23)00808-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ARAUJO-CHAVERON L, Sicsic J, Moffroid H, Diaz Luevano C, et al
Impact of a COVID-19 certificate requirement on vaccine uptake pattern and intention for future vaccination. A cross-sectional study among French adults.
Vaccine. 2023 Jul 20:S0264-410X(23)00805-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KIM YA, Mousavi K, Yazdi A, Zwierzyna M, et al
Computational design of mRNA vaccines.
Vaccine. 2023 Jul 20:S0264-410X(23)00836-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ORAMI T, Aho C, Ford RL, Pomat WS, et al
Pneumococcal carriage, serotype distribution, and antimicrobial susceptibility in Papua New Guinean children vaccinated with PCV10 or PCV13 in a head-to-head trial.
Vaccine. 2023 Jul 19:S0264-410X(23)00838-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CANTARERO D, Ocana D, Onieva-Garcia MA, Rodriguez-Garcia J, et al
Cost-utility analysis of the use of the 20-valent anti-pneumococcal vaccine (PCV20) in adults older than 60 years in Spain.
Vaccine. 2023 Jul 19:S0264-410X(23)00828-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

JESUDASON T, Rodarte A, Tordrup D, Carias C, et al
Systematic review of rotavirus vaccination cost-effectiveness in high income settings utilising dynamic transmission modelling techniques.
Vaccine. 2023 Jul 19:S0264-410X(23)00749-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CLIMACO MC, de Figueiredo LA, Lucas RC, Pinheiro GRG, et al
Development of chimeric protein as a multivalent vaccine for human Kinetoplastid infections: Chagas disease and leishmaniasis.
Vaccine. 2023 Jul 19:S0264-410X(23)00832-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PISL V, Vevera J
COVID-19 vaccine uptake in mental healthcare users: Czech nationwide register study.
Vaccine. 2023 Jul 19:S0264-410X(23)00840-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KATHERINE YIH W, Daley MF, Duffy J, Fireman B, et al
Safety signal identification for COVID-19 bivalent booster vaccination using tree-based scan statistics in the Vaccine Safety Datalink.
Vaccine. 2023 Jul 19:S0264-410X(23)00823-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

VIETRI J, Sato R, Averin A, Weycker D, et al
Pneumococcal vaccine uptake among Medicare Beneficiaries aged >/=65 years following the shared clinical decision-making recommendation for 13-valent pneumococcal conjugate vaccine in 2019.
Vaccine. 2023 Jul 18:S0264-410X(23)00855-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ZIMMERMAN RK, Patricia Nowalk M, Dauer K, Clarke L, et al
Vaccine effectiveness of recombinant and standard dose influenza vaccines against influenza related hospitalization using a retrospective test-negative design.
Vaccine. 2023 Jul 18:S0264-410X(23)00741-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DAS SK, Khan J
Timeliness in the uptake of hepatitis B birth dose among Indian children under age five: A population-based study.
Vaccine. 2023 Jul 17:S0264-410X(23)00827-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BATOOL R, Yousafzai MT, Qureshi S, Muhammad S, et al
Parental acceptance of typhoid conjugate vaccine for children aged 6 months to 15 years in an outbreak setting of Lyari Town Karachi, Pakistan.
Vaccine. 2023 Jul 16:S0264-410X(23)00806-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SABAT I, Neumann-Bohme S, Barros PP, Torbica A, et al
Vaccine hesitancy comes in waves: Longitudinal evidence on willingness to vaccinate against COVID-19 from seven European countries.
Vaccine. 2023 Jul 15:S0264-410X(23)00829-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SCHAEFER GO, Emanuel EJ, Atuire CA, Leland RJ, et al
Equitable global allocation of monkeypox vaccines.
Vaccine. 2023 Jul 15:S0264-410X(23)00835-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MOROS A, Prenafeta A, Barreiro A, Perozo E, et al
Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate.
Vaccine. 2023 Jul 15:S0264-410X(23)00820-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CLOUSTON SAP, Hanes DW, Link BG
Social inequalities and the early provision and dispersal of COVID-19 vaccinations in the United States: A population trends study.
Vaccine. 2023 Jul 15:S0264-410X(23)00833-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MYERS MG
Beginning to address vaccine reluctance and refusal.
Vaccine. 2023 Jul 14:S0264-410X(23)00851-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GIERSING B, Karron R, Tufet-Bayona M, Trotter C, et al
Vaccine Value profiles.
Vaccine. 2023 Jul 14:S0264-410X(23)00786-7. doi: 10.1016/j.vaccine.2023.
PubMed

TALOTTA R
COVID-19 mRNA vaccines as hypothetical epigenetic players: Results from an in silico analysis, considerations and perspectives.
Vaccine. 2023 Jul 13:S0264-410X(23)00819-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GLESER D, Spinner K, Klement E
Effectiveness of the strain 919 bovine ephemeral fever virus vaccine in the face of a real-world outbreak: A field study in Israeli dairy herds.
Vaccine. 2023 Jul 12:S0264-410X(23)00747-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ALABANZA C, Gavrilov V, Scott T, Yang RS, et al
Quantitation of strain-specific hemagglutinin trimers in mosaic quadrivalent influenza nanoparticle vaccine by ELISA.
Vaccine. 2023 Jul 12:S0264-410X(23)00821-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

AGRAWAL P, Damania D, Cseh A, Grab J, et al
Impact of COVID vaccine and comorbidities in patients receiving casirivimab-imdevimab monoclonal antibody during SARS-CoV-2 B.1.617.2 (Delta) surge: A real-world study.
Vaccine. 2023 Jul 12:S0264-410X(23)00822-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

YAMAGUCHI K, Shimizu H, Takahashi K, Nagatomo T, et al
Characterization of epitopes of human monoclonal antibodies against cytomegalovirus glycoprotein B for neutralization and antibody-dependent phagocytosis.
Vaccine. 2023;41:4497-4507.
PubMed Abstract available

MINCHIN J, Harris GH, Baumann S, Smith ER, et al
Exclusion of pregnant people from emergency vaccine clinical trials: A systematic review of clinical trial protocols and reporting from 2009 to 2019.
Vaccine. 2023 Jul 11:S0264-410X(23)00776-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MIELLET WR, Pluister G, Sikking M, Tappel M, et al
Surveillance of Neisseria meningitidis carriage four years after menACWY vaccine implementation in the Netherlands reveals decline in vaccine-type and rise in genogroup e circulation.
Vaccine. 2023 Jul 7:S0264-410X(23)00781-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WILLIS DE, Reece S, Gurel-Headley M, Selig JP, et al
Social processes, practical issues, and COVID-19 vaccination among hesitant adults.
Vaccine. 2023 Jul 7:S0264-410X(23)00809-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FLEMING JA, Baral R, Higgins D, Khan S, et al
Value profile for respiratory syncytial virus vaccines and monoclonal antibodies.
Vaccine. 2023 Jul 6:S0264-410X(22)01212-9. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

ZHANG X, Shen P, Liu J, Ji X, et al
Evaluating the effectiveness and cost-effectiveness of free influenza vaccination policy for older adults in Yinzhou, China: Study protocol of a real-world analyses.
Vaccine. 2023 Jul 5:S0264-410X(23)00790-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WAGNER A, Juvalta S, Speranza C, Suggs LS, et al
Let's talk about COVID-19 vaccination: Relevance of conversations about COVID-19 vaccination and information sources on vaccination intention in Switzerland.
Vaccine. 2023 Jul 5:S0264-410X(23)00807-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LE H, de Klerk N, Blyth CC, Gidding H, et al
Non-specific benefit of seasonal influenza vaccine on respiratory syncytial virus-hospitalisations in children: An instrumental variable approach using population-based data.
Vaccine. 2023 Jul 3:S0264-410X(23)00788-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ROSHCHINA Y, Rozhkova K, Roshchin S
Between nudges and mandates: The drivers of COVID-19 vaccination intentions and subsequent uptake in Russia.
Vaccine. 2023 Jul 3:S0264-410X(23)00756-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PATEL UC, Schultz T, Schmidt J
Veteran influenza vaccination acceptance rates after completion of the COVID-19 vaccination series among historical influenza vaccine refusers.
Vaccine. 2023 Jul 3:S0264-410X(23)00803-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TUCKERMAN J, Kaufman J, Overmars I, Holland P, et al
Barriers to COVID-19 vaccination of migrant populations: A qualitative interview study of immunisation providers in Victoria, Australia.
Vaccine. 2023 Jul 3:S0264-410X(23)00804-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TROGSTAD L, Laake I, Robertson AH, Mjaaland S, et al
Heavy bleeding and other menstrual disturbances in young women after COVID-19 vaccination.
Vaccine. 2023 Jul 3:S0264-410X(23)00801-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GRUZDEV N, Pitcovski J, Katz C, Ruimi N, et al
Development of toxin-antitoxin self-destructive bacteria, aimed for salmonella vaccination.
Vaccine. 2023 Jul 1:S0264-410X(23)00777-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

IZUMI F, Miyamoto S, Masatani T, Sasaki M, et al
Generation and characterization of a genetically modified live rabies vaccine strain with attenuating mutations in multiple viral proteins and evaluation of its potency in dogs.
Vaccine. 2023 Jul 1:S0264-410X(23)00779-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KELLY M, Mandlik A, Charles RC, Verma S, et al
Development of Shigella conjugate vaccines targeting Shigella flexneri 2a and S. flexneri 3a using a simple platform-approach conjugation by squaric acid chemistry.
Vaccine. 2023 Jul 1:S0264-410X(23)00738-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

June 2023

LIU Z, Pang C, Deng Y, Guo C, et al
Humoral immune response following the inactivated quadrivalent influenza vaccination among HIV-infected and HIV-uninfected adults.
Vaccine. 2023 Jun 30:S0264-410X(23)00616-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SHINJOH M, Furuichi M, Tsuzuki S, Iqbal A, et al
Effectiveness of inactivated influenza and COVID-19 vaccines in hospitalized children in 2022/23 season in Japan - The first season of co-circulation of influenza and COVID-19.
Vaccine. 2023 Jun 30:S0264-410X(23)00785-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LIU Y, Zhang A, Wang Y, Yang J, et al
Immunogenicity and protective effects of recombinant bivalent COVID-19 vaccine in mice and rhesus macaques.
Vaccine. 2023 Jun 30:S0264-410X(23)00789-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KU JH, Sy LS, Qian L, Ackerson BK, et al
Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: Interim results from an observational cohort study.
Vaccine. 2023;41:4212-4219.
PubMed Abstract available

VAN DER BOOR SC, Schmitz-de Vries ETJ, Smits D, Scholl JHG, et al
Spontaneously reported adverse events following COVID-19 basic and booster immunizations in the Netherlands.
Vaccine. 2023;41:4319-4326.
PubMed Abstract available

ISHIKAWA K, Nascimento MC, Asano M, Hirata H, et al
One year safety and immunogenicity of AZD1222 (ChAdOx1 nCoV-19): Final analysis of a randomized, placebo-controlled phase 1/2 trial in Japan.
Vaccine. 2023;41:4199-4205.
PubMed Abstract available

LEE KS, Rader NA, Miller-Stump OA, Cooper M, et al
Intranasal VLP-RBD vaccine adjuvanted with BECC470 confers immunity against Delta SARS-CoV-2 challenge in K18-hACE2-mice.
Vaccine. 2023 Jun 28:S0264-410X(23)00783-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SHENG Y, Li Z, Lin X, Ma Y, et al
The position of Spy Tag/Catcher system in hepatitis B core protein particles affects the immunogenicity and stability of the synthetic vaccine.
Vaccine. 2023 Jun 28:S0264-410X(23)00759-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CARRERA JM, Aktepe TE, Earnest L, Christiansen D, et al
Adenovirus vector produced Zika virus-like particles induce a long-lived neutralising antibody response in mice.
Vaccine. 2023 Jun 28:S0264-410X(23)00757-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

YUKI Y, Harada N, Sawada SI, Uchida Y, et al
Biodistribution assessment of cationic pullulan nanogel, a nasal vaccine delivery system, in mice and non-human primates.
Vaccine. 2023 Jun 27:S0264-410X(23)00754-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DOMNICH A, Orsi A, Ogliastro M, Trombetta CS, et al
Influenza vaccine effectiveness in preventing hospital encounters for laboratory-confirmed infection among Italian adults, 2022/23 season.
Vaccine. 2023 Jun 27:S0264-410X(23)00775-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KIM S, Ko M, Heo Y, Lee YK, et al
Safety surveillance of the NVX-CoV2373 COVID-19 vaccine among Koreans aged 18 years and over.
Vaccine. 2023 Jun 27:S0264-410X(23)00780-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GONZALES BE, Mercado EH, Castillo-Tokumori F, Montero AE, et al
Pneumococcal serotypes and antibiotic resistance in healthy carriage children after introduction of PCV13 in Lima, Peru.
Vaccine. 2023;41:4106-4113.
PubMed Abstract available

CARNEIRO GB, Castro JT, Davi M, Miyaji EN, et al
Immune responses and protection against Streptococcus pneumoniae elicited by recombinant Bordetella pertussis adenylate cyclase (CyaA) carrying fragments of pneumococcal surface protein A, PspA.
Vaccine. 2023;41:4170-4182.
PubMed Abstract available

BAUER BU, Schwecht KM, Jahnke R, Matthiesen S, et al
Humoral and cellular immune responses in sheep following administration of different doses of an inactivated phase I vaccine against Coxiella burnetii.
Vaccine. 2023 Jun 23:S0264-410X(23)00746-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DU J, Wang T, Xu L, Wang C, et al
Clostridium perfringens epsilon prototoxin mutant rpETX(Y30A/Y71A/H106P/Y196A) as a vaccine candidate against enterotoxemia.
Vaccine. 2023 Jun 23:S0264-410X(23)00719-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HOWARD MC
Integrating the person-centered approach with the study of vaccine hesitancy: Applying latent profile analysis to identify vaccine hesitancy subpopulations and assess their relations with correlates and vaccination outcomes.
Vaccine. 2023 Jun 23:S0264-410X(23)00742-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BOLIO A, Goldstein I, Rauh L, Ratzan S, et al
Statement: Multisectoral actions to build trust at the local and community level to promote vaccine acceptance.
Vaccine. 2023 Jun 23:S0264-410X(23)00693-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CHAUDHARY A, Madhavan R, Babji S, Raju R, et al
Characterization of immune responses to two and three doses of the adenoviral vectored vaccine ChAdOx1 nCov-19 and the whole virion inactivated vaccine BBV152 in a mix-and-match study in India.
Vaccine. 2023 Jun 23:S0264-410X(23)00744-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HAIST V, Bellebeau-Barbier F, Montange C, Lemaitre L, et al
Comparison of the local safety of two multi-component feline vaccines, adjuvanted (1 mL) versus non-adjuvanted at reduced volume (0.5 mL), using computed tomography imaging.
Vaccine. 2023 Jun 23:S0264-410X(23)00720-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TORP HANSEN K, Kusk Povlsen F, Hammer Bech B, Nygaard Hansen S, et al
Immediate adverse reactions following COVID-19 vaccination among 16-65-year-old Danish citizens.
Vaccine. 2023 Jun 23:S0264-410X(23)00758-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TURLEY CB, Tables L, Fuller T, Sanders LJ, et al
Modifiers of COVID-19 vaccine efficacy: Results from four COVID-19 prevention network efficacy trials.
Vaccine. 2023 Jun 23:S0264-410X(23)00755-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SALEH SN, McDonald SA, Basit MA, Kumar S, et al
Public perception of COVID-19 vaccines through analysis of Twitter content and users.
Vaccine. 2023 Jun 23:S0264-410X(23)00743-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DE MELO ARAUJO AC, da Silva Aragao J, de Souza WV, Rodrigues LC, et al
The impact of implementing the 10-valent pneumococcal conjugate vaccine on hospitalizations for pneumonia among children.
Vaccine. 2023 Jun 21:S0264-410X(23)00724-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FUKUSHIMA S, Kiyohara T, Nakano T, Tada Y, et al
Delaying the third dose of Japanese aluminum-free hepatitis A vaccine Aimmugen elicits effective immune responses against hepatitis A in adults.
Vaccine. 2023 Jun 21:S0264-410X(23)00723-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

JIANG B, Luo Y, Yan N, Shen Z, et al
An X-ray inactivated vaccine against Pseudomonas aeruginosa Keratitis in mice.
Vaccine. 2023 Jun 21:S0264-410X(23)00627-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KIM J, Han K, Chung SJ, Kim C, et al
Psychometric validation of the Korean versions of the Vaccine Hesitancy Scale and Vaccination Attitudes Examination Scale.
Vaccine. 2023 Jun 21:S0264-410X(23)00721-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PERRILLO R, Garrido LF, Ma TW, Rahimi R, et al
Vaccination with HepB-CpG vaccine in individuals undergoing immune suppressive drug therapy.
Vaccine. 2023 Jun 21:S0264-410X(23)00716-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

AUGUSTYNIAK A, Szymanski T, Porzucek F, Mieloch AA, et al
A cohort study reveals different dynamics of SARS-CoV-2-specific antibody formation after Comirnaty and Vaxzevria vaccination.
Vaccine. 2023 Jun 21:S0264-410X(23)00665-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LUANGASANATIP N, Painter C, Pan-Ngum W, Saralamba S, et al
How to model the impact of vaccines for policymaking when the characteristics are uncertain: A case study in Thailand prior to the vaccine rollout during the COVID-19 pandemic.
Vaccine. 2023 Jun 20:S0264-410X(23)00740-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CHEN X, Lin Y, Yue S, Yang Y, et al
PD-1/PD-L1 blockade restores tumor-induced COVID-19 vaccine bluntness.
Vaccine. 2023 Jun 20:S0264-410X(23)00737-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KREMER P, Haruna F, Tuffour Sarpong R, Agamah D, et al
An impact assessment of the use of aerial logistics to improve access to vaccines in the Western-North Region of Ghana.
Vaccine. 2023 Jun 19:S0264-410X(23)00701-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SUZUKI H, Fujita H, Iwai K, Kuroki H, et al
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine in Japanese healthy infants: A phase III study (V114-033).
Vaccine. 2023 Jun 19:S0264-410X(23)00625-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

EKIMOV A, Arunachalam AB, Blake T, Bodle J, et al
Assessing the stability-indicating properties of alternative potency assays for inactivated influenza vaccine.
Vaccine. 2023 Jun 19:S0264-410X(23)00726-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

AILLOUD J, Branchereau M, Fall E, Juneau C, et al
How can we improve the acceptability of vaccination against Human Papillomavirus (HPV) in France? An original qualitative study with focus groups comprising parents and school staff, interviewed separately.
Vaccine. 2023 Jun 19:S0264-410X(23)00656-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TATON M, Willems F, Widomski C, Martin C, et al
Impact of pregnancy on polyfunctional IgG and memory B cell responses to Tdap immunization.
Vaccine. 2023;41:4009-4018.
PubMed Abstract available

TAFURI S, Cuscianna E, Bianchi FP
Prevalence of poliovirus neutralizing antibodies in Italian population: A systematic review and meta-analysis.
Vaccine. 2023;41:4057-4063.
PubMed Abstract available

HONDA-OKUBO Y, Li L, Andre G, Leong KH, et al
An Advax-CpG55.2 adjuvanted recombinant spike protein vaccine protects cynomolgus macaques from a homologous SARS-CoV-2 virus challenge.
Vaccine. 2023 Jun 19:S0264-410X(23)00748-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

UDA K, Okubo Y, Tsuge M, Tsukahara H, et al
Impacts of routine varicella vaccination program and COVID-19 pandemic on varicella and herpes zoster incidence and health resource use among children in Japan.
Vaccine. 2023 Jun 19:S0264-410X(23)00739-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TZENG R, Huang FY, Lee J
Compliance, procrastination and refusal: American COVID-19 vaccination trust and value orientation.
Vaccine. 2023 Jun 19:S0264-410X(23)00745-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ORANGZEB S, Watle SV, Caugant DA
Adherence to vaccination guidelines of patients with complete splenectomy in Norway, 2008-2020.
Vaccine. 2023 Jun 17:S0264-410X(23)00699-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HAMEL BL, Patel J, Still J, Joshi A, et al
A diagnostic quandary: Rotavirus vaccine associated diarrhea.
Vaccine. 2023 Jun 17:S0264-410X(23)00715-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MASOUD D, Pierz A, Rauh L, Cruz AK, et al
Vaccine Trust Gauge: Mixed methods research to measure and understand vaccine trust.
Vaccine. 2023 Jun 17:S0264-410X(23)00690-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DOYON-PLOURDE P, Przepiorkowski J, Young K, Zhao L, et al
Intraseasonal waning immunity of seasonal influenza vaccine - A systematic review and meta-analysis.
Vaccine. 2023 Jun 16:S0264-410X(23)00713-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SINGH A, Boggiano C, Eller MA, Maciel M Jr, et al
Optimizing the Immunogenicity of HIV Vaccines by Adjuvants - NIAID Workshop Report.
Vaccine. 2023 Jun 16:S0264-410X(23)00694-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DUNN DT, Gilson R, McCormack S, McCoy LE, et al
Licenced doses of approved COVID-19 vaccines may not be optimal: A review of the early-phase, dose-finding trials.
Vaccine. 2023 Jun 16:S0264-410X(23)00712-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BISWAS RK, Afiaz A, Huq S, Farzana M, et al
Public opinion on COVID-19 vaccine prioritization in Bangladesh: Who gets the vaccine and whom do you leave out?
Vaccine. 2023 Jun 16:S0264-410X(23)00725-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PIGNATTI P, Ramirez GA, Russo M, Marraccini P, et al
Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients.
Vaccine. 2023 Jun 15:S0264-410X(23)00714-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MUANGNOICHAROEN S, Wiangcharoen R, Nanthapisal S, Kamolratakul S, et al
Single Ad26.COV2.S booster dose following two doses of BBIBP-CorV vaccine against SARS-CoV-2 infection in adults: Day 28 results of a phase 1/2 open-label trial.
Vaccine. 2023 Jun 15:S0264-410X(23)00718-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KENIGSBERG TA, Hanson KE, Klein NP, Zerbo O, et al
Safety of simultaneous vaccination with COVID-19 vaccines in the Vaccine Safety Datalink.
Vaccine. 2023 Jun 15:S0264-410X(23)00717-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PUTHANAKIT T, Chokephaibulkit K, Chaithongwongwatthana S, Bhat N, et al
A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women.
Vaccine. 2023 Jun 15:S0264-410X(23)00657-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

NISHIYAMA A, Adachi Y, Tonouchi K, Moriyama S, et al
Post-fusion influenza vaccine adjuvanted with SA-2 confers heterologous protection via Th1-polarized, non-neutralizing antibody responses.
Vaccine. 2023 Jun 15:S0264-410X(23)00685-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SHOAIBI A, Lloyd PC, Wong HL, Clarke TC, et al
Evaluation of potential adverse events following COVID-19 mRNA vaccination among adults aged 65 years and older: Two self-controlled studies in the U.S.
Vaccine. 2023 Jun 14:S0264-410X(23)00682-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CIEMINS EL, Gillen A, Tallam M
RSV: A vaccine is coming, time to educate providers.
Vaccine. 2023 Jun 14:S0264-410X(23)00695-3. doi: 10.1016/j.vaccine.2023.
PubMed

MUWONGE R, Basu P
Re: Using observational data to explore the hypothesis that a single dose of current HPV vaccines can provide durable protection: Reply to the commentary written by Christine Velicer, Alain Luxembourg, Ya-Ting Chen, Melvin Kohn, and Alfred Saah, Merck
Vaccine. 2023 Jun 14:S0264-410X(23)00696-5. doi: 10.1016/j.vaccine.2023.
PubMed

WOO EJ, Gee J, Marquez P, Baggs J, et al
Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021-February 2022.
Vaccine. 2023 Jun 13:S0264-410X(23)00687-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

YOUNG S, Goldin S, Dumolard L, Shendale S, et al
National vaccination policies for health workers - A cross-sectional global overview.
Vaccine. 2023 Jun 13:S0264-410X(23)00518-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CINCONZE E, Rosillon D, Rappuoli R, Vadivelu K, et al
Challenges in synthesis of real-world vaccine effects on meningococcal serogroup B disease for 4CMenB vaccine post-licensure effectiveness studies: A systematic review.
Vaccine. 2023 Jun 13:S0264-410X(23)00552-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SAADATIAN-ELAHI M, Henaff L, Elias C, Nunes MC, et al
Patient influenza vaccination reduces the risk of hospital-acquired influenza: An incident test negative-case control study in Lyon university hospital, France (2004-2020).
Vaccine. 2023 Jun 13:S0264-410X(23)00621-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SMITH WJ, Thompson R, Egan PM, Zhang Y, et al
Impact of aluminum adjuvants on the stability of pneumococcal polysaccharide-protein conjugate vaccines.
Vaccine. 2023 Jun 13:S0264-410X(23)00620-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ACEVES-SANCHEZ MJ, Barrios-Payan JA, Segura-Cerda CA, Flores-Valdez MA, et al
BCGâˆ†BCG1419c and BCG differ in induction of autophagy, c-di-GMP content, proteome, and progression of lung pathology in Mycobacterium tuberculosis HN878-infected male BALB/c mice.
Vaccine. 2023;41:3824-3835.
PubMed Abstract available

MUNOZ FM, Posavad CM, Richardson BA, Badell ML, et al
COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn.
Vaccine. 2023 Jun 13:S0264-410X(23)00698-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WATESKA AR, Nowalk MP, Lin CJ, Harrison LH, et al
Cost-effectiveness of an in-development adult-formulated pneumococcal vaccine in older US adults.
Vaccine. 2023 Jun 12:S0264-410X(23)00669-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SATO R
Revisiting the measurement of vaccine hesitancy: Comparison between routine immunization and supplementary immunization activity in Nigeria.
Vaccine. 2023 Jun 12:S0264-410X(23)00691-6. doi: 10.1016/j.vaccine.2023.
PubMed

AL-RASHEED M, Ball C, Parthiban S, Ganapathy K, et al
Evaluation of protection and immunity induced by infectious bronchitis vaccines administered by oculonasal, spray or gel routes in commercial broiler chicks.
Vaccine. 2023 Jun 12:S0264-410X(23)00642-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TINGGAARD M, Slotved HC, Jorgensen CS, Kronborg G, et al
Predictors of serological non-response to the 13-valent pneumococcal conjugate vaccine followed by the 23-valent polysaccharide vaccine among adults living with HIV.
Vaccine. 2023 Jun 12:S0264-410X(23)00686-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MA D, Tian S, Qin Q, Yu Y, et al
Construction of an inhalable recombinant M2e-FP-expressing Bacillus subtilis spores-based vaccine and evaluation of its protection efficacy against influenza in a mouse model.
Vaccine. 2023 Jun 10:S0264-410X(23)00655-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ACKERSON B, Sy LS, Slezak J, Qian L, et al
Post-licensure safety study of new-onset immune-mediated diseases, herpes zoster, and anaphylaxis in adult recipients of HepB-CpG vaccine versus HepB-alum vaccine.
Vaccine. 2023 Jun 10:S0264-410X(23)00661-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

NAKAO R, Hirayama S, Yamaguchi T, Senpuku H, et al
A bivalent outer membrane vesicle-based intranasal vaccine to prevent infection of periodontopathic bacteria.
Vaccine. 2023 Jun 9:S0264-410X(23)00619-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MADRAN B, Kayi I, Beser A, Ergonul O, et al
Uptake of COVID-19 vaccines among healthcare workers and the effect of nudging interventions: A mixed methods study.
Vaccine. 2023 Jun 9:S0264-410X(23)00688-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

UI M, Hirama T, Akiba M, Honda M, et al
Cellular and humoral immune responses after a third dose of SARS-CoV-2 mRNA vaccine in lung transplant recipients in Japan.
Vaccine. 2023 Jun 9:S0264-410X(23)00663-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MARTINEZ MR, Gao J, Wan H, Kang H, et al
Inactivated influenza virions are a flexible vaccine platform for eliciting protective antibody responses against neuraminidase.
Vaccine. 2023 Jun 8:S0264-410X(23)00629-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DE GIER B, van Asten L, Boere TM, van Roon A, et al
Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021-January 2022.
Vaccine. 2023 Jun 8:S0264-410X(23)00660-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

NOGAREDA F, Gharpure R, Contreras M, Velandia M, et al
Seasonal influenza vaccination in the Americas: Progress and challenges during the COVID-19 pandemic.
Vaccine. 2023 Jun 8:S0264-410X(23)00689-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KALKOWSKA DA, Badizadegan K, Thompson KM
Outbreak management strategies for cocirculation of multiple poliovirus types.
Vaccine. 2023;41:3718-3727.
PubMed Abstract available

MWENDA V, Jalang'o R, Miano C, Bor JP, et al
Impact, cost-effectiveness, and budget implications of HPV vaccination in Kenya: A modelling study.
Vaccine. 2023 Jun 7:S0264-410X(23)00546-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SHAW RJ, Doyle AJ, Millen EA, Stowe J, et al
Re-evaluation of the risk of venous thromboembolism after COVID-19 vaccination using haematological criteria.
Vaccine. 2023 Jun 7:S0264-410X(23)00662-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KATO H, Hozawa T, Fukushima W, Nobusawa E, et al
Influenza vaccine viruses and the development of seasonal vaccines: A Japanese perspective.
Vaccine. 2023 Jun 6:S0264-410X(23)00640-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MITCHELL SL, Schulkin J, Power ML
Vaccine hesitancy in pregnant Women: A narrative review.
Vaccine. 2023 Jun 6:S0264-410X(23)00608-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KIM DELUCA E, Gebremariam A, Rose A, Biggerstaff M, et al
Cost-effectiveness of routine annual influenza vaccination by age and risk status.
Vaccine. 2023 Jun 6:S0264-410X(23)00495-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PELLETIER C, Labbe F, Bettinger JA, Curran J, et al
From high hopes to disenchantment: A qualitative analysis of editorial cartoons on COVID-19 vaccines in Canadian newspapers.
Vaccine. 2023 Jun 6:S0264-410X(23)00658-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KIM WJ, Roberts CC, Song JY, Yoon JG, et al
Immune response enhancement with GLS-5310 DNA primary vaccine against SARS-CoV-2 followed by administration of an mRNA vaccine heterologous boost.
Vaccine. 2023 Jun 6:S0264-410X(23)00683-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ELDER E, Bangalore Revanna C, Johansson C, Wallin RPA, et al
Protective immunity induced by an inhaled SARS-CoV-2 subunit vaccine.
Vaccine. 2023 Jun 6:S0264-410X(23)00684-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

YANAI T, Yoshida S, Takeuchi M, Kawakami K, et al
Pneumonia hospitalization after introduction of pneumococcal conjugate vaccine in Japan: Descriptive study using a nationwide claims database.
Vaccine. 2023 Jun 5:S0264-410X(23)00626-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MAKANUT S, Wangteeraprasert A, Jitpewngam W, Ngoenkam J, et al
Immunological responses and adverse reactions of the heterologous second booster dose of BNT162b2 after two-dose CoronaVac for COVID-19 vaccination in healthcare workers of Faculty of Medicine, Naresuan University.
Vaccine. 2023 Jun 5:S0264-410X(23)00666-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WESSELINK AK, Lovett SM, Weinberg J, Geller RJ, et al
COVID-19 vaccination and menstrual cycle characteristics: A prospective cohort study.
Vaccine. 2023 Jun 5:S0264-410X(23)00681-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KOZMA GT, Meszaros T, Berenyi P, Facsko R, et al
Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: Evidence for immunogenicity of PEG.
Vaccine. 2023 Jun 5:S0264-410X(23)00667-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

VOHRA P, Bremner A, Nicholls B, Chintoan-Uta C, et al
Evaluation of N-glycan-decorated live attenuated Escherichia coli and outer membrane vesicles as vaccines against Campylobacter jejuni colonisation in chickens.
Vaccine. 2023 Jun 3:S0264-410X(23)00595-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ERGUN T, Hosgoren Tekin S, Apti Sengun O, Akin Cakici O, et al
Immunogenicity, efficacy, and safety of CoronaVac and Pfizer/BioNTech mRNA vaccines in patients with psoriasis receiving systemic therapies: A prospective cohort study.
Vaccine. 2023 Jun 3:S0264-410X(23)00615-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FEDDEMA JJ, Fernald KDS, Schikan HGCP, van de Burgwal LHM, et al
Upscaling vaccine manufacturing capacity - Kkey bottlenecks and lessons learned.
Vaccine. 2023 Jun 3:S0264-410X(23)00554-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

RAINA MACINTYRE C, Lim S, Gurdasani D, Miranda M, et al
Early detection of emerging infectious diseases - implications for vaccine development.
Vaccine. 2023 Jun 2:S0264-410X(23)00630-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MVUNDURA M, Ng J, Reynolds K, Theng Ng Y, et al
Vaccine wastage in Ghana, Mozambique, and Pakistan: An assessment of wastage rates for four vaccines and the context, causes, drivers, and knowledge, attitudes and practices for vaccine wastage.
Vaccine. 2023 Jun 1:S0264-410X(23)00582-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SANDERS C, Matthews RL, Esfahani SHZ, Khan N, et al
Cross-neutralizing protection of vaginal and oral mucosa from HPV challenge by vaccination in a mouse model.
Vaccine. 2023 Jun 1:S0264-410X(23)00618-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

May 2023

CHORIN O, Markovich MP, Avramovich E, Rahmani S, et al
Oral and fecal polio vaccine excretion following bOPV vaccination among Israeli infants.
Vaccine. 2023 May 31:S0264-410X(23)00585-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

OLIVERA MESA D, Winskill P, Ghani AC, Hauck K, et al
The societal cost of vaccine refusal: A modelling study using measles vaccination as a case study.
Vaccine. 2023 May 30:S0264-410X(23)00589-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SCHLEY K, Borchert K, Seidel K, Jacob C, et al
Did the change of the vaccination schedule effect pneumococcal conjugate vaccination compliance and adherence of premature and mature born infants in Germany? Answers from a claims database analysis.
Vaccine. 2023 May 30:S0264-410X(23)00594-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WANG LJ, Tsai CS, Chou WJ, Li CJ, et al
Medical outcomes of children with neurodevelopmental disorders after SARS-CoV-2 vaccination: A six-month follow-up study.
Vaccine. 2023 May 29:S0264-410X(23)00628-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ARROSPIDE A, Sagardui MG, Larizgoitia I, Iturralde A, et al
Effectiveness of the booster dose of COVID-19 vaccine in the Basque Country during the sixth wave: A nationwide cohort study.
Vaccine. 2023 May 29:S0264-410X(23)00622-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HU S, Xiong C, Zhao Y, Yuan X, et al
Vaccination, human mobility, and COVID-19 health outcomes: Empirical comparison before and during the outbreak of SARS-Cov-2 B.1.1.529 (Omicron) variant.
Vaccine. 2023 May 29:S0264-410X(23)00617-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PAYNTER J, Howe AS, Best E, Petousis-Harris H, et al
A retrospective cohort study investigating the comparative effectiveness of pneumococcal vaccines against hospitalisation with otitis media and pneumonia in New Zealand.
Vaccine. 2023 May 25:S0264-410X(23)00591-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MILLER ER, Moro PL, Shimabukuro TT, Carlock G, et al
COVID-19 vaccine safety inquiries to the centers for disease control and prevention immunization safety office.
Vaccine. 2023 May 24:S0264-410X(23)00613-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HORI D, Keneda Y, Ozaki A, Tabuchi T, et al
Sexual orientation was associated with intention to be vaccinated with a smallpox vaccine against mpox: A cross-sectional preliminary survey in Japan.
Vaccine. 2023 May 24:S0264-410X(23)00611-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CURTIS MG, Davoudpour S, Rodriguez-Ortiz AE, Felt D, et al
Predictors of Mpox vaccine uptake among sexual and gender minority young adults living in Illinois: Unvaccinated vs. double vs. single dose vaccine recipients.
Vaccine. 2023 May 24:S0264-410X(23)00593-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

RAO S, Abeyratne E, Freitas JR, Yang C, et al
A booster regime of liposome-delivered live-attenuated CHIKV vaccine RNA genome protects against chikungunya virus disease in mice.
Vaccine. 2023 May 23:S0264-410X(23)00571-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MOHAMMED AM, Musa A, Etapelong SG, Bolori MT, et al
Expanding polio surveillance reach beyond vaccination reach in Borno State, Nigeria: The contribution of community informants from insecure areas engaged to conduct polio surveillance in security compromised areas, 2018-2019.
Vaccine. 2023 May 23:S0264-410X(23)00547-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CHOUDHARY P, Boamah B, Hon Ng S, White A, et al
Solidified saturated fats coating subunit vaccines greatly extended vaccine booster release and contributed to a Th1/Th2 mixed immune response in mice.
Vaccine. 2023 May 23:S0264-410X(23)00550-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

NUGENT C, Abul Y, White EM, Shehadeh F, et al
Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers.
Vaccine. 2023;41:3403-3409.
PubMed Abstract available

WANG R, Fan X, Jiang Y, Li G, et al
Immunogenicity and efficacy analyses of EPC002, ECA006, and EPCP009 protein subunit combinations as tuberculosis vaccine candidates.
Vaccine. 2023 May 22:S0264-410X(23)00385-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

EGER J, Kaplan LC, Sternberg H
How to reduce vaccination hesitancy? The relevance of evidence and its communicator.
Vaccine. 2023 May 22:S0264-410X(23)00298-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ALICANDRO G, Orena BS, Rosazza C, Cariani L, et al
Humoral and cell-mediated immune responses to BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis.
Vaccine. 2023 May 22:S0264-410X(23)00590-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GHAZNAVI C, Eguchi A, Suu Lwin K, Yoneoka D, et al
Estimating global changes in routine childhood vaccination coverage during the COVID-19 pandemic, 2020-2021.
Vaccine. 2023 May 22:S0264-410X(23)00583-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GUO BQ, Li HB, Yang LQ
Incidence of myopericarditis after mRNA COVID-19 vaccination: A meta-analysis with focus on adolescents aged 12-17 years.
Vaccine. 2023 May 22:S0264-410X(23)00610-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BOLSEWICZ KT, Steffens MS, King C, Abdi I, et al
A qualitative study on COVID-19 pandemic impacts on parental attitudes and intentions for routine adolescent vaccinations: The role of trust.
Vaccine. 2023 May 22:S0264-410X(23)00586-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

JOUDEH AI, Lutf AQ, Mahdi S, Tran G, et al
Efficacy and safety of mRNA and AstraZeneca COVID-19 vaccines in patients with autoimmune rheumatic diseases: A systematic review.
Vaccine. 2023 May 22:S0264-410X(23)00609-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

EMBI PJ, Levy ME, Patel P, DeSilva MB, et al
Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: An observational study of real-world data across 10 US states from August-December 2021.
Vaccine. 2023 May 22:S0264-410X(23)00588-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MALO B, Labbe F, Meyer SB, Filice E, et al
"I Want People to Be Able to Make an Informed Choice": How Quebec naturopaths discuss vaccination in their practice.
Vaccine. 2023 May 18:S0264-410X(23)00553-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SHAW CA, August A, Bart S, Booth PJ, et al
A phase 1, randomized, placebo-controlled, dose-ranging study to evaluate the safety and immunogenicity of an mRNA-based chikungunya virus vaccine in healthy adults.
Vaccine. 2023 May 18:S0264-410X(23)00488-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BOING AF, Boing AC, Barberia L, Borges ME, et al
Uncovering inequities in Covid-19 vaccine coverage for adults and elderly in Brazil: A multilevel study of 2021-2022 data.
Vaccine. 2023 May 17:S0264-410X(23)00569-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MARTINON-TORRES F, Wysocki J, Szenborn L, Carmona-Martinez A, et al
A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1).
Vaccine. 2023;41:3387-3398.
PubMed Abstract available

WANLAPAKORN N, Pruetarat N, Sarawanangkoor N, Phanphanit K, et al
Immunogenicity of the pentavalent DTwP-HB-Hib vaccine (Shan-5) used in the Thai Expanded Program on Immunization compared to the hexavalent DTaP-HB-Hib-IPV and DTwP-HB-Hib (Quinvaxem) vaccines administered to infants at 2, 4, 6 months of age.
Vaccine. 2023 May 16:S0264-410X(23)00541-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ZHOU ZH, Cortese MM, Fang JL, Wood R, et al
Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination.
Vaccine. 2023 May 16:S0264-410X(23)00568-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LIMAYE RJ, Singh P, Paul A, Fesshaye B, et al
COVID-19 vaccine decision-making among pregnant and lactating women in Bangladesh.
Vaccine. 2023 May 15:S0264-410X(23)00551-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SUN W
Monkeypox, smallpox, FDA, and accelerated approval of vaccines - A regulatory perspective.
Vaccine. 2023 May 15:S0264-410X(23)00526-1. doi: 10.1016/j.vaccine.2023.
PubMed

SHATO T, Humble S, Anandarajah A, Barnette A, et al
Influences of sociodemographic characteristics and parental HPV vaccination hesitancy on HPV vaccination coverage in five US states.
Vaccine. 2023 May 15:S0264-410X(23)00517-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BLACK SB, Chandler RE, Edwards KM, Sturkenboom MCJM, et al
Assessing vaccine safety during a pandemic: Recent experience and lessons learned for the future.
Vaccine. 2023 May 15:S0264-410X(23)00468-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

OHM M, van Straalen JW, Zijlstra M, de Joode-Smink G, et al
Meningococcal ACWY conjugate vaccine immunogenicity and safety in adolescents with juvenile idiopathic arthritis and inflammatory bowel disease: A prospective observational cohort study.
Vaccine. 2023 May 15:S0264-410X(23)00480-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GARCIA-FOGEDA I, Besbassi H, Lariviere Y, Ogunjimi B, et al
Within-host modeling to measure dynamics of antibody responses after natural infection or vaccination: A systematic review.
Vaccine. 2023 May 15:S0264-410X(23)00422-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SURIE D, Bonnell LN, DeCuir J, Gaglani M, et al
Comparison of mRNA vaccine effectiveness against COVID-19-associated hospitalization by vaccination source: Immunization information systems, electronic medical records, and self-report-IVY Network, February 1-August 31, 2022.
Vaccine. 2023 May 15:S0264-410X(23)00567-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MARRON L, Ferenczi A, O'Brien KM, Cotter S, et al
A national survey of parents' views on childhood vaccinations in Ireland.
Vaccine. 2023 May 13:S0264-410X(23)00522-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GEORGE TK, Nair NP, Singh AK, Dilesh Kumar A, et al
Development of a Choice-framework for Covid vaccines in India using a multi-criteria decision analysis approach.
Vaccine. 2023 May 12:S0264-410X(23)00486-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

VESIKARI T, Langley JM, Spaans JN, Petrov I, et al
The persistence of seroprotective levels of antibodies after vaccination with PreHevbrio, a 3-antigen hepatitis B vaccine.
Vaccine. 2023 May 11:S0264-410X(23)00528-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CHOI Y, Lee GS, Li S, Lee JW, et al
Hepatitis B vaccine delivered by microneedle patch: Immunogenicity in mice and rhesus macaques.
Vaccine. 2023 May 11:S0264-410X(23)00524-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PIERRE E, Pladys A, Bayat-Makoei S, Tattevin P, et al
Pneumococcal vaccination coverage at the initiation of chronic dialysis, and its association with mortality during the first year.
Vaccine. 2023 May 11:S0264-410X(23)00521-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KEHAGIA E, Papakyriakopoulou P, Valsami G
Advances in intranasal vaccine delivery: A promising non-invasive route of immunization.
Vaccine. 2023 May 11:S0264-410X(23)00529-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MIDDLETON BF, Danchin M, Cunliffe NA, Jones MA, et al
Histo-blood group antigen profile of Australian Aboriginal children and seropositivity following oral rotavirus vaccination.
Vaccine. 2023 May 11:S0264-410X(23)00525-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ROBERTS-MCCARTHY E, Buck PO, Smith-Ray RL, Van de Velde N, et al
Factors associated with receipt of mRNA-1273 vaccine at a United States national retail pharmacy during the COVID-19 pandemic.
Vaccine. 2023 May 11:S0264-410X(23)00383-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

VAN IERSEL SCJL, McDonald SA, de Gier B, Knol MJ, et al
Number of COVID-19 hospitalisations averted by vaccination: Estimates for the Netherlands, January 6, 2021 through August 30, 2022.
Vaccine. 2023 May 10:S0264-410X(23)00545-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GOVINDAN V, Ganaie FA, Ramakrishnan SM, Ravindran S, et al
Estimation of baseline IgG antibody levels to 23 pneumococcal vaccine-type capsular polysaccharides in healthy vaccine naive Indian adults.
Vaccine. 2023 May 10:S0264-410X(23)00497-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

RUBIN THOMPSON LJ, Grubo M, Veller M, Badenhorst RH, et al
Building global vaccine manufacturing capacity: Spotlight on Africa.
Vaccine. 2023 May 10:S0264-410X(23)00527-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WILSON RJ, Leigh L, Bah H, Larson HJ, et al
HPV vaccination acceptance and perceptions related to fertility and population control in the Gambia: An anthropological analysis.
Vaccine. 2023 May 10:S0264-410X(23)00508-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LANGLETE P, Tesli M, Veneti L, Starrfelt J, et al
Estimated vaccine effectiveness against SARS-CoV-2 Delta and Omicron infections among health care workers and the general adult population in Norway, August 2021 - January 2022.
Vaccine. 2023 May 10:S0264-410X(23)00549-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SMITH K, Hegazy K, Cai MR, McKnight I, et al
Safety of the NVX-CoV2373 COVID-19 vaccine in randomized placebo-controlled clinical trials.
Vaccine. 2023 May 10:S0264-410X(23)00543-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BERRY A, Kapelus D, Singh P, Groome M, et al
ABO blood types, but not Secretor or Lewis blood types, influence strength of antibody response to Hepatitis B vaccine in Black South African children.
Vaccine. 2023 May 9:S0264-410X(23)00465-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HIEBERT J, Saboui M, Frost JR, Zubach V, et al
Mumps resurgence in a highly vaccinated population: Insights gained from surveillance in Canada, 2002-2020.
Vaccine. 2023 May 9:S0264-410X(23)00513-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CHIAVENNA C, Leone LP, Melegaro A, Rotesi T, et al
Personal risk or societal benefit? Investigating adults' support for COVID-19 childhood vaccination.
Vaccine. 2023 May 9:S0264-410X(23)00544-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

OLUSANYA OA, Tomar A, Thomas J, Alonge K, et al
Application of the theoretical domains framework to identify factors influencing catch-up HPV vaccinations among male college students in the United States: A review of evidence and recommendations.
Vaccine. 2023 May 8:S0264-410X(23)00509-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SUTTON WJH, Branham PJ, Williamson YM, Cooper HC, et al
Quantification of SARS-CoV-2 spike protein expression from mRNA vaccines using isotope dilution mass spectrometry.
Vaccine. 2023 May 8:S0264-410X(23)00458-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BORDALO FERREIRA F, Rafael MA, Coimbra L, Boavida N, et al
Anti-tumor necrosis factor therapy is associated with attenuated humoral response to SARS-COV-2 vaccines in patients with inflammatory bowel disease.
Vaccine. 2023 May 8:S0264-410X(23)00530-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KURIYAMA K, Murakami K, Masuda T, Sugiura K, et al
Immunogenicity and safety of a single booster dose of NVX-CoV2373 (TAK-019) in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: Primary analysis report of a phase 3 open-label trial.
Vaccine. 2023 May 8:S0264-410X(23)00519-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FITZ-PATRICK D, Young M, Yacisin K, McElwee K, et al
Randomized trial to evaluate the safety, tolerability, and immunogenicity of a booster (third dose) of BNT162b2 COVID-19 vaccine coadministered with 20-valent pneumococcal conjugate vaccine in adults >/=65 years old.
Vaccine. 2023 May 8:S0264-410X(23)00520-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GOLDBLATT D, Andrews NJ, Sheppard CL, Rose S, et al
Pneumococcal carriage following PCV13 delivered as one primary and one booster dose (1 + 1) compared to two primary doses and a booster (2 + 1) in UK infants.
Vaccine. 2023;41:3019-3023.
PubMed Abstract available

KPOZEHOUEN EB, Heywood AE, Menzies R, Seale H, et al
Informing the design of a whole of life immunisation register for Australia.
Vaccine. 2023;41:3011-3018.
PubMed Abstract available

LEWIS CY, Mishra K, Sun Y, Sechrist SJ, et al
Recombinant zoster vaccine coverage in the United States: An analysis of claims-based data.
Vaccine. 2023 May 5:S0264-410X(23)00491-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CZIBENER C, Rey Serantes DA, Romani AM, Bruno L, et al
Bm Delta-pgm, a vaccine for the control of Brucella melitensis with cross-species protective properties.
Vaccine. 2023 May 5:S0264-410X(23)00511-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

RODRIGUEZ DM, Major CG, Sanchez-Gonzalez L, Jones E, et al
Dengue vaccine acceptability before and after the availability of COVID-19 vaccines in Puerto Rico.
Vaccine. 2023 May 5:S0264-410X(23)00516-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KINGSLEY T, Phelan D, Poland GA
Corrigendum to "A review of 2023 adult immunization schedule updates" [Vaccine 41(16) (2023) 2631-2633].
Vaccine. 2023 May 3:S0264-410X(23)00462-0. doi: 10.1016/j.vaccine.2023.
PubMed

TALBIRD SE, Anderson SA, Nossov M, Beattie N, et al
Cost-effectiveness of a 3-antigen versus single-antigen vaccine for the prevention of hepatitis B in adults in the United States.
Vaccine. 2023 May 3:S0264-410X(23)00414-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KU JH, Sy LS, Qian L, Ackerson BK, et al
Vaccine effectiveness of the mRNA-1273 3-dose primary series against COVID-19 in an immunocompromised population: A prospective observational cohort study.
Vaccine. 2023 May 3:S0264-410X(23)00498-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BERAN J, Lattanzi M, Costantini M, Pammolli A, et al
Sustained antibody persistence for at least 15 years after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules: Third 5-year follow-up.
Vaccine. 2023 May 2:S0264-410X(23)00485-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

VOSS SS, Norgaard SK, Valentiner-Branth P
Identification of subgroups in the Danish population for targeted human papillomavirus vaccination efforts.
Vaccine. 2023 May 2:S0264-410X(23)00484-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FUKUNAGA R, Kaplan ZE, Rodriguez T, Hagan L, et al
Attitudes towards COVID-19 vaccination among incarcerated persons in the Federal Bureau of Prisons, June-July 2021.
Vaccine. 2023 May 2:S0264-410X(23)00512-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SIDDIQUE M, Iftikhar S, Dharma VK, Shah MT, et al
Using geographic information system to track children and optimize immunization coverage and equity in Karachi, Pakistan.
Vaccine. 2023;41:2922-2931.
PubMed Abstract available

VEREEN RJ, Aden JK, Drumm CM
Newborn medication adherence and childhood under-immunization in military beneficiaries.
Vaccine. 2023;41:2887-2892.
PubMed Abstract available

LEFFERTS B, Bruden D, Plumb ID, Hodges E, et al
Effectiveness of the COVID-19 vaccines on preventing symptomatic SARS-CoV-2 infections and hospitalizations in Southwestern Alaska, January-December 2021.
Vaccine. 2023 May 1:S0264-410X(23)00496-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MESINA FZ, Sapinoso FAD, De Castro JAV, Vaswani PPM, et al
Hematologic adverse events reported after COVID-19 vaccination in the Philippines: A national database study.
Vaccine. 2023 May 1:S0264-410X(23)00490-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KUHLBRANDT C, McGowan CR, Stuart R, Grenfell P, et al
COVID-19 vaccination decisions among Gypsy, Roma, and Traveller communities: A qualitative study moving beyond "vaccine hesitancy".
Vaccine. 2023 May 1:S0264-410X(23)00515-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HUSSAINI L, Labberton AS, Winje BA, Kraft KB, et al
COVID-19 vaccination rates among adolescents (12-17 years) by immigrant background and sociodemographic factors: A nationwide registry study in Norway.
Vaccine. 2023 May 1:S0264-410X(23)00514-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

April 2023

CHU K, Li Y, Yu D, Song Y, et al
Immunogenicity and immune persistence in 4-year-old children completing four doses of Sabin strain or wild strain inactivated poliovirus vaccine: A phase IV, open-labeled, parallel-controlled observational study.
Vaccine. 2023 Apr 29:S0264-410X(23)00259-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MARCHESE AM, Zhou X, Kinol J, Underwood E, et al
NVX-CoV2373 vaccine efficacy against hospitalization: A post hoc analysis of the PREVENT-19 phase 3, randomized, placebo-controlled trial.
Vaccine. 2023 Apr 29:S0264-410X(23)00467-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HALSEY N, Evans S, Santosham M, Hacker A, et al
Considerations for unblinding individual study participants during vaccine trials.
Vaccine. 2023 Apr 28:S0264-410X(23)00425-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

COSTA JP, Jesus S, Colaco M, Duarte A, et al
Endotoxin contamination of nanoparticle formulations: A concern in vaccine adjuvant mechanistic studies.
Vaccine. 2023 Apr 28:S0264-410X(23)00487-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

IMMINK MM, van der Maas NAT, de Melker HE, Ferreira JA, et al
Socio-psychological determinants of second trimester maternal pertussis vaccination acceptance in the Netherlands.
Vaccine. 2023 Apr 28:S0264-410X(23)00482-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BLACK S, Evans S
Serious adverse events following mRNA vaccination in randomized trials in adults.
Vaccine. 2023 Apr 28:S0264-410X(23)00432-2. doi: 10.1016/j.vaccine.2023.
PubMed

VANNI T, da Graca Salomao M, Viscondi JYK, Braga PE, et al
A randomized, double-blind, non-inferiority trial comparing the immunogenicity and safety of two seasonal inactivated influenza vaccines in adults.
Vaccine. 2023 Apr 28:S0264-410X(23)00464-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DE LA TORRE ARRIETA J, Briceno D, de Castro IG, Roser B, et al
A thermostable tetanus/diphtheria (Td) vaccine in the StablevaX pre-filled delivery system.
Vaccine. 2023 Apr 28:S0264-410X(23)00431-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KOEN AL, Izu A, Baillie V, Kwatra G, et al
Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005).
Vaccine. 2023 Apr 27:S0264-410X(23)00483-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KIM C, Aminawung JA, Brinkley-Rubinstein L, Wang EA, et al
COVID-19 vaccine deliberation in individuals directly impacted by incarceration.
Vaccine. 2023 Apr 26:S0264-410X(23)00492-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GREENBERG V, Vazquez-Benitez G, Kharbanda EO, Daley MF, et al
Tdap vaccination during pregnancy and risk of chorioamnionitis and related infant outcomes.
Vaccine. 2023 Apr 26:S0264-410X(23)00457-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SHARFF KA, Tandy TK, Lewis PF, Johnson ES, et al
Cardiac events following JYNNEOS vaccination for prevention of Mpox.
Vaccine. 2023 Apr 26:S0264-410X(23)00466-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ALSUHEBANY N, Alowais SA, Aldairem A, Almohareb SN, et al
Identifying gaps in vaccination perception after mandating the COVID-19 vaccine in Saudi Arabia.
Vaccine. 2023 Apr 26:S0264-410X(23)00481-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LU X, Masuda S, Horlad H, Katoh T, et al
Safety and adverse effects of the coronavirus disease 2019 vaccine among the general Japanese adult population.
Vaccine. 2023 Apr 26:S0264-410X(23)00469-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SMITH MJ, Emanuel EJ
Learning from five bad arguments against mandatory vaccination.
Vaccine. 2023 Apr 25:S0264-410X(23)00461-9. doi: 10.1016/j.vaccine.2023.
PubMed

KIM SJ, Kwon SL, Lee JY, Oh J, et al
Why school is crucial to increase vaccination coverage for children: Evaluation of school vaccination check program in South Korea 2021-2022.
Vaccine. 2023 Apr 25:S0264-410X(23)00430-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

JIANG M, Vaisanen E, Kolehmainen P, Huttunen M, et al
COVID-19 adenovirus vector vaccine induces higher interferon and pro-inflammatory responses than mRNA vaccines in human PBMCs, macrophages and moDCs.
Vaccine. 2023 Apr 25:S0264-410X(23)00463-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CAI B, Peyrani P, Beeslaar J, Burman C, et al
Modeling persistence of hSBA titers over time following a primary series and a booster dose of MenB-FHbp.
Vaccine. 2023;41:2729-2733.
PubMed Abstract available

WALTER D, Ophir Y, Ye H
Conspiracies, misinformation and resistance to public health measures during COVID-19 in white nationalist online communication.
Vaccine. 2023;41:2868-2877.
PubMed Abstract available

CHARLTON CL, Bailey AM, Thompson LA, Kanji JN, et al
What's in a number? The value of titers as routine proof of immunity for medical students.
Vaccine. 2023;41:2734-2738.
PubMed Abstract available

KLOSE SM, De Souza DP, Disint JF, Andrews DM, et al
Reversion of mutations in a live mycoplasma vaccine alters its metabolism.
Vaccine. 2023 Apr 24:S0264-410X(23)00459-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ROPER RL, Garzino-Demo A, Del Rio C, Brechot C, et al
Monkeypox (Mpox) requires continued surveillance, vaccines, therapeutics and mitigating strategies.
Vaccine. 2023 Apr 21:S0264-410X(23)00393-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MA L, Brecher M, Soufal A, Gaiotto T, et al
Structural interrogation of a trimeric prefusion RSV fusion protein vaccine candidate by a camelid nanobody.
Vaccine. 2023 Apr 19:S0264-410X(23)00413-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CLARKE L, Brighton T, Chunilal SD, Lee CSM, et al
Vaccine-induced immune thrombotic thrombocytopenia post dose 2 ChAdOx1 nCoV19 vaccination: Less severe but remains a problem.
Vaccine. 2023 Apr 19:S0264-410X(23)00379-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TERRINONI M, Nordqvist SL, Lofstrand M, Nilsson F, et al
A thermostable, dry formulation inactivated Hikojima whole cell/cholera toxin B subunit oral cholera vaccine.
Vaccine. 2023 Apr 19:S0264-410X(23)00387-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GIRNDT M, Houser P, Manllo-Karim R, Ervin JE, et al
Long-term immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B) compared with HepB-Eng (Engerix-B) in adults with chronic kidney disease.
Vaccine. 2023 Apr 19:S0264-410X(23)00420-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BAO Y, He L, Miao B, Zhong Z, et al
BBIBP-CorV vaccination accelerates anti-viral antibody responses in heterologous Omicron infection: A retrospective observation study in Shanghai.
Vaccine. 2023 Apr 19:S0264-410X(23)00377-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TOPAZIAN HM, Schmit N, Gerard-Ursin I, Charles GD, et al
Modelling the relative cost-effectiveness of the RTS,S/AS01 malaria vaccine compared to investment in vector control or chemoprophylaxis.
Vaccine. 2023 Apr 18:S0264-410X(23)00394-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PILLSBURY A, Phillips A, Deng L, Quinn H, et al
Background incidence rates of selected adverse events of special interest (AESI) to monitor the safety of COVID-19 vaccines.
Vaccine. 2023 Apr 18:S0264-410X(23)00441-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MIDDELDORP M, Steens A, Lagerweij G, van Sorge NM, et al
The burden of invasive meningococcal disease in the Netherlands, 2011-2020.
Vaccine. 2023;41:2664-2670.
PubMed Abstract available

HOUTSMA C, Raines AM, Reggio A, Rushing LK, et al
COVID-19 vaccine distribution: A high reliability organization approach.
Vaccine. 2023 Apr 17:S0264-410X(23)00423-1. doi: 10.1016/j.vaccine.2023.
PubMed

GORDON SF, Lam J, Vasquez JT, Cercone R, et al
A tailored COVID-19 vaccination pathway for children 5-11 years in Victoria, Australia.
Vaccine. 2023 Apr 17:S0264-410X(23)00424-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TCHOUALEU DD, Fleming M, Traicoff DA
A systematic review of pre-service training on vaccination and immunization.
Vaccine. 2023 Apr 15:S0264-410X(23)00369-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KANG B, Goldlust S, Lee EC, Hughes J, et al
Spatial distribution and determinants of childhood vaccination refusal in the United States.
Vaccine. 2023 Apr 15:S0264-410X(23)00402-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LUDWIKOWSKA KM, Popiel A, Matkowska-Kocjan A, Biela M, et al
COVID-19 mRNA BNT162b2 vaccine immunogenicity among children with a history of paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS-TS).
Vaccine. 2023 Apr 14:S0264-410X(23)00427-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FREITAG TL, Fagerlund R, Karam NL, Leppanen VM, et al
Intranasal administration of adenoviral vaccines expressing SARS-CoV-2 spike protein improves vaccine immunity in mouse models.
Vaccine. 2023 Apr 14:S0264-410X(23)00403-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KUAN-MAHECHA MA, Rahman S, Martinez-Rivera P, Lamb MM, et al
Differences in parental vaccine confidence and attitudes by health system in Guatemala and their impact on immunization timeliness.
Vaccine. 2023 Apr 13:S0264-410X(23)00371-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ANDRAUD M, Herve S, Gorin S, Barbier N, et al
Evaluation of early single dose vaccination on swine influenza A virus transmission in piglets: From experimental data to mechanistic modelling.
Vaccine. 2023 Apr 13:S0264-410X(23)00401-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KATTSTROM M, Uggla B, Tina E, Kimby E, et al
Improved plasmablast response after repeated pneumococcal revaccinations following primary immunization with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia.
Vaccine. 2023 Apr 13:S0264-410X(23)00399-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FORTUNA LBDP, Miranda FM, Antunes IMF, Silva AB, et al
Prevalence, capsular types, antimicrobial resistance and risk factors associated with pneumococcal carriage among children after long-term 10-valent pneumococcal conjugate vaccine use in Brazil.
Vaccine. 2023 Apr 13:S0264-410X(23)00415-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LI J, Shi LW, Yu BW, Huang LR, et al
Safety and immunogenicity of a pichia pastoris-expressed bivalent human papillomavirus (types 16 and 18) L1 virus-like particle vaccine in healthy Chinese women aged 9-45 years: A randomized, double-blind, placebo-controlled phase 1 clinical trial.
Vaccine. 2023 Apr 13:S0264-410X(23)00392-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KHANAM F, Babu G, Rahman N, Liu X, et al
Immune responses in children after vaccination with a typhoid Vi-tetanus toxoid conjugate vaccine in Bangladesh.
Vaccine. 2023 Apr 13:S0264-410X(23)00397-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ESTEPHAN L, Lin YC, Lin YT, Chen YH, et al
Safety and immunogenicity of homologous versus heterologous booster dose with AZD1222, mRNA-1273, or MVC-COV1901 SARS-CoV-2 vaccines in adults: An observer-blinded, multi-center, phase 2 randomized trial.
Vaccine. 2023 Apr 12:S0264-410X(23)00421-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

YOUNG G, Zahralban-Steele M, Dean HJ
Impact of prior flavivirus vaccination on immunogenicity and efficacy of an inactivated Zika vaccine in Indian rhesus macaques.
Vaccine. 2023 Apr 11:S0264-410X(23)00398-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KIM GL, Pyo SW, Yi H, Kim SH, et al
Immunogenicity and Protective Efficacy of Recombinant Protective Antigen Anthrax Vaccine (GC1109) in A/J Mice Model.
Vaccine. 2023 Apr 11:S0264-410X(23)00386-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

UEMURA K, Ono S, Michihata N, Yamana H, et al
Duration of influenza vaccine effectiveness in the elderly in Japan: A retrospective cohort study using large-scale population-based registry data.
Vaccine. 2023 Apr 10:S0264-410X(23)00373-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

RATHORE APS, St John AL
Promises and challenges of mucosal COVID-19 vaccines.
Vaccine. 2023 Apr 10:S0264-410X(23)00396-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KAWADE A, Dayma G, Apte A, Telang N, et al
Effect of reduced two-dose (1+1) schedule of 10 and 13-valent pneumococcal conjugate vaccines (Synflorix(TM) and Prevenar13(TM))) on nasopharyngeal carriage and serotype-specific immune response in the first two years of life: Results from an open-lab
Vaccine. 2023 Apr 10:S0264-410X(23)00388-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PERKINS-OINES S, Dias N, Krafsur G, Abdelsalam K, et al
The effect of neonatal vaccination for bovine respiratory disease in the face of a dual challenge with bovine viral diarrhea virus and Mannheimia hemolytica.
Vaccine. 2023 Apr 10:S0264-410X(23)00391-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CHANG CC, Algaissi A, Lai CC, Chang CK, et al
Subunit vaccines with a saponin-based adjuvant boost humoral and cellular immunity to MERS coronavirus.
Vaccine. 2023 Apr 10:S0264-410X(23)00390-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DOLD C, Zhu H, Silva-Reyes L, Blackwell L, et al
Immunisation with purified Coxiella burnetii phase I lipopolysaccharide confers partial protection in mice independently of co-administered adenovirus vectored vaccines.
Vaccine. 2023 Apr 8:S0264-410X(23)00395-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HARRIS C, Cottrell S, Perry M, Meaden R, et al
A pilot intervention to improve uptake and equality of childhood influenza vaccination in an area of Wales, through the introduction of a mixed delivery model including nursery school immunisation sessions.
Vaccine. 2023 Apr 8:S0264-410X(23)00382-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HARRIS JN, Mauro CM, Morgan TL, de Roche A, et al
Factors impacting parental uptake of COVID-19 vaccination for U.S. Children ages 5-17.
Vaccine. 2023 Apr 7:S0264-410X(23)00384-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HAMAD SAIED M, van Straalen JW, de Roock S, de Joode-Smink GCJ, et al
Safety of Measles-Mumps-Rubella booster vaccination in patients with juvenile idiopathic arthritis: A long-term follow-up study.
Vaccine. 2023 Apr 7:S0264-410X(23)00381-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

JAGNE I, von Mollendorf C, Wee-Hee A, Ortika B, et al
A systematic review of pneumococcal conjugate vaccine impact on pneumococcal nasopharyngeal colonisation density in children under 5 years of age.
Vaccine. 2023 Apr 7:S0264-410X(23)00370-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

VARGAS-ZAMBRANO JC, Clark LR, Johnson DR, Monfredo C, et al
Prenatal tetanus-diphtheria-acellular pertussis vaccine effectiveness at preventing infant pertussis.
Vaccine. 2023 Apr 7:S0264-410X(23)00342-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LIU J, Guo S, Jin Z, Zhao K, et al
Adjuvanted quaternized chitosan composite aluminum nanoparticles-based vaccine formulation promotes immune responses in chickens.
Vaccine. 2023 Apr 7:S0264-410X(23)00374-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LEIGH HOBBS J, Paul LA, Buchan SA, Harris T, et al
Methodological changes implemented over time to support accurate and timely COVID-19 vaccine coverage estimates: Ontario, Canada.
Vaccine. 2023 Apr 7:S0264-410X(23)00389-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SMITS PD, Gratzl S, Simonov M, Nachimuthu SK, et al
Risk of COVID-19 breakthrough infection and hospitalization in individuals with comorbidities.
Vaccine. 2023;41:2447-2455.
PubMed Abstract available

HEMPEL K, McDonald W, Osgood ND, Fisman D, et al
Evaluation of the effectiveness of maternal immunization against pertussis in Alberta using agent-based modeling: A Canadian immunization research network study.
Vaccine. 2023;41:2430-2438.
PubMed Abstract available

AFSAR A, Mallya A, Mohammed AAG, Anand S, et al
Monovalent type 2 OPV (mOPV2) management in the field: Interventions and lessons learned.
Vaccine. 2023;41 Suppl 1:A79-A84.
PubMed Abstract available

GOLD MS, Amarasinghe A, Greenhawt M, Kelso JM, et al
Anaphylaxis: Revision of the Brighton collaboration case definition.
Vaccine. 2023;41:2605-2614.
PubMed Abstract available

BURKHOLDER B, Wadood Z, Kassem AM, Ehrhardt D, et al
The immediate impact of the COVID-19 pandemic on polio immunization and surveillance activities.
Vaccine. 2023;41 Suppl 1:A2-A11.
PubMed Abstract available

VOORMAN A, O'Reilly K, Lyons H, Goel AK, et al
Real-time prediction model of cVDPV2 outbreaks to aid outbreak response vaccination strategies.
Vaccine. 2023;41 Suppl 1:A105-A112.
PubMed Abstract available

KALKOWSKA DA, Pallansch MA, Wassilak SGF, Cochi SL, et al
Serotype 2 oral poliovirus vaccine (OPV2) choices and the consequences of delaying outbreak response.
Vaccine. 2023;41 Suppl 1:A136-A141.
PubMed Abstract available

KALKOWSKA DA, Voorman A, Pallansch MA, Wassilak SGF, et al
The impact of disruptions caused by the COVID-19 pandemic on global polio eradication.
Vaccine. 2023;41 Suppl 1:A12-A18.
PubMed Abstract available

PAYNE JR, Bose S, Kubiak RW, Nolen LD, et al
Evaluation of mortality risk after COVID-19 vaccination, Utah 2021.
Vaccine. 2023 Apr 5:S0264-410X(23)00380-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WANG SM, Keegan EA, Bryan KM, Kazma J, et al
Human papillomavirus vaccination receipt and provider counseling rates among high-risk patients.
Vaccine. 2023 Apr 5:S0264-410X(23)00378-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BRAEYE T, Catteau L, Brondeel R, van Loenhout JAF, et al
Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021-2022.
Vaccine. 2023 Apr 5:S0264-410X(23)00376-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MACHIDA M, Inoue S
Patterns of HPV vaccine hesitancy among catch-up generations in Japan: A descriptive study.
Vaccine. 2023 Apr 4:S0264-410X(23)00355-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KIM H, Cho HK, Kang YM, Sagong M, et al
Protective efficacy of a bivalent H5 influenza vaccine candidate against both clades 2.3.2.1 and 2.3.4.4 high pathogenic avian influenza viruses in SPF chickens.
Vaccine. 2023 Apr 4:S0264-410X(23)00311-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PRADA E, Langbecker A, Catalan-Matamoros D
Public discourse and debate about vaccines in the midst of the covid-19 pandemic: A qualitative content analysis of Twitter.
Vaccine. 2023 Apr 4:S0264-410X(23)00375-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FRODLUND M, Nived P, Chatzidionysiou A, Sodergren A, et al
The impact of immunomodulating treatment on the immunogenicity of COVID-19 vaccines in patients with immune-mediated inflammatory rheumatic diseases compared to healthy controls. A Swedish nationwide study (COVID19-REUMA).
Vaccine. 2023 Apr 4:S0264-410X(23)00372-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TOSHKOV D
What accounts for the variation in COVID-19 vaccine hesitancy in Eastern, Southern and Western Europe?
Vaccine. 2023 Apr 4:S0264-410X(23)00314-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

URQUIDI C, Santelices E, Lagomarcino AJ, Teresa Valenzuela M, et al
The added effect of non-pharmaceutical interventions and lifestyle behaviors on vaccine effectiveness against severe COVID-19 in Chile: A matched case-double control study.
Vaccine. 2023 Apr 3:S0264-410X(23)00354-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MAQUILING A, Jeevakanthan A, Ho Mi Fane B
The effect of vaccine mandate announcements on vaccine uptake in Canada: An interrupted time series analysis.
Vaccine. 2023 Apr 3:S0264-410X(23)00334-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ALI Y, Piche-Renaud PP, Karimi-Shahrbabak E, Farrar DS, et al
Pediatricians' perceptions, practices, and barriers regarding COVID-19 vaccine for children: A cross-sectional survey in Ontario, Canada.
Vaccine. 2023 Apr 3:S0264-410X(23)00335-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PRASAD N, Stoecker C, Xing W, Cho BH, et al
Public health impact and cost-effectiveness of 15-valent pneumococcal conjugate vaccine use among the pediatric population of the United States.
Vaccine. 2023 Apr 1:S0264-410X(23)00338-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CRIADO MF, Kassa A, Bertran K, Kwon JH, et al
Efficacy of multivalent recombinant herpesvirus of turkey vaccines against high pathogenicity avian influenza, infectious bursal disease, and Newcastle disease viruses.
Vaccine. 2023 Apr 1:S0264-410X(23)00349-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LYTRAS T, Athanasiadou M, Demetriou A, Stylianou D, et al
Lack of association between vaccination rates and excess mortality in Cyprus during the COVID-19 pandemic.
Vaccine. 2023 Apr 1:S0264-410X(23)00316-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

March 2023

XU S, Zhang B, Yao J, Ruan W, et al
A new H9 influenza virus mRNA vaccine elicits robust protective immunity against infection.
Vaccine. 2023 Mar 31:S0264-410X(23)00343-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DATAR RS, Fette LM, Hinkelman AN, Hammershaimb EA, et al
Factors associated with COVID-19 vaccination during June-October 2021: A multi-site prospective study.
Vaccine. 2023 Mar 31:S0264-410X(23)00352-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HU Y, Wang Y, Shao T, Tang W, et al
Safety and immunogenicity of heterologous ChAdOx1-nCoV19 and BNT162b2 vaccination: A meta-analysis of the heterologous COVID-19 vaccination outcomes.
Vaccine. 2023 Mar 30:S0264-410X(23)00350-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

STEIN-ZAMIR C, Shoob H, Abramson D
Measles clinical presentation, hospitalization and vaccination status among children in a community-wide outbreak.
Vaccine. 2023 Mar 29:S0264-410X(23)00337-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FUKUDA H, Maeda M, Murata F
Development of a COVID-19 vaccine effectiveness and safety assessment system in Japan: The VENUS study.
Vaccine. 2023 Mar 29:S0264-410X(23)00353-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SANTI LAURINI G, Montanaro N, Broccoli M, Bonaldo G, et al
Real-life safety profile of mRNA vaccines for COVID-19: An analysis of VAERS database.
Vaccine. 2023 Mar 28:S0264-410X(23)00348-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SU WJ, Arnold Chan K, Chuang JH, Wang TA, et al
Acute reactions after a homologous primary COVID-19 vaccination series: Analysis of Taiwan V-Watch data.
Vaccine. 2023 Mar 28:S0264-410X(23)00336-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DUGOVICH AM, Cox TH, Weeda ER, Garner SS, et al
First hepatitis B vaccine uptake in neonates prior to and during the COVID-19 pandemic.
Vaccine. 2023 Mar 27:S0264-410X(23)00333-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PANNUS P, Depickere S, Kemlin D, Georges D, et al
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naive nursing home residents and healthy adults.
Vaccine. 2023 Mar 27:S0264-410X(23)00340-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GIDENGIL CA, Parker AM, Markowitz LE, Gedlinske AM, et al
Health care provider knowledge around shared clinical decision-making regarding HPV vaccination of adults aged 27-45 years in the United States.
Vaccine. 2023 Mar 27:S0264-410X(23)00186-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CIAPPONI A, Berrueta M, P K Parker E, Bardach A, et al
Safety of COVID-19 vaccines during pregnancy: A systematic review and meta-analysis.
Vaccine. 2023 Mar 27:S0264-410X(23)00332-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HU B, Yang W, Bouanchaud P, Chongo Y, et al
Determinants of COVID-19 vaccine acceptance in Mozambique: The role of institutional trust.
Vaccine. 2023 Mar 27:S0264-410X(23)00347-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KANG SW, Park H, Yeun Kim J, Bae JY, et al
Comparison of culture-competent virus shedding duration of SARS-CoV-2 Omicron variant in regard to vaccination status: A prospective cohort study.
Vaccine. 2023 Mar 27:S0264-410X(23)00339-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CESUR F, Atasever Z, Ozoran Y
Impact of vitamin D3 supplementation on COVID-19 vaccine response and immunoglobulin G antibodies in deficient women: A randomized controlled trial.
Vaccine. 2023 Mar 27:S0264-410X(23)00341-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DE SANTIS R, Faggioni G, Amoroso A, Ciammaruconi A, et al
Durability of neutralizing antibodies against yellow fever virus after vaccination in healthy adults.
Vaccine. 2023 Mar 24:S0264-410X(23)00284-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

THWAITES CL, Thanh TT, Ny NTH, Nguyet LA, et al
Seroprotection against tetanus in southern Vietnam.
Vaccine. 2023;41:2208-2213.
PubMed Abstract available

FREEMAN RE, Leary CS, Graham JM, Albers AN, et al
Geographic proximity to immunization providers and vaccine series completion among children ages 0-24 months.
Vaccine. 2023 Mar 22:S0264-410X(23)00297-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

VAN KESSEL R, Forman R, Milstein R, Mastylak A, et al
Divergent COVID-19 vaccine policies: Policy mapping of ten European countries.
Vaccine. 2023 Mar 22:S0264-410X(23)00320-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PHOOLCHAROEN W, Shanmugaraj B, Khorattanakulchai N, Sunyakumthorn P, et al
Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant.
Vaccine. 2023 Mar 21:S0264-410X(23)00312-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SATO R
Vaccine hesitancy against COVID-19 vaccine over time in Nigeria.
Vaccine. 2023 Mar 21:S0264-410X(23)00313-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MCCARTY JM, Cassie D, Bedell L
Immunogenicity of partial doses of live oral cholera vaccine CVD 103-HgR in children in the United States.
Vaccine. 2023 Mar 21:S0264-410X(23)00260-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

XU S, Duan H, An Y, Jin X, et al
Effect of adjuvanting RBD-dimer-based subunit COVID-19 vaccines with Sepivac SWE.
Vaccine. 2023 Mar 21:S0264-410X(23)00319-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

YANG J, Huo X, Jiang Q, Liao Y, et al
Preclinical safety evaluation of intradermal SARS-CoV-2 inactivated vaccine (Vero cells) administration in macaques.
Vaccine. 2023 Mar 21:S0264-410X(23)00317-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MURPHY A, Kirby A, De Blasio F
The economic impact of the introduction of universal rotavirus vaccination on rotavirus gastroenteritis related hospitalisations in children in Ireland.
Vaccine. 2023 Mar 20:S0264-410X(23)00257-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ATMAR RL, Bernstein DI, Winokur P, Frey SE, et al
Safety and immunogenicity of Multimeric-001 (M-001) followed by seasonal quadrivalent inactivated influenza vaccine in young adults - A randomized clinical trial.
Vaccine. 2023 Mar 18:S0264-410X(23)00285-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WILSON GJ, Rodriguez B, Li SS, Allen M, et al
Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trial.
Vaccine. 2023 Mar 17:S0264-410X(23)00262-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SHAHID S, Ahmed S, Qazi MF, Ali R, et al
Differential coverage for vaccines in the expanded program on immunization (EPI) among children in rural Pakistan.
Vaccine. 2023 Mar 16:S0264-410X(23)00254-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

NAKANO T
Changes in vaccination administration in Japan.
Vaccine. 2023 Mar 16:S0264-410X(23)00282-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PEREZ MA, Hsiao HM, Chen X, Kunkel A, et al
Serologic responses to COVID-19 vaccination in children with history of multisystem inflammatory syndrome (MIS-C).
Vaccine. 2023 Mar 15:S0264-410X(23)00283-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

RIDDLE MS, Louis Bourgeois A, Clifford A, Jeon S, et al
Challenges and opportunities in developing a Shigella-containing combination vaccine for children in low- and middle-income countries: Report of an expert convening.
Vaccine. 2023 Mar 15:S0264-410X(23)00250-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LIN JH, Huang YT, Yu JC, Chan KA, et al
Mediation and instrumental variable analyses for vaccine-induced antibody titer against influenza B.
Vaccine. 2023 Mar 14:S0264-410X(23)00261-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LAMUDA PA, Azar A, Taylor BG, Balawajder EF, et al
Latent class analysis of medical mistrust and COVID-19 vaccine hesitancy among adults in the United States just prior to FDA emergency use authorization.
Vaccine. 2023 Mar 13:S0264-410X(23)00263-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KELLY D, O'Donnell K, Marron L, Dwyer R, et al
Immunocompromise among vaccinated versus unvaccinated COVID-19 cases admitted to critical care in Ireland, July to October 2021.
Vaccine. 2023 Mar 13:S0264-410X(23)00258-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WONODI C, Moss W
Editorial from guest editors for vaccine supplement: Vaccine-derived poliovirus type 2 outbreaks after the cessation of use of oral poliovirus vaccine type 2_ 2016-2021 journal supplement.
Vaccine. 2023 Mar 11:S0264-410X(23)00244-X. doi: 10.1016/j.vaccine.2023.
PubMed

KWAK HW, Park HJ, Jung SY, Oh EY, et al
Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants.
Vaccine. 2023;41:1892-1901.
PubMed Abstract available

KIM E, He J, Kaufhold RM, McGuinness D, et al
Evaluation of cross-protection between S. Pneumoniae serotypes 35B and 29 in a mouse model.
Vaccine. 2023;41:1774-1777.
PubMed Abstract available

LIU YC, Munoz FM, Izurieta HS, Tamborska AA, et al
Anosmia: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
Vaccine. 2023;41:1902-1910.
PubMed Abstract available

SRIVASTAV A, Lu PJ, Amaya A, Dever JA, et al
Prevalence of influenza-specific vaccination hesitancy among adults in the United States, 2018.
Vaccine. 2023 Mar 10:S0264-410X(23)00255-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ALLEMAN MM, Jorba J, Riziki Y, Henderson E, et al
Vaccine-derived poliovirus serotype 2 outbreaks and response in the Democratic Republic of the Congo, 2017-2021.
Vaccine. 2023 Mar 10:S0264-410X(23)00177-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CLAY PA, Thompson TD, Markowitz LE, Ekwueme DU, et al
Updated estimate of the annual direct medical cost of screening and treatment for human papillomavirus associated disease in the United States.
Vaccine. 2023 Mar 10:S0264-410X(23)00184-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SEAL AJ, Mohamed HA, Stokes-Walter R, Mohamed S, et al
Use of an adapted participatory learning and action cycle to increase knowledge and uptake of child vaccination in internally displaced persons camps (IVACS): A cluster-randomised controlled trial.
Vaccine. 2023 Mar 9:S0264-410X(23)00142-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SYLVIE YANG R, Yang Y, Gowetski DB, Tsybovsky Y, et al
Characterization of Flu MOSAIC nanoparticle vaccine candidate using high performance size-exclusion chromatography to support vaccine process development.
Vaccine. 2023 Mar 9:S0264-410X(23)00248-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

RIVAS DRZ, Ticona JPA, Doss-Gollin S
Lessons from the Bolivian vaccine mandate.
Vaccine. 2023 Mar 9:S0264-410X(23)00251-7. doi: 10.1016/j.vaccine.2023.
PubMed

SANCHEZ L, Nakama T, Nagai H, Matsuoka O, et al
Superior immunogenicity of high-dose quadrivalent inactivated influenza vaccine versus Standard-Dose vaccine in Japanese Adults >/= 60 years of age: Results from a phase III, randomized clinical trial.
Vaccine. 2023 Mar 9:S0264-410X(23)00225-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PLUMB ID, Fette LM, Tjaden AH, Feldstein L, et al
Estimated COVID-19 vaccine effectiveness against seroconversion from SARS-CoV-2 Infection, March-October, 2021.
Vaccine. 2023 Mar 9:S0264-410X(23)00253-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

IKEWAKI N, Kurosawa G, Levy GA, Preethy S, et al
Antibody dependent disease enhancement (ADE) after COVID-19 vaccination and beta glucans as a safer strategy in management.
Vaccine. 2023 Mar 8:S0264-410X(23)00252-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CHOWDHURY F, Aziz AB, Ahmmed F, Ahmed T, et al
The interplay between WASH practices and vaccination with oral cholera vaccines in protecting against cholera in urban Bangladesh: Reanalysis of a cluster-randomized trial.
Vaccine. 2023 Mar 8:S0264-410X(23)00197-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MANANDHAR P, Wannemuehler K, Danovaro-Holliday MC, Nic Lochlainn L, et al
Corrigendum to "Use of catch-up vaccinations in the second year of life (2YL) platform to close immunity gaps: A secondary DHS analysis in Pakistan, Philippines, and South Africa" [Vaccine 41(1) (2023) 61-67].
Vaccine. 2023 Mar 8:S0264-410X(23)00168-8. doi: 10.1016/j.vaccine.2023.
PubMed

GILBERT M, Ablona A, Chang HJ, Grennan T, et al
Uptake of Mpox vaccination among transgender people and gay, bisexual and other men who have sex with men among sexually-transmitted infection clinic clients in Vancouver, British Columbia.
Vaccine. 2023 Mar 7:S0264-410X(23)00229-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BACON A, Teixeira M, Costa V, Bone P, et al
Generation of a thermostable, oral Zika vaccine that protects against virus challenge in non-human primates.
Vaccine. 2023 Mar 7:S0264-410X(23)00198-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BOONE AC, Kulkarni RR, Cortes AL, Villalobos T, et al
In ovo HVT vaccination enhances cellular responses at hatch and addition of poly I:C offers minimal adjuvant effects.
Vaccine. 2023 Mar 7:S0264-410X(23)00238-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

YELVERTON V, Hair NL, Ghosh SH, Mfinanga SG, et al
Corrigendum to "Beyond coverage: Rural-urban disparities in the timeliness of childhood vaccinations in Tanzania" [Vaccine 40(37) (2022) 5483-5493].
Vaccine. 2023 Mar 6:S0264-410X(23)00218-9. doi: 10.1016/j.vaccine.2023.
PubMed

HART RJ, Baumer-Mouradian S, Bone JN, Olson P, et al
Factors associated with US caregivers' uptake of pediatric COVID-19 vaccine by race and ethnicity.
Vaccine. 2023 Mar 6:S0264-410X(23)00242-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PRYSLIAK T, Menghwar H, Perez-Casal J
Complement-mediated killing of Mycoplasma bovis does not play a role in the protection of animals against an experimental challenge.
Vaccine. 2023;41:1743-1752.
PubMed Abstract available

GELORMINI M, Gripenberg M, Marke D, Murray M, et al
Coverage survey and lessons learned from a pre-emptive cholera vaccination campaign in urban and rural communities affected by landslides and floods in Freetown Sierra Leone.
Vaccine. 2023 Mar 3:S0264-410X(23)00037-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WU L, Yang S, Huang Z, Liu J, et al
Safety of concomitant administration of inactivated hepatitis A vaccine with other vaccines in children under 16 years old in post-marketing surveillance.
Vaccine. 2023 Mar 3:S0264-410X(23)00226-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BAEK YJ, Kim WJ, Ko JH, Lee YJ, et al
A heterologous AZD1222 priming and BNT162b2 boosting regimen more efficiently elicits neutralizing antibodies, but not memory T cells, than the homologous BNT162b2 regimen.
Vaccine. 2023;41:1694-1702.
PubMed Abstract available

GRIGNOLIO CORSINI A, Zagarella RM, Adamo M, Caporale C, et al
From COVID-19 vaccine candidates to compulsory vaccination: The attitudes of Italian citizens in the key 7-month of vaccination campaign.
Vaccine. 2023 Mar 3:S0264-410X(23)00243-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ESTEPHAN L, Liu LT, Lien CE, Smith ER, et al
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Medigen COVID-19 protein vaccine.
Vaccine. 2023 Mar 3:S0264-410X(23)00245-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GOLDMAN RD, Hart RJ, Bone JN, Seiler M, et al
Willingness to vaccinate children against COVID-19 declined during the pandemic.
Vaccine. 2023 Mar 2:S0264-410X(23)00223-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

XIE S, Monteiro K, Gjelsvik A
The association between maternal influenza vaccination during pregnancy and adverse birth outcomes in the United States: Pregnancy risk Assessment Monitoring System (PRAMS).
Vaccine. 2023 Mar 2:S0264-410X(23)00228-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

NEWALL AT, Beutels P, Kis Z, Towse A, et al
Placing a value on increased flexible vaccine manufacturing capacity for future pandemics.
Vaccine. 2023 Mar 2:S0264-410X(23)00219-0. doi: 10.1016/j.vaccine.2023.
PubMed

NARII N, Kitamura T, Komukai S, Zha L, et al
Association of pneumococcal vaccination with cardiovascular diseases in older adults: The vaccine effectiveness, networking, and universal safety (VENUS) study.
Vaccine. 2023 Mar 2:S0264-410X(23)00240-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LUDWIKOWSKA KM, Popiel A, Matkowska-Kocjan A, Olbromski MJ, et al
COVID-19 mRNA BNT162b2 vaccine safety and B-cell and T-cell reactogenicity among children with a history of paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS-TS) - preliminary study.
Vaccine. 2023 Mar 2:S0264-410X(23)00227-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BEAUJEAN M, Uijen RF, Langereis JD, Boccara D, et al
The immunological effects of intradermal particle-based vaccine delivery using a novel microinjection needle studied in a human skin explant model.
Vaccine. 2023 Mar 2:S0264-410X(23)00175-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HURSTAK EE, Paasche-Orlow MK, Hahn EA, Henault LE, et al
The mediating effect of health literacy on COVID-19 vaccine confidence among a diverse sample of urban adults in Boston and Chicago.
Vaccine. 2023 Mar 2:S0264-410X(23)00202-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

NA L, Banks S, Wang PP
Racial and ethnic disparities in COVID-19 vaccine uptake: A mediation framework.
Vaccine. 2023 Mar 1:S0264-410X(23)00241-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

February 2023

DARWAR R, Biya O, Greene SA, Jorba J, et al
Assessing country compliance with circulating vaccine-derived poliovirus type 2 outbreak response standard operating procedures: April 2016 to December 2020.
Vaccine. 2023 Feb 28:S0264-410X(23)00214-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

AL ALAWI S, Al Zaabi O, Heffernan ME, Arulappan J, et al
Knowledge, attitudes and acceptance toward Human papillomavirus (HPV) vaccination: Perspectives of Muslim women and men.
Vaccine. 2023 Feb 27:S0264-410X(23)00217-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ITAMOCHI M, Yazawa S, Inasaki N, Saga Y, et al
Neutralization of Omicron subvariants BA.1 and BA.5 by a booster dose of COVID-19 mRNA vaccine in a Japanese nursing home cohort.
Vaccine. 2023 Feb 27:S0264-410X(23)00222-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MALTEZOU HC, Hatziantoniou S, Theodoridou K, Vasileiou K, et al
Anaphylaxis rates following mRNA COVID-19 vaccination in children and adolescents: Analysis of data reported to EudraVigilance.
Vaccine. 2023 Feb 27:S0264-410X(23)00221-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TAMANDJOU TCHUEM CR, Auvigne V, Vaux S, Montagnat C, et al
Vaccine effectiveness and duration of protection of COVID-19 mRNA vaccines against Delta and Omicron BA.1 symptomatic and severe COVID-19 outcomes in adults aged 50 years and over in France.
Vaccine. 2023 Feb 27:S0264-410X(23)00216-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

O'KENNEDY MM, Abolnik C, Smith T, Motlou T, et al
Immunogenicity of adjuvanted plant-produced SARS-CoV-2 Beta spike VLP vaccine in New Zealand white rabbits.
Vaccine. 2023 Feb 27:S0264-410X(23)00185-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GUERIN RJ, Naeim A, Baxter-King R, Okun AH, et al
Erratum to "Parental intentions to vaccinate children against COVID-19: Findings from a U.S. National Survey" [Vaccine 41(1) (2023) 101-108.
Vaccine. 2023 Feb 25:S0264-410X(23)00107-X. doi: 10.1016/j.vaccine.2023.
PubMed

CHANG AM, Chen CC, Lee JW, Hou DL, et al
Effects of a novel recombinant Gonadotropin-Releasing Hormone-1 vaccine on the reproductive function of mixed-breed dogs (Canis familiaris) in Taiwan.
Vaccine. 2023 Feb 25:S0264-410X(23)00215-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BAKHSHIZADEH GASHTI A, Chahal PS, Gaillet B, Garnier A, et al
Purification of recombinant vesicular stomatitis virus-based HIV vaccine candidate.
Vaccine. 2023 Feb 24:S0264-410X(23)00201-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ZHANG Y, Na D, Zhang W, Liu X, et al
Development of stable HEK293T cell pools expressing CSFV E2 protein: A potential antigen expression platform.
Vaccine. 2023;41:1573-1583.
PubMed Abstract available

FEITSMA EA, Janssen YF, Boersma HH, van Sleen Y, et al
A randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452.
Vaccine. 2023 Feb 23:S0264-410X(23)00200-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FANTINATO FFST, Wachira VK, Porto VBG, Peixoto HM, et al
Factors associated with yellow fever vaccine failure: A systematic literature review.
Vaccine. 2023 Feb 23:S0264-410X(23)00133-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HOSSEINNEZHAD-LAZARJANI E, Doosti A, Sharifzadeh A
Novel csuC-DNA nanovaccine based on chitosan candidate vaccine against infection with Acinetobacter baumannii.
Vaccine. 2023 Feb 23:S0264-410X(23)00181-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BENFIELD T, Ramet M, Valentini P, Seppa I, et al
Safety, tolerability, and immunogenicity of V114 pneumococcal vaccine compared with PCV13 in a 2+1 regimen in healthy infants: A phase III study (PNEU-PED-EU-2).
Vaccine. 2023 Feb 23:S0264-410X(23)00176-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KABIR SULAIMAN S, Sale Musa M, Isma'il Tsiga-Ahmed F, Muhammad Dayyab F, et al
COVID-19 vaccine hesitancy among people living with HIV in a low-resource setting: A multi-center study of prevalence, correlates and reasons.
Vaccine. 2023 Feb 23:S0264-410X(23)00199-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CANNON K, Cardona JF, Yacisin K, Thompson A, et al
Safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine coadministered with quadrivalent influenza vaccine: A phase 3 randomized trial.
Vaccine. 2023 Feb 22:S0264-410X(22)01459-1. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

KASSTAN B, Chantler T, Marcus B, Mounier-Jack S, et al
Linked poliovirus incidents in the UK, USA and Israel: Silent transmission or missed warnings of vaccine inequity?
Vaccine. 2023 Feb 22:S0264-410X(23)00178-0. doi: 10.1016/j.vaccine.2023.
PubMed

KOUIAVSKAIA D, Mirochnitchenko O, Troy S, Chumakov K, et al
Antigenic diversity of type 1 polioviruses and its implications for the efficacy of polio vaccines.
Vaccine. 2023 Feb 22:S0264-410X(23)00052-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ZHANG H, Chen L, Huang Z, Li D, et al
The effects of parent's health literacy and health beliefs on vaccine hesitancy.
Vaccine. 2023 Feb 21:S0264-410X(23)00161-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SABATO B, Augusto PSA, Lima Goncalves Pereira R, Coutinho Batista Esteves F, et al
Safety and immunogenicity of the anti-cocaine vaccine UFMG-VAC-V4N2 in a non-human primate model.
Vaccine. 2023 Feb 21:S0264-410X(23)00166-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HAMBURG M, Poland GA
The time is now for committed and comprehensive action to attain more broadly protective coronavirus vaccines: The coronavirus vaccines R&D roadmap.
Vaccine. 2023 Feb 21:S0264-410X(23)00196-2. doi: 10.1016/j.vaccine.2023.
PubMed

MOORE KA, Leighton T, Ostrowsky JT, Anderson CJ, et al
A research and development (R&D) roadmap for broadly protective coronavirus vaccines: A pandemic preparedness strategy.
Vaccine. 2023 Feb 21:S0264-410X(23)00167-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MOTTA M, Callaghan T, Lunz-Trujillo K, Lockman A, et al
Erroneous Consonance. How inaccurate beliefs about physician opinion influence COVID-19 vaccine hesitancy.
Vaccine. 2023 Feb 20:S0264-410X(23)00195-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

LU L, Ma W, Johnson CH, Khan SA, et al
In silico designed mRNA vaccines targeting CA-125 neoantigen in breast and ovarian cancer.
Vaccine. 2023 Feb 20:S0264-410X(23)00183-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DUDLEY MZ, Gerber JE, Budigan Ni H, Blunt M, et al
Vaccinomics: A scoping review.
Vaccine. 2023 Feb 18:S0264-410X(23)00135-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

USTYUGOVA IV, Pougatcheva S, Farrell T, Strugnell T, et al
AF03 adjuvant improves anti-hemagglutinin and anti-neuraminidase immune responses induced by licensed seasonal quadrivalent influenza vaccines in mice.
Vaccine. 2023 Feb 18:S0264-410X(23)00169-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GEOGHEGAN S, Acosta F, Stephens LC, Gillan H, et al
Maternity care provider acceptance of a future Group B Streptococcus vaccine - A qualitative study in three countries.
Vaccine. 2023 Feb 18:S0264-410X(23)00172-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

YI W, Wang H, Qin H, Wang Q, et al
Construction and efficacy of a new live chimeric C-strain vaccine with DIVA characteristics against classical swine fever.
Vaccine. 2023 Feb 18:S0264-410X(23)00179-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FORD A, Hwang A, Mo AX, Baqar S, et al
Meeting Summary: Global Vaccine and Immunization Research Forum, 2021.
Vaccine. 2023 Feb 18:S0264-410X(23)00163-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SHERMAN SM, Lingley-Heath N, Lai J, Sim J, et al
Parental acceptance of and preferences for administration of routine varicella vaccination in the UK: A study to inform policy.
Vaccine. 2023;41:1438-1446.
PubMed Abstract available

RANADE D, Jena R, Patil K, Dogar V, et al
A novel high throughput plate-based method for 2-PE quantification in novel multidose vaccines (R21 malaria, Covishield and Covovax) and combination vaccines (Hexavalent).
Vaccine. 2023 Feb 17:S0264-410X(23)00174-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PARODI A, Martini M
History of vaccine and immunization: Vaccine-hesitancy discussion in Germany in XIX century.
Vaccine. 2023 Feb 17:S0264-410X(23)00164-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MORAIS A, Morais J, Felix M, Neto Z, et al
Genetic and epidemiological description of an outbreak of circulating vaccine-derived polio-virus type 2 (cVDPV2) in Angola, 2019-2020.
Vaccine. 2023 Feb 17:S0264-410X(23)00170-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DA SILVA AB, Cardoso-Marques NT, Dolores IM, Teixeira LM, et al
Carriage prevalence, serotype distribution, antimicrobial resistance, pspA typing and pilus islets of Streptococcus pneumoniae isolated from adults living in a Brazilian urban slum.
Vaccine. 2023;41:1431-1437.
PubMed Abstract available

MEYER C, Goffe L, Antonopoulou V, Graham F, et al
Using the precaution adoption process model to understand decision-making about the COVID-19 booster vaccine in England.
Vaccine. 2023 Feb 17:S0264-410X(23)00182-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ZIMMERMANN BM, Paul KT, Araujo ER, Buyx A, et al
The social and socio-political embeddedness of COVID-19 vaccination decision-making: A five-country qualitative interview study from Europe.
Vaccine. 2023 Feb 16:S0264-410X(23)00139-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PILIC A, Reda S, Jo CL, Burchett H, et al
Use of existing systematic reviews for the development of evidence-based vaccination recommendations: Guidance from the SYSVAC expert panel.
Vaccine. 2023 Feb 16:S0264-410X(23)00162-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BENEDICT KPOZEHOUEN E, Arrudsivah B, Raina Macintyre C
Knowledge, attitudes and practices of health care workers in a cardiology department on influenza vaccination.
Vaccine. 2023 Feb 15:S0264-410X(23)00112-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KLOUWENS MJ, Trentelman JJA, Barriales D, Ersoz JI, et al
The Ixodes ricinus salivary gland proteome during feeding and B. Afzelii infection: New avenues for an anti-tick vaccine.
Vaccine. 2023 Feb 14:S0264-410X(23)00129-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WAHAB MT, Tan RKJ, Cook AR, Prem K, et al
Impact of including boys in the national school-based human papillomavirus vaccination programme in Singapore: A modelling-based cost-effectiveness analysis.
Vaccine. 2023 Feb 14:S0264-410X(23)00160-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

VOJICIC J, Grajales AG, Cane A
Vaccine effectiveness of the 7-valent and 13-valent pneumococcal conjugate vaccines in Canada: An IMPACT study.
Vaccine. 2023 Feb 14:S0264-410X(23)00130-5. doi: 10.1016/j.vaccine.2023.
PubMed

SAELEE R, Chandra Murthy N, Patel Murthy B, Zell E, et al
Minority Health Social Vulnerability Index and COVID-19 vaccination coverage - The United States, December 14, 2020-January 31, 2022.
Vaccine. 2023 Feb 13:S0264-410X(23)00157-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WANKHEDE D, Grover S, Hofman P
Determinants of humoral immune response to SARS-CoV-2 vaccines in solid cancer patients: A systematic review and meta-analysis.
Vaccine. 2023 Feb 13:S0264-410X(23)00115-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

AFREH OK, Angwaawie P, Attivor E, Boateng LA, et al
Examining confidence and hesitancy towards COVID-19 vaccines: A cross-sectional survey using in-person data collection in rural Ghana.
Vaccine. 2023 Feb 13:S0264-410X(23)00159-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

CAMPMAN SL, van Rossem G, Boyd A, Coyer L, et al
Intent to vaccinate against SARS-CoV-2 and its determinants across six ethnic groups living in Amsterdam, the Netherlands: A cross-sectional analysis of the HELIUS study.
Vaccine. 2023 Feb 13:S0264-410X(23)00165-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BARNES K, Faasse K, Colagiuri B
The impact of side effect framing on COVID-19 booster vaccine intentions in an Australian sample.
Vaccine. 2023 Feb 13:S0264-410X(23)00158-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GETCHELL M, Mantaring EJ, Yee K, Pronyk P, et al
Cost-effectiveness of sub-national geographically targeted vaccination programs: A systematic review.
Vaccine. 2023 Feb 11:S0264-410X(23)00132-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

O'LEARY ST, Spina CI, Spielvogle H, Robinson JD, et al
Development of PIVOT with MI: A motivational Interviewing-Based vaccine communication training for pediatric clinicians.
Vaccine. 2023 Feb 10:S0264-410X(23)00136-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FACCHIN G, Bella A, Del Manso M, Rota MC, et al
Decline in reported measles cases in Italy in the COVID-19 era, January 2020 - July 2022: The need to prevent a resurgence upon lifting non-pharmaceutical pandemic measures.
Vaccine. 2023;41:1286-1289.
PubMed Abstract available

SELL H, Raj Paudel Y, Voaklander D, MacDonald SE, et al
School immunization coverage in adolescents during the COVID-19 pandemic: A retrospective cohort study.
Vaccine. 2023;41:1333-1341.
PubMed Abstract available

DE VRIES M, Claassen L, Lambooij MS, Timen A, et al
Did the temporary suspension of Vaxzveria vaccinations influence COVID-19 vaccination intentions, vaccination perceptions and trust in the vaccination campaign? A repeated survey study in the Netherlands.
Vaccine. 2023 Feb 10:S0264-410X(23)00138-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HOSAIN R, Aquino P, Baccarini C, Smolenov I, et al
Six-month safety follow-up of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in adults: A phase 2/3, double-blind, randomized study.
Vaccine. 2023 Feb 10:S0264-410X(23)00144-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FEIKIN DR, Higdon MM, Andrews N, Collie S, et al
Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health Organization.
Vaccine. 2023 Feb 9:S0264-410X(23)00146-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SILVA VASCONCELOS G, da Conceicao Rodrigues Fernandes M, Cardoso Matsui T, Claudia Dos Santos Luciano M, et al
Persistent SARS-COV-2 infection in vaccinated individual with three doses of COVID-19 vaccine.
Vaccine. 2023 Feb 9:S0264-410X(23)00145-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BUNTINX E, Brochado L, Borja-Tabora C, Yu CY, et al
Immunogenicity of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in SARS-CoV-2-naive and exposed individuals in a phase 2/3, double-blind, randomized study.
Vaccine. 2023 Feb 9:S0264-410X(23)00143-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

OK BAIK Y, Lee Y, Lee C, Kyung Kim S, et al
A Phase II/III, Multicenter, Observer-blinded, Randomized, Non-inferiority and Safety, study of typhoid conjugate vaccine (EuTCV) compared to Typbar-TCV(R) in healthy 6 Months-45 years aged participants.
Vaccine. 2023 Feb 9:S0264-410X(22)01524-9. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

SHEN AK, Browne S, Srivastava T, Kornides ML, et al
Persuading the "Movable Middle": Characteristics of effective messages to promote routine and COVID-19 vaccinations for adults and children - The impact of COVID-19 on beliefs and attitudes.
Vaccine. 2023 Feb 9:S0264-410X(23)00141-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WATANABE A, Iwagami M, Yasuhara J, Takagi H, et al
Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis.
Vaccine. 2023 Feb 8:S0264-410X(23)00134-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PERETTI A, Scorpio DG, Kong WP, Pang YS, et al
A multivalent polyomavirus vaccine elicits durable neutralizing antibody responses in macaques.
Vaccine. 2023 Feb 8:S0264-410X(23)00128-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BUGHIN J, Cincera M, Peters K, Reykowska D, et al
Make it or break it: On-time vaccination intent at the time of Covid-19.
Vaccine. 2023 Feb 8:S0264-410X(23)00140-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DENG HM, Romero N, Allard N, Rowe S, et al
Uptake of perinatal immunoprophylaxis for infants born to women with a record of hepatitis B in Victoria (2009-2017).
Vaccine. 2023 Feb 7:S0264-410X(23)00076-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ERDEM R, De Coster I, Withanage K, Mercer LD, et al
Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized study.
Vaccine. 2023 Feb 4:S0264-410X(23)00078-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

FELL DB, Torok E, Sprague AE, Regan AK, et al
Temporal trends and determinants of COVID-19 vaccine coverage and series initiation during pregnancy in Ontario, Canada, December 2020 to December 2021: A population-based retrospective cohort study.
Vaccine. 2023 Feb 3:S0264-410X(23)00114-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HASSAN RAZA S, Yousaf M, Zaman U, Waheed Khan S, et al
Unlocking infodemics and mysteries in COVID-19 vaccine hesitancy: Nexus of conspiracy beliefs, digital informational support, psychological Well-being, and religious fatalism.
Vaccine. 2023 Feb 3:S0264-410X(23)00079-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SEESEN M, Jearanaiwitayakul T, Limthongkul J, Midoeng P, et al
A bivalent form of nanoparticle-based dengue vaccine stimulated responses that potently eliminate both DENV-2 particles and DENV-2-infected cells.
Vaccine. 2023 Feb 3:S0264-410X(23)00096-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PARK I, Unger ER, Kemp TJ, Pinto LA, et al
The second HPV serology meeting: Progress and challenges in standardization of human papillomavirus serology assays.
Vaccine. 2023;41:1177-1181.
PubMed Abstract available

LI R, Liu H, Fairley CK, Ong JJ, et al
mRNA-based COVID-19 booster vaccination is highly effective and cost-effective in Australia.
Vaccine. 2023 Feb 3:S0264-410X(23)00126-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MALTEZOU HC, Basoulis D, Bonelis K, Gamaletsou MN, et al
Effectiveness of full (booster) COVID-19 vaccination against severe outcomes and work absenteeism in hospitalized patients with COVID-19 during the Delta and Omicron waves in Greece.
Vaccine. 2023 Feb 2:S0264-410X(23)00109-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ANDREJKO KL, Myers JF, Fukui N, Nelson L, et al
Real-world uptake of COVID-19 vaccination among individuals expressing vaccine hesitancy: A registry-linkage study.
Vaccine. 2023 Feb 1:S0264-410X(23)00108-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HAMADA H, Futamura M, Ito H, Yamamoto R, et al
Association of a third vaccination with antibody levels and side reactions in essential workers: A prospective cohort study.
Vaccine. 2023 Feb 1:S0264-410X(23)00082-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

JOHNSON R, Djaafara B, Haw D, Doohan P, et al
The societal value of SARS-CoV-2 booster vaccination in Indonesia.
Vaccine. 2023 Feb 1:S0264-410X(23)00110-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

January 2023

UWAMINO Y, Yokoyama T, Sato Y, Shibata A, et al
Humoral and cellular immune response dynamics in Japanese healthcare workers up to six months after receiving a third dose of BNT162b2 monovalent vaccine.
Vaccine. 2023 Jan 31:S0264-410X(23)00081-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PATRICIA WODI A, Marquez P, Mba-Jonas A, Barash F, et al
Spontaneous reports of primary ovarian insufficiency after vaccination: A review of the vaccine adverse event reporting system (VAERS).
Vaccine. 2023 Jan 31:S0264-410X(22)01563-8. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

STONE AE, Rambaran S, Trinh IV, Estrada M, et al
Route and antigen shape immunity to dmLT-adjuvanted vaccines to a greater extent than biochemical stress or formulation excipients.
Vaccine. 2023 Jan 31:S0264-410X(23)00055-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HUANG CY, Chi H, Chang L, Chiu NC, et al
Typical time courses and appearance of skin reactions at the site of Bacillus Calmette-Guerin vaccination for infants inoculated at 5-8 months of age.
Vaccine. 2023 Jan 30:S0264-410X(23)00083-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KABIR SULAIMAN S, Isma'il Tsiga-Ahmed F, Sale Musa M, Kabir Sulaiman A, et al
Prevalence, determinants, and reasons for malaria vaccine hesitancy among caregivers of under-five children in Nigeria: Results from a nationwide cross-sectional survey.
Vaccine. 2023 Jan 30:S0264-410X(23)00089-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

RAABE V, Lai L, Morales J, Xu Y, et al
Cellular and humoral immunity to Ebola Zaire glycoprotein and viral vector proteins following immunization with recombinant vesicular stomatitis virus-based Ebola vaccine (rVSVDeltaG-ZEBOV-GP).
Vaccine. 2023 Jan 30:S0264-410X(23)00090-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

SESHADRI S, Martin SW, Hills SL, Collins LC Jr, et al
Comparative frequency of specified adverse events following Vero cell culture-derived Japanese encephalitis and Vi capsular polysaccharide typhoid vaccines in U.S. military personnel, July 2011-August 2019.
Vaccine. 2023 Jan 30:S0264-410X(23)00093-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GRESSENS SB, Wiedemann A, Dechenaud M, Dupuis J, et al
Anti-SARS-CoV-2 cellular response after 2 and 3 doses of BNT162b2 mRNA vaccine in lymphoma patients receiving anti-CD20 antibodies.
Vaccine. 2023 Jan 30:S0264-410X(23)00095-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

HARBIN A, Laventhal N, Navin M
Ethics of age de-escalation in pediatric vaccine trials: Attending to the case of COVID-19.
Vaccine. 2023 Jan 27:S0264-410X(23)00087-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PARODI JB, Indavere A, Bobadilla Jacob P, Toledo GC, et al
Impact of COVID-19 vaccination in post-COVID cardiac complications.
Vaccine. 2023 Jan 27:S0264-410X(23)00084-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MATTA MG, Pulido L, Herrera-Paz JJ, Picco JM, et al
Influenza and pneumococcal vaccine prescription for adults during COVID-19 first wave in three regions of Argentina.
Vaccine. 2023 Jan 27:S0264-410X(23)00088-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BARAL R, Levin A, Odero C, Pecenka C, et al
Cost of introducing and delivering RTS,S/AS01 malaria vaccine within the malaria vaccine implementation program.
Vaccine. 2023 Jan 27:S0264-410X(23)00064-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

PIRAS-DOUCE F, Broudic K, Chautard E, Raynal F, et al
Evaluation of safety and immuno-efficacy of a next generation live-attenuated yellow fever vaccine in cynomolgus macaques.
Vaccine. 2023 Jan 24:S0264-410X(22)01464-5. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

SUZUKI F, Maeyama JI, Kubota A, Nishimune A, et al
Effect of cigarette smoke on mucosal vaccine response with activation of plasmacytoid dendritic cells: The outcomes of in vivo and in vitro experiments.
Vaccine. 2023 Jan 24:S0264-410X(23)00030-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TENG Y, Hanibuchi T, Machida M, Nakaya T, et al
Psychological determinants of COVID-19 vaccine acceptance: A comparison between immigrants and the host population in Japan.
Vaccine. 2023 Jan 23:S0264-410X(23)00056-7. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ZOLOTAROVA T, Dussault C, Park H, Varsaneux O, et al
Education increases COVID-19 vaccine uptake among people in Canadian federal prisons in a prospective randomized controlled trial: The EDUCATE study.
Vaccine. 2023 Jan 23:S0264-410X(23)00061-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MYERS TR, Marquez PL, Gee JM, Hause AM, et al
The v-safe after vaccination health checker: Active vaccine safety monitoring during CDC's COVID-19 pandemic response.
Vaccine. 2023 Jan 23:S0264-410X(22)01545-6. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

JOSHI K, Rumpler E, Kennedy-Shaffer L, Bosan R, et al
Comparative performance of between-population vaccine allocation strategies with applications for emerging pandemics.
Vaccine. 2023 Jan 23:S0264-410X(22)01579-1. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

STRATHDEE SA, Abramovitz D, Vera CF, Artamonova I, et al
Predictors of COVID-19 vaccine uptake among people who inject drugs.
Vaccine. 2023 Jan 23:S0264-410X(23)00063-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KRAUSE NM, Beets B, Howell EL, Tosteson H, et al
Collateral damage from debunking mRNA vaccine misinformation.
Vaccine. 2023;41:922-929.
PubMed Abstract available

RENNERT W, Hindiyeh M, Allahham M, Mercer LD, et al
Introducing ROTAVAC(R) to the occupied Palestinian Territories: Impact on diarrhea incidence, rotavirus prevalence and genotype composition.
Vaccine. 2023;41:945-954.
PubMed Abstract available

KUZEL TG, Fu J, Anderson M, Stec M, et al
Effects of a booster dose of BNT162b2 on spike-binding antibodies to SARS-CoV-2 Omicron BA.2, BA.3, BA.4 and BA.5 subvariants in infection-naive and previously-infected individuals.
Vaccine. 2023;41:879-882.
PubMed Abstract available

FAIZULOEV E, Gracheva A, Korchevaya E, Smirnova D, et al
Cold-adapted SARS-CoV-2 variants with different temperature sensitivity exhibit an attenuated phenotype and confer protective immunity.
Vaccine. 2023;41:892-902.
PubMed Abstract available

GROSSMAN-GIRON A, Tzur Bitan D, Shemesh S, Mayer Y, et al
COVID-19 vaccine hesitancy scale and its association with actual COVID-19 vaccine uptake in Israel.
Vaccine. 2023 Jan 23:S0264-410X(23)00065-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MALLAH SI, Alawadhi A, Jawad J, Wasif P, et al
Safety and efficacy of COVID-19 prime-boost vaccinations: Homologous BBIBP-CorV versus heterologous BNT162b2 boosters in BBIBP-CorV-primed individuals.
Vaccine. 2023 Jan 23:S0264-410X(23)00053-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

VATCHARAVONGVAN P, Boonyanitchayakul N, Khampachuea P, Sinturong I, et al
Health Belief Model and parents' acceptance of the Pfizer-BioNTech and Sinopharm COVID-19 vaccine for children aged 5-18 years Old: A national survey.
Vaccine. 2023 Jan 23:S0264-410X(23)00050-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GRASSLY NC, Andrews N, Cooper G, Stephens L, et al
Effect of maternal immunisation with multivalent vaccines containing inactivated poliovirus vaccine (IPV) on infant IPV immune response: A phase 4, multi-centre randomised trial.
Vaccine. 2023 Jan 21:S0264-410X(23)00057-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KRAMER C, Song M, Sufrin CB, Eber GB, et al
COVID-19 vaccination hesitancy and uptake: Perspectives from people released from the Federal Bureau of Prisons.
Vaccine. 2023 Jan 21:S0264-410X(23)00060-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DARBY B, Alexander V, Murphy J
SARS-CoV-2 vaccine breakthrough infections in Virginia, January 17, 2021 - June 30, 2021.
Vaccine. 2023 Jan 20:S0264-410X(23)00062-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BIANCHI FP, Stefanizzi P, Martinelli A, Brescia N, et al
COVID-19 vaccination hesitancy in people affected by diabetes and strategies to increase vaccine compliance: A systematic narrative review and meta-analysis.
Vaccine. 2023 Jan 20:S0264-410X(23)00058-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DUDLEY MZ, Schuh HB, Shaw J, Rimal RN, et al
COVID-19 vaccination among different types of US Healthcare Personnel.
Vaccine. 2023 Jan 20:S0264-410X(23)00051-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TRICOU V, Eyre S, Ramjee M, Collini P, et al
A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus vaccine in a dengue non-endemic country.
Vaccine. 2023 Jan 19:S0264-410X(23)00007-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MARSHALL S, Fleming A, Sahm LJ, Moore AC, et al
Identifying intervention strategies to improve HPV vaccine decision-making using behaviour change theory.
Vaccine. 2023 Jan 18:S0264-410X(23)00036-1. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

GHORBANI A, Ngunjiri JM, Edward C Abundo M, Pantin-Jackwood M, et al
Development of in Ovo-Compatible NS1-truncated live attenuated influenza vaccines by modulation of hemagglutinin cleavage and polymerase Acidic X Frameshifting sites.
Vaccine. 2023 Jan 18:S0264-410X(23)00029-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

ZABALZA-BARANGUA A, Poveda-Urkixo I, Mena-Bueno S, Ramirez GA, et al
Vaccine properties of Brucella melitensis 16MDeltawzm and reactivation of placental infection in pregnant sheep.
Vaccine. 2023 Jan 16:S0264-410X(23)00028-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MOINI A, Rabiei M, Pirjani R, Abiri A, et al
COVIDâ€‘19 vaccine hesitancy among pregnant women and their reported reasons for vaccine refusal - A prospective study in Tehran, Iran.
Vaccine. 2023 Jan 16:S0264-410X(23)00032-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

YANG H, Li Z, Zhang R, Guo S, et al
Safety of primary immunization using inactivated SARS-CoV-2 vaccine (CoronaVac(R)) among population aged 3 years and older in a large-scale use: A multi-center open-label study in China.
Vaccine. 2023 Jan 13:S0264-410X(23)00031-2. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KALRA S, Kalra D, Grafova I, Rubin JS, et al
Association of death or illness from COVID-19 among family and friends on vaccine uptake within four months of the Emergency Use Authorization. Findings from a national survey in the United States.
Vaccine. 2023 Jan 13:S0264-410X(23)00035-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

BEDSTON S, Lowthian E, Jarvis CI, Akbari A, et al
COVID-19 booster vaccination uptake and infection breakthrough amongst health care workers in Wales: A national prospective cohort study.
Vaccine. 2023 Jan 13:S0264-410X(23)00034-8. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KLUWER B, Margrethe Rydland K, Nybru Gleditsch R, Mamelund SE, et al
Social and demographic patterns of influenza vaccination coverage in Norway, influenza seasons 2014/15 to 2020/21.
Vaccine. 2023 Jan 11:S0264-410X(23)00013-0. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

DU J, Liu B, Wang T, Zhu Z, et al
A non-toxic recombinant bivalent chimeric protein rETX(m3)CSA(m4/TMD) as a potential vaccine candidate against enterotoxemia and braxy.
Vaccine. 2023 Jan 10:S0264-410X(22)01419-0. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

ELLISON TJ, Talbott GC, Henderson DR
Intradermal delivery of a quadrivalent cell-based seasonal influenza vaccine using an adjuvanted skin patch vaccination platform.
Vaccine. 2023;41:304-314.
PubMed Abstract available

MOELLER-ARENDT M, van de Witte S, Nauta J, de Voogd H, et al
Enhanced passive safety surveillance of Influvac(R) and Influvac(R) Tetra: Results from seven consecutive seasons.
Vaccine. 2023;41:606-613.
PubMed Abstract available

TAKAHASHI H, Morita M, Kamiya H, Fukusumi M, et al
Genomic characterization of Japanese meningococcal strains isolated over a 17-year period between 2003 and 2020 in Japan.
Vaccine. 2023;41:416-426.
PubMed Abstract available

DESCHANVRES C, Levieux K, Launay E, Huby AC, et al
Non-immunization associated with increased risk of sudden unexpected death in infancy: A national case-control study.
Vaccine. 2023;41:391-396.
PubMed Abstract available

WAGNER AL, Moniz MH, Stout MJ, Townsel C, et al
Experiences, risk perceptions, and COVID-19 vaccination outcomes among hospital workers.
Vaccine. 2023 Jan 9:S0264-410X(23)00012-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

NAVIN MC, Scherer AM, Bradley E, Attwell K, et al
School staff as vaccine advocates: Perspectives on vaccine mandates and the student registration process.
Vaccine. 2023 Jan 9:S0264-410X(23)00014-2. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

MENON I, Kang SM, Braz Gomes K, Uddin MN, et al
Laser-assisted intradermal delivery of a microparticle vaccine for respiratory syncytial virus induces a robust immune response.
Vaccine. 2023 Jan 9:S0264-410X(23)00002-6. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

KEVIN YIN J, Harris RC, Loiacono MM, Chit A, et al
Letter to editor regarding a review of MF59-adjuvanted influenza vaccine by Gartner et al.
Vaccine. 2023 Jan 9:S0264-410X(22)01559-6. doi: 10.1016/j.vaccine.2022.
PubMed

CHAWANPAIBOON S, Anuwutnawin S, Kanjanapongporn A, Pooliam J, et al
Breastfeeding women's attitudes towards and acceptance and rejection of COVID-19 vaccination: Implementation research.
Vaccine. 2023 Jan 9:S0264-410X(23)00015-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

OZAKI T, Nishimura N, Gotoh K, Takemoto K, et al
Anti-varicella-zoster virus antibody titers and seroprotection status from before the first dose of varicella vaccination to before entering elementary school in one region in Japan.
Vaccine. 2023 Jan 9:S0264-410X(23)00010-5. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

WHITEHEAD HS, French CE, Caldwell DM, Letley L, et al
A systematic review of communication interventions for countering vaccine misinformation.
Vaccine. 2023 Jan 9:S0264-410X(22)01593-6. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

TULLOCH JSP, Lawrenson K, Gordon AL, Ghebrehewet S, et al
COVID-19 vaccine hesitancy in care home staff: A survey of Liverpool care homes.
Vaccine. 2023 Jan 9:S0264-410X(23)00009-9. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

MORO PL, Zhang B, Ennulat C, Harris M, et al
Safety of co-administration of mRNA COVID-19 and seasonal inactivated influenza vaccines in the vaccine adverse event reporting system (VAERS) during July 1, 2021-June 30, 2022.
Vaccine. 2023 Jan 9:S0264-410X(23)00016-6. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

EBRAHIMI N, Mazdak M, Shaygannejad V, Mirmosayyeb O, et al
CNS demyelinating disease following inactivated or viral vector SARS-CoV-2 vaccines: A case series.
Vaccine. 2023 Jan 6:S0264-410X(23)00004-X. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

JANG Y, Cho H, Chun J, Park K, et al
Baculoviral COVID-19 Delta DNA vaccine cross-protects against SARS-CoV2 variants in K18-ACE2 transgenic mice.
Vaccine. 2023 Jan 6:S0264-410X(22)01602-4. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

LUPINACCI R, Rupp R, Wittawatmongkol O, Jones J, et al
A phase 3, multicenter, randomized, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants (PNEU-PED).
Vaccine. 2023 Jan 6:S0264-410X(22)01575-4. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

LONG Z, He J, Shuai Q, Zhang K, et al
Influenza vaccination-induced H3 stalk-reactive memory B-cell clone expansion.
Vaccine. 2023 Jan 6:S0264-410X(22)01603-6. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

CUTLAND CL, Peyrani P, Webber C, Newton R, et al
A phase 3, randomized, controlled, open-label study to evaluate the persistence up to 5 years of 1 or 2 doses of meningococcal conjugate vaccine MenACWY-TT given with or without 13-valent pneumococcal conjugate vaccine in 12-14-month-old children.
Vaccine. 2023 Jan 6:S0264-410X(22)01461-X. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

XIE L, Ren J, Min S, Zhu X, et al
Knowledge, attitude, and perception regarding HPV-related diseases and vaccination among the general public in Guizhou Province of China.
Vaccine. 2023 Jan 5:S0264-410X(22)01538-9. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

TSUCHIYA Y, Tamura H, Fujii K, Numaguchi H, et al
Safety, reactogenicity, and immunogenicity of Ad26.COV2.S: Results of a phase 1, randomized, double-blind, placebo-controlled COVID-19 vaccine trial in Japan.
Vaccine. 2023 Jan 5:S0264-410X(23)00006-3. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

TORALES J, Cuenca-Torres O, Barrios L, Armoa-Garcia L, et al
An evaluation of the safety and immunogenicity of MVC-COV1901: Results of an interim analysis of a phase III, parallel group, randomized, double-blind, active-controlled immunobridging study in Paraguay.
Vaccine. 2023;41:109-118.
PubMed Abstract available

HOMAIRA N, Strachan R, Quinn H, Beggs S, et al
Real world impact of 13vPCV in preventing invasive pneumococcal pneumonia in Australian children: A national study.
Vaccine. 2023;41:85-91.
PubMed Abstract available

MAERTZDORF KM, Rietman ML, Lambooij MS, Verschuren WMM, et al
Willingness to get vaccinated against influenza, pneumococcal disease, pertussis, and herpes zoster - A pre-COVID-19 exploration among the older adult population.
Vaccine. 2023 Jan 4:S0264-410X(23)00001-4. doi: 10.1016/j.vaccine.2023.
PubMed Abstract available

VALENCIA-HERNANDEZ AM, Zillinger T, Ge Z, Tan PS, et al
Complexing CpG adjuvants with cationic liposomes enhances vaccine-induced formation of liver T(RM) cells.
Vaccine. 2023 Jan 4:S0264-410X(22)01572-9. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

IMMINK MM, Kemmeren JM, Broeders L, Bekker MN, et al
Reactogenicity and safety of second trimester maternal tetanus, diphtheria and acellular pertussis vaccination in the Netherlands.
Vaccine. 2023 Jan 3:S0264-410X(22)01596-1. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

BAGGA S, Krishnan A, Dar L
Revisiting live attenuated influenza vaccine efficacy among children in developing countries.
Vaccine. 2023 Jan 3:S0264-410X(22)01594-8. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

REGO RT, Kenney B, Ngugi AK, Espira L, et al
COVID-19 vaccination refusal trends in Kenya over 2021.
Vaccine. 2023 Jan 3:S0264-410X(22)01601-2. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

OVERBO J, Aziz A, Zaman K, Clemens J, et al
Immunogenicity and safety of a two-dose regimen with hepatitis E virus vaccine in healthy adults in rural Bangladesh: A randomized, double-blind, controlled, phase 2/pilot trial.
Vaccine. 2023 Jan 2:S0264-410X(22)01599-7. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

SONGOL A, Amiri-Farahani L, Haghani S, Pezaro S, et al
Comparing the effect of parental education via both lecture and film upon vaccination uptake for children under one year of age: A cluster randomized clinical trial.
Vaccine. 2023 Jan 2:S0264-410X(22)01522-5. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

SHOOK NJ, Oosterhoff B, Sevi B
A longitudinal assessment of variability in COVID-19 vaccine hesitancy and psychosocial correlates in a national United States sample.
Vaccine. 2023 Jan 2:S0264-410X(22)01600-0. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

FORD JS, Rouleau SG, Wagner JL, Adams CB, et al
Assessment of a COVID-19 vaccination protocol for unhoused patients in the emergency department.
Vaccine. 2023 Jan 2:S0264-410X(22)01598-5. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

December 2022

MOETLHOA B, Tjale M, Pretorius A, Hayeshi R, et al
Rift Valley Fever vaccine strategies: Enhanced stability of RVF Clone 13.
Vaccine. 2022 Dec 31:S0264-410X(22)01591-2. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

AZUMA M, Oishi K, Akeda Y, Morino S, et al
Safety and immunogenicity of sequential administration of PCV13 followed by PPSV23 in pneumococcal vaccine-naive adults aged >/= 65 years: Comparison of booster effects based on intervals of 0.5 and 1.0 year.
Vaccine. 2022 Dec 31:S0264-410X(22)01595-X. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

KIM TV, Pham TND, Le DH, Dao DVB, et al
Significant gaps in hepatitis B vaccination in adults in Viet Nam: Important targets toward hepatitis B elimination by 2030.
Vaccine. 2022 Dec 30:S0264-410X(22)01577-8. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

BURROWS H, Antillon M, Gauld JS, Kim JH, et al
Comparison of model predictions of typhoid conjugate vaccine public health impact and cost-effectiveness.
Vaccine. 2022 Dec 29:S0264-410X(22)01557-2. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

ZUBKOVA I, Zhao Y, Cui Q, Kachko A, et al
Assessing the impact of hepatitis B immune globulin (HBIG) on responses to hepatitis B vaccine during co-administration.
Vaccine. 2022 Dec 29:S0264-410X(22)01590-0. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

WANG H, Cao L, Logue CM, Barbieri NL, et al
Evaluation of immunogenicity and efficacy of the enterobactin conjugate vaccine in protecting chickens from colibacillosis.
Vaccine. 2022 Dec 28:S0264-410X(22)01592-4. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

TOTTEY S, Shoji Y, Mark Jones R, Musiychuk K, et al
Engineering of a plant-produced virus-like particle to improve the display of the Plasmodium falciparum Pfs25 antigen and transmission-blocking activity of the vaccine candidate.
Vaccine. 2022 Dec 28:S0264-410X(22)01573-0. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

GAMBLE A, Hastings TJ, Westrick SC, Smith M, et al
COVID-19 booster vaccination in rural community pharmacies.
Vaccine. 2022 Dec 26:S0264-410X(22)01576-6. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

XIE Z, Hamadi HY, Mainous AG, Hong YR, et al
Association of dual COVID-19 and seasonal influenza vaccination with COVID-19 infection and disease severity.
Vaccine. 2022 Dec 23:S0264-410X(22)01568-7. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

ANDREJKO KL, Myers JF, Openshaw J, Fukui N, et al
Receipt of COVID-19 and seasonal influenza vaccines in California (USA) during the 2021-2022 influenza season.
Vaccine. 2022 Dec 23:S0264-410X(22)01578-X. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

CURRY S, Kaufhold RM, Monslow MA, Zhang Y, et al
Preclinical evaluation of an investigational 21-valent pneumococcal conjugate vaccine, V116, in adult-rhesus monkey, rabbit, and mouse models.
Vaccine. 2022 Dec 22:S0264-410X(22)01531-6. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

SAIAG E, Alcalay Y, Marudi O, Orr-Urtreger A, et al
Cellular and humoral immune response to the fourth Pfizer-BioNTech COVID-19 vaccine dose in individuals aged 60 years and older.
Vaccine. 2022 Dec 21:S0264-410X(22)01560-2. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

WAND O, Breslavsky A, Bar-Shai A, Levy C, et al
One-year dynamics of antibody titers after three doses of SARS-CoV-2 BNT162b2 vaccine.
Vaccine. 2022 Dec 21:S0264-410X(22)01567-5. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

TYAGI P, Ganguly M, Manney S, Wadkar K, et al
Neurovirulence, viscerotropism and immunogenicity of live attenuated yellow fever 17D vaccine virus in non-human primates.
Vaccine. 2022 Dec 21:S0264-410X(22)01543-2. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

SIENA E, Schiavetti F, Borgogni E, Taccone M, et al
Systems analysis of human responses to an aluminium hydroxide-adsorbed TLR7 agonist (AS37) adjuvanted vaccine reveals a dose-dependent and specific activation of the interferon-mediated antiviral response.
Vaccine. 2022 Dec 21:S0264-410X(22)01519-5. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

XU S, Huang R, Sy LS, Hong V, et al
A safety study evaluating non-COVID-19 mortality risk following COVID-19 vaccination.
Vaccine. 2022 Dec 20:S0264-410X(22)01561-4. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

RANE MS, Robertson MM, Kulkarni SG, Frogel D, et al
Effectiveness of Covid-19 vaccines against symptomatic and asymptomatic SARS-CoV-2 infections in an urgent care setting.
Vaccine. 2022 Dec 20:S0264-410X(22)01564-X. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

WILLIAMS KV, Moehling Geffel K, Alcorn JF, Patricia Nowalk M, et al
Factors associated with humoral immune response in older adults who received egg-free influenza vaccine.
Vaccine. 2022 Dec 19:S0264-410X(22)01566-3. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

DUDLEY MZ, Barnett EE, Paulenich A, Omer SB, et al
Characterization of parental intention to vaccinate elementary school aged children in the state of California.
Vaccine. 2022 Dec 19:S0264-410X(22)01544-4. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

BOISSON A, Morgan CE, Stover A, Ngimbi P, et al
Changes in hepatitis B vaccine perception in response to the COVID-19 pandemic: Development of the Shift in vaccine confidence (SVC) survey tool.
Vaccine. 2022 Dec 16:S0264-410X(22)01542-0. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

YIH WK, Daley MF, Duffy J, Fireman B, et al
A broad assessment of covid-19 vaccine safety using tree-based data-mining in the vaccine safety datalink.
Vaccine. 2022 Dec 16:S0264-410X(22)01541-9. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

MIDDLETON BF, Danchin M, Fathima P, Bines JE, et al
Review of the health impact of the oral rotavirus vaccine program in children under 5 years in Australia: 2006 - 2021.
Vaccine. 2022 Dec 16:S0264-410X(22)01525-0. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

SONOYAMA T, Iwata S, Shinkai M, Iwata-Yoshikawa N, et al
Results from a preclinical study in rodents and a Phase 1/2, randomized, double-blind, placebo-controlled, parallel-group study of COVID-19 vaccine S-268019-a in Japanese adults.
Vaccine. 2022 Dec 16:S0264-410X(22)01540-7. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

PAPAZACHARIOU A, Tsioutis C, Lytras T, Malikides O, et al
The impact of seasonal influenza vaccination uptake on COVID-19 vaccination attitudes in a rural area in Greece.
Vaccine. 2022 Dec 15:S0264-410X(22)01539-0. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

VAUX S, Fonteneau L, Pefau M, Venier AG, et al
Vaccination against influenza, measles, pertussis and varicella in workers in healthcare facilities in France: A national cross-sectional study in 2019.
Vaccine. 2022 Dec 15:S0264-410X(22)01537-7. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

OLAYINKA F, Sauer M, Menning L, Summers D, et al
Building and sustaining public and political commitment to the value of vaccination: Recommendations for the Immunization Agenda 2030 (Strategic Priority Area 2).
Vaccine. 2022 Dec 15:S0264-410X(22)01451-7. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

MAERTENS K, Orije MRP, Huoi C, Boisnard F, et al
Immunogenicity of a liquid hexavalent DTaP-IPV-HB-PRP approximately T vaccine after primary and booster vaccination of term and preterm infants born to women vaccinated with Tdap during pregnancy.
Vaccine. 2022 Dec 15:S0264-410X(22)01535-3. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

CHEN L, Levine MZ, Zhou S, Bai T, et al
Mild and asymptomatic influenza B virus infection among unvaccinated pregnant persons: Implication for effectiveness of non-pharmaceutical intervention and vaccination to prevent influenza.
Vaccine. 2022 Dec 14:S0264-410X(22)01468-2. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

OHNO M, Sagata M, Sekiya T, Nomura N, et al
Assessing the pyrogenicity of whole influenza virus particle vaccine in cynomolgus macaques.
Vaccine. 2022 Dec 14:S0264-410X(22)01534-1. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

IBROCI E, Liu X, Lieb W, Jessel R, et al
Impact of prenatal COVID-19 vaccination on delivery and neonatal outcomes: Results from a New York City cohort.
Vaccine. 2022 Dec 14:S0264-410X(22)01226-9. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

PALMU AAM, Nieminen H, Lahdenkari M, Palmu AA, et al
A retrospective nationwide register-based study to evaluate the non-specific effects of first MMR vaccination among children in Finland.
Vaccine. 2022 Dec 14:S0264-410X(22)01536-5. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

BISANZIO D, Davis AE, Talbird SE, Van Effelterre T, et al
Targeted preventive vaccination campaigns to reduce Ebola outbreaks: An individual-based modeling study.
Vaccine. 2022 Dec 14:S0264-410X(22)01449-9. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

GATWOOD J, Brookhart A, Kinney O, Hagemann T, et al
Impact of patient and provider nudges on addressing herpes zoster vaccine series completion.
Vaccine. 2022 Dec 14:S0264-410X(22)01530-4. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

SUN L, Zhao N, Li H, Wang B, et al
Construction of a Lactobacillus plantarum-based claudin-3 targeting delivery system for the development of vaccines against Eimeria tenella.
Vaccine. 2022 Dec 14:S0264-410X(22)01528-6. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

SAINI SJ, Carle AC, Forsyth AR, Chi DL, et al
Association between caregiver opposition to topical fluoride and COVID-19 vaccines.
Vaccine. 2022 Dec 14:S0264-410X(22)01532-8. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

MARIA FP, Maria BA, Dario RO, Paula AP, et al
Effectiveness of the hepatitis B vaccine adjuvanted with AS04C in patients with biological therapies.
Vaccine. 2022 Dec 13:S0264-410X(22)01521-3. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

BILI A, Dobson S, Quinones J, Phongsamart W, et al
A phase 3, multicenter, randomized, double-blind study to evaluate the interchangeability of V114, a 15-valent pneumococcal conjugate vaccine, and PCV13 with respect to safety, tolerability, and immunogenicity in healthy infants (PNEU-DIRECTION).
Vaccine. 2022 Dec 13:S0264-410X(22)01344-5. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

GUO J, Zhang H, Zhang H, Lai X, et al
Cost-effectiveness of pneumococcal vaccines among adults aged 65 years and older in China: A comparative study.
Vaccine. 2022 Dec 13:S0264-410X(22)01515-8. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

SALVATORE PP, Lee CC, Sleweon S, McCormick DW, et al
Transmission potential of vaccinated and unvaccinated persons infected with the SARS-CoV-2 Delta variant in a federal prison, July-August 2021.
Vaccine. 2022 Dec 13:S0264-410X(22)01458-X. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

HALL PA, Meng G, Boudreau C, Hudson A, et al
Social cognitive predictors of vaccination status, uptake and mitigation behaviors in the Canadian COVID-19 Experiences survey.
Vaccine. 2022 Dec 12:S0264-410X(22)01526-2. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

CHO BH, Athar HM, Bates LG, Yarnoff BO, et al
Patient flow time data of COVID-19 vaccination clinics in 23 sites, United States, April and May 2021.
Vaccine. 2022 Dec 12:S0264-410X(22)01527-4. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

CHIBA S, Hatta M, Pattinson D, Yasuhara A, et al
Ferret model to mimic the sequential exposure of humans to historical H3N2 influenza viruses.
Vaccine. 2022 Dec 12:S0264-410X(22)01518-3. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

CUDDIHY MT, Berger WL, Cummings PL, Keith R, et al
An organizational assessment of 101 Community-Based Adult Services centers to identify and address gaps in influenza vaccination among Medicare-Medicaid beneficiaries.
Vaccine. 2022 Dec 10:S0264-410X(22)01490-6. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

PEPIN S, Samson SI, Alvarez FP, Dupuy M, et al
Corrigendum to "Impact of a quadrivalent inactivated influenza vaccine on influenza-associated complications and health care use in children aged 6 to 35 months: Analysis of data from a phase III trial in the northern and southern Hemispheres" [Vaccin
Vaccine. 2022 Dec 9:S0264-410X(22)01483-9. doi: 10.1016/j.vaccine.2022.
PubMed

FERNANDES NEHAB M, Goncalves Camacho K, Teixeira Reis A, Junqueira-Marinho MF, et al
Willingness of Brazilian caregivers in having their children and adolescents vaccinated against Covid-19.
Vaccine. 2022 Dec 9:S0264-410X(22)01520-1. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

WALLACE AS, Ryman TK, Privor-Dumm L, Morgan C, et al
Leaving no one behind: Defining and implementing an integrated life course approach to vaccination across the next decade as part of the immunization Agenda 2030.
Vaccine. 2022 Dec 8:S0264-410X(22)01452-9. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

CHEN S, Gao S, Li J, Li J, et al
Cost-benefit analysis of rotavirus vaccine included in the national immunization program in China.
Vaccine. 2022 Dec 8:S0264-410X(22)01498-0. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

CERNUSCHI T, Hall S, Malvolti S, Bloem P, et al
Improving access to human papillomavirus vaccines: A case study in the IA2030 core principle of partnership.
Vaccine. 2022 Dec 7:S0264-410X(22)01453-0. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

HEININGER U, Buttery J, Kochhar S
Harmonized case definitions for endpoints in vaccine efficacy trials are needed.
Vaccine. 2022 Dec 7:S0264-410X(22)01494-3. doi: 10.1016/j.vaccine.2022.
PubMed

NAGEL J, Jonsson G, Nilsson JA, Manuswin C, et al
Reduced risk of serious pneumococcal infections up to 10 years after a dose of pneumococcal conjugate vaccine in established arthritis.
Vaccine. 2022 Dec 7:S0264-410X(22)01499-2. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

ANDERSON-CHAVARRIA M, Turner J
Searching for the 'Trigger': An ethnographic analysis of parental beliefs regarding autism causation and vaccination in Puerto Rico.
Vaccine. 2022 Dec 7:S0264-410X(22)01488-8. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

LATKIN C, Dayton L, Miller J, Eschliman E, et al
Trusted information sources in the early months of the COVID-19 pandemic predict vaccination uptake over one year later.
Vaccine. 2022 Dec 6:S0264-410X(22)01510-9. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

NGUYEN KH, Zhao R, Mullins C, Corlin L, et al
Trends in vaccination schedules and up-to-date status of children 19-35 months, United States, 2015-2020.
Vaccine. 2022 Dec 5:S0264-410X(22)01422-0. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

PROSPERI C, Thangaraj JWV, Hasan AZ, Kumar MS, et al
Added value of the measles-rubella supplementary immunization activity in reaching unvaccinated and under-vaccinated children, a cross-sectional study in five Indian districts, 2018-20.
Vaccine. 2022 Dec 5:S0264-410X(22)01396-2. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

SERISIER A, Beale S, Boukari Y, Hoskins S, et al
A case-crossover study of the effect of vaccination on SARS-CoV-2 transmission relevant behaviours during a period of national lockdown in England and Wales.
Vaccine. 2022 Dec 5:S0264-410X(22)01497-9. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

UTTEKAR S, MacDonald N, Orenstein WA, Danchin M, et al
Empowering Health Workers to Build Public Trust in Vaccination: Experience from the International Pediatric Association's Online Vaccine Trust Course, 2020-2021.
Vaccine. 2022 Dec 2:S0264-410X(22)01485-2. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

FENG T, Wang X, Li J, Wang C, et al
Common issues and improvement solution of vaccine hesitancy in children with underlying neurological conditions: Experience from one National Children's Medical Center in China.
Vaccine. 2022 Dec 2:S0264-410X(22)01486-4. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

HOES J, King AJ, Berkhof J, de Melker HE, et al
High vaccine effectiveness persists for ten years after HPV16/18 vaccination among young Dutch women.
Vaccine. 2022 Dec 2:S0264-410X(22)01471-2. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

IWAI-SAITO K, Sato K, Kondo K
Associations of influenza and pneumococcal vaccinations with burdens of older family caregivers: The Japan Gerontological Evaluation study (JAGES) cross-sectional study.
Vaccine. 2022 Dec 2:S0264-410X(22)01460-8. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

MACAJ M, Perdochova L, Jakubikova J
Streptococcus pneumoniae as cause of acute otitis media (AOM) in Slovak children in the pneumococcal conjugate vaccine era (2008-2019).
Vaccine. 2022 Dec 2:S0264-410X(22)01423-2. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

CASPERSEN IH, Juvet LK, Feiring B, Laake I, et al
Menstrual disturbances in 12- to 15-year-old girls after one dose of COVID-19 Comirnaty vaccine: Population-based cohort study in Norway.
Vaccine. 2022 Dec 2:S0264-410X(22)01492-X. doi: 10.1016/j.vaccine.2022.
PubMed

STOLIAROFF-PEPIN A, Peine C, Herath T, Lachmann J, et al
Effectiveness of vaccines in preventing hospitalization due to COVID-19: A multicenter hospital-based case-control study, Germany, June 2021 to January 2022.
Vaccine. 2022 Dec 2:S0264-410X(22)01489-X. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

AL-KASSAB-CORDOVA A, Silva-Perez C, Mendez-Guerra C, Sangster-Carrasco L, et al
Inequalities in infant vaccination coverage during the COVID-19 pandemic: A population-based study in Peru.
Vaccine. 2022 Dec 2:S0264-410X(22)01491-8. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

INGRAM C, Roe M, Downey V, Phipps L, et al
Exploring key informants' perceptions of Covid-19 vaccine hesitancy in a disadvantaged urban community in Ireland: Emergence of a '4Cs' model.
Vaccine. 2022 Dec 2:S0264-410X(22)01496-7. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

BENDER FL, Rief W, Wilhelm M
Really just a little prick? A meta-analysis on adverse events in placebo control groups of seasonal influenza vaccination RCTs.
Vaccine. 2022 Dec 1:S0264-410X(22)01431-1. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

WONG HL, Tworkoski E, Ke Zhou C, Hu M, et al
Surveillance of COVID-19 vaccine safety among elderly persons aged 65 years and older.
Vaccine. 2022 Dec 1:S0264-410X(22)01493-1. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

November 2022

HSIAO A, Struckmann V, Stephani V, Mmbando D, et al
Costs of delivering human papillomavirus vaccination using a one- or two-dose strategy in Tanzania.
Vaccine. 2022 Nov 29:S0264-410X(22)01430-X. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

TURNER OVERTON E, Schmidt D, Vidojkovic S, Menius E, et al
A randomized phase 3 trial to assess the immunogenicity and safety of 3 consecutively produced lots of freeze-dried MVA-BN(R) vaccine in healthy adults.
Vaccine. 2022 Nov 29:S0264-410X(22)01333-0. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

SULLIVAN KM, Farraye FA, Winthrop KL, Willer DO, et al
Safety and efficacy of recombinant and live herpes zoster vaccines for prevention in at-risk adults with chronic diseases and immunocompromising conditions.
Vaccine. 2022 Nov 29:S0264-410X(22)01329-9. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

TANG S, Liu X, Jia Y, Chen H, et al
Education level modifies parental hesitancy about COVID-19 vaccinations for their children.
Vaccine. 2022 Nov 29:S0264-410X(22)01484-0. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

SUN Y, Huang SK, Arlikatti S, Lindell MK, et al
What attributes influence rural household's willingness to get vaccinated for COVID-19? Perspectives from six Chinese townships.
Vaccine. 2022 Nov 29:S0264-410X(22)01487-6. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

POOLEY HB, Panag G, Plain KM, de Silva K, et al
IP10 is a predictor of successful vaccine protection against paratuberculosis infection in sheep.
Vaccine. 2022 Nov 28:S0264-410X(22)01418-9. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

UIJEN RF, van Beek LF, van Opzeeland F, Simonetti E, et al
Intradermal administration of the pneumococcal conjugate vaccine in mice results in lower antibody responses as compared to intramuscular administration.
Vaccine. 2022 Nov 26:S0264-410X(22)01456-6. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

CHRISTOU-ERGOS M, Wiley KE, Leask J
Willingness to receive a vaccine is influenced by adverse events following immunisation experienced by others.
Vaccine. 2022 Nov 26:S0264-410X(22)01447-5. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

JOSHI S, Anantharaman D, Muwonge R, Bhatla N, et al
Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination.
Vaccine. 2022 Nov 26:S0264-410X(22)01457-8. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

STOCKER A, Hoffmann J, Mause L, Neufeind J, et al
What impact does the attitude toward COVID-19 vaccination have on physicians as vaccine providers? A cross sectional study from the German outpatient sector.
Vaccine. 2022 Nov 25:S0264-410X(22)01466-9. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

ZARZECZNA N, Bertlich T, Veckalov B, Rutjens BT, et al
Spirituality is associated with Covid-19 vaccination scepticism.
Vaccine. 2022 Nov 25:S0264-410X(22)01463-3. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

RADER B, Chiang ME, Kriner DL, Weintraub RL, et al
Persistent drop in confidence following US recommended pause of Ad26.COV2.S vaccine administration.
Vaccine. 2022 Nov 25:S0264-410X(22)01448-7. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

MICHELLE DRIEDGER S, Capurro G, Tustin J, Jardine CG, et al
"I won't be a guinea pig": Rethinking public health communication and vaccine hesitancy in the context of COVID-19.
Vaccine. 2022 Nov 25:S0264-410X(22)01469-4. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

LIP A, Pateman M, Fullerton MM, Chen HM, et al
Vaccine hesitancy educational tools for healthcare providers and trainees: A scoping review.
Vaccine. 2022 Nov 24:S0264-410X(22)01225-7. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

BUDIGAN NI H, de Broucker G, Patenaude BN, Dudley MZ, et al
Economic impact of vaccine safety incident in Ukraine: The economic case for safety system investment.
Vaccine. 2022 Nov 24:S0264-410X(22)01374-3. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

KATHERINE YIH W, Daley MF, Duffy J, Fireman B, et al
Tree-based data mining for safety assessment of first COVID-19 booster doses in the Vaccine Safety Datalink.
Vaccine. 2022 Nov 24:S0264-410X(22)01467-0. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

HUMBLE RM, Scott SD, Dube E, Olson J, et al
The impact of the COVID-19 pandemic on parents' perceptions and acceptance of routine childhood vaccination in Canada: A national longitudinal study.
Vaccine. 2022 Nov 24:S0264-410X(22)01465-7. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

TANAKA H, Mukai J, Kushibiki K, Mizushima S, et al
Effect of the third dose of BNT162b2 COVID-19 mRNA vaccine on anti-SARS-CoV-2 antibody levels in healthcare workers.
Vaccine. 2022 Nov 24:S0264-410X(22)01462-1. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

TSURANE K, Umehara N, Nakayama T, Okada K, et al
Pertussis, diphtheria, and tetanus antibodies seroprevalence in pregnant women and neonates, as a preliminary data for introduction of preconception or prenatal DTaP vaccination among Japanese society.
Vaccine. 2022;40:7122-7129.
PubMed Abstract available

CAETANO C, Morgado ML, Patricio P, Leite A, et al
Measuring the impact of COVID-19 vaccination and immunity waning: A modelling study for Portugal.
Vaccine. 2022;40:7115-7121.
PubMed Abstract available

MARCHETTI F, Lamiani G, Bona M, Amerighi C, et al
Developing communication tools on rotavirus vaccination to support family paediatricians in Italy.
Vaccine. 2022;40:7108-7114.
PubMed Abstract available

KAUFMANN J, DeVoe JE, Angier H, Moreno L, et al
Association of parent influenza vaccination and early childhood vaccinations using linked electronic health record data.
Vaccine. 2022;40:7097-7107.
PubMed Abstract available

HASSAN YAM, Daud Ali M, Al-Eid RR, Al-Ghuraya FA, et al
A retrospective evaluation of side-effects associated with the booster dose of Pfizer-BioNTech/BNT162b2 COVID-19 vaccine among females in Eastern Province, Saudi Arabia.
Vaccine. 2022;40:7087-7096.
PubMed Abstract available

FRANCO C, Herazo-Padilla N, Castaneda JA
A queueing Network approach for capacity planning and patient Scheduling: A case study for the COVID-19 vaccination process in Colombia.
Vaccine. 2022;40:7073-7086.
PubMed Abstract available

ZHOU W, Tang B, Bai Y, Shao Y, et al
The resurgence risk of COVID-19 in China in the presence of immunity waning and ADE: A mathematical modelling study.
Vaccine. 2022;40:7141-7150.
PubMed Abstract available

WILLAME C, Dodd C, Duran CE, Elbers R, et al
Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort study.
Vaccine. 2022 Nov 22:S0264-410X(22)01429-3. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

OZDARENDELI A, Sezer Z, Pavel STI, Inal A, et al
Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials.
Vaccine. 2022 Nov 22:S0264-410X(22)01380-9. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

MATHEWS KO, Norris JM, Phalen D, Malikides N, et al
Factors associated with Q fever vaccination in Australian wildlife rehabilitators.
Vaccine. 2022 Nov 21:S0264-410X(22)01364-0. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

TRAN QM, Soda J, Siraj A, Moore S, et al
Expected endpoints from future chikungunya vaccine trial sites informed by serological data and modeling.
Vaccine. 2022 Nov 21:S0264-410X(22)01426-8. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

SEEGER JD, Amend KL, Turnbull BR, Zhou L, et al
Incident autoimmune conditions among males receiving quadrivalent human papillomavirus vaccine in the United States.
Vaccine. 2022 Nov 21:S0264-410X(22)01307-X. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

ELICABE RJ, Distel MN, Jofre BL, Leporati M, et al
Assessing the long-stand antibody response induced by COVID-19 vaccines: A study in an educational cohort in San Luis, Argentina.
Vaccine. 2022 Nov 21:S0264-410X(22)01416-5. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

UTAZI CE, Aheto JMK, Wigley A, Tejedor-Garavito N, et al
Mapping the distribution of zero-dose children to assess the performance of vaccine delivery strategies and their relationships with measles incidence in Nigeria.
Vaccine. 2022 Nov 19:S0264-410X(22)01420-7. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

FEKETE M, Horvath A, Santa B, Tomisa G, et al
COVID-19 vaccination coverage in patients with chronic obstructive pulmonary disease - A cross-sectional study in Hungary.
Vaccine. 2022 Nov 18:S0264-410X(22)01415-3. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

ZHANG Z, Shi J, Zhang X, Guo X, et al
Willingness of parents of 9-to-18-year-old females in China to vaccinate their daughters with HPV vaccine.
Vaccine. 2022 Nov 18:S0264-410X(22)01404-9. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

NOVAK A, Hindriks E, Hoek A, Veraart C, et al
Cellular and humoral immune responsiveness to inactivated Leptospira interrogans in dogs vaccinated with a tetravalent Leptospira vaccine.
Vaccine. 2022 Nov 18:S0264-410X(22)01417-7. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

NIQUEUX E, Flodrops M, Allee C, Lebras MO, et al
Evaluation of three hemagglutinin-based vaccines for the experimental control of a panzootic clade 2.3.4.4b A(H5N8) high pathogenicity avian influenza virus in mule ducks.
Vaccine. 2022 Nov 18:S0264-410X(22)01398-6. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

AMPOFO AG, Mackenzie L, Boyes AW
HPV vaccination: Intention to participate among female senior high school students in Ghana.
Vaccine. 2022 Nov 18:S0264-410X(22)01383-4. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

MCCORMICK DW, Hagan LM, Salvatore PP, Magleby R, et al
SARS-CoV-2 viral shedding in vaccinated and unvaccinated persons: A case series.
Vaccine. 2022 Nov 18:S0264-410X(22)01428-1. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

KAHN AL, Steffen CA, Henaff L, MacDonald NE, et al
COVID-19 vaccine policy development in a sample of 44 countries - Key findings from a December 2021 survey of National Immunization Technical Advisory Groups (NITAGs).
Vaccine. 2022 Nov 17:S0264-410X(22)01427-X. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

KIM J, Kim ED, Shin HS, Han SJ, et al
Effectiveness and safety of injectable human papilloma virus vaccine administered as eyedrops.
Vaccine. 2022 Nov 16:S0264-410X(22)01192-6. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

KALKOWSKA DA, Wassilak SGF, Pallansch MA, Burns CC, et al
Outbreak response strategies with type 2-containing oral poliovirus vaccines.
Vaccine. 2022 Nov 16:S0264-410X(22)01336-6. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

POURIAYEVALI MH, Teimoori A, Esmaeili S, Abdoli A, et al
Corrigendum to "Potency, toxicity and protection evaluation of PastoCoAd candidate vaccines: Novel preclinical mix and match rAd5 S, rAd5 RBD-N and SOBERANA dimeric-RBD protein" [Vaccine 40(20) (2022) 2856-2868].
Vaccine. 2022;40:7009.
PubMed

PANICKAN S, Bhatia S, Bhat S, Bhandari N, et al
Reverse genetics based H5N2 vaccine provides clinical protection against H5N1, H5N8 and H9N2 avian influenza infection in chickens.
Vaccine. 2022;40:6998-7008.
PubMed Abstract available

ALFANO V, Ercolano S
Your vaccine attitude determines your altitude. What are the determinants of attitudes toward vaccination?
Vaccine. 2022;40:6987-6997.
PubMed Abstract available

TURBYFILL C, Adams K, Tenforde MW, Murray NL, et al
Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States.
Vaccine. 2022;40:6979-6986.
PubMed Abstract available

KULKARNI AV, Jaggaiahgari S, Iyengar S, Simhadri V, et al
Poor immune response to coronavirus disease vaccines in decompensated cirrhosis patients and liver transplant recipients.
Vaccine. 2022;40:6971-6978.
PubMed Abstract available

MOORE KL, Tan L
Preferential recommendations for vaccines: Time for a structured, transparent process.
Vaccine. 2022;40:6893-6894.
PubMed

HE H, Zhu Y, Jin M, Zhou Y, et al
The decline in immunity and circulation of pertussis among Chinese population during the COVID-19 pandemic: A cross-sectional sero-epidemiological study.
Vaccine. 2022;40:6956-6962.
PubMed Abstract available

ATTWELL K, Rizzi M, Paul KT
Consolidating a research agenda for vaccine mandates.
Vaccine. 2022 Nov 14. pii: S0264-410X(22)01384.
PubMed Abstract available

HANSEN J, Yee A, Lewis N, Li S, et al
Safety of 9-valent human papillomavirus vaccine administered to males and females in routine use.
Vaccine. 2022 Nov 14. pii: S0264-410X(22)01395.
PubMed Abstract available

MANANDHAR P, Wannemuehler K, Danovaro-Holliday MC, Nic Lochlainn L, et al
Use of catch-up vaccinations in the second year of life (2YL) platform to close immunity gaps: A secondary DHS analysis in Pakistan, Philippines, and South Africa.
Vaccine. 2022 Nov 14. pii: S0264-410X(22)01301.
PubMed Abstract available

FIX J, Vielot NA, Lund JL, Weber DJ, et al
Patterns of use of recombinant zoster vaccine among commercially-insured immunocompetent and immunocompromised adults 50-64 years old in the United States.
Vaccine. 2022 Nov 14. pii: S0264-410X(22)01347.
PubMed Abstract available

ZIMMERMAN T, Shiroma K, Fleischmann KR, Xie B, et al
Misinformation and COVID-19 vaccine hesitancy.
Vaccine. 2022 Nov 14:S0264-410X(22)01402-5. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

VANWORMER JJ, Alicea G, Weichelt BP, Berg RL, et al
COVID-19 vaccine coverage disparities in rural and farm children.
Vaccine. 2022 Nov 14:S0264-410X(22)01403-7. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

FABIANI M, Mateo-Urdiales A, Sacco C, Rota MC, et al
Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy: A retrospective matched cohort study.
Vaccine. 2022 Nov 14:S0264-410X(22)01399-8. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

JACKSON ML, Phillips CH, Wellwood S, Kiniry E, et al
Burden of medically attended influenza infection and cases averted by vaccination - United States, 2016/17 through 2018/19 influenza seasons.
Vaccine. 2022 Nov 12. pii: S0264-410X(22)01397.
PubMed Abstract available

KPOZEHOUEN EB, Tan T, Macintyre CR
Uptake of influenza, pneumococcal and herpes zoster vaccines among people with heart failure and atrial fibrillation.
Vaccine. 2022 Nov 12. pii: S0264-410X(22)01377.
PubMed Abstract available

QI W, Qingfeng L, Jing Z, Maolin Z, et al
A novel multi-epitope vaccine of HPV16 E5E6E7 oncoprotein delivered by HBc VLPs induced efficient prophylactic and therapeutic antitumor immunity in tumor mice model.
Vaccine. 2022 Nov 11. pii: S0264-410X(22)01327.
PubMed Abstract available

LUKEHART SA, Molini B, Gomez A, Godornes C, et al
Immunization with a tri-antigen syphilis vaccine significantly attenuates chancre development, reduces bacterial load, and inhibits dissemination of Treponema pallidum.
Vaccine. 2022 Nov 11. pii: S0264-410X(22)01372.
PubMed Abstract available

DE FIGUEIREDO A, Simas C, Larson HJ
COVID-19 vaccine acceptance and its socio-demographic and emotional determinants: A multi-country cross-sectional study.
Vaccine. 2022 Nov 10:S0264-410X(22)01310-X. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

YU Z, Keskinocak P, Sokol J, Chen YH, et al
Flexible analytic model to inform multi-stakeholder pediatric vaccine scheduling decisions.
Vaccine. 2022 Nov 9. pii: S0264-410X(22)01198.
PubMed Abstract available

BAI Q, Wang Z, An Y, Tian J, et al
Chitosan-functionalized graphene oxide as adjuvant in HEV P239 vaccine.
Vaccine. 2022 Nov 9. pii: S0264-410X(22)01375.
PubMed Abstract available

YU X, Suo L, Li W, Chen W, et al
Molecular surveillance of rubella virus in Beijing, China during 2010-2021: Progress and challenges in rubella elimination.
Vaccine. 2022;40:6857-6863.
PubMed Abstract available

REN H, Li H, Cao L, Wang Z, et al
Intranasal immunization with HRSV prefusion F protein and CpG adjuvant elicits robust protective effects in mice.
Vaccine. 2022;40:6830-6838.
PubMed Abstract available

ECHEVERRIA-LONDONO S, Hartner AM, Li X, Roth J, et al
Exploring the subnational inequality and heterogeneity of the impact of routine measles immunisation in Africa.
Vaccine. 2022;40:6806-6817.
PubMed Abstract available

MARTINI M, Orsini D
The fight against poliomyelitis through the history: past, present and hopes for the future. Albert Sabin's missing Nobel and his "gift to all the world's children".
Vaccine. 2022;40:6802-6805.
PubMed Abstract available

TRENTELMAN JJA, de Vogel FA, Colstrup E, Sima R, et al
Identification of novel conserved Ixodes vaccine candidates; a promising role for non-secreted salivary gland proteins.
Vaccine. 2022 Nov 8. pii: S0264-410X(22)01292.
PubMed Abstract available

MARSHALL T, Addison M, Crawford NW, Buttery JP, et al
Aiming too high: Shoulder injury related to vaccine administration (SIRVA): A case series.
Vaccine. 2022 Nov 8. pii: S0264-410X(22)01368.
PubMed Abstract available

HASHIMOTO M, Aoe S, Kawazu Y, Seki NM, et al
Homologous and heterologous booster vaccinations of S-268019-b, a recombinant S protein-based vaccine with a squalene-based adjuvant, enhance neutralization breadth against SARS-CoV-2 Omicron subvariants in cynomolgus macaques.
Vaccine. 2022 Nov 8. pii: S0264-410X(22)01379.
PubMed Abstract available

MOLL K, Lufkin B, Fingar KR, Ke Zhou C, et al
Background rates of adverse events of special interest for COVID-19 vaccine safety monitoring in the United States, 2019-2020.
Vaccine. 2022 Nov 8:S0264-410X(22)01373-1. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

LOPEZ-DORIGA RUIZ P, Gunnes N, Michael Gran J, Karlstad O, et al
Short-term safety of COVID-19 mRNA vaccines with respect to all-cause mortality in the older population in Norway.
Vaccine. 2022 Nov 7. pii: S0264-410X(22)01367.
PubMed Abstract available

KIRTLAND KA, Raghunathan T, Patel Murthy B, Li J, et al
Estimating vaccination coverage for routinely recommended vaccines among children aged 24months and adolescents aged 13 through 17years using data from immunization information systems in the United States.
Vaccine. 2022 Nov 7. pii: S0264-410X(22)01341.
PubMed Abstract available

OSOWICKI J, Morgan HJ, Harris A, Clothier HJ, et al
Guillain-Barre syndrome temporally associated with COVID-19 vaccines in Victoria, Australia.
Vaccine. 2022 Nov 7. pii: S0264-410X(22)01366.
PubMed Abstract available

HAO XB, Anand M, Wang TR, Rao AR, et al
Reducing COVID vaccine hesitancy by inducing a comparative mindset.
Vaccine. 2022 Nov 7. pii: S0264-410X(22)01359.
PubMed Abstract available

BEALE S, Burns R, Braithwaite I, Byrne T, et al
Occupation, Worker Vulnerability, and COVID-19 Vaccination Uptake: Analysis of the Virus Watch prospective cohort study.
Vaccine. 2022 Nov 7. pii: S0264-410X(22)01362.
PubMed Abstract available

SKAWRAN S, Schiesser H, Maurer A, Sartoretti T, et al
Frequency and temporal evolution of COVID-19 vaccination rate among oncological patients undergoing 18F-FDG-PET.
Vaccine. 2022 Nov 7. pii: S0264-410X(22)01376.
PubMed Abstract available

WU YY, Zhang W
Demographic disparities in COVID-19 vaccine hesitancy among U.S. adults: Analysis of household pulse survey data from Jul 21 to Oct 11 in 2021.
Vaccine. 2022 Nov 7. pii: S0264-410X(22)01381.
PubMed Abstract available

TAKEUCHI Y, Iwagami M, Ono S, Michihata N, et al
A post-marketing safety assessment of COVID-19 mRNA vaccination for serious adverse outcomes using administrative claims data linked with vaccination registry in a city of Japan.
Vaccine. 2022 Nov 7. pii: S0264-410X(22)01370.
PubMed Abstract available

GUERIN RJ, Naeim A, Baxter-King R, Okun AH, et al
Parental intentions to vaccinate children against COVID-19: Findings from a U.S. National Survey.
Vaccine. 2022 Nov 7:S0264-410X(22)01371-8. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

GHIANI M, Hagemann C, Friedrich J, Maywald U, et al
Can risk area designation help increase vaccination coverage for Tick-Borne Encephalitis? Evidence from German claims data.
Vaccine. 2022 Nov 5. pii: S0264-410X(22)01346.
PubMed Abstract available

LEUNG J, Gray EB, Anderson TC, Sharkey SM, et al
Recombinant zoster vaccine (RZV) second-dose series completion in adults aged 50-64 years in the United States.
Vaccine. 2022 Nov 5. pii: S0264-410X(22)01328.
PubMed Abstract available

THOMMES E, Coudeville L, Muhammad R, Martin M, et al
Public health impact and cost-effectiveness of implementing a 'pre-vaccination screening' strategy with the dengue vaccine in Puerto Rico.
Vaccine. 2022 Nov 5. pii: S0264-410X(22)01343.
PubMed Abstract available

KRASSELT J, Robin D, Fadda M, Geutjes A, et al
Tick-Talk: Parental online discourse about TBE vaccination.
Vaccine. 2022 Nov 5. pii: S0264-410X(22)01326.
PubMed Abstract available

PRIYAMVADA L, Carson WC, Ortega E, Navarra T, et al
Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo.
Vaccine. 2022 Nov 4. pii: S0264-410X(22)01360.
PubMed Abstract available

MORSTEAD T, Zheng J, Sin NL, DeLongis A, et al
Perceived threat and coping responses during the COVID-19 pandemic: Prospective associations with vaccine hesitancy.
Vaccine. 2022 Nov 4. pii: S0264-410X(22)01363.
PubMed Abstract available

RICKS T, Trent MJ, MacIntyre CR
Predictors of herpes zoster vaccination among Australian adults aged 65 and over.
Vaccine. 2022 Nov 3. pii: S0264-410X(22)01332.
PubMed Abstract available

WATESKA AR, Patricia Nowalk M, Lin CJ, Harrison LH, et al
Cost-effectiveness of revised US pneumococcal vaccination recommendations in underserved minority adults < 65-years-old.
Vaccine. 2022 Nov 3. pii: S0264-410X(22)01340.
PubMed Abstract available

MALDEN DE, Gee J, Glenn S, Li Z, et al
Reactions following Pfizer-BioNTech COVID-19 mRNA vaccination and related healthcare encounters among 7,077 children aged 5-11 years within an integrated healthcare system.
Vaccine. 2022 Nov 3. pii: S0264-410X(22)01361.
PubMed Abstract available

KURATA T, Miyama T, Kanbayashi D, Kaida Y, et al
Increasing seroprevalence but waning herd immunity against measles after elimination: Longitudinal seroepidemiology of measles in Osaka Prefecture, Japan, 2003-2020.
Vaccine. 2022;40:6581-6588.
PubMed Abstract available

HAYMAN B, Kumar Suri R, Downham M
Sustainable vaccine manufacturing in low- and middle-Income countries.
Vaccine. 2022 Nov 2. pii: S0264-410X(22)01305.
PubMed Abstract available

FISHER DG, Gnazzo V, Holthausen DJ, Lopez CB, et al
Non-standard viral genome-derived RNA activates TLR3 and type I IFN signaling to induce cDC1-dependent CD8+ T-cell responses during vaccination in mice.
Vaccine. 2022 Nov 1. pii: S0264-410X(22)01312.
PubMed Abstract available

CAREY KA, Newman LM, Spicknall IH
Estimating the population level impact of a gonococcal vaccine candidate: Predictions from a simple mathematical model.
Vaccine. 2022 Nov 1. pii: S0264-410X(22)01291.
PubMed Abstract available

MORRILL JC, Peters CJ, Bettinger GE, Palermo PM, et al
Rift Valley fever MP-12 vaccine elicits an early protective immune response in mice.
Vaccine. 2022 Nov 1. pii: S0264-410X(22)01339.
PubMed Abstract available

TOMPKINS LK, Baggs J, Myers TR, Gee JM, et al
Association between history of SARS-CoV-2 infection and severe systemic adverse events after mRNA COVID-19 vaccination among U.S. adults.
Vaccine. 2022 Nov 1. pii: S0264-410X(22)01342.
PubMed Abstract available

CHANG CT, Lim XJ, Chew CC, Rajan P, et al
Preferences and willingness of accepting COVID-19 vaccine booster: Results from a middle-income country.
Vaccine. 2022 Nov 1. pii: S0264-410X(22)01334.
PubMed Abstract available

LUCINDE RK, Karia B, Ouma N, Amadi D, et al
The impact of the COVID-19 pandemic on vaccine coverage in Kilifi, Kenya: A retrospective cohort study.
Vaccine. 2022 Nov 1:S0264-410X(22)01345-7. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

October 2022

KUNASEKARAN M, Moa A, Hooshmand E, Trent M, et al
Effectiveness estimates for enhanced trivalent influenza vaccines in an aged care summer outbreak.
Vaccine. 2022 Oct 31. pii: S0264-410X(22)00766.
PubMed Abstract available

KUNASEKARAN M, Poulos CJ, Chughtai AA, Heslop DJ, et al
Factors associated with repeated influenza vaccine uptake among aged care staff in an Australian sample from 2017 to 2019.
Vaccine. 2022 Oct 31. pii: S0264-410X(22)00981.
PubMed Abstract available

TONG C, Liu H, Wang J, Sun Y, et al
Safety, efficacy, and DIVA feasibility on a novel live attenuated CSFV marker vaccine candidate.
Vaccine. 2022 Oct 31. pii: S0264-410X(22)01293.
PubMed Abstract available

THULUVA S, Paradkar V, Gunneri S, Yerroju V, et al
Safety, tolerability and immunogenicity of Biological E's CORBEVAX vaccine in children and adolescents: A prospective, randomised, double-blind, placebo controlled, phase-2/3 study.
Vaccine. 2022 Oct 31. pii: S0264-410X(22)01308.
PubMed Abstract available

LIMAYE RJ, Paul A, Gur-Arie R, Zavala E, et al
A socio-ecological exploration to identify factors influencing the COVID-19 vaccine decision-making process among pregnant and lactating women: Findings from Kenya.
Vaccine. 2022 Oct 31. pii: S0264-410X(22)01331.
PubMed Abstract available

CAPURRO G, Maier R, Tustin J, Jardine CG, et al
"They're trying to bribe you and taking away your freedoms": COVID-19 vaccine hesitancy in communities with traditionally low vaccination rates.
Vaccine. 2022 Oct 31. pii: S0264-410X(22)01338.
PubMed Abstract available

SIANI A, Tranter A
Is vaccine confidence an unexpected victim of the COVID-19 pandemic?
Vaccine. 2022 Oct 31. pii: S0264-410X(22)01337.
PubMed Abstract available

MARIE REINHART A, Tian Y, Lilly AE
The role of trust in COVID-19 vaccine hesitancy and acceptance among Black and White Americans.
Vaccine. 2022 Oct 31. pii: S0264-410X(22)01330.
PubMed Abstract available

CRUZ MC, Nascimento-Carvalho CM
The early evolution of COVID-19 incidence and mortality among people aged under 80 years or 80 years and above after COVID-19 vaccine implementation in the state of Bahia, Brazil.
Vaccine. 2022 Oct 31. pii: S0264-410X(22)01335.
PubMed Abstract available

GILLES C, Rozenberg S, Buxant F, Manigart Y, et al
HPV genotyping in biopsies of HSIL and invasive cervical cancers in women living with HIV: A cohort- and a nested -case control study.
Vaccine. 2022 Oct 31. pii: S0264-410X(22)01288.
PubMed Abstract available

XIE L, Li Y
Advances in vaccinia virus-based vaccine vectors, with applications in flavivirus vaccine development.
Vaccine. 2022 Oct 29. pii: S0264-410X(22)01311.
PubMed Abstract available

HEYERDAHL LW, Dielen S, Dodion H, Van Riet C, et al
Strategic silences, eroded trust: The impact of divergent COVID-19 vaccine sentiments on healthcare workers' relations with peers and patients.
Vaccine. 2022 Oct 27. pii: S0264-410X(22)01306.
PubMed Abstract available

BAMOUH Z, Hamdi J, Elkarhat Z, Fellahi S, et al
Attenuation and genetic characteristics of a Moroccan strain of Camel pox virus.
Vaccine. 2022;40:6471-6480.
PubMed Abstract available

SCHIFF J, Schmidt AR, Pham PK, Perez JB, et al
Parental attitudes in the pediatric emergency department about the COVID-19 vaccine.
Vaccine. 2022 Oct 26. pii: S0264-410X(22)01309.
PubMed Abstract available

MALTEZOU HC, Ledda C, Gagneux-Brunon A, Botelho-Nevers E, et al
Mandatory COVID-19 vaccination for healthcare personnel in the era of new SARS-CoV-2 variants.
Vaccine. 2022 Oct 26. pii: S0264-410X(22)01313.
PubMed

MALTEZOU HC, Gamaletsou MN, Koukou DM, Giannouchos TV, et al
Association between COVID-19 vaccination status, time elapsed since the last vaccine dose, morbidity, and absenteeism among healthcare personnel: A prospective, multicenter study.
Vaccine. 2022 Oct 26. pii: S0264-410X(22)01304.
PubMed Abstract available

TADDIO A, McMurtry CM, Logeman C, Gudzak V, et al
Prevalence of pain and fear as barriers to vaccination in children - Systematic review and meta-analysis.
Vaccine. 2022 Oct 22. pii: S0264-410X(22)01287.
PubMed Abstract available

PHOKSAWAT W, Nithichanon A, Lerdsamran H, Wongratanacheewin S, et al
Phenotypic and functional changes of T cell subsets after CoronaVac vaccination.
Vaccine. 2022 Oct 22. pii: S0264-410X(22)01265.
PubMed Abstract available

SHU Y, Yu Y, Ji Y, Zhang L, et al
Immunogenicity and safety of two novel human papillomavirus 4- and 9-valent vaccines in Chinese women aged 20-45 years: A randomized, blinded, controlled with Gardasil (type 6/11/16/18), phase III non-inferiority clinical trial.
Vaccine. 2022 Oct 22. pii: S0264-410X(22)01281.
PubMed Abstract available

SERRA L, Webber C, Burman C, Bueti P, et al
Clinical trial and postmarketing safety experience with MenACWY-TT, a meningococcal group A, C, W, and Y tetanus conjugate vaccine.
Vaccine. 2022 Oct 22. pii: S0264-410X(22)01197.
PubMed Abstract available

RABE APJ, Costello P, Were JJ, Farrer A, et al
The burden of selected vaccine-preventable diseases on the secondary care health system in England: Results from a five-year administrative healthcare dataset.
Vaccine. 2022 Oct 21. pii: S0264-410X(22)01263.
PubMed Abstract available

MADEWELL ZJ, Chacon-Fuentes R, Badilla-Vargas X, Ramirez C, et al
Knowledge, attitudes, and practices regarding seasonal influenza vaccination during pregnancy in Costa Rica: A mixed-methods study.
Vaccine. 2022 Oct 21. pii: S0264-410X(22)01284.
PubMed Abstract available

NAYAR R, Pattath B, Mantha N, Debnath S, et al
Routine childhood vaccination in India from 2005-2006 to 2015-2016: Temporal trends and geographic variation.
Vaccine. 2022 Oct 21. pii: S0264-410X(22)01285.
PubMed Abstract available

ARASA J, Lopez-Lacort M, Diez-Domingo J, Orrico-Sanchez A, et al
Impact of rotavirus vaccination on seizure hospitalizations in children: A systematic review.
Vaccine. 2022 Oct 21. pii: S0264-410X(22)01228.
PubMed Abstract available

ARRIETA A, Garcia-Prado A, Sarmiento JP, Paz Castro C, et al
Identifying early adopters of COVID-19 vaccines in Latin America.
Vaccine. 2022 Oct 21. pii: S0264-410X(22)01294.
PubMed Abstract available

SUN R, Budhwani H
Negative sentiments toward novel coronavirus (COVID-19) vaccines.
Vaccine. 2022 Oct 21. pii: S0264-410X(22)01297.
PubMed Abstract available

BLANCO S, Spinsanti L, Javier Aguilar J, Diaz A, et al
Neutralizing response elicited by homologous and heterologous prime booster vaccination against ancestral SARS-CoV-2 B.1, P.1, C.37 and B.1.617.2 variants.
Vaccine. 2022 Oct 20. pii: S0264-410X(22)01283.
PubMed Abstract available

SANTIBANEZ TA, Black CL, Vogt TM, Chatham-Stephens K, et al
Where are children ages 5-17 years receiving their COVID-19 vaccinations? Variations over time and by sociodemographic characteristics, United States.
Vaccine. 2022 Oct 20. pii: S0264-410X(22)01282.
PubMed Abstract available

STONER MCD, Tweedy D, Comello MGL, Toval C, et al
Using narratives to inform the development of a digital health intervention related to COVID-19 vaccination in Black young adults in Georgia, North Carolina and Alabama.
Vaccine. 2022 Oct 20. pii: S0264-410X(22)01286.
PubMed Abstract available

DUCLOS P, MacDonald NE, Dochez C, Thacker N, et al
Report of the 2nd workshop of the International Collaboration on advanced vaccinology training.
Vaccine. 2022 Oct 20. pii: S0264-410X(22)01222.
PubMed Abstract available

ZHONG VW, Li X, Ran J, Hu G, et al
Vaccination, symptomatic infection and negative conversion of viral RNA by body mass index, diabetes, and age: An observational study.
Vaccine. 2022 Oct 20. pii: S0264-410X(22)01262.
PubMed Abstract available

HOSHI SL, Shono A, Seposo X, Okubo R, et al
Cost-effectiveness analyses of 15- and 20-valent pneumococcal conjugate vaccines for Japanese elderly.
Vaccine. 2022 Oct 20. pii: S0264-410X(22)01259.
PubMed Abstract available

LAI L, Rouphael N, Xu Y, Kabbani S, et al
An Oil-in-Water adjuvant significantly increased influenza A/H7N9 split virus Vaccine-Induced circulating follicular helper T (cTFH) cells and antibody responses.
Vaccine. 2022 Oct 20. pii: S0264-410X(22)01146.
PubMed Abstract available

HALL PA, Meng G, Sakib MN, Quah ACK, et al
Do the vaccinated perform less distancing, mask wearing and hand hygiene? A test of the risk compensation hypothesis in a representative sample during the COVID-19 pandemic.
Vaccine. 2022 Oct 20. pii: S0264-410X(22)01289.
PubMed Abstract available

FUJI N, Pichichero M, Kaur R
Pathogenesis of Streptococcus pneumoniae serotype 3 during natural colonization and infections among children and its IgG correlate of protection in a mouse model.
Vaccine. 2022;40:6412-6421.
PubMed Abstract available

RUAN J, Dong W, Liu Y, Zhang Y, et al
Establishment of a model to assess mumps virus neurovirulence in neonatal Wistar rats.
Vaccine. 2022;40:6397-6403.
PubMed Abstract available

GOLLAMUDI J, Sartain SE, Navaei AH, Aneja S, et al
Thrombosis and thromboembolism: Brighton collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
Vaccine. 2022;40:6431-6444.
PubMed Abstract available

SAPUAN S, Andrews N, Hallis B, Hole L, et al
An observational, cohort, multi-centre, open label phase IV extension study comparing preschool DTAP-IPV booster vaccine responses in children whose mothers were randomised to one of two pertussis-containing vaccines or received no pertussis-containin
Vaccine. 2022 Oct 19. pii: S0264-410X(22)01243.
PubMed Abstract available

PENG M, Joo J, Alvarado-Martinez Z, Tabashsum Z, et al
Intracellular autolytic whole cell Salmonella vaccine prevents colonization of pathogenic Salmonella Typhimurium in chicken.
Vaccine. 2022 Oct 19. pii: S0264-410X(22)01261.
PubMed Abstract available

URUENA A, Ruiz JI, Lew DA, David J, et al
Opinions, attitudes, and barriers to pediatric vaccination in Argentina.
Vaccine. 2022 Oct 19. pii: S0264-410X(22)01256.
PubMed Abstract available

LIAO SH, Chang WJ, Hsu CY, Ming-Fang Yen A, et al
Evaluating correlates of protection for mix-match vaccine against COVID-19 VOCs with potential of evading immunity.
Vaccine. 2022 Oct 17. pii: S0264-410X(22)01258.
PubMed Abstract available

AKSOY N, Ozturk N, Ulusoy S, Omur MF, et al
Knowledge and attitude of students studying at health department towards HPV and HPV vaccination.
Vaccine. 2022 Oct 17. pii: S0264-410X(22)01264.
PubMed Abstract available

TAKAHASHI Y, Ishitsuka K, Sampei M, Okawa S, et al
COVID-19 vaccine literacy and vaccine hesitancy among pregnant women and mothers of young children in Japan.
Vaccine. 2022 Oct 17. pii: S0264-410X(22)01227.
PubMed Abstract available

RHODES S, Smith N, Evans T, White R, et al
Identifying COVID-19 optimal vaccine dose using mathematical immunostimulation/immunodynamic modelling.
Vaccine. 2022 Oct 17. pii: S0264-410X(22)01260.
PubMed Abstract available

CREISHER PS, Campbell AD, Perry JL, Roznik K, et al
Influenza subtype-specific maternal antibodies protect offspring against infection but inhibit vaccine-induced immunity and protection in mice.
Vaccine. 2022 Oct 14. pii: S0264-410X(22)01241.
PubMed Abstract available

HUDSON A, Hall PA, Hitchman SC, Meng G, et al
Cognitive predictors of COVID-19 mitigation behaviors in vaccinated and unvaccinated general population members.
Vaccine. 2022 Oct 13. pii: S0264-410X(22)01242.
PubMed Abstract available

AROCHO ROSARIO CM, Miller RJ, Klafke GM, Coates C, et al
Interaction between anti-tick vaccine and a macrocyclic lactone improves acaricidal efficacy against Rhipicephalus (Boophilus) microplus (Canestrini) (Acari: Ixodidae) in experimentally infested cattle.
Vaccine. 2022 Oct 13. pii: S0264-410X(22)01230.
PubMed Abstract available

SAADE EA, Abul Y, McConeghy K, Edward Davidson H, et al
High-dose influenza vaccines for the prevention of hospitalization due to cardiovascular events in older adults in the nursing home: Post-hoc analysis of a cluster-randomized trial.
Vaccine. 2022 Oct 13. pii: S0264-410X(22)01215.
PubMed Abstract available

MO Y, Li Y, Liu G, Chen J, et al
A phase II, single-center, randomized, double-blind, parallel control clinical study evaluating the immunogenicity and safety of a two-dose schedule of serogroups ACYW meningococcal polysaccharide conjugate vaccine.
Vaccine. 2022 Oct 12. pii: S0264-410X(22)00948.
PubMed Abstract available

LIU S, Yang G, Li M, Sun F, et al
Transcutaneous immunization via dissolving microneedles protects mice from lethal influenza H7N9 virus challenge.
Vaccine. 2022 Oct 12. pii: S0264-410X(22)01102.
PubMed Abstract available

WHALEY M, Axon DR
Factors associated with pneumococcal vaccine uptake among vulnerable older adults in the United States primary care setting.
Vaccine. 2022 Oct 10. pii: S0264-410X(22)01229.
PubMed Abstract available

BUDDY CREECH C, Jimenez-Truque N, Kown N, Sokolow K, et al
Safety and immunogenicity of live, attenuated intranasal Bordetella pertussis vaccine (BPZE1) in healthy adults.
Vaccine. 2022 Oct 8. pii: S0264-410X(22)01196.
PubMed Abstract available

VOGELSANG EM, Polonijo AN
Scarier than the flu shot? : The social determinants of shingles and influenza vaccinations among U.S. older adults.
Vaccine. 2022 Oct 8. pii: S0264-410X(22)01183.
PubMed Abstract available

CHONG CY, Tan NW, Yung CF, Li J, et al
Effectiveness of maternal pertussis vaccination in Singapore: A test-negative case-control study.
Vaccine. 2022 Oct 8. pii: S0264-410X(22)01219.
PubMed Abstract available

RUGHINIS C, Vulpe SN, Flaherty MG, Vasile S, et al
Shades of doubt: Measuring and classifying vaccination confidence in Europe.
Vaccine. 2022 Oct 7. pii: S0264-410X(22)01147.
PubMed Abstract available

CHEN JY, Hsieh SM, Hwang SJ, Liu CS, et al
Immunogenicity and safety of high-dose quadrivalent influenza vaccine in older adults in Taiwan: A phase III, randomized, multi-center study.
Vaccine. 2022 Oct 7. pii: S0264-410X(22)01200.
PubMed Abstract available

RUSTANDI RR, Hamm M, Onimus M, Yuan Y, et al
Monitoring bromide loss in bromoacetyl-derivatized polyribosylribitol polysaccharide in Haemophilus influenzae type b for PedvaxHIB(R) by capillary electrophoresis and NMR spectroscopy.
Vaccine. 2022;40:6012-6016.
PubMed Abstract available

KATZ S, Townsend-Payne K, Louth J, Lee-Jones L, et al
Validation and use of a serum bactericidal antibody assay for Neisseria meningitidis serogroup X in a seroprevalence study in Niger, West Africa.
Vaccine. 2022;40:6042-6047.
PubMed Abstract available

MARLOWE E, Pranikoff S, Borsheim B, Salafian K, et al
Pilot study to determine effect of an altruism intervention focusing on herd immunity to enhance influenza vaccination rates.
Vaccine. 2022 Oct 6. pii: S0264-410X(22)01194.
PubMed Abstract available

KRAAY ANM, Steele MK, Baker JM, Hall EW, et al
Predicting the long-term impact of rotavirus vaccination in 112 countries from 2006 to 2034: A transmission modeling analysis.
Vaccine. 2022 Oct 6. pii: S0264-410X(22)01193.
PubMed Abstract available

WOLF AS, Mitsi E, Jones S, Jochems SP, et al
Quality of antibody responses by adults and young children to 13-valent pneumococcal conjugate vaccination and Streptococcus pneumoniae colonisation.
Vaccine. 2022 Oct 6. pii: S0264-410X(22)01190.
PubMed Abstract available

BYRNE A, Thompson LA, Filipp SL, Ryan K, et al
COVID-19 vaccine perceptions and hesitancy amongst parents of school-aged children during the pediatric vaccine rollout.
Vaccine. 2022 Oct 5. pii: S0264-410X(22)01221.
PubMed Abstract available

SIMON JK, Kennedy SB, Mahon BE, Dubey SA, et al
Immunogenicity of rVSVDeltaG-ZEBOV-GP Ebola vaccine (ERVEBO(R)) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trials.
Vaccine. 2022 Oct 5. pii: S0264-410X(22)01145.
PubMed Abstract available

PAGUIO JA, Ojikutu BO, Alfonso PG, Yao JS, et al
Association of culturally competent care with influenza vaccination coverage in the United States.
Vaccine. 2022 Oct 5. pii: S0264-410X(22)01065.
PubMed Abstract available

CHUGHTAI AA, Mohammed S, Al Ariqi L, McCarron M, et al
Development of a road map to scale up the uptake and utilization of influenza vaccine in 22 countries of Eastern Mediterranean Region.
Vaccine. 2022 Oct 5. pii: S0264-410X(22)01159.
PubMed Abstract available

VAN EWIJK CE, Hazelhorst EI, Hahne SJM, Knol MJ, et al
COVID-19 outbreak in an elderly care home: Very low vaccine effectiveness and late impact of booster vaccination campaign.
Vaccine. 2022 Oct 4. pii: S0264-410X(22)01213.
PubMed Abstract available

AL-SHAIKH A, Mahmoud RI, Boukerdenna H, Muthu N, et al
Counselling of non-communicable diseases' patients for COVID-19 vaccine uptake in Jordan: Evaluating the intervention.
Vaccine. 2022 Oct 3. pii: S0264-410X(22)01214.
PubMed Abstract available

FERREIRA LS, de Almeida GB, Borges ME, Simon LM, et al
Modelling optimal vaccination strategies against COVID-19 in a context of Gamma variant predominance in Brazil.
Vaccine. 2022 Oct 3. pii: S0264-410X(22)01216.
PubMed Abstract available

CHAO CR, Xu L, Cannizzaro N, Bronstein D, et al
Trends in HPV vaccine administration and HPV vaccine coverage in children by race/ethnicity and socioeconomic status during the COVID-19 pandemic in an integrated health care system in California.
Vaccine. 2022 Oct 3. pii: S0264-410X(22)01195.
PubMed Abstract available

ODIO CD, Katzelnick LC
'Mix and Match' vaccination: Is dengue next?
Vaccine. 2022 Oct 1. pii: S0264-410X(22)01101.
PubMed Abstract available

September 2022

MANJATE F, Quinto L, Chirinda P, Acacio S, et al
Impact of rotavirus vaccination on diarrheal hospitalizations in children younger than 5 years of age in a rural southern Mozambique.
Vaccine. 2022 Sep 30. pii: S0264-410X(22)01158.
PubMed Abstract available

NAKASHIMA K, Suzuki K, Aoshima M, Murabata M, et al
Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in older individuals after the introduction of childhood 13-valent pneumococcal conjugate vaccine: A multicenter hospital-based case-control study
Vaccine. 2022 Sep 29. pii: S0264-410X(22)01163.
PubMed Abstract available

SILVA-VALENCIA J, Soto-Becerra P, Escobar-Agreda S, Fernandez-Navarro M, et al
Relative vaccine effectiveness of the booster dose of COVID-19 vaccine for preventing death in individuals with a primary regimen based on the BBIBP-CorV, ChAdOx1-S, or BNT162b2 vaccines during the Omicron wave in Peru: A nested case-control study usi
Vaccine. 2022 Sep 28. pii: S0264-410X(22)01189.
PubMed Abstract available

TRAKARNVANICH T, Ngamvichchukorn T, Phumisantiphong U, Pholtawornkulchai K, et al
Immune response after COVID-19 vaccination among patients with chronic kidney disease and kidney transplant.
Vaccine. 2022 Sep 28. pii: S0264-410X(22)01187.
PubMed Abstract available

MERDRIGNAC L, Acosta L, Habington A, Garcia Cenoz M, et al
Effectiveness of pertussis vaccination in pregnancy to prevent hospitalisation in infants aged <2 months and effectiveness of both primary vaccination and mother's vaccination in pregnancy in infants aged 2-11 months.
Vaccine. 2022 Sep 28. pii: S0264-410X(22)01160.
PubMed Abstract available

SPETZ M, Lundberg L, Nwaru C, Li H, et al
An intersectional analysis of sociodemographic disparities in Covid-19 vaccination: A nationwide register-based study in Sweden.
Vaccine. 2022 Sep 28. pii: S0264-410X(22)01186.
PubMed Abstract available

HATHAWAY CA, Siegel EM, Gonzalez BD, Oswald LB, et al
Individual-level factors associated with COVID-19 vaccine acceptance among U.S. patients with cancer.
Vaccine. 2022 Sep 28. pii: S0264-410X(22)01184.
PubMed Abstract available

MARCHESE AM, Beyhaghi H, Orenstein WA
With established safe and effective use, protein vaccines offer another choice against COVID-19.
Vaccine. 2022 Sep 28. pii: S0264-410X(22)01185.
PubMed

CERVANTES-TORRES J, Rosales-Mendoza S, Cabello C, Montero L, et al
Towards the development of an epitope-focused vaccine for SARS-CoV-2.
Vaccine. 2022 Sep 27. pii: S0264-410X(22)01168.
PubMed Abstract available

LLOYD PC, Hu M, Wong HL, Shoaibi A, et al
Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 years.
Vaccine. 2022 Sep 27. pii: S0264-410X(22)01167.
PubMed Abstract available

ZHU H, Li X, Ren X, Chen H, et al
Improving cross-protection against influenza virus in mice using a nanoparticle vaccine of mini-HA.
Vaccine. 2022 Sep 26. pii: S0264-410X(22)01165.
PubMed Abstract available

OHTA M, Kambayashi Y, Mita H, Kuroda T, et al
Protective efficacy of a reverse genetics-derived inactivated vaccine against equine influenza virus in horses.
Vaccine. 2022 Sep 26. pii: S0264-410X(22)01155.
PubMed Abstract available

STOFFEL ST, Colaninno A, Bram R, Schwenkglenks M, et al
Pneumococcal vaccination among adult risk patient with axial spondyloarthritis in Switzerland: Data from the survey of the ankylosing spondylitis association of Switzerland (SVMB).
Vaccine. 2022 Sep 26. pii: S0264-410X(22)01164.
PubMed Abstract available

TOLSTRUP WESTER C, Lybecker Scheel-Hincke L, Bovil T, Andersen-Ranberg K, et al
Prayer frequency and COVID-19 vaccine hesitancy among older adults in Europe.
Vaccine. 2022 Sep 26. pii: S0264-410X(22)01153.
PubMed Abstract available

GATES DM, Cohen SA, Orr K, Caffrey AR, et al
Pediatric influenza vaccination rates lower than previous estimates in the United States.
Vaccine. 2022 Sep 24. pii: S0264-410X(22)01162.
PubMed Abstract available

NOMURA Y, Noda K, Oohashi Y, Okuda S, et al
Proposal for the revision of guidelines for clinical trials of vaccines to prevent infectious diseases in Japan.
Vaccine. 2022 Sep 24. pii: S0264-410X(22)01144.
PubMed Abstract available

MUES KE, Kirk B, Patel DA, Gelman A, et al
Real-world comparative effectiveness of mRNA-1273 and BNT162b2 vaccines among immunocompromised adults identified in administrative claims data in the United States.
Vaccine. 2022 Sep 23. pii: S0264-410X(22)01120.
PubMed Abstract available

POLAND GA
The human immune response to vaccines is symphonic, polyphonic, homophonic, and megaphonic.
Vaccine. 2022 Sep 23. pii: S0264-410X(22)01099.
PubMed

MOHAMMED AH, Hassan BAR, Wayyes AM, Gadhban AQ, et al
Parental health beliefs, intention, and strategies about covid-19 vaccine for their children: A cross-sectional analysis from five Arab countries in the Middle East.
Vaccine. 2022 Sep 23. pii: S0264-410X(22)01161.
PubMed Abstract available

KUIPER VP, van der Plas P, Hoogerwerf MA, Pieter R Koopman J, et al
A comparison of two Fendrix hepatitis B vaccination schedules in patients with inflammatory bowel disease.
Vaccine. 2022 Sep 22. pii: S0264-410X(22)01100.
PubMed Abstract available

RUCKSTUHL L, Czock A, Haile SR, Lang P, et al
Influence of cantonal health policy frameworks & activities on the influenza vaccination rate in patients with non-communicable diseases in Switzerland.
Vaccine. 2022 Sep 22. pii: S0264-410X(22)01148.
PubMed Abstract available

ROMER D, Winneg KM, Jamieson PE, Brensinger C, et al
Misinformation about vaccine safety and uptake of COVID-19 vaccines among adults and 5-11-year-olds in the United States.
Vaccine. 2022 Sep 22. pii: S0264-410X(22)01154.
PubMed Abstract available

KIEFER MK, Mehl R, Rood KM, Germann K, et al
Association between social vulnerability and COVID-19 vaccination hesitancy and vaccination in pregnant and postpartum individuals.
Vaccine. 2022 Sep 21. pii: S0264-410X(22)01152.
PubMed Abstract available

DYSON EH, Simpson AJH, Gwyther RJ, Cuthbertson H, et al
Serological responses to Anthrax Vaccine Precipitated (AVP) increase with time interval between booster doses.
Vaccine. 2022 Sep 21. pii: S0264-410X(22)01045.
PubMed Abstract available

LIU B, Gidding H, Stepien S, Cretikos M, et al
Relative effectiveness of COVID-19 vaccination with 3 compared to 2 doses against SARS-CoV-2 B.1.1.529 (Omicron) among an Australian population with low prior rates of SARS-CoV-2 infection.
Vaccine. 2022 Sep 21. pii: S0264-410X(22)01126.
PubMed Abstract available

FENG T, Li M, Zhang L, Li S, et al
Immunity of two novel hepatitis C virus polyepitope vaccines.
Vaccine. 2022 Sep 20. pii: S0264-410X(22)01115.
PubMed Abstract available

BANNIETTIS N, Wysocki J, Szenborn L, Phongsamart W, et al
A phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of catch-up vaccination regimens of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants, c
Vaccine. 2022 Sep 20. pii: S0264-410X(22)01086.
PubMed Abstract available

SHAPIRO JR, Privor-Dumm L, Rosser EN, Leng SX, et al
The intersection of gender and race in older adults' decision to receive COVID-19 vaccines.
Vaccine. 2022 Sep 20:S0264-410X(22)01151-3. doi: 10.1016/j.vaccine.2022.
PubMed Abstract available

GRAAF A, Petric PP, Sehl-Ewert J, Henritzi D, et al
Cold-passaged isolates and bat-swine influenza a chimeric viruses as modified live-attenuated vaccines against influenza a viruses in pigs.
Vaccine. 2022 Sep 19. pii: S0264-410X(22)01108.
PubMed Abstract available

SHI T, Meng L, Li D, Jin N, et al
Effect of different vaccine strategies for the control of Japanese encephalitis in mainland China from 1961 to 2020: A quantitative analysis.
Vaccine. 2022 Sep 19. pii: S0264-410X(22)01127.
PubMed Abstract available

NTZIORA F, Georgia Kostaki E, Karapanou A, Mylona M, et al
Protection of vaccination versus hybrid immunity against infection with COVID-19 Omicron variants among Health-Care Workers.
Vaccine. 2022 Sep 19. pii: S0264-410X(22)01150.
PubMed Abstract available

HUANG ST, Huang YC, Kuo E, Yang YM, et al
Impacts of Catch-Up Immunization program with the 13-Valent pneumococcal Conjugate vaccine in Taiwan: Focus on age-stratified differences and high-risk population (2001-2015).
Vaccine. 2022 Sep 17. pii: S0264-410X(22)01084.
PubMed Abstract available

LI L, Li Y, Bai Y, Li G, et al
Neutralizing antibody activity, safety and immunogenicity of human anti-rabies virus monoclonal antibody (Ormutivimab) in Chinese healthy adults: A phase b randomized, double-blind, parallel-controlled study.
Vaccine. 2022 Sep 16. pii: S0264-410X(22)01114.
PubMed Abstract available

TILEY KS, White JM, Andrews N, Tessier E, et al
Equity of the Meningitis B vaccination programme in England, 2016-2018.
Vaccine. 2022 Sep 15. pii: S0264-410X(22)01111.
PubMed Abstract available

YU M, Chi X, Huang S, Wang Z, et al
A bacterially expressed triple-type chimeric vaccine against human papillomavirus types 51, 69, and 26.
Vaccine. 2022 Sep 15. pii: S0264-410X(22)01103.
PubMed Abstract available

FRANKENTHAL D, Zatlawi M, Karni-Efrati Z, Keinan-Boker L, et al
COVID-19 vaccine hesitancy among Israeli adults before and after vaccines' availability: A cross-sectional national survey.
Vaccine. 2022 Sep 14. pii: S0264-410X(22)01078.
PubMed Abstract available

CREVECOEUR J, Hens N, Neyens T, Lariviere Y, et al
Change in COVID19 outbreak pattern following vaccination in long-term care facilities in Flanders, Belgium.
Vaccine. 2022 Sep 14. pii: S0264-410X(22)01124.
PubMed Abstract available

CARRENO JM, Singh G, Tcheou J, Srivastava K, et al
mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations.
Vaccine. 2022 Sep 14. pii: S0264-410X(22)01003.
PubMed Abstract available

ACEIL J, Paschall AV, Knoot CJ, Robinson LS, et al
Immunogenicity and protective efficacy of a prototype pneumococcal bioconjugate vaccine.
Vaccine. 2022 Sep 14. pii: S0264-410X(22)01112.
PubMed Abstract available

SUZUKI H, Noguchi T, Matsugu N, Suzuki A, et al
Safety and immunogenicity of parvovirus B19 virus-like particle vaccine lacking phospholipase A2 activity.
Vaccine. 2022 Sep 13. pii: S0264-410X(22)01104.
PubMed Abstract available

STANFIELD BA, Bravo FJ, Dixon DA, Chouljenko VN, et al
Cross protective efficacy of the Non-Neurotropic live attenuated herpes simplex virus type 1 vaccine VC-2 is enhanced by intradermal vaccination and deletion of glycoprotein G.
Vaccine. 2022 Sep 13. pii: S0264-410X(22)01119.
PubMed Abstract available

DIEMERT DJ, Zumer M, Campbell D, Grahek S, et al
Safety and immunogenicity of the Na-APR-1 hookworm vaccine in infection-naive adults.
Vaccine. 2022 Sep 13. pii: S0264-410X(22)01113.
PubMed Abstract available

OSEI I, Sarwar G, Hossain I, Sonko K, et al
Attendance and vaccination at immunization clinics in rural Gambia before and during the COVID-19 pandemic.
Vaccine. 2022 Sep 13. pii: S0264-410X(22)01125.
PubMed Abstract available

ZACE D, La Gatta E, Petrella L, Di Pietro ML, et al
The impact of COVID-19 vaccines on fertility-A systematic review and meta-analysis.
Vaccine. 2022 Sep 12. pii: S0264-410X(22)01118.
PubMed Abstract available

MONFARED IG
The connection between COVID-19 vaccine abundance, vaccination coverage, and public trust in government across the globe.
Vaccine. 2022 Sep 12. pii: S0264-410X(22)01107.
PubMed Abstract available

FRIEDMAN-KLABANOFF DJ, Tjaden AH, Santacatterina M, Munawar I, et al
Vaccine-induced seroconversion in participants in the North Carolina COVID-19 community Research Partnership.
Vaccine. 2022 Sep 12. pii: S0264-410X(22)01116.
PubMed Abstract available

YAMANAKA A, Rattanaamnuaychai P, Matsuda M, Suzuki R, et al
Engineered flavivirus vaccines control induction of crossreactive infection-enhancing and -neutralizing antibodies.
Vaccine. 2022 Sep 12. pii: S0264-410X(22)01110.
PubMed Abstract available

HAO F, Bai Y, Xie X, Yuan T, et al
Phenotypic characteristics and protective efficacy of an attenuated Mycoplasma hyopneumoniae vaccine by aerosol administration.
Vaccine. 2022 Sep 12. pii: S0264-410X(22)01080.
PubMed Abstract available

DAY ME, Klein M, Sucharew H, Carol Burkhardt M, et al
Declining influenza vaccination rates in an underserved pediatric primary care center during the COVID-19 pandemic.
Vaccine. 2022 Sep 12. pii: S0264-410X(22)01121.
PubMed Abstract available

NAEIM A, Guerin RJ, Baxter-King R, Okun AH, et al
Strategies to increase the intention to get vaccinated against COVID-19: Findings from a nationally representative survey of US adults, October 2020 to October 2021.
Vaccine. 2022 Sep 12. pii: S0264-410X(22)01117.
PubMed Abstract available

NOWALK MP, D'Agostino H, Dauer K, Stiegler M, et al
Corrigendum to "Estimating the burden of adult hospitalized RSV infection including special populations". [Vaccine 40(31) (2022) 4121-4127].
Vaccine. 2022 Sep 10. pii: S0264-410X(22)01123.
PubMed

NIEMINEN H, Lahdenkari M, Syrjanen RK, Nohynek H, et al
Lower incidence of hospital-treated infections in infants under 3 months of age vaccinated with BCG.
Vaccine. 2022 Sep 9. pii: S0264-410X(22)01087.
PubMed Abstract available

DEIFALLAH YOUSIF M, Felek A, Saydam M, Wilson S, et al
Sublingual immunisation with GBS serotype III capsular polysaccharide-tetanus toxoid conjugate vaccine induces systemic and mucosal antibody responses which are opsonophagocytic and inhibit GBS colonisation of vaginal epithelial cells.
Vaccine. 2022 Sep 9. pii: S0264-410X(22)01062.
PubMed Abstract available

ISHIGURO C, Mimura W, Murata F, Fukuda H, et al
Development and application of a Japanese vaccine database for comparative assessments in the post-authorization phase: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study.
Vaccine. 2022 Sep 9. pii: S0264-410X(22)01077.
PubMed Abstract available

VANDEBRIEL RJ, Stalpers CAL, Vermeulen JP, Remkes M, et al
Development of a cell line-based in vitro assay for assessment of Diphtheria, Tetanus and acellular Pertussis (DTaP)-induced inflammasome activation.
Vaccine. 2022;40:5601-5607.
PubMed Abstract available

MOORE KA, Osterholm MT, Lackritz EM, Poland GA, et al
A research and development (R&D) roadmap for broadly protective coronavirus vaccines: Setting a path to address coronavirus threats.
Vaccine. 2022 Sep 8. pii: S0264-410X(22)01079.
PubMed

TEPEROWSKI MONRAD J, Quaade S, Powell-Jackson T
Supply, then demand? Health expenditure, political leanings, cost obstacles to care, and vaccine hesitancy predict state-level COVID-19 vaccination rates.
Vaccine. 2022 Sep 8. pii: S0264-410X(22)01041.
PubMed Abstract available

JOSE PRIYA TA, Kappalli S
Modern biotechnological strategies for vaccine development in aquaculture - Prospects and challenges.
Vaccine. 2022 Sep 7. pii: S0264-410X(22)01083.
PubMed Abstract available

CEANNT R, Vallieres F, Burns H, Murphy J, et al
Covid-19 vaccine hesitancy and resistance amongst parents of children under 18 years of age in Ireland.
Vaccine. 2022 Sep 7. pii: S0264-410X(22)01082.
PubMed Abstract available

MOK CC, Chan KL, Tse SM
Hesitancy for SARS-CoV-2 vaccines and post-vaccination flares in patients with systemic lupus erythematosus.
Vaccine. 2022 Sep 6. pii: S0264-410X(22)01067.
PubMed Abstract available

LUBIS TA, Gunardi H, Herqutanto, Soedjatmiko S, et al
Educational videos to address vaccine hesitancy in childhood immunization.
Vaccine. 2022 Sep 6. pii: S0264-410X(22)01035.
PubMed Abstract available

HABERSAAT KB, Narayan S, Malue Nielsen S, Scherzer M, et al
How health workers can make a difference in the public COVID-19 vaccination response.
Vaccine. 2022 Sep 6. pii: S0264-410X(22)01081.
PubMed

PERRIER Q, Lupo J, Gerster T, Augier C, et al
SARS-CoV-2 anti-spike antibodies after a fourth dose of COVID-19 vaccine in adult solid-organ transplant recipients.
Vaccine. 2022 Sep 6. pii: S0264-410X(22)01064.
PubMed Abstract available

NUORTI JP, Rinta-Kokko H, Toropainen M, Siira L, et al
Long-term population impact of infant 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in adults in Finland.
Vaccine. 2022 Sep 5. pii: S0264-410X(22)01037.
PubMed Abstract available

LUHATA LUNGAYO C, Burke RM, Cikomola A, Mukamba E, et al
Epidemiology and pre-vaccine burden of rotavirus diarrhea in Democratic Republic of Congo (DRC): Results of sentinel surveillance, 2009-2019.
Vaccine. 2022 Sep 3. pii: S0264-410X(22)01031.
PubMed Abstract available

ARORA AK, Chinsky K, Keller C, Mayers I, et al
A detailed analysis of possible efficacy signals of NTHi-Mcat vaccine against severe COPD exacerbations in a previously reported randomised phase 2b trial.
Vaccine. 2022 Sep 3. pii: S0264-410X(22)01042.
PubMed Abstract available

QI L, Sun Y, Juraska M, Moodie Z, et al
Neutralizing antibody correlates of sequence specific dengue disease in a tetravalent dengue vaccine efficacy trial in Asia.
Vaccine. 2022 Sep 3. pii: S0264-410X(22)01043.
PubMed Abstract available

SALUJA T, Rai GK, Chaudhary S, Kanodia P, et al
Immune non-interference and safety study of Vi-DT typhoid conjugate vaccine with a measles, mumps and rubella containing vaccine in 9-15 months old Nepalese infants.
Vaccine. 2022 Sep 2. pii: S0264-410X(22)01009.
PubMed Abstract available

MANOHAR MM, Campbell BE, Walduck AK, Moore RJ, et al
Enhancement of live vaccines by co-delivery of immune modulating proteins.
Vaccine. 2022 Sep 2. pii: S0264-410X(22)01049.
PubMed Abstract available

SAEZ-LLORENS X, Chan M, DeAntonio R, Petersen T, et al
Persistence of protective anti-poliovirus antibody levels in 4-year-old children previously primed with Picovax(R), a trivalent, aluminium-adjuvanted reduced dose inactivated polio vaccine.
Vaccine. 2022 Sep 2. pii: S0264-410X(22)00858.
PubMed Abstract available

LEWIN B, Qian L, Huang R, Sy LS, et al
Travelers and travel vaccines at six health care systems in the Vaccine Safety Datalink.
Vaccine. 2022 Sep 2. pii: S0264-410X(22)01002.
PubMed Abstract available

VESGA JF, Metras R, Clark MHA, Ayazi E, et al
Vaccine efficacy trials for Crimean-Congo haemorrhagic fever: Insights from modelling different epidemiological settings.
Vaccine. 2022 Sep 1. pii: S0264-410X(22)01051.
PubMed Abstract available

BOLSEWICZ KT, Steffens MS, Karpish L, Bullivant B, et al
"Every interaction you have ...should be an opportunity to discuss and offer influenza vaccination". Health service perspectives on influenza vaccination promotion and delivery to Aboriginal families living in New South Wales, Australia.
Vaccine. 2022 Sep 1. pii: S0264-410X(22)01047.
PubMed Abstract available

August 2022

HRIN ML, Emmerich VK, Ip EH, Feldman SR, et al
Development and validation of a COVID-19 vaccine hesitancy scale for adults in the United States.
Vaccine. 2022 Aug 31. pii: S0264-410X(22)01052.
PubMed Abstract available

FRAIMAN J, Erviti J, Jones M, Greenland S, et al
Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults.
Vaccine. 2022 Aug 30. pii: S0264-410X(22)01028.
PubMed Abstract available

JACOBSON M, Chang TY, Shah M, Pramanik R, et al
Can financial incentives and other nudges increase COVID-19 vaccinations among the vaccine hesitant? A randomized trial.
Vaccine. 2022 Aug 30. pii: S0264-410X(22)01050.
PubMed Abstract available

SANCHEZ-SAEZ F, Peiro S, Cuenca L, Vanaclocha H, et al
Side effects during the week after first dose vaccination with four Covid-19 vaccines. Results of the ProVaVac Survey Study with 13,837 people in Spain.
Vaccine. 2022 Aug 29. pii: S0264-410X(22)01007.
PubMed Abstract available

SARKAR P, Chandrasekaran V, Gunasekaran D, Chinnakali P, et al
COVID-19 vaccine hesitancy among health care worker-parents (HCWP) in Puducherry, India and its implications on their children: A cross sectional descriptive study.
Vaccine. 2022 Aug 29. pii: S0264-410X(22)01040.
PubMed Abstract available

CAO X, Zai J, Zhao Q, Xie L, et al
Intranasal immunization with recombinant Vaccinia virus encoding trimeric SARS-CoV-2 spike receptor-binding domain induces neutralizing antibody.
Vaccine. 2022 Aug 29. pii: S0264-410X(22)01044.
PubMed Abstract available

KAMAL HOSSAIN M, Hassanzadeganroudsari M, Feehan J, Deraos G, et al
Development and characterization of a novel conjugated methamphetamine vaccine.
Vaccine. 2022 Aug 27. pii: S0264-410X(22)01033.
PubMed Abstract available

DOYON-PLOURDE P, Fortin E, Quach C
Evaluation of the 2018-2019 vaccine effectiveness against medically attended influenza-like illness using medical records and claims data.
Vaccine. 2022 Aug 27. pii: S0264-410X(22)00976.
PubMed Abstract available

ROSHCHINA Y, Roshchin S, Rozhkova K
Determinants of COVID-19 vaccine hesitancy and resistance in Russia.
Vaccine. 2022 Aug 26. pii: S0264-410X(22)01032.
PubMed Abstract available

TERESA VIETRI M, D'Elia G, Caliendo G, Passariello L, et al
Antibody levels after BNT162b2 vaccine booster and SARS-CoV-2 Omicron infection.
Vaccine. 2022 Aug 26. pii: S0264-410X(22)01034.
PubMed Abstract available

PHAM D, Shukla A, Welch K, Villa A, et al
Assessing knowledge of human papillomavirus among men who have sex with men (MSM) using targeted dating applications.
Vaccine. 2022;40:5376-5383.
PubMed Abstract available

CHUAN VOO T, Savulescu J, Schaefer O, Ho Zhi Ling A, et al
COVID-19 differentiated measures for unvaccinated individuals: The need for clear goals and strong justifications.
Vaccine. 2022;40:5333-5337.
PubMed Abstract available

HEMMI T, Ainai A, Hashiguchi T, Tobiume M, et al
Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology.
Vaccine. 2022 Aug 26. pii: S0264-410X(22)01038.
PubMed Abstract available

KIKUT A, Clark D, Jesch E, Hornik R, et al
Strengthened belief in vaccine effectiveness predicted increased COVID-19 vaccination intention and behaviour: Results from a nationally representative longitudinal survey of U.S. adults from July 2020 to April/May 2021.
Vaccine. 2022 Aug 26. pii: S0264-410X(22)01036.
PubMed Abstract available

OKUYAMA M, Morino S, Tanaka K, Nakamura-Miwa H, et al
Vasovagal reactions after COVID-19 vaccination in Japan.
Vaccine. 2022 Aug 25. pii: S0264-410X(22)01046.
PubMed Abstract available

CATHARINA DE BEER J, Goto D, Miller-Janson H, Holl R, et al
Vaccine financing in the Middle East and Africa: An overview from 2010 to 2019.
Vaccine. 2022 Aug 24. pii: S0264-410X(22)00817.
PubMed Abstract available

CALO WA, Lennon RP, Ruffin Iv MT, Keller C, et al
Support for HPV vaccine school-entry requirements in the United States: The role of exemption policies.
Vaccine. 2022 Aug 24. pii: S0264-410X(22)00983.
PubMed Abstract available

LIM AH, Ab Rahman N, Ong SM, Paraja J, et al
Evaluation of BNT162b2 vaccine effectiveness in Malaysia: test negative case-control study.
Vaccine. 2022 Aug 24. pii: S0264-410X(22)01005.
PubMed Abstract available

ESSON R, Rodrigues De Sousa E, Benair L, Devard N, et al
Phenotypic and genetic characterization of a next generation live-attenuated yellow fever vaccine candidate.
Vaccine. 2022 Aug 23. pii: S0264-410X(22)00939.
PubMed Abstract available

KURUKULASURIYA S, Ahmed KA, Ojkic D, Gunawardana T, et al
Evaluation of five circulating strains of variant infectious bursal disease virus (varIBDV) for their immunogenicity as broiler breeder vaccines and protective efficacy in neonatal broiler chicks.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01000.
PubMed Abstract available

ROMANO L, Tosti ME, Zanetti AR
Beyond 30 years of universal anti-hepatitis B vaccination in Italy: Success and areas of improvement.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)00966.
PubMed

PRUDDEN HJ, Achilles SL, Schocken C, Broutet N, et al
Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021-March 2022.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)00999.
PubMed Abstract available

MACKLIN GR, Goel AK, Mach O, Tallis G, et al
Epidemiology of type 2 vaccine-derived poliovirus outbreaks between 2016 and 2020.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)00962.
PubMed Abstract available

MARRON L, Ferenczi A, O'Brien KM, Cotter S, et al
Views on COVID-19 vaccination of young children in Ireland, results from a cross-sectional survey of parents.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01013.
PubMed Abstract available

STIVANELLO E, Beghelli C, Cardoni F, Giansante C, et al
Short-term mortality following COVID-19 vaccination in Bologna, Italy: a one-year study.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01029.
PubMed Abstract available

WANG X, Deng Y, Zhao L, Wang L, et al
Safety, immunogenicity, and immune persistence of two inactivated COVID-19 vaccines replacement vaccination in China: An observational cohort study.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01030.
PubMed Abstract available

KANOKUDOM S, Assawakosri S, Suntronwong N, Chansaenroj J, et al
Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01011.
PubMed Abstract available

DOCHEZ C, Duclos P, MacDonald N, Steffen C, et al
Advanced vaccinology training globally: Update and impact of the COVID-19 crisis.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01006.
PubMed Abstract available

KURASHIMA K, Numano T, Yoshino A, Osawa A, et al
Antibody titers among healthcare workers for coronavirus disease 2019 at 6 months after BNT162b2 vaccination.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01027.
PubMed Abstract available

WILLIS GA, Bloomfield L, Berry M, Bulsara C, et al
The impact of a vaccine mandate and the COVID-19 pandemic on influenza vaccination uptake in Western Australian health care students.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01026.
PubMed Abstract available

TOAPANTA-YANCHAPAXI L, Chiquete E, Avila-Rojo E, Lopez-Yanez S, et al
Humoral response to different SARS-CoV-2 vaccines in orthotopic liver transplant recipients.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01012.
PubMed Abstract available

CLEMENS SAC, Fortaleza CMCB, Crowe M, Pollard A, et al
Safety of the Fiocruz ChAdOx COVID-19 vaccine used in a mass vaccination campaign in Botucatu, Brazil.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01010.
PubMed Abstract available

JAFFRY M, Mostafa F, Mandava K, Rosario S, et al
No significant increase in Guillain-Barre syndrome after COVID-19 vaccination in adults: A vaccine adverse event reporting system study.
Vaccine. 2022 Aug 22. pii: S0264-410X(22)01025.
PubMed Abstract available

PSARIDI L, Maltezou HC, Simonidou S, Lialliou I, et al
Neutralizing antibody responses in healthcare personnel after three doses of mRNA BNT162b2 vaccine and association with baseline characteristics and past SARS-CoV-2 infection.
Vaccine. 2022 Aug 19. pii: S0264-410X(22)01008.
PubMed Abstract available

MOHAMED TJ, Fong SM, Nadarajaw T, Choo CM, et al
Burden of pertussis among young infants in Malaysia: A hospital-based surveillance study.
Vaccine. 2022;40:5241-5247.
PubMed Abstract available

DEJONG MA, Wolf MA, Bitzer GJ, Hall JM, et al
CpG 1018(R) adjuvant enhances Tdap immune responses against Bordetella pertussis in mice.
Vaccine. 2022;40:5229-5240.
PubMed Abstract available

STOECKEL F, Stockli S, Phillips J, Lyons B, et al
Stamping the vaccine passport? Public support for lifting COVID-19 related restrictions for vaccinated citizens in France, Germany, and Sweden.
Vaccine. 2022 Aug 18. pii: S0264-410X(22)00965.
PubMed Abstract available

LAFFAN MA, Rees S, Yadavalli M, Ferstenberg LB, et al
Thrombosis with thrombocytopenia after AZD1222 (ChAdOx1 nCov-19) vaccination: Case characteristics and associations.
Vaccine. 2022 Aug 18. pii: S0264-410X(22)00964.
PubMed Abstract available

PRINGLE W, Greyson D, Graham JE, Dube E, et al
Suitable but requiring support: How the midwifery model of care offers opportunities to counsel the vaccine hesitant pregnant population.
Vaccine. 2022 Aug 18. pii: S0264-410X(22)00953.
PubMed Abstract available

AMANI A, Ngo Bama S, Dia M, Nguefack Lekelem S, et al
Challenges, best practices, and lessons learned from oral cholera mass vaccination campaign in urban Cameroon during the COVID-19 era.
Vaccine. 2022 Aug 18. pii: S0264-410X(22)01004.
PubMed Abstract available

ISHIDA M, Mulou N, Mahal A
Travel time to health facilities in Papua New Guinea: Implications for coverage and equity in child vaccinations.
Vaccine. 2022 Aug 17. pii: S0264-410X(22)00958.
PubMed Abstract available

LINNANDER E, Ineza L, Mupeta Bobo P, Bechtold K, et al
Improving management of vaccine supply chains: A multi-methods evaluation of vSTEP in Zambia.
Vaccine. 2022 Aug 17. pii: S0264-410X(22)00914.
PubMed Abstract available

WYMORE BRAND M, Anderson TK, Kitikoon P, Brian Kimble J, et al
Bivalent hemagglutinin and neuraminidase influenza replicon particle vaccines protect pigs against influenza a virus without causing vaccine associated enhanced respiratory disease.
Vaccine. 2022 Aug 17. pii: S0264-410X(22)00937.
PubMed Abstract available

VISKUPIC F, Wiltse DL, Badahdah A
Reminders of existing vaccine mandates increase support for a COVID-19 vaccine mandate: Evidence from a survey experiment.
Vaccine. 2022 Aug 15. pii: S0264-410X(22)00978.
PubMed Abstract available

ELLIOTT CBP, Chambers CS
A historical analysis of vaccine mandates in the United States military and its application to the COVID-19 vaccine mandate.
Vaccine. 2022 Aug 15. pii: S0264-410X(22)00982.
PubMed Abstract available

ALKETBI LMB, Al Hosani F, Al Memari S, Al Mazrouei S, et al
Parents' views on the acceptability of a COVID-19 vaccine for their children: A cross-sectional study in Abu Dhabi-United Arab Emirates.
Vaccine. 2022 Aug 15. pii: S0264-410X(22)00954.
PubMed Abstract available

MATSUURA T, Fukushima W, Nakagama Y, Kido Y, et al
Kinetics of anti-SARS-CoV-2 antibody titer in healthy adults up to 6 months after BNT162b2 vaccination measured by two immunoassays: A prospective cohort study in Japan.
Vaccine. 2022 Aug 15. pii: S0264-410X(22)00984.
PubMed Abstract available

CASEROTTI M, Gavaruzzi T, Girardi P, Sellaro R, et al
People's perspectives about COVID-19 vaccination certificate: Findings from a representative Italian sample.
Vaccine. 2022 Aug 15. pii: S0264-410X(22)00980.
PubMed Abstract available

SCHMIDTKE KA, Skrybant M, Kudrna L, Russell S, et al
A workshop to co-design messages that may increase uptake of vaccines: A case study.
Vaccine. 2022 Aug 12. pii: S0264-410X(22)00951.
PubMed Abstract available

XIROGIANNI A, Marmaras N, Georgakopoulou T, Papandreou A, et al
Pneumococcal meningitis in Greece: A retrospective serotype surveillance study in the post-PCV13 era (2010-2020).
Vaccine. 2022;40:5079-5087.
PubMed Abstract available

OMER SB, O'Leary ST, Bednarczyk RA, Ellingson MK, et al
Multi-tiered intervention to increase maternal immunization coverage: A randomized, controlled trial.
Vaccine. 2022;40:4955-4963.
PubMed Abstract available

HALASA N, Williams J, Faouri S, Shehabi A, et al
Corrigendum to "Natural history and epidemiology of respiratory syncytial virus infection in the Middle East: Hospital surveillance for children under age two in Jordan" [Vaccine 33(47) (2015) 6479-6487].
Vaccine. 2022 Aug 11. pii: S0264-410X(22)00959.
PubMed

HOSHI SL, Okubo R, Tabuchi K, Seposo X, et al
Cost-effectiveness analyses of monovalent mumps vaccination programs for Japanese children.
Vaccine. 2022 Aug 11. pii: S0264-410X(22)00960.
PubMed Abstract available

MARKOWITZ LE, Drolet M, Lewis RM, Lemieux-Mellouki P, et al
Human papillomavirus vaccine effectiveness by number of doses: Updated systematic review of data from national immunization programs.
Vaccine. 2022 Aug 11. pii: S0264-410X(22)00834.
PubMed Abstract available

MAEDA H, Gopal Dhoubhadel B, Sando E, Suzuki M, et al
Long-term impact of pneumococcal conjugate vaccines for children on adult pneumococcal pneumonia in Japan: Two multicenter observational studies from 2011 to 2020.
Vaccine. 2022 Aug 10. pii: S0264-410X(22)00938.
PubMed Abstract available

GUSMAO MR, Ostolin TLVDP, Carvalho LM, Costa AFP, et al
Immunoprophylaxis using polypeptide chimera vaccines plus adjuvant system promote Th1 response controlling the spleen parasitism in hamster model of visceral leishmaniasis.
Vaccine. 2022 Aug 10. pii: S0264-410X(22)00961.
PubMed Abstract available

YELVERTON V, Hair NL, Ghosh SH, Mfinanga SG, et al
Beyond coverage: Rural-urban disparities in the timeliness of childhood vaccinations in Tanzania.
Vaccine. 2022 Aug 9. pii: S0264-410X(22)00907.
PubMed Abstract available

PROUT A, Rustandi RR, Tubbs C, Winters MA, et al
Functional profiling of Covid 19 vaccine candidate by flow virometry.
Vaccine. 2022 Aug 9. pii: S0264-410X(22)00963.
PubMed Abstract available

PERROUD JM, Soldano S, Avancena ALV, Wagner A, et al
Adult vaccination uptake strategies in low- and middle-income countries: A systematic review.
Vaccine. 2022 Aug 8. pii: S0264-410X(22)00952.
PubMed Abstract available

HU S, Xiong C, Li Q, Wang Z, et al
COVID-19 vaccine hesitancy cannot fully explain disparities in vaccination coverage across the contiguous United States.
Vaccine. 2022 Aug 8. pii: S0264-410X(22)00947.
PubMed Abstract available

THOBANI RS, Yousafzai MT, Sultana S, Kazi AM, et al
Field evaluation of typhoid conjugate vaccine in a catch-up campaign among children aged 9 months to 15 years in Sindh, Pakistan.
Vaccine. 2022 Aug 6. pii: S0264-410X(22)00840.
PubMed Abstract available

ESTRELA M, Magalhaes Silva T, Roque V, Rebelo Gomes E, et al
Unravelling the drivers behind COVID-19 vaccination hesitancy and refusal among teachers: A nationwide study.
Vaccine. 2022 Aug 5. pii: S0264-410X(22)00955.
PubMed Abstract available

BURGER E, Baussano I, Kim JJ, Laprise JF, et al
Recent economic evaluation of 1-dose HPV vaccination uses unsupported assumptions.
Vaccine. 2022 Aug 5. pii: S0264-410X(22)00910.
PubMed

GAGNEUX-BRUNON A, Guyot E, Detoc M, Botelho-Nevers E, et al
Midwives' attitudes toward participation of pregnant individuals in a preventive vaccine hypothetical clinical trial.
Vaccine. 2022 Aug 5. pii: S0264-410X(22)00945.
PubMed Abstract available

DE SWART RL, de Leeuw OS, Oreshkova N, Gerhards NM, et al
Intranasal administration of a live-attenuated recombinant newcastle disease virus expressing the SARS-CoV-2 Spike protein induces high neutralizing antibody levels and protects from experimental challenge infection in hamsters.
Vaccine. 2022;40:4676-4681.
PubMed Abstract available

HAO L, Kuttel MM, Ravenscroft N, Thompson A, et al
Streptococcus pneumoniae serotype 15B polysaccharide conjugate elicits a cross-functional immune response against serotype 15C but not 15A.
Vaccine. 2022;40:4872-4880.
PubMed Abstract available

LI YA, Sun Y, Zhang Y, Wang S, et al
Live attenuated Salmonella enterica serovar Choleraesuis vector delivering a virus-like particles induces a protective immune response against porcine circovirus type 2 in mice.
Vaccine. 2022;40:4732-4741.
PubMed Abstract available

YEO J, Furr Gudmundsen C, Fazel S, Corrigan A, et al
A behavior change model to address caregiver hesitancy around COVID-19 vaccination in pediatrics.
Vaccine. 2022 Aug 5. pii: S0264-410X(22)00949.
PubMed Abstract available

ULRICH AK, Pankratz GK, Bohn B, Yendell S, et al
COVID-19 vaccine confidence and reasons for vaccination among health care workers and household members.
Vaccine. 2022 Aug 5. pii: S0264-410X(22)00956.
PubMed Abstract available

TOIZUMI M, Satoh C, Quilty BJ, Nguyen HAT, et al
Effect of pneumococcal conjugate vaccine on prevalence of otitis media with effusion among children in Vietnam.
Vaccine. 2022 Aug 4. pii: S0264-410X(22)00944.
PubMed Abstract available

SQUIRE JD, Joshi AY
Response to mRNA COVID-19 vaccination in three XLA patients.
Vaccine. 2022 Aug 3. pii: S0264-410X(22)00941.
PubMed Abstract available

LOURENCO GUIMARAES E, Chissaque A, Pecenka C, Clark A, et al
Cost-effectiveness of rotavirus vaccination in Mozambique.
Vaccine. 2022 Aug 3. pii: S0264-410X(22)00940.
PubMed Abstract available

QUIAMBAO BP, Lim JG, Bosch Castells V, Augard C, et al
One-week intramuscular or intradermal pre-exposure prophylaxis with human diploid cell vaccine or Vero cell rabies vaccine, followed by simulated post-exposure prophylaxis at one year: A phase III, open-label, randomized, controlled trial to assess im
Vaccine. 2022 Aug 3. pii: S0264-410X(22)00923.
PubMed Abstract available

SINGH H, Chase AJ
Measuring vaccine acceptance and knowledge within health professions education.
Vaccine. 2022 Aug 3. pii: S0264-410X(22)00926.
PubMed Abstract available

SNYDER J, Goldenberg M, Crooks VA, Katz R, et al
Crowdfunding narratives and the valuation of vaccines for COVID-19.
Vaccine. 2022 Aug 3. pii: S0264-410X(22)00946.
PubMed Abstract available

CIMA MJ, McCormick D, Porter A 3rd, Zohoori N, et al
COVID-19 vaccine uptake among Arkansas public K-12 school teachers and staff.
Vaccine. 2022 Aug 2. pii: S0264-410X(22)00942.
PubMed Abstract available

DE MUNTER AC, Hautvast JLA, Ruijs WLM, Henri Spaan D, et al
Deciding about maternal pertussis vaccination: associations between intention, and needs and values in a vaccine-hesitant religious group.
Vaccine. 2022 Aug 1. pii: S0264-410X(22)00924.
PubMed

NARSINGAM S, Munson J, Drescher F
Comparative effectiveness of individual pneumococcal vaccines with dual pneumococcal vaccination in older United States Veterans.
Vaccine. 2022 Aug 1. pii: S0264-410X(22)00922.
PubMed Abstract available

BAUMER-MOURADIAN SH, Hart RJ, Bone JN, Seiler M, et al
Should COVID-19 vaccines be mandated in schools? - an international caregiver perspective.
Vaccine. 2022 Aug 1. pii: S0264-410X(22)00921.
PubMed Abstract available

KORODI M, Horvath I, Rakosi K, Jenei Z, et al
Longitudinal determination of BNT162b2 vaccine induced strongly binding SARS-CoV-2 IgG antibodies in a cohort of Romanian healthcare workers.
Vaccine. 2022 Aug 1. pii: S0264-410X(22)00936.
PubMed Abstract available

July 2022

SHINKAI M, Sonoyama T, Kamitani A, Shibata RY, et al
Immunogenicity and safety of booster dose of S-268019-b or BNT162b2 in Japanese participants: An interim report of phase 2/3, randomized, observer-blinded, noninferiority study.
Vaccine. 2022;40:4328-4333.
PubMed Abstract available

DE BROUWER L, David D, Espitia Ballestas M, Sloots A, et al
Prevalidation of the cAMP-PTx reporter assay for quantitative assessment of pertussis toxin activity.
Vaccine. 2022;40:4513-4521.
PubMed Abstract available

COWLING BJ, Wong IOL, Shiu EYC, Lai AYT, et al
Strength and durability of antibody responses to BNT162b2 and CoronaVac.
Vaccine. 2022;40:4312-4317.
PubMed Abstract available

SADOFF J, Le Gars M, Brandenburg B, Cardenas V, et al
Durable antibody responses elicited by 1 dose of Ad26.COV2.S and substantial increase after boosting: 2 randomized clinical trials.
Vaccine. 2022;40:4403-4411.
PubMed Abstract available

LIU Z, Hosomi K, Kunisawa J
Utilization of gut environment-mediated control system of host immunity in the development of vaccine adjuvants.
Vaccine. 2022 Jul 30. pii: S0264-410X(22)00918.
PubMed Abstract available

NOWALK MP, D'Agostino H, Dauer K, Stiegler M, et al
Estimating the burden of adult hospitalized RSV infection including special populations.
Vaccine. 2022;40:4121-4127.
PubMed Abstract available

BOTTCHER J, Bauer BU, Ambros C, Alex M, et al
Long-term control of Coxiellosis in sheep by annual primary vaccination of gimmers.
Vaccine. 2022 Jul 29. pii: S0264-410X(22)00917.
PubMed Abstract available

CHEN H, Huang Z, Chang S, Hu M, et al
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in China: A multicentre, non-inferiorit
Vaccine. 2022 Jul 29. pii: S0264-410X(22)00919.
PubMed Abstract available

ROSE O, Erzkamp S, Schobel W, Grajeda M, et al
COVID-19 vaccinations in German pharmacies: A survey on patient and provider satisfaction.
Vaccine. 2022 Jul 28. pii: S0264-410X(22)00925.
PubMed Abstract available

MARIN-LOPEZ A, Wang Y, Jiang J, Ledizet M, et al
Erratum to "AgBR1 and NeSt1 antisera protect mice from Aedes aegypti-borne Zika infection" [Vaccine 39(12) (2021) 1675-1679].
Vaccine. 2022 Jul 27. pii: S0264-410X(22)00608.
PubMed

BYRNE C, Coombs D, Gantt S
Modestly protective cytomegalovirus vaccination of young children effectively prevents congenital infection at the population level.
Vaccine. 2022 Jul 27. pii: S0264-410X(22)00913.
PubMed Abstract available

RAMMAURO F, Carrion F, Olivero-Deibe N, Flo M, et al
Humoral immune response characterization of heterologous prime-boost vaccination with CoronaVac and BNT162b2.
Vaccine. 2022 Jul 27. pii: S0264-410X(22)00911.
PubMed Abstract available

QUIAMBAO B, Montalban C, Minutello AM, Guinet-Morlot F, et al
Serum-free purified Vero rabies vaccine is safe and immunogenic in children: Results of a randomized phaseII pre-exposure prophylaxis regimen study.
Vaccine. 2022 Jul 26. pii: S0264-410X(22)00830.
PubMed Abstract available

KRAUSE PR, Arora N, Dowling W, Munoz-Fontela C, et al
Making more COVID-19 vaccines available to address global needs: Considerations and a framework for their evaluation.
Vaccine. 2022 Jul 26. pii: S0264-410X(22)00916.
PubMed

SHENYU W, Xiaoqian D, Bo C, Xuan D, et al
Immunogenicity and safety of a SARS-CoV-2 inactivated vaccine (CoronaVac) co-administered with an inactivated quadrivalent influenza vaccine: A randomized, open-label, controlled study in healthy adults aged 18 to 59 years in China.
Vaccine. 2022 Jul 26. pii: S0264-410X(22)00908.
PubMed Abstract available

O'KENNEDY MM, Coetzee P, Koekemoer O, du Plessis L, et al
Protective immunity of plant-produced African horse sickness virus serotype 5 chimaeric virus-like particles (VLPs) and viral protein 2 (VP2) vaccines in IFNAR(-/-) mice.
Vaccine. 2022 Jul 25. pii: S0264-410X(22)00848.
PubMed Abstract available

SPENCER CLINTON JL, Hoornweg TE, Tan J, Peng R, et al
EEHV1A glycoprotein B subunit vaccine elicits humoral and cell-mediated immune responses in mice.
Vaccine. 2022 Jul 22. pii: S0264-410X(22)00891.
PubMed Abstract available

CHANG MJ, Ollivault-Shiflett M, Schuman R, Ngoc Nguyen S, et al
Genetically detoxified tetanus toxin as a vaccine and conjugate carrier protein.
Vaccine. 2022 Jul 21. pii: S0264-410X(22)00886.
PubMed Abstract available

SIMSEK C, Bloemen M, Jansen D, Descheemaeker P, et al
Rotavirus vaccine-derived cases in Belgium: Evidence for reversion of attenuating mutations and alternative causes of gastroenteritis.
Vaccine. 2022 Jul 21. pii: S0264-410X(22)00853.
PubMed Abstract available

PAWASKAR M, Gil-Rojas Y, Irene Parellada C, Rey-Velasco A, et al
The impact of universal varicella vaccination on the clinical burden of varicella in Colombia: A National database Analysis, 2008-2019.
Vaccine. 2022 Jul 21. pii: S0264-410X(22)00889.
PubMed Abstract available

MCADAMS D, Estrada M, Holland D, Singh J, et al
Concordance of in vitro and in vivo measures of non-replicating rotavirus vaccine potency.
Vaccine. 2022 Jul 21. pii: S0264-410X(22)00892.
PubMed Abstract available

LORENZETTI L, Haydarov R, Namey E, Lawton A, et al
Exploring public perceptions of vaccine-derived poliovirus and a novel oral polio vaccine in the Democratic Republic of the Congo, Kenya, and Nigeria.
Vaccine. 2022 Jul 20. pii: S0264-410X(22)00591.
PubMed Abstract available

DUGORD C, Franc C
Trajectories and individual determinants of repeated seasonal flu vaccination use over the long term using data from the French E3N cohort.
Vaccine. 2022 Jul 18. pii: S0264-410X(22)00855.
PubMed Abstract available

MCMILLAN CLD, Amarilla AA, Modhiran N, Choo JJY, et al
Skin-patch delivered subunit vaccine induces broadly neutralising antibodies against SARS-CoV-2 variants of concern.
Vaccine. 2022 Jul 18. pii: S0264-410X(22)00888.
PubMed Abstract available

SETHY G, Chisema M, Sharma L, Joshi K, et al
COVID-19 vaccine express strategy in Malawi: An effort to reach the un-reach.
Vaccine. 2022 Jul 18. pii: S0264-410X(22)00887.
PubMed Abstract available

MIMURA W, Ishiguro C, Fukuda H
Influenza vaccine effectiveness against hospitalization during the 2018/2019 season among older persons aged>/=75years in Japan: The LIFE-VENUS Study.
Vaccine. 2022 Jul 15. pii: S0264-410X(22)00852.
PubMed Abstract available

WALTON S, Cortina-Borja M, Dezateux C, Griffiths LJ, et al
Linking cohort data and Welsh routine health records to investigate children at risk of delayed primary vaccination.
Vaccine. 2022 Jul 13. pii: S0264-410X(22)00849.
PubMed Abstract available

IMANISHI Y, Kinoshita T, Sakamoto M, Ichimiya M, et al
Importance of human papillomavirus vaccination leaflets focusing on the safety profile targeted pediatricians in Japan.
Vaccine. 2022 Jul 13. pii: S0264-410X(22)00861.
PubMed Abstract available

VASUDEVAN L, Bruening R, Hung A, Woolson S, et al
COVID-19 vaccination intention and activation among health care system employees: A mixed methods study.
Vaccine. 2022 Jul 13. pii: S0264-410X(22)00884.
PubMed Abstract available

ORTQVIST AK, Dahlqwist E, Magnus MC, Ljung R, et al
COVID-19 vaccination in pregnant women in Sweden and Norway.
Vaccine. 2022 Jul 12. pii: S0264-410X(22)00859.
PubMed Abstract available

PRIDDY FH, Williams M, Carson S, Lavender B, et al
Immunogenicity of BNT162b2 COVID-19 vaccine in New Zealand adults.
Vaccine. 2022 Jul 12. pii: S0264-410X(22)00885.
PubMed Abstract available

GODDARD K, Lewis N, Fireman B, Weintraub E, et al
Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination.
Vaccine. 2022 Jul 12. pii: S0264-410X(22)00860.
PubMed Abstract available

CUFFEL A, Maylin S, Le Buanec H, Delaugerre C, et al
Humoral and cellular responses to SARS-CoV-2 BNT162b2 vaccination in allogeneic hematopoietic stem cell transplantation recipients.
Vaccine. 2022 Jul 11. pii: S0264-410X(22)00857.
PubMed Abstract available

PADRON-REGALADO E, Medina-Rivero E
Perspectives for licensing vaccines in Mexico.
Vaccine. 2022 Jul 11. pii: S0264-410X(22)00854.
PubMed Abstract available

HATFALUDI T, Rezaee MS, Liebhart D, Bilic I, et al
Experimental reproduction of histomonosis caused by Histomonas meleagridis genotype 2 in turkeys can be prevented by oral vaccination of day-old birds with a monoxenic genotype 1 vaccine candidate.
Vaccine. 2022 Jul 11. pii: S0264-410X(22)00851.
PubMed Abstract available

COURCIER EA, Collins SF, McCormick CM, Arnold ME, et al
The impact of BCG strains and repeat vaccinations on immunodiagnostic tests in Eurasian badgers (Meles meles).
Vaccine. 2022 Jul 9. pii: S0264-410X(22)00850.
PubMed Abstract available

WYPLOSZ B, Fernandes J, Sultan A, Roche N, et al
Pneumococcal and influenza vaccination coverage among at-risk adults: A 5-year French national observational study.
Vaccine. 2022 Jul 7. pii: S0264-410X(22)00841.
PubMed Abstract available

MISCHLINGER J, Jaeger VK, Ciurea A, Gabay C, et al
Long-term persistence of antibodies after diphtheria/tetanus vaccination in immunosuppressed patients with inflammatory rheumatic diseases and healthy controls.
Vaccine. 2022 Jul 7. pii: S0264-410X(22)00760.
PubMed Abstract available

ZHANG Y, Wang Y, Jia C, Li G, et al
Immunogenicity and safety of an egg culture-based quadrivalent inactivated non-adjuvanted subunit influenza vaccine in subjects >/=3 years: A randomized, multicenter, double-blind, active-controlled phase III, non-inferiority trial.
Vaccine. 2022 Jul 7. pii: S0264-410X(22)00846.
PubMed Abstract available

BADRAN G, Angrand L, Masson JD, Crepeaux G, et al
Physico-chemical properties of aluminum adjuvants in vaccines: Implications for toxicological evaluation.
Vaccine. 2022 Jul 6. pii: S0264-410X(22)00833.
PubMed Abstract available

REINHARDT A, Rossmann C, Engel E
Radio public service announcements to promote vaccinations for older adults: Effects of framing and distraction.
Vaccine. 2022 Jul 6. pii: S0264-410X(22)00805.
PubMed Abstract available

CHADWICK C, Friede M, Moen A, Nannei C, et al
Technology transfer programme for influenza vaccines - Lessons from the past to inform the future.
Vaccine. 2022 Jul 6. pii: S0264-410X(22)00826.
PubMed

OSTROPOLETS A, Shoener Dunham L, Johnson KD, Liu J, et al
Pneumococcal vaccination coverage among adults newly diagnosed with underlying medical conditions and regional variation in the U.S.
Vaccine. 2022 Jul 5. pii: S0264-410X(22)00837.
PubMed Abstract available

XIRIDOU M, Adam P, Meiberg A, Visser M, et al
The impact of the COVID-19 pandemic on hepatitis B virus vaccination and transmission among men who have sex with men: A mathematical modelling study.
Vaccine. 2022 Jul 4. pii: S0264-410X(22)00847.
PubMed Abstract available

MCCORMICK DW, Konkle SL, Magleby R, Chakrabarti AK, et al
SARS-CoV-2 infection risk among vaccinated and unvaccinated household members during the Alpha variant surge - Denver, Colorado, and San Diego, California, January-April 2021.
Vaccine. 2022 Jul 4. pii: S0264-410X(22)00835.
PubMed Abstract available

CASTILLO-CANO B, Martin-Perez M, Llorente-Garcia A, Montero-Corominas D, et al
Assessment of thyroiditis risk associated with HPV vaccination among girls aged 9-18 years: A time-varying cohort study.
Vaccine. 2022 Jul 2. pii: S0264-410X(22)00829.
PubMed Abstract available

BARNARD JG, Marsh R, Anderson-Mellies A, Williams JL, et al
Pre-implementation evaluation for an HPV vaccine provider communication intervention among primary care clinics.
Vaccine. 2022 Jul 2. pii: S0264-410X(22)00844.
PubMed Abstract available

HOU Z, Guo J, Lai X, Zhang H, et al
Influenza vaccination hesitancy and its determinants among elderly in China: A national cross-sectional study.
Vaccine. 2022 Jul 1. pii: S0264-410X(22)00832.
PubMed Abstract available

SKIRROW H, Barnett S, Bell S, Mounier-Jack S, et al
Women's views and experiences of accessing pertussis vaccination in pregnancy and infant vaccinations during the COVID-19 pandemic: A multi-methods study in the UK.
Vaccine. 2022 Jul 1. pii: S0264-410X(22)00845.
PubMed Abstract available

BARRALL AL, Hoff NA, Nkamba DM, Musene K, et al
Hesitancy to receive the novel coronavirus vaccine and potential influences on vaccination among a cohort of healthcare workers in the Democratic Republic of the Congo.
Vaccine. 2022 Jul 1. pii: S0264-410X(22)00842.
PubMed Abstract available

June 2022

NASREEN S, Gebretekle GB, Lynch M, Kurdina A, et al
Understanding predictors of pneumococcal vaccine uptake in older adults aged 65 years and older in high-income countries across the globe: A scoping review.
Vaccine. 2022 Jun 30. pii: S0264-410X(22)00825.
PubMed Abstract available

HILLS T, Paterson A, Woodward R, Middleton F, et al
The effect of needle length and skin to deltoid muscle distance in adults receiving an mRNA COVID-19 vaccine.
Vaccine. 2022 Jun 29. pii: S0264-410X(22)00839.
PubMed Abstract available

PICHON S, Moureau A, Petit C, Chu L, et al
Safety and immunogenicity of a serum-free purified Vero rabies vaccine in healthy adults: A randomised phase II pre-exposure prophylaxis study.
Vaccine. 2022 Jun 28. pii: S0264-410X(22)00806.
PubMed Abstract available

BETTENCOURT C, Nogueira P, Paulo Gomes J, Joao Simoes M, et al
Vaccines against Neisseria meningitidis serogroup B strains - What does genomics reveal on the Portuguese strain's coverage.
Vaccine. 2022 Jun 28. pii: S0264-410X(22)00807.
PubMed Abstract available

MEDEIROS MZ, Soares PF, Fialho BC, Gauss L, et al
Vaccine innovation model: A technology transfer perspective in pandemic contexts.
Vaccine. 2022 Jun 27. pii: S0264-410X(22)00823.
PubMed Abstract available

WONG SC, Chan VW, Lam GKM, Yuen LL, et al
The impact of personal coaching on influenza vaccination among healthcare workers before and during COVID-19 pandemic.
Vaccine. 2022 Jun 27. pii: S0264-410X(22)00836.
PubMed Abstract available

LEE JT, Sean Hu S, Zhou T, Bonner KE, et al
Employer requirements and COVID-19 vaccination and attitudes among healthcare personnel in the U.S.: Findings from National Immunization Survey Adult COVID Module, August - September 2021.
Vaccine. 2022 Jun 27. pii: S0264-410X(22)00838.
PubMed Abstract available

UFFMAN EA, Li SH, Chen JL, Allen N, et al
Kinetics of pneumococcal antibodies among HIV-exposed, uninfected infants in Botswana.
Vaccine. 2022 Jun 27. pii: S0264-410X(22)00828.
PubMed Abstract available

MOGHNIEH R, Abdallah D, Sayegh MH, Rahman Bizri A, et al
Response to letter to the editor: Immunophenotyping of SARS-CoV-2 and vaccine design.
Vaccine. 2022;40:3987-3988.
PubMed

CIMOLAI N
Immunophenotyping of SARS-CoV-2 and vaccine design.
Vaccine. 2022;40:3985-3986.
PubMed

HU G, Jin WP, Yang ZH, Lv SY, et al
Efficacy of Coxsackievirus A2 vaccine candidates correlating to humoral immunity in mice challenged with a mouse-adapted strain.
Vaccine. 2022 Jun 24. pii: S0264-410X(22)00768.
PubMed Abstract available

STRAUS W, Rubin H
COVID-19 vaccine safety monitoring in low and middle income countries - Time for a bold new approach.
Vaccine. 2022 Jun 24. pii: S0264-410X(22)00822.
PubMed

SHIVJI R, Conocchia R, Korakianiti E, Jekerle V, et al
Considerations for the chemistry, manufacturing and Controls (CMC) - quality package for COVID-19 vaccines- interim lessons learnt by the European medicines Agency (EMA).
Vaccine. 2022 Jun 24. pii: S0264-410X(22)00827.
PubMed Abstract available

SEYRAN M
Artificial intelligence and clinical data suggest the T cell-mediated SARS-CoV-2 nonstructural protein intranasal vaccines for global COVID-19 immunity.
Vaccine. 2022 Jun 24. pii: S0264-410X(22)00821.
PubMed Abstract available

AL-MUSTAPHA AI, Okechukwu O, Olayinka A, Muhammed OR, et al
A national survey of COVID-19 vaccine acceptance in Nigeria.
Vaccine. 2022 Jun 23. pii: S0264-410X(22)00818.
PubMed Abstract available

LOHMANN S, Albarracin D
Trust in the public health system as a source of information on vaccination matters most when environments are supportive.
Vaccine. 2022 Jun 23. pii: S0264-410X(22)00759.
PubMed Abstract available

HUANG L, Wasserman M, Grant L, Farkouh R, et al
Burden of pneumococcal disease due to serotypes covered by the 13-valent and new higher-valent pneumococcal conjugate vaccines in the United States.
Vaccine. 2022 Jun 23. pii: S0264-410X(22)00773.
PubMed Abstract available

ZHAO Z, Liao Y, Li Y, Jiang G, et al
Immunogenicity and safety of the inactivated enterovirus 71 vaccine administered concomitantly with the measles-rubella vaccine in infants aged 8 months in China: A noninferiority randomized controlled trial.
Vaccine. 2022 Jun 23. pii: S0264-410X(22)00776.
PubMed Abstract available

CARTANYA-HUESO A, Martinez-Sanchez JM, Carlos Martin-Sanchez J, Lidon-Moyano C, et al
Relationship between double COVID-19 vaccine uptake and trust in effectiveness and safety of vaccination in general in 23 Member states of the European Union: an ecological study.
Vaccine. 2022 Jun 23. pii: S0264-410X(22)00820.
PubMed Abstract available

MAERTENS K, Leuridan E, Munoz FM, Zimmermann P, et al
Impact of vaccination during pregnancy on infants' immune responses to vaccinations- definitions and statistical approaches.
Vaccine. 2022 Jun 21. pii: S0264-410X(22)00811.
PubMed

BRAZ HMB, Silva MF, Carvalho TP, Silva LAD, et al
Pathogenesis of Brucella ovis in pregnant mice and protection induced by the candidate vaccine strain B. Ovis DeltaabcBA.
Vaccine. 2022 Jun 21. pii: S0264-410X(22)00812.
PubMed Abstract available

RONZANI P, Panizza F, Martini C, Savadori L, et al
Countering vaccine hesitancy through medical expert endorsement.
Vaccine. 2022 Jun 21. pii: S0264-410X(22)00780.
PubMed Abstract available

SOARES GH, Sethi S, Hedges J, Jamieson L, et al
Disparities in Human Papillomavirus vaccination coverage among adolescents in Australia: A geospatial analysis.
Vaccine. 2022 Jun 21. pii: S0264-410X(22)00777.
PubMed Abstract available

WANG L, Zhang J, Meng S, Ge L, et al
Safety and immunogenicity of human rabies vaccine for the Chinese population after PEP: A systematic review and meta-analysis.
Vaccine. 2022 Jun 21. pii: S0264-410X(22)00784.
PubMed Abstract available

HONDA-OKUBO Y, Cartee RT, Thanawastien A, Seung Yang J, et al
A typhoid fever protein capsular matrix vaccine candidate formulated with Advax-CpG adjuvant induces a robust and durable anti-typhoid Vi polysaccharide antibody response in mice, rabbits and nonhuman primates.
Vaccine. 2022 Jun 21. pii: S0264-410X(22)00809.
PubMed Abstract available

KORVES C, Izurieta HS, Smith J, Zwain GM, et al
Relative effectiveness of booster vs. 2-dose mRNA Covid-19 vaccination in the Veterans Health Administration: Self-controlled risk interval analysis.
Vaccine. 2022 Jun 21. pii: S0264-410X(22)00816.
PubMed Abstract available

ULANOVA M, Huska B, Dubois S, McCready W, et al
Opsonophagocytic activity against Streptococcus pneumoniae in Indigenous and non-Indigenous patients with severe chronic kidney disease immunized with 13-valent pneumococcal conjugate vaccine.
Vaccine. 2022 Jun 20. pii: S0264-410X(22)00810.
PubMed Abstract available

DIONATO FAV, Jalalizadeh M, Buosi K, Visacri MB, et al
BCG vaccine safety in COVID-19 convalescent adults: BATTLE a randomized controlled trial.
Vaccine. 2022 Jun 20. pii: S0264-410X(22)00803.
PubMed Abstract available

KASAIJA PD, Contreras M, Kabi F, Mugerwa S, et al
Oral vaccine formulation combining tick Subolesin with heat inactivated mycobacteria provides control of cross-species cattle tick infestations.
Vaccine. 2022 Jun 18. pii: S0264-410X(22)00804.
PubMed Abstract available

CASAGRANDE TZ, Costa-Rocha IAD, Gavi MBRO, Miyamoto ST, et al
Previous biological therapy and impairment of the IFN-gamma/IL-10 axis are associated with low immune response to 17DD-YF vaccination in patients with spondyloarthritis.
Vaccine. 2022 Jun 18. pii: S0264-410X(22)00703.
PubMed Abstract available

ATWELL JE, Lutz CS, Sparrow EG, Feikin DR, et al
Biological factors that may impair transplacental transfer of RSV antibodies: Implications for maternal immunization policy and research priorities for low- and middle-income countries.
Vaccine. 2022 Jun 17. pii: S0264-410X(22)00783.
PubMed Abstract available

UWAMINO Y, Kurafuji T, Takato K, Sakai A, et al
Dynamics of antibody titers and cellular immunity among Japanese healthcare workers during the 6 months after receiving two doses of BNT162b2 mRNA vaccine.
Vaccine. 2022 Jun 16. pii: S0264-410X(22)00763.
PubMed Abstract available

CANADAY LM, Resnick JD, Liu H, Powell H, et al
HA and M2 sequences alter the replication of 2013-16 H1 live attenuated influenza vaccine infection in human nasal epithelial cell cultures.
Vaccine. 2022 Jun 16. pii: S0264-410X(22)00733.
PubMed Abstract available

TAY S, Bowen AC, Blyth CC, Clifford P, et al
A quality improvement study: Optimizing pneumococcal vaccination rates in children with cochlear implants.
Vaccine. 2022 Jun 16. pii: S0264-410X(22)00769.
PubMed Abstract available

MOUTA NUNES DE OLIVEIRA P, Mendes-de-Almeida DP, Bertollo Gomes Porto V, Crespo Cordeiro C, et al
Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil.
Vaccine. 2022 Jun 16. pii: S0264-410X(22)00761.
PubMed Abstract available

GAMBRELL A, Sundaram M, Bednarczyk RA
Estimating the number of US children susceptible to measles resulting from COVID-19-related vaccination coverage declines.
Vaccine. 2022 Jun 15. pii: S0264-410X(22)00782.
PubMed Abstract available

TSENG HF, Sy LS, Ackerson BK, Lee GS, et al
Safety of tetanus, diphtheria, acellular pertussis (Tdap) vaccination during pregnancy.
Vaccine. 2022 Jun 15. pii: S0264-410X(22)00756.
PubMed Abstract available

BRAUNFELD JB, Carson HN, Williams SR, Schwartz LM, et al
Clinical endpoints to inform vaccine policy: A systematic review of outcome measures from pediatric influenza vaccine efficacy trials.
Vaccine. 2022 Jun 15. pii: S0264-410X(22)00778.
PubMed Abstract available

ARAUJO BC, Simakawa R, Munhoz LG, Carmo FB, et al
Rubella antibodies in vertically and horizontally HIV-infected young adults vaccinated early in life and response to a booster dose in those with seronegative results.
Vaccine. 2022 Jun 15. pii: S0264-410X(22)00774.
PubMed Abstract available

FOLEGATTI PM, Jenkin D, Morris S, Gilbert S, et al
Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment.
Vaccine. 2022 Jun 14. pii: S0264-410X(22)00755.
PubMed Abstract available

HERNANDEZ LM, Sumathy K, Sahastrabuddhe S, Excler JL, et al
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for an inactivated viral vaccine against Chikungunya virus.
Vaccine. 2022 Jun 14. pii: S0264-410X(22)00753.
PubMed Abstract available

CHUNG JR, Kim SS, Flannery B, Smith ME, et al
Vaccine-associated attenuation of subjective severity among outpatients with influenza.
Vaccine. 2022 Jun 14. pii: S0264-410X(22)00767.
PubMed Abstract available

RAZZAGHI H, Yankey D, Vashist K, Lu PJ, et al
COVID-19 vaccination coverage and intent among women aged 18-49 years by pregnancy status, United States, April-November 2021.
Vaccine. 2022 Jun 13. pii: S0264-410X(22)00779.
PubMed Abstract available

PHATARPHEKAR A, Vidyadhar Reddy GEC, Gokhale A, Karanam G, et al
RelCoVax(R), a two antigen subunit protein vaccine candidate against SARS-CoV-2 induces strong immune responses in mice.
Vaccine. 2022 Jun 13. pii: S0264-410X(22)00775.
PubMed Abstract available

SHOOTS-REINHARD B, Lawrence ER, Schulkin J, Peters E, et al
Excluding numeric side-effect information produces lower vaccine intentions.
Vaccine. 2022 Jun 10. pii: S0264-410X(22)00747.
PubMed Abstract available

ROLLIER CS, Dold C, Blackwell L, Linder A, et al
Immunogenicity of a single 4CMenB vaccine booster in adolescents 11 years after childhood immunisation.
Vaccine. 2022 Jun 10. pii: S0264-410X(22)00539.
PubMed Abstract available

HEININGER U
Referring to: Wilkinson K, Righolt CH, Elliott LJ, Fanella S, Mahmud SM. Pertussis vaccine effectiveness and duration of protection - a systematic review and meta-analysis. Vaccine. 2021 May 27;39(23):3120-3130.
Vaccine. 2022;40:3530.
PubMed

WIEMKEN TL, Salas J, Hoft DF, Jacobs C, et al
In response to: JVAC-D-21-02863, detection of a potential error in the results of the manuscript, dementia risk following influenza vaccination in a large veteran cohort, that could call into question the main conclusion.
Vaccine. 2022;40:3529.
PubMed

VUICHARD-GYSIN D, Schoenenberger A
Detection of a potential error in the results of the manuscript "Dementia risk following influenza vaccination in a large veteran cohort" that could eventually call into question the main conclusion.
Vaccine. 2022;40:3528.
PubMed

SCHENK J, Abrams S, Litzroth A, Cornelissen L, et al
Identifying immunity gaps for measles using Belgian serial serology data.
Vaccine. 2022;40:3676-3683.
PubMed Abstract available

POLLET J, Strych U, Chen WH, Versteeg L, et al
Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern.
Vaccine. 2022;40:3655-3663.
PubMed Abstract available

SPARROW E, Adetifa I, Chaiyakunapruk N, Cherian T, et al
WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants - Key considerations for global use.
Vaccine. 2022;40:3506-3510.
PubMed Abstract available

EVANS B, Jombart T
Worldwide routine immunisation coverage regressed during the first year of the COVID-19 pandemic.
Vaccine. 2022;40:3531-3535.
PubMed Abstract available

ZHAO FJ, Liu LT, Wang Z, Wang NX, et al
Development and immunogenicity evaluation of porcine deltacoronavirus inactivated vaccine with different adjuvants in mice.
Vaccine. 2022 Jun 9. pii: S0264-410X(22)00721.
PubMed Abstract available

HALME J, Syrjanen RK, Baum U, Palmu AA, et al
Effectiveness of trivalent influenza vaccines against hospitalizations due to laboratory-confirmed influenza a in the elderly: Comparison of test-negative design with register-based designs.
Vaccine. 2022 Jun 9. pii: S0264-410X(22)00716.
PubMed Abstract available

KUNASEKARAN MP, Chughtai AA, Heslop DJ, Poulos CJ, et al
Influenza cases in nine aged care facilities in Sydney, Australia over a three-year surveillance period, 2018-2020.
Vaccine. 2022 Jun 9. pii: S0264-410X(22)00476.
PubMed Abstract available

LEAV B, Straus W, White P, Leav A, et al
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273).
Vaccine. 2022 Jun 9. pii: S0264-410X(22)00752.
PubMed Abstract available

DIAZ-MENENDEZ M, de la Calle-Prieto F, Montejano R, Arsuaga M, et al
Clinical characteristics and outcome of hospitalized elderly patients with COVID- 19 after vaccine failure.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00751.
PubMed Abstract available

LIGHTOWLER MS, Manangazira P, Nackers F, Van Herp M, et al
Effectiveness of typhoid conjugate vaccine in Zimbabwe used in response to an outbreak among children and young adults: A matched case control study.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00552.
PubMed Abstract available

CHICHILI GR, Smulders R, Santos V, Cywin B, et al
Phase 1/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00715.
PubMed Abstract available

OKUNO H, Satoh H, Morino S, Arai S, et al
Characteristics and incidence of vaccine adverse events after Bacille Calmette-Guerin vaccination: A national surveillance study in Japan from 2013 to 2017.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00672.
PubMed Abstract available

LIN K, Liu M, Bao L, Lv Q, et al
Safety and protective capability of an inactivated SARS-CoV-2 vaccine on pregnancy, lactation and the growth of offspring in hACE2 mice.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00765.
PubMed Abstract available

ZHANG H, Li Y, Peng S, Jiang Y, et al
The effect of health literacy on COVID-19 vaccine hesitancy among community population in China: The moderating role of stress.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00762.
PubMed Abstract available

KOBAYASHI T, Nishina Y, Tomoi H, Harada K, et al
Corowa-kun: A messenger app chatbot delivers COVID-19 vaccine information, Japan 2021.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00754.
PubMed Abstract available

BASS JR, Poland GA
Shoulder injury related to vaccine administration (SIRVA) after COVID-19 vaccination.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00750.
PubMed Abstract available

NIESSEN FA, Knol MJ, Hahne SJM, Bonten MJM, et al
Vaccine effectiveness against COVID-19 related hospital admission in the Netherlands: A test-negative case-control study.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00758.
PubMed Abstract available

SMITH WJ, Ahl PL, Wang B, Hamm M, et al
Analytical technology development to monitor the stability of Polysaccharide-Protein conjugate vaccines.
Vaccine. 2022 Jun 7. pii: S0264-410X(22)00673.
PubMed Abstract available

SLOTTE P, Karlsson LC, Soveri A
Attitudes towards mandatory vaccination and sanctions for vaccination refusal.
Vaccine. 2022 Jun 7. pii: S0264-410X(22)00697.
PubMed Abstract available

WALKER JL, Schultze A, Tazare J, Tamborska A, et al
Safety of COVID-19 vaccination and acute neurological events: A self-controlled case series in England using the OpenSAFELY platform.
Vaccine. 2022 Jun 7. pii: S0264-410X(22)00757.
PubMed Abstract available

WYNBERG E, Han AX, Boyd A, van Willigen HDG, et al
The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study.
Vaccine. 2022 Jun 7. pii: S0264-410X(22)00748.
PubMed Abstract available

DAYTON L, Miller J, Strickland J, Davey-Rothwell M, et al
A socio-ecological perspective on parents' intentions to vaccinate their children against COVID-19.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00736.
PubMed Abstract available

EL-SHESHENY R, El Taweel A, Gomaa MR, Roshdy WH, et al
Induced humoral immunity of different types of vaccines against most common variants of SARS-CoV-2 in Egypt prior to Omicron outbreak.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00734.
PubMed Abstract available

SHANMUGARAJ B, Khorattanakulchai N, Panapitakkul C, Malla A, et al
Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: Protective efficacy, immunogenicity, safety, and toxicity.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00735.
PubMed Abstract available

HASHIMOTO M, Nagata N, Homma T, Maeda H, et al
Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00718.
PubMed Abstract available

EUGENIA-TOLEDO-ROMANI M, Verdecia-Sanchez L, Rodriguez-Gonzalez M, Rodriguez-Noda L, et al
Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00717.
PubMed Abstract available

FLYNN JA, Weber T, Cejas PJ, Cox KS, et al
Characterization of humoral and cell-mediated immunity induced by mRNA vaccines expressing influenza hemagglutinin stem and nucleoprotein in mice and nonhuman primates.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00382.
PubMed Abstract available

SLARVE M, Holznecht N, Reza H, Gilkes A, et al
Recombinant Aspergillus fumigatus antigens Asp f 3 and Asp f 9 in liposomal vaccine protect mice against invasive pulmonary aspergillosis.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00674.
PubMed Abstract available

WATANABE A, Nishida S, Burcu T, Shibahara T, et al
Safety and immunogenicity of a quadrivalent seasonal influenza vaccine adjuvanted with hydroxypropyl-beta-cyclodextrin: A phase 1 clinical trial.
Vaccine. 2022 Jun 4. pii: S0264-410X(22)00677.
PubMed Abstract available

AB RAHMAN N, Lim MT, Lee FY, Lee SC, et al
Risk of serious adverse events after the BNT162b2, CoronaVac, and ChAdOx1 vaccines in Malaysia: A self-controlled case series study.
Vaccine. 2022 Jun 3. pii: S0264-410X(22)00700.
PubMed Abstract available

JANSSEN DF
A familiar species of Crank: Anti-Vaccinationists in medical history.
Vaccine. 2022 Jun 3. pii: S0264-410X(22)00665.
PubMed Abstract available

BILGIN GM, Lokuge K, Glass K
Modelling the impact of maternal pneumococcal vaccination on infant pneumococcal disease in low-income settings.
Vaccine. 2022 Jun 3. pii: S0264-410X(22)00684.
PubMed Abstract available

STEAD M, Ford A, Eadie D, Biggs H, et al
A "step too far" or "perfect sense"? A qualitative study of British adults' views on mandating COVID-19 vaccination and vaccine passports.
Vaccine. 2022 Jun 3. pii: S0264-410X(22)00696.
PubMed Abstract available

May 2022

AHMED S, Iqbal J, Sadiq K, Umrani F, et al
Association of Anti-Rotavirus IgA Seroconversion with Growth, Environmental Enteric Dysfunction and Enteropathogens in Rural Pakistani Infants.
Vaccine. 2022;40:3444-3451.
PubMed Abstract available

PILLSBURY M, Carias C, Samant S, Greenberg D, et al
Comparison of performance of varicella vaccines via infectious disease modeling.
Vaccine. 2022 May 31. pii: S0264-410X(22)00574.
PubMed Abstract available

HISYAM BIN ISMAIL CMK, Raihan Mohammad Shabani N, Chuah C, Hassan Z, et al
Shigella iron-binding proteins: An insight into molecular physiology, pathogenesis, and potential target vaccine development.
Vaccine. 2022 May 31. pii: S0264-410X(22)00679.
PubMed Abstract available

TOOR J, Li X, Jit M, Trotter CL, et al
COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recovery.
Vaccine. 2022 May 30. pii: S0264-410X(22)00698.
PubMed Abstract available

WOO EJ, Dimova RB
Thrombocytopenia after Ad.26.COV2.S COVID-19 vaccine: Reports to the vaccine adverse event reporting system.
Vaccine. 2022 May 30. pii: S0264-410X(22)00704.
PubMed Abstract available

MERRICK E, Weissman JP, Patel SJ
Utilizing Google trends to monitor coronavirus vaccine interest and hesitancies.
Vaccine. 2022 May 30. pii: S0264-410X(22)00699.
PubMed Abstract available

FISHMAN J, Salmon MK, Scheitrum D, Aleks Schaefer K, et al
Comparative effectiveness of mandates and financial policies targeting COVID-19 vaccine hesitancy: A randomized, controlled survey experiment.
Vaccine. 2022 May 30. pii: S0264-410X(22)00702.
PubMed Abstract available

HEMMING-HARLO M, Gylling A, Herse F, Haavisto I, et al
Long-term surveillance of rotavirus vaccination after implementation of a national immunization program in Finland (2008-2018).
Vaccine. 2022 May 28. pii: S0264-410X(22)00584.
PubMed Abstract available

KLEINWAKS G, Schmit V, Morrison J
Corrigendum to "Considering human challenge trials for tuberculosis vaccine development" [Vaccine 40(2) (2022) 173-174].
Vaccine. 2022 May 28. pii: S0264-410X(22)00675.
PubMed

SHAPIRO BEN DAVID S, Mizrahi B, Rahamim-Cohen D, Supino-Rosin L, et al
Robust antibody response after a third BNT162b2 vaccine compared to the second among immunocompromised and healthy individuals, a prospective longitudinal cohort study.
Vaccine. 2022 May 28. pii: S0264-410X(22)00668.
PubMed Abstract available

SHIOHARA M, Suzuki S, Shichinohe S, Ishigaki H, et al
Inactivated whole influenza virus particle vaccines induce neutralizing antibodies with an increase in immunoglobulin gene subclones of B-lymphocytes in cynomolgus macaques.
Vaccine. 2022 May 28. pii: S0264-410X(22)00640.
PubMed Abstract available

RODES-SANCHEZ M, Spencer J, Tantri A, Mitrovich R, et al
Working towards a sustainable, healthy market for vaccines: A framework to support evidence-based policymaking.
Vaccine. 2022 May 27. pii: S0264-410X(22)00671.
PubMed

MACDONALD NE, Dube E, Comeau JL
Have vaccine hesitancy models oversimplified a complex problem to our detriment? The Adapted Royal Society of Canada vaccine uptake framework.
Vaccine. 2022 May 27. pii: S0264-410X(22)00669.
PubMed

SAVULESCU C, Krizova P, Valentiner-Branth P, Ladhani S, et al
Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SpIDnet observational multicentre study.
Vaccine. 2022 May 27. pii: S0264-410X(22)00581.
PubMed Abstract available

LAI X, Li M, Hou Z, Guo J, et al
Factors associated with caregivers' hesitancy to vaccinate children against influenza: A cross-sectional survey in China.
Vaccine. 2022 May 27. pii: S0264-410X(22)00606.
PubMed Abstract available

PATEL KM, Shafiq M, Malik AA, Cobanoglu A, et al
Relationship between the use of nonpharmaceutical interventions and COVID-19 vaccination among U.S. child care providers: A prospective cohort study.
Vaccine. 2022 May 27. pii: S0264-410X(22)00680.
PubMed Abstract available

SOEGIARTO G, Wulandari L, Purnomosari D, Dhia Fahmita K, et al
Hypertension is associated with antibody response and breakthrough infection in health care workers following vaccination with inactivated SARS-CoV-2.
Vaccine. 2022 May 27. pii: S0264-410X(22)00676.
PubMed Abstract available

DUBE C, Paris-Robidas S, Andreani G, Gutzeit C, et al
Broad neutralization against SARS-CoV-2 variants induced by ancestral and B.1.351 AS03-Adjuvanted recombinant Plant-Derived Virus-Like particle vaccines.
Vaccine. 2022 May 27. pii: S0264-410X(22)00641.
PubMed Abstract available

MOSS P, Berenbaum F, Curigliano G, Grupper A, et al
Benefit-risk evaluation of COVID-19 vaccination in special population groups of interest.
Vaccine. 2022 May 27. pii: S0264-410X(22)00682.
PubMed Abstract available

HALSTEAD IN, McKay RT, Lewis GJ
COVID-19 and seasonal flu vaccination hesitancy: Links to personality and general intelligence in a large, UK cohort.
Vaccine. 2022 May 27. pii: S0264-410X(22)00678.
PubMed Abstract available

MOUSSAOUI S, Combes S, Ibanez G, Gautier A, et al
Are immigrants living in France more reluctant to receive vaccines than native-born French citizens? findings from the national health Barometer study.
Vaccine. 2022 May 26. pii: S0264-410X(22)00636.
PubMed Abstract available

ILESANMI MM, Adeyinka DA, Olakunde BO
Sustainable Development Goals and childhood measles vaccination in Ekiti State, Nigeria: Results from spatial and interrupted time series analyses.
Vaccine. 2022 May 26. pii: S0264-410X(22)00632.
PubMed Abstract available

LARSEN L, Bistrup C, Sorensen SS, Boesby L, et al
Immunogenicity and safety of double dosage of pneumococcal vaccines in adult kidney transplant recipients and waiting list patients: A non-blinded, randomized clinical trial.
Vaccine. 2022 May 26. pii: S0264-410X(22)00635.
PubMed Abstract available

TAFURI S, Bianchi FP, Stefanizzi P
The public health and the question of the "best vaccine".
Vaccine. 2022 May 26. pii: S0264-410X(22)00639.
PubMed

HOFFMAN BL, Batra Hershey T, Chu KH, Sidani JE, et al
Moving vaccination beyond partisan politics.
Vaccine. 2022 May 26. pii: S0264-410X(22)00664.
PubMed

ZHOU Y, Hu X, Chen R, Wu J, et al
Impact of maternal and pre-existing antibodies on immunogenicity of inactivated rotavirus vaccines.
Vaccine. 2022 May 26. pii: S0264-410X(22)00620.
PubMed Abstract available

JANKO MM, Joffe J, Michael D, Earl L, et al
Cost-effectiveness of rotavirus vaccination in children under five years of age in 195 countries: A meta-regression analysis.
Vaccine. 2022 May 25. pii: S0264-410X(22)00637.
PubMed Abstract available

DUBE E, Gagnon D, MacDonald N
Between persuasion and compulsion: The case of COVID-19 vaccination in Canada.
Vaccine. 2022 May 25. pii: S0264-410X(22)00670.
PubMed

GAGHAN C, Adams D, Mohammed J, Crespo R, et al
Characterization of vaccine-induced immune responses against coccidiosis in broiler chickens.
Vaccine. 2022 May 25. pii: S0264-410X(22)00638.
PubMed Abstract available

ABRAHAM N, Spruin S, Rossi T, Fireman B, et al
Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines.
Vaccine. 2022 May 25. pii: S0264-410X(22)00667.
PubMed Abstract available

BECK E, Biundo E, Devlin N, Doherty TM, et al
Capturing the value of vaccination within health technology assessment and health economics: Literature review and novel conceptual framework.
Vaccine. 2022 May 23. pii: S0264-410X(22)00490.
PubMed Abstract available

MALTER KB, Tugel ME, Gil-Rodriguez M, de la Guardia G, et al
Corrigendum to "Variability in non-core vaccination rates of dogs and cats in veterinary clinics across the United States" [Vaccine 40(7) (2022) 1001-1009].
Vaccine. 2022 May 23. pii: S0264-410X(22)00619.
PubMed

QUINN MK, Edmond KM, Fawzi WW, Hurt L, et al
Non-specific effects of BCG and DTP vaccination on infant mortality: An analysis of birth cohorts in Ghana and Tanzania.
Vaccine. 2022 May 23. pii: S0264-410X(22)00536.
PubMed Abstract available

CHANG CM, Awanye AM, Marsay L, Dold C, et al
Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trial.
Vaccine. 2022 May 21. pii: S0264-410X(22)00616.
PubMed Abstract available

MOLLER A, Schwamborn K, Spillmann A, Hoogstraate J, et al
Travel vaccines are strongly associated to reduced mortality in prostate cancer patients - a real effect or residual confounding?
Vaccine. 2022 May 21. pii: S0264-410X(22)00611.
PubMed Abstract available

OSMAN S, Crowcroft N, McLachlan E, Hatchette T, et al
Population immunity to measles in Canada using Canadian Health Measures survey data - A Canadian Immunization Research Network (CIRN) study.
Vaccine. 2022;40:3228-3235.
PubMed Abstract available

LLAVE CL, Uy MEV, Lam HY, Aldaba JG, et al
The cost-effectiveness of human papillomavirus vaccination in the Philippines.
Vaccine. 2022 May 20. pii: S0264-410X(22)00609.
PubMed Abstract available

FOO D, Sarna M, Pereira G, Moore HC, et al
Maternal influenza vaccination and child mortality: Longitudinal, population-based linked cohort study.
Vaccine. 2022 May 20. pii: S0264-410X(22)00614.
PubMed Abstract available

KITCHEN M, Leierer G, Kistner O, Wodal W, et al
High seroprotection rates and geometric mean titre increases after repeated annual influenza vaccinations in a cohort of HIV-infected adults in Austria.
Vaccine. 2022 May 20. pii: S0264-410X(22)00575.
PubMed Abstract available

MCELFISH PA, Selig JP, Scott AJ, Rowland B, et al
Associations between 5-year influenza vaccination and sociodemographic factors and healthcare access among Arkansans.
Vaccine. 2022 May 20. pii: S0264-410X(22)00615.
PubMed Abstract available

SZANYI J, Wilson T, Scott N, Blakely T, et al
A log-odds system for waning and boosting of COVID-19 vaccine effectiveness.
Vaccine. 2022 May 20. pii: S0264-410X(22)00634.
PubMed Abstract available

SIQUEIRA PG, Duarte HO, Moura MDC
Risk-based cost-benefit analysis of alternative vaccines against COVID-19 in Brazil: Coronavac vs. Astrazeneca vs. Pfizer.
Vaccine. 2022 May 19. pii: S0264-410X(22)00633.
PubMed Abstract available

CARSON B, Isaacs J, Carilli T
Jabbing together? The complementarity between social capital, formal public health rules, and COVID-19 vaccine rates in the United States.
Vaccine. 2022 May 19. pii: S0264-410X(22)00612.
PubMed Abstract available

STEELFISHER GK, Caporello H, McIntosh R, Muhammad Safdar R, et al
Preventing erosion of oral polio vaccine acceptance: A role for vaccinator visits and social norms.
Vaccine. 2022 May 19. pii: S0264-410X(22)00567.
PubMed Abstract available

ZHANG Y, Lin L, Yang J, Lv Q, et al
Two Bordetella bronchiseptica attenuated vaccine candidates confer protection against lethal challenge with B. Bronchiseptica and Pasteurella multocida toxin in mouse models.
Vaccine. 2022 May 19. pii: S0264-410X(22)00604.
PubMed Abstract available

POSTMA M, Biundo E, Chicoye A, Devlin N, et al
Capturing the value of vaccination within health technology assessment and health economics: Country analysis and priority value concepts.
Vaccine. 2022 May 18. pii: S0264-410X(22)00442.
PubMed Abstract available

VESIKARI T, Saez-Llorens X, Blazevic V, Lopez P, et al
Immunogenicity of a bivalent virus-like particle norovirus vaccine in children from 1 to 8 years of age: A phase 2 randomized, double-blind study.
Vaccine. 2022 May 17. pii: S0264-410X(22)00550.
PubMed Abstract available

SALO-TUOMINEN K, Teros-Jaakkola T, Toivonen L, Ollila H, et al
Parental socioeconomic and psychological determinants of the 2009 pandemic influenza A(H1N1) vaccine uptake in children.
Vaccine. 2022 May 17. pii: S0264-410X(22)00582.
PubMed Abstract available

ROBERTSON DA, Mohr KS, Barjakova M, Lunn PD, et al
Experimental pre-tests of public health communications on the COVID-19 vaccine: A null finding for medical endorsement, risk and altruism.
Vaccine. 2022 May 16. pii: S0264-410X(22)00613.
PubMed Abstract available

NAZURDINOV A, Azizov Z, Mullojonova M, Sadykova U, et al
Impact and effectiveness of monovalent rotavirus vaccine in Tajik children.
Vaccine. 2022 May 14. pii: S0264-410X(22)00589.
PubMed Abstract available

SULIS G, Horn M, Borrow R, Basta NE, et al
A comparison of national vaccination policies to prevent serogroup B meningococcal disease.
Vaccine. 2022 May 14. pii: S0264-410X(22)00568.
PubMed Abstract available

POLAND GA, van Dijk N
John D. Bailey retiring after more than 20years of service to Vaccine.
Vaccine. 2022 May 13. pii: S0264-410X(22)00618.
PubMed

CHAMBERS C, Deeks SL, Sutradhar R, Cox J, et al
Increases in human papillomavirus vaccine coverage over 12 months among a community-recruited cohort of gay, bisexual, and other men who have sex with men in Canada.
Vaccine. 2022 May 13. pii: S0264-410X(22)00590.
PubMed Abstract available

KUMAR SURI R, Hayman B, Prasad SD, Makhoana M, et al
Vaccines: New challenges, new paradigms, new opportunities: Report of the 22nd DCVMN Annual General Meeting.
Vaccine. 2022 May 13. pii: S0264-410X(22)00576.
PubMed Abstract available

DUC DANG A, Dinh Vu T, Hai Vu H, Thanh Ta V, et al
Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam.
Vaccine. 2022 May 13. pii: S0264-410X(22)00526.
PubMed Abstract available

TSAI SY, Yeh TY, Chiu NC, Huang CT, et al
National safety surveillance of quadrivalent recombinant influenza vaccine in Taiwan during NH 20/21.
Vaccine. 2022 May 13. pii: S0264-410X(22)00588.
PubMed Abstract available

RUSKIN AC, Rice S, O'Connor M, Ruskin KJ, et al
Effects of vaccination status in the United States on willingness to undergo surgery during a pandemic: A prospective survey study.
Vaccine. 2022 May 13. pii: S0264-410X(22)00583.
PubMed Abstract available

LI F, Freed D, Heidecker G, Galli J, et al
A novel high throughput assay to quantify Epstein-Barr virus neutralizing antibody activity against B-cell and epithelial cell infections for vaccine and therapeutic developments.
Vaccine. 2022 May 13. pii: S0264-410X(22)00569.
PubMed Abstract available

IWATA S, Sonoyama T, Kamitani A, Shibata R, et al
Phase 1/2 clinical trial of COVID-19 vaccine in Japanese participants: A report of interim findings.
Vaccine. 2022 May 13. pii: S0264-410X(22)00494.
PubMed Abstract available

ALYA WA, Maraqa B, Nazzal Z, Odeh M, et al
COVID-19 vaccine uptake and its associated factors among Palestinian healthcare workers: Expectations beaten by reality.
Vaccine. 2022 May 13. pii: S0264-410X(22)00610.
PubMed Abstract available

MANCARELLA M, Natarelli F, Bertolini C, Zagari A, et al
Catch-up vaccination campaign in children between 6 and 8 years old during COVID-19 pandemic: The experience in a COVID hub in Milan, Italy.
Vaccine. 2022 May 12. pii: S0264-410X(22)00573.
PubMed Abstract available

CUMMINS NW, Badley AD
Could proteasome inhibition improve therapeutic vaccine response in HIV?
Vaccine. 2022 May 12. pii: S0264-410X(22)00578.
PubMed

CHONG-VALBUENA A, De-Jesus-Maria I, Agurto-Ramirez A, Puchades-Gimeno F, et al
Safety of Pfizer-BioNTech vaccine in a cohort of healthcare providers: Differences between naive and previously infected by SARS-CoV-2.
Vaccine. 2022 May 12. pii: S0264-410X(22)00586.
PubMed Abstract available

OSTER G, Bornheimer R, Ottino K, Stevenson C, et al
Adult immunization against hepatitis B: Does the number of jabs matter?
Vaccine. 2022 May 12. pii: S0264-410X(22)00534.
PubMed Abstract available

TEASDALE CA, Ratzan S, Stuart Lathan H, Rauh L, et al
Acceptability of COVID-19 vaccine mandates among New York City parents, November 2021.
Vaccine. 2022 May 11. pii: S0264-410X(22)00580.
PubMed Abstract available

SHAUM A, Mujuru HA, Takamiya M, Ticklay I, et al
Enhanced surveillance for adverse events following immunization during the 2019 typhoid conjugate vaccine campaign in Harare, Zimbabwe.
Vaccine. 2022 May 11. pii: S0264-410X(22)00551.
PubMed Abstract available

FERNANDES C, Alves J, Rodrigues A, Azevedo J, et al
Corrigendum to "Epidemiological impact of the human papillomavirus vaccination program on genital warts in Portugal: A retrospective, chart review study" [Vaccine 40(2) (2022) 275-281].
Vaccine. 2022 May 11. pii: S0264-410X(22)00537.
PubMed

ISLAM N, Xu C, Lau CL, Mills DJ, et al
Persistence of antibodies, boostability, and interchangeability of Japanese encephalitis vaccines: A systematic review and dose-response meta-analysis.
Vaccine. 2022 May 11. pii: S0264-410X(22)00535.
PubMed Abstract available

GUPTA C, Sachdeva A, Khamar J, Bu C, et al
Effectiveness of the influenza vaccine at reducing adverse events in patients with heart failure: A systematic review and meta-analysis.
Vaccine. 2022 May 10. pii: S0264-410X(22)00468.
PubMed Abstract available

KITRO A, Sirikul W, Thongkum W, Soponpong S, et al
Dynamic of anti-spike receptor binding domain (RBD) levels and short-term adverse events following a heterologous booster dose of BNT162b2 after two doses of CoronaVac in Thai health care workers.
Vaccine. 2022;40:2915-2924.
PubMed Abstract available

MARTIN J, Barrett ADT, Lei D, Minor P, et al
WHO working group meeting to amend WHO Recommendations to assure the quality, safety and efficacy of live attenuated yellow fever vaccines.
Vaccine. 2022 May 9. pii: S0264-410X(22)00548.
PubMed Abstract available

ZOLA MATUVANGA T, Lariviere Y, Lemey G, De Bie J, et al
Setting-up an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo: Challenges, mitigations, and lessons learned.
Vaccine. 2022 May 9. pii: S0264-410X(22)00544.
PubMed Abstract available

YI S, Choe YJ, Lim DS, Lee HR, et al
Impact of national Covid-19 vaccination Campaign, South Korea.
Vaccine. 2022 May 8. pii: S0264-410X(22)00572.
PubMed Abstract available

BIFULCO M, Di Zazzo E, Pisanti S, Martini M, et al
The nineteenth-century experience of the kingdom of the two Sicilies on mandatory vaccination: An Italian phenomenon?
Vaccine. 2022 May 6. pii: S0264-410X(22)00492.
PubMed Abstract available

CROTHERS JW, Ross Colgate E, Cowan KJ, Dickson DM, et al
Corrigendum to "Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus sero
Vaccine. 2022 May 6. pii: S0264-410X(22)00571.
PubMed

LUMBRERAS ARETA M, Valiton A, Diana A, Morales M, et al
Flu and pertussis vaccination during pregnancy in Geneva during the COVID-19 pandemic: A multicentric, prospective, survey-based study.
Vaccine. 2022 May 6. pii: S0264-410X(22)00533.
PubMed Abstract available

YU Y, Ma YL, Luo S, Wang S, et al
Prevalence and factors of influenza vaccination during the COVID-19 pandemic among university students in China.
Vaccine. 2022 May 5. pii: S0264-410X(22)00532.
PubMed Abstract available

COLE JW, Chen AMH, McGuire K, Berman S, et al
Erratum to "Motivational interviewing and vaccine acceptance in children: The MOTIVE study" [Vaccine 40(12) (2022) 1846-1854].
Vaccine. 2022 May 5. pii: S0264-410X(22)00538.
PubMed

VELICER C, Luxembourg A, Chen YT, Kohn M, et al
Using observational data to explore the hypothesis that a single dose of current HPV vaccines can provide durable protection.
Vaccine. 2022 May 5. pii: S0264-410X(22)00542.
PubMed

NAULT L, Marchitto L, Goyette G, Tremblay-Sher D, et al
Covid-19 vaccine immunogenicity in people living with HIV-1.
Vaccine. 2022 May 5. pii: S0264-410X(22)00543.
PubMed Abstract available

GASTEIGER N, Gasteiger C, Vedhara K, Broadbent E, et al
Characteristics associated with the willingness to receive a COVID-19 vaccine and an exploration of the general public's perceptions: A mixed-methods approach.
Vaccine. 2022 May 5. pii: S0264-410X(22)00547.
PubMed Abstract available

REES F, Geiger M, Lilleholt L, Zettler I, et al
Measuring parents' readiness to vaccinate themselves and their children against COVID-19.
Vaccine. 2022 May 5. pii: S0264-410X(22)00549.
PubMed Abstract available

LEIGH JP, Moss SJ, White TM, Picchio CA, et al
Factors affecting COVID-19 vaccine hesitancy among healthcare providers in 23 countries.
Vaccine. 2022 May 5. pii: S0264-410X(22)00545.
PubMed Abstract available

PERSSON U, Olofsson S, Althin R, Palmborg A, et al
Acceptance and application of a broad population health perspective when evaluating vaccine.
Vaccine. 2022 May 4. pii: S0264-410X(22)00425.
PubMed Abstract available

LIU W, Lien YH, Lee PI, Chan TC, et al
Impact of prior infection and repeated vaccination on post-vaccination antibody titers of the influenza A(H1N1)pdm09 strain in Taiwan schoolchildren: Implications for public health.
Vaccine. 2022 May 4. pii: S0264-410X(22)00358.
PubMed Abstract available

GUTIERREZ-TOBAR IF, Londono-Ruiz JP, Marino-Drews C, Beltran-Higuera S, et al
Epidemiological characteristics and serotype distribution of culture-confirmed pediatric pneumococcal pneumonia before and after PCV 10 introduction, a multicenter study in Bogota, Colombia, 2008-2019.
Vaccine. 2022;40:2875-2883.
PubMed Abstract available

BOTHUN LS, Feeder SE, Poland GA
Readability of COVID-19 vaccine information for the general public.
Vaccine. 2022 May 3. pii: S0264-410X(22)00546.
PubMed Abstract available

NANTANEE R, Aikphaibul P, Jaru-Ampornpan P, Sodsai P, et al
Immunogenicity and reactogenicity after booster dose with AZD1222 via intradermal route among adult who had received CoronaVac.
Vaccine. 2022 May 2. pii: S0264-410X(22)00521.
PubMed Abstract available

FEIKIN DR, Abu-Raddad LJ, Andrews N, Davies MA, et al
Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization.
Vaccine. 2022 May 2. pii: S0264-410X(22)00523.
PubMed Abstract available

April 2022

TOLL M, Li A
Vaccine mandates on childcare entry without conscientious objection exemptions: A quasi-experimental panel study.
Vaccine. 2022 Apr 29. pii: S0264-410X(22)00461.
PubMed Abstract available

GREYSON D, Carpiano RM, Bettinger JA
Support for a vaccination documentation mandate in British Columbia, Canada.
Vaccine. 2022 Apr 29. pii: S0264-410X(22)00247.
PubMed Abstract available

TAMURA K, Kohnoe M, Takashino A, Kobayashi K, et al
TAK - 021, an inactivated Enterovirus 71 vaccine candidate, provides cross-protection against heterologous sub-genogroups in human scavenger receptor B2 transgenic mice.
Vaccine. 2022 Apr 29. pii: S0264-410X(22)00518.
PubMed Abstract available

MASUDA T, Murakami K, Sugiura K, Sakui S, et al
Safety and immunogenicity of NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults: Interim report of a phase I/II randomized controlled trial.
Vaccine. 2022 Apr 29. pii: S0264-410X(22)00463.
PubMed Abstract available

HUSSAIN B, Latif A, Timmons S, Nkhoma K, et al
Overcoming COVID-19 vaccine hesitancy among ethnic minorities: A systematic review of UK studies.
Vaccine. 2022 Apr 28. pii: S0264-410X(22)00446.
PubMed Abstract available

DEMIR E, Dheir H, Safak S, Serra Artan A, et al
Differences in clinical outcomes of COVID-19 among vaccinated and unvaccinated kidney transplant recipients.
Vaccine. 2022 Apr 27. pii: S0264-410X(22)00519.
PubMed Abstract available

TAMURA K, Chang B, Shimbashi R, Watanabe H, et al
Dynamic changes in clinical characteristics and serotype distribution of invasive pneumococcal disease among adults in Japan after introduction of the pediatric 13-valent pneumococcal conjugate vaccine in 2013-2019.
Vaccine. 2022 Apr 27. pii: S0264-410X(22)00502.
PubMed Abstract available

NASREEN S, Calzavara A, Buchan SA, Thampi N, et al
Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance.
Vaccine. 2022 Apr 27. pii: S0264-410X(22)00520.
PubMed Abstract available

LV H, Wang S, Liang Z, Yu W, et al
Immunogenicity and safety of the 9-valent human papillomavirus vaccine in Chinese females 9-45 years of age: A phase 3 open-label study.
Vaccine. 2022 Apr 26. pii: S0264-410X(22)00205.
PubMed Abstract available

MARKOVITZ NH, Strome AL, Patel PK
Commentary: "The vaccine Selfie" and its influence on COVID-19 vaccine acceptance.
Vaccine. 2022 Apr 26. pii: S0264-410X(22)00503.
PubMed

JAFFLIN K, Deml MJ, Schwendener CL, Kiener L, et al
Parental and provider vaccine hesitancy and non-timely childhood vaccination in Switzerland.
Vaccine. 2022 Apr 26. pii: S0264-410X(22)00472.
PubMed Abstract available

KOULIDIATI JL, Kabore R, I Nebie E, Sidibe A, et al
Timely completion of childhood vaccination and its predictors in Burkina Faso.
Vaccine. 2022 Apr 26. pii: S0264-410X(22)00497.
PubMed Abstract available

MCCOSKER LK, El-Heneidy A, Seale H, Ware RS, et al
Strategies to improve vaccination rates in people who are homeless: A systematic review.
Vaccine. 2022 Apr 25. pii: S0264-410X(22)00436.
PubMed Abstract available

KRUPP K, Galea J, Madhivanan P, Gerald L, et al
Conversational artificial intelligence: A new approach for increasing influenza vaccination rates in children with asthma?
Vaccine. 2022 Apr 25. pii: S0264-410X(22)00496.
PubMed

YUKI Y, Nojima M, Kashima K, Sugiura K, et al
Oral MucoRice-CTB vaccine is safe and immunogenic in healthy US adults.
Vaccine. 2022 Apr 25. pii: S0264-410X(22)00491.
PubMed Abstract available

ZHU FC, Zeng H, Li JX, Wang B, et al
Evaluation of a recombinant five-antigen Staphylococcus aureus vaccine: The randomized, single-centre phase 1a/1b clinical trials.
Vaccine. 2022 Apr 23. pii: S0264-410X(22)00462.
PubMed Abstract available

PERCIACCANTE A, Asensi V, Cucu AI, Charlier P, et al
War, pandemic and vaccination - Upcoming health problems by the refugee wave in Europe?
Vaccine. 2022 Apr 23. pii: S0264-410X(22)00465.
PubMed

BEYER WEP, Palache AM, Boulfich M, Osterhaus ADME, et al
Clinical relevance of increased antibody titres in older adults upon vaccination with squalene-adjuvanted versus non-adjuvanted influenza vaccines.
Vaccine. 2022 Apr 23. pii: S0264-410X(22)00489.
PubMed Abstract available

STRECKENBACH B, Baldt J, Heidler F, Frahm N, et al
General vaccination willingness and current vaccination status in relation to clinical and psychological variables in patients with multiple sclerosis.
Vaccine. 2022 Apr 23. pii: S0264-410X(22)00428.
PubMed Abstract available

ONNIS V, Moriconi A, Paludi M, Giannini S, et al
Clinically proven specification setting for a meningococcal serogroup a conjugate vaccine.
Vaccine. 2022 Apr 23. pii: S0264-410X(22)00493.
PubMed Abstract available

ANTONOPOULOU T, Athanassakis I
SARS-CoV-2 immunogenicity: Is S protein the best target for vaccination?
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00501.
PubMed

SHEA LL, Becker A, Lee BK, Miller KK, et al
Self-reported COVID-19 vaccination acceptance and hesitancy among autistic adults.
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00500.
PubMed Abstract available

HAMID FA, Marker CL, Raleigh MD, Khaimraj A, et al
Pre-clinical safety and toxicology profile of a candidate vaccine to treat oxycodone use disorder.
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00364.
PubMed Abstract available

SEPPALA E, Brathen Kristoffersen A, Boas H, Frimann Vestrheim D, et al
Pertussis epidemiology including direct and indirect effects of the childhood pertussis booster vaccinations, Norway, 1998-2019.
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00466.
PubMed Abstract available

BEULENS C, Raven SFH, van Jaarsveld CHM, van Loo I, et al
Evaluation of a personalized, dose-sparing revaccination strategy in hepatitis B vaccine non-responders.
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00470.
PubMed Abstract available

STALPERS CAL, Retmana IA, Pennings JLA, Vandebriel RJ, et al
Corrigendum to "Variability of in vivo potency tests of Diphtheria, Tetanus and acellular Pertussis (DTaP) vaccines" [Vaccine 39(18) (2021) 2506-2516].
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00475.
PubMed

SALO H, Lehtonen T, Auranen K, Baum U, et al
Predictors of hospitalisation and death due to SARS-CoV-2 infection in Finland: A population-based register study with implications to vaccinations.
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00495.
PubMed Abstract available

TAMANG ST, Dorji T
COVID-19 vaccinations in Bhutan - Mix-and-Match to Boosters: An experience.
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00499.
PubMed Abstract available

ORTIZ JR, Spearman PW, Goepfert PA, Cross K, et al
Safety and immunogenicity of monovalent H7N9 influenza vaccine with AS03 adjuvant given sequentially or simultaneously with a seasonal influenza vaccine: A randomized clinical trial.
Vaccine. 2022 Apr 21. pii: S0264-410X(22)00366.
PubMed Abstract available

CAN G, Acar HC, Aydin SN, Balkan II, et al
Waning effectiveness of CoronaVac in real life: A retrospective cohort study in health care workers.
Vaccine. 2022;40:2574-2579.
PubMed Abstract available

LEBLANC JJ, ElSherif M, Ye L, MacKinnon-Cameron D, et al
Recalibrated estimates of non-bacteremic and bacteremic pneumococcal community acquired pneumonia in hospitalized Canadian adults from 2010 to 2017 with addition of an extended spectrum serotype-specific urine antigen detection assay.
Vaccine. 2022;40:2635-2646.
PubMed Abstract available

THOMPSON D, Metz SW, Abad C, Beaty S, et al
Immunological implications of diverse production approaches for Chikungunya virus-like particle vaccines.
Vaccine. 2022 Apr 19. pii: S0264-410X(22)00435.
PubMed Abstract available

GARTNER BC, Weinke T, Wahle K, Kwetkat A, et al
Importance and value of adjuvanted influenza vaccine in the care of older adults from a European perspective - A systematic review of recently published literature on real-world data.
Vaccine. 2022 Apr 19. pii: S0264-410X(22)00440.
PubMed Abstract available

LI L, Honda-Okubo Y, Baldwin J, Bowen R, et al
Covax-19/Spikogen(R) vaccine based on recombinant spike protein extracellular domain with Advax-CpG55.2 adjuvant provides single dose protection against SARS-CoV-2 infection in hamsters.
Vaccine. 2022 Apr 18. pii: S0264-410X(22)00469.
PubMed Abstract available

WANLAPAKORN N, Suntronwong N, Phowatthanasathian H, Yorsaeng R, et al
Immunogenicity of heterologous inactivated and adenoviral-vectored COVID-19 vaccine: Real-world data.
Vaccine. 2022 Apr 18. pii: S0264-410X(22)00471.
PubMed Abstract available

SAADE A, Cha L, Tadie E, Jurado B, et al
Delay between COVID-19 complete vaccination and SARS-CoV-2 infection among healthcare workers.
Vaccine. 2022 Apr 18. pii: S0264-410X(22)00473.
PubMed Abstract available

CHRISSIAN AA, Oyoyo UE, Patel P, Lawrence Beeson W, et al
Impact of COVID-19 vaccine-associated side effects on health care worker absenteeism and future booster vaccination.
Vaccine. 2022 Apr 18. pii: S0264-410X(22)00474.
PubMed Abstract available

XU S, Hong V, Sy LS, Glenn SC, et al
Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic.
Vaccine. 2022 Apr 18. pii: S0264-410X(22)00464.
PubMed Abstract available

SINGH BK, Walker J, Paul P, Reddy S, et al
De-escalation of asymptomatic testing and potential of future COVID-19 outbreaks in US nursing homes amidst rising community vaccination coverage: A modeling study.
Vaccine. 2022 Apr 18. pii: S0264-410X(22)00467.
PubMed Abstract available

ANDERSON A
Attitudes towards vaccination and knowledge about antibiotics: Analysis of Wellcome Monitor survey data.
Vaccine. 2022 Apr 15. pii: S0264-410X(22)00429.
PubMed Abstract available

BAROUTSOU V, Wymann M, Zens K, Sinniger P, et al
National and regional variations in timely adherence to recommended measles vaccination scheme in 2-years old in Switzerland, 2005-2019.
Vaccine. 2022 Apr 15. pii: S0264-410X(22)00424.
PubMed Abstract available

KUSHNER T, Huang V, Janssen R
Safety and immunogenicity of HepB-CpG in women with documented pregnancies post-vaccination: A retrospective chart review.
Vaccine. 2022 Apr 13. pii: S0264-410X(22)00443.
PubMed Abstract available

FENOLLAR F, Thomas L, Raoult D, Gautret P, et al
Screening for SARS-CoV-2 antibodies to save vaccine doses.
Vaccine. 2022 Apr 12. pii: S0264-410X(22)00444.
PubMed

YAN Y, Naito T, Tabe Y, Ito K, et al
Increased delta variant SARS-CoV-2 infections in a highly vaccinated medical center in Japan.
Vaccine. 2022 Apr 12. pii: S0264-410X(22)00445.
PubMed Abstract available

BRAEYE T, Catteau L, Brondeel R, van Loenhout JAF, et al
Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021.
Vaccine. 2022 Apr 12. pii: S0264-410X(22)00441.
PubMed Abstract available

MORO PL, Olson CK, Clark E, Marquez P, et al
Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 - October 2021.
Vaccine. 2022 Apr 12. pii: S0264-410X(22)00447.
PubMed Abstract available

ZHU XM, Yan W, Sun J, Liu L, et al
Patterns and influencing factors of COVID-19 vaccination willingness among college students in China.
Vaccine. 2022 Apr 11. pii: S0264-410X(22)00433.
PubMed Abstract available

SHINJOH M, Furuichi M, Kobayashi H, Yamaguchi Y, et al
Trends in effectiveness of inactivated influenza vaccine in children by age groups in seven seasons immediately before the COVID-19 era.
Vaccine. 2022 Apr 11. pii: S0264-410X(22)00449.
PubMed Abstract available

SPRINGER S, Kaatz M, Zieger M
Evaluation of weekly COVID-19 vaccination and case data supports negative correlation between incidence and vaccination in German federal states and cities during 4th wave.
Vaccine. 2022 Apr 11. pii: S0264-410X(22)00430.
PubMed Abstract available

CEYLAN ME, Onen Unsalver B, Donmez A, Kaya Yertutanol FD, et al
A case of myocarditis and isolated hypopotassemia after Biontech-Pfizer vaccine for Covid-19.
Vaccine. 2022 Apr 11. pii: S0264-410X(22)00432.
PubMed

LJUNG R, Feychting M, Burstrom B, Moller J, et al
Differences by region of birth in SARS-CoV-2 vaccine coverage and positive SARS-CoV-2 test among 400 000 healthcare workers and the general population in Sweden.
Vaccine. 2022 Apr 11. pii: S0264-410X(22)00431.
PubMed Abstract available

OKTARIA V, Bines JE, Murni IK, Dinari R, et al
Timeliness of routine childhood vaccinations in Indonesian infants in the first year of life.
Vaccine. 2022 Apr 11. pii: S0264-410X(22)00420.
PubMed Abstract available

BENINGER P
Need for a contingency dimension when planning vaccine development in a pandemic environment.
Vaccine. 2022 Apr 11. pii: S0264-410X(22)00401.
PubMed

PARK SJ, Kang YM, Cho HK, Kim DY, et al
Corrigendum to 'Cross-protective efficacy of inactivated whole influenza vaccines against Korean Y280 and Y439 lineage H9N2 viruses in mice' [Vaccine 39 (2021) 6213-6220].
Vaccine. 2022 Apr 9. pii: S0264-410X(22)00221.
PubMed

AINSLIE KEC, Riley S
Is annual vaccination best? A modelling study of influenza vaccination strategies in children.
Vaccine. 2022 Apr 8. pii: S0264-410X(22)00384.
PubMed Abstract available

TIANSHUO Z, Hanyu L, Bingfeng H, Bei L, et al
Evaluation of the reliability and validity of a vaccine hesitancy scale on knowledge, attitude, trust and vaccination environment (KATE-S) in Chinese parents.
Vaccine. 2022 Apr 8. pii: S0264-410X(22)00388.
PubMed Abstract available

MAYFIELD HJ, Lau CL, Sinclair JE, Brown SJ, et al
Designing an evidence-based Bayesian network for estimating the risk versus benefits of AstraZeneca COVID-19 vaccine.
Vaccine. 2022 Apr 8. pii: S0264-410X(22)00418.
PubMed Abstract available

BELDA F, Mora O, Lopez Martinez M, Torres N, et al
Seroconversion panels demonstrate anti-SARS-CoV-2 antibody development after administration of the mRNA-1273 vaccine.
Vaccine. 2022 Apr 8. pii: S0264-410X(22)00419.
PubMed Abstract available

ERFANI P, Sandoval RS, Rich KM, Ojo A, et al
Ask Me Anything": Lessons learned in implementing a COVID-19 vaccine information initiative in Massachusetts jails.
Vaccine. 2022 Apr 8. pii: S0264-410X(22)00439.
PubMed Abstract available

KENIGSBERG TA, Hause AM, McNeil MM, Nelson JC, et al
Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the vaccine safety datalink.
Vaccine. 2022 Apr 8. pii: S0264-410X(22)00426.
PubMed Abstract available

LINKINS LA, Iorio A, Little J, Lavis J, et al
Extended reporting guidance for vaccine effectiveness studies for variants of concern for COVID-19.
Vaccine. 2022 Apr 7. pii: S0264-410X(22)00422.
PubMed

DE-LOS-RIOS-PINTO A, Fernandez-Guzman D, Soriano-Moreno DR, Sangster-Carrasco L, et al
Factors associated with the intention to participate in COVID-19 vaccine clinical trials: A cross-sectional study in Peru.
Vaccine. 2022 Apr 7. pii: S0264-410X(22)00421.
PubMed Abstract available

SHAH S, Gui H, Chua PEY, Tan JB, et al
Factors associated with COVID-19 vaccination intent in Singapore, Australia and Hong Kong.
Vaccine. 2022 Apr 5. pii: S0264-410X(22)00381.
PubMed Abstract available

HASSAN PM, Ali T, Saber E, Asghar A, et al
Potency, toxicity and protection evaluation of PastoCoAd candidate vaccines: Novel preclinical mix and match rAd5 S, rAd5 RBD-N and SOBERANA dimeric-RBD protein.
Vaccine. 2022 Apr 4. pii: S0264-410X(22)00385.
PubMed Abstract available

LEWIS RM, Markowitz LE
Disparities in human papillomavirus vaccination coverage in the United States, National Health and Nutrition Examination Survey, January 2017-March 2020.
Vaccine. 2022 Apr 4. pii: S0264-410X(22)00317.
PubMed Abstract available

WALTERS JN, Schouest B, Patel A, Reuschel EL, et al
Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates.
Vaccine. 2022 Apr 4. pii: S0264-410X(22)00368.
PubMed Abstract available

ENTRICAN G, Francis MJ
Applications of platform technologies in veterinary vaccinology and the benefits for one health.
Vaccine. 2022 Apr 2. pii: S0264-410X(22)00371.
PubMed Abstract available

FRISE R, Baillon L, Zhou J, Kugathasan R, et al
A self-amplifying RNA vaccine protects against SARS-CoV-2 (D614G) and Alpha variant of concern (B.1.1.7) in a transmission-challenge hamster model.
Vaccine. 2022 Apr 1. pii: S0264-410X(22)00383.
PubMed Abstract available

MA C, Sun W, Tang T, Jia M, et al
Effectiveness of adenovirus type 5 vectored and inactivated COVID-19 vaccines against symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the B.1.617.2 (Delta) variant: Evidence from an outbreak in Yunnan, China, 2021.
Vaccine. 2022 Apr 1. pii: S0264-410X(22)00386.
PubMed Abstract available

SUGHAYER MA, Souan L, Abu Alhowr MM, Al Rimawi D, et al
Comparison of the effectiveness and duration of anti-RBD SARS-CoV-2 IgG antibody response between different types of vaccines: Implications for vaccine strategies.
Vaccine. 2022 Apr 1. pii: S0264-410X(22)00387.
PubMed Abstract available

March 2022

GERTOSIO C, Licari A, De Silvestri A, Rebuffi C, et al
Efficacy, immunogenicity, and safety of available vaccines in children on biologics: A systematic review and meta-analysis.
Vaccine. 2022 Mar 31. pii: S0264-410X(22)00341.
PubMed Abstract available

TEJADA RA, Malagon T, Franco EL
Cost-effectiveness of human papillomavirus vaccination in girls living in Latin American countries: A systematic review and meta-analysis.
Vaccine. 2022 Mar 31. pii: S0264-410X(22)00357.
PubMed Abstract available

VANDOORN E, Parys A, Chepkwony S, Chiers K, et al
Efficacy of the NS1-truncated live attenuated influenza virus vaccine for swine against infection with viruses of major North American and European H3N2 lineages.
Vaccine. 2022 Mar 30. pii: S0264-410X(22)00362.
PubMed Abstract available

BURNY W, Herve C, Caubet M, Yarzabal JP, et al
Utility of urinary cytokine levels as predictors of the immunogenicity and reactogenicity of AS01-adjuvanted hepatitis B vaccine in healthy adults.
Vaccine. 2022 Mar 30. pii: S0264-410X(22)00361.
PubMed Abstract available

CROTHERS JW, Ross Colgate E, Cowan KJ, Dickson DM, et al
Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a rando
Vaccine. 2022 Mar 30. pii: S0264-410X(22)00367.
PubMed Abstract available

EFUA SACKEY M, Markey K, Grealish A
Healthcare professional's promotional strategies in improving Human papillomavirus (HPV) vaccination uptake in adolescents: A systematic review.
Vaccine. 2022 Mar 30. pii: S0264-410X(22)00365.
PubMed Abstract available

TADDIO A, Gudzak V, Jantzi M, Logeman C, et al
Impact of the CARD (Comfort Ask Relax Distract) system on school-based vaccinations: A cluster randomized trial.
Vaccine. 2022 Mar 29. pii: S0264-410X(22)00224.
PubMed Abstract available

MCRAE J, Blyth CC, Cheng AC, Quinn HE, et al
Preventing severe influenza in Australian infants: Maternal influenza vaccine effectiveness in the PAEDS-FluCAN networks using the test-negative design.
Vaccine. 2022 Mar 29. pii: S0264-410X(22)00353.
PubMed

ESTIVARIZ CF, Kovacs SD, Mach O
Review of use of inactivated poliovirus vaccine in campaigns to control type 2 circulating vaccine derived poliovirus (cVDPV) outbreaks.
Vaccine. 2022 Mar 29. pii: S0264-410X(22)00304.
PubMed Abstract available

ISITT C, Sjoholm D, Hergens MP, Granath F, et al
The early impact of vaccination against SARS-CoV-2 in Region Stockholm, Sweden.
Vaccine. 2022 Mar 29. pii: S0264-410X(22)00372.
PubMed Abstract available

KATO H, Miyakawa K, Ohtake N, Yamaoka Y, et al
Vaccine-induced humoral response against SARS-CoV-2 dramatically declined but cellular immunity possibly remained at 6 months post BNT162b2 vaccination.
Vaccine. 2022 Mar 29. pii: S0264-410X(22)00369.
PubMed Abstract available

LI K, Yu T, Seabury SA, Dor A, et al
Trends and disparities in the utilization of influenza vaccines among commercially insured US adults during the COVID-19 pandemic.
Vaccine. 2022 Mar 29. pii: S0264-410X(22)00370.
PubMed Abstract available

JUDDOO V, Juddoo S, Megarbane B
Erythema nodosum triggered by BNT162b2 mRNA COVID-19 vaccine.
Vaccine. 2022 Mar 28. pii: S0264-410X(22)00363.
PubMed

BREAKWELL L, Marke D, Kaiser R, Tejada-Strop A, et al
Assessing the impact of the routine childhood hepatitis B immunization program and the need for hepatitis B vaccine birth dose in Sierra Leone, 2018.
Vaccine. 2022 Mar 28. pii: S0264-410X(22)00360.
PubMed Abstract available

FUNK PR, Yogurtcu ON, Forshee RA, Anderson SA, et al
Benefit-risk assessment of COVID-19 vaccine, mRNA (Comirnaty) for age 16-29 years.
Vaccine. 2022 Mar 28. pii: S0264-410X(22)00329.
PubMed Abstract available

WELLS K, Moore KL, Bednarczyk R
Supporting immunization programs to address COVID-19 vaccine hesitancy: Recommendations for national and community-based stakeholders.
Vaccine. 2022 Mar 28. pii: S0264-410X(22)00339.
PubMed

RICKETSON LJ, Bettinger JA, Sadarangani M, Halperin SA, et al
Vaccine effectiveness of the 7-valent and 13-valent pneumococcal conjugate vaccines in Canada: An IMPACT study.
Vaccine. 2022 Mar 26. pii: S0264-410X(22)00359.
PubMed Abstract available

SIMMONS LA, Whipps MDM, Phipps JE, Satish NS, et al
Understanding COVID-19 vaccine uptake during pregnancy: 'Hesitance', knowledge, and evidence-based decision-making.
Vaccine. 2022 Mar 25. pii: S0264-410X(22)00355.
PubMed Abstract available

FARAH W, Breeher L, Shah V, Hainy C, et al
Disparities in COVID-19 vaccine uptake among health care workers.
Vaccine. 2022 Mar 25. pii: S0264-410X(22)00356.
PubMed Abstract available

NOMURA Y, Noda K, Oohashi Y, Okuda S, et al
Proposal for the revision of the guidelines for Non-clinical studies of vaccines for the prevention of infectious diseases in Japan.
Vaccine. 2022 Mar 24. pii: S0264-410X(22)00354.
PubMed Abstract available

NANTHAPISAL S, Puthanakit T, Jaru-Ampornpan P, Nantanee R, et al
A randomized clinical trial of a booster dose with low versus standard dose of AZD1222 in adult after 2 doses of inactivated vaccines.
Vaccine. 2022 Mar 24. pii: S0264-410X(22)00336.
PubMed Abstract available

ST JEAN DT, Rogawski McQuade ET, Edwards JK, Thompson P, et al
Effect of early life antibiotic use on serologic responses to oral rotavirus vaccine in the MAL-ED birth cohort study.
Vaccine. 2022 Mar 24. pii: S0264-410X(22)00300.
PubMed Abstract available

LEACH K, Checchi F
The utilisation of vaccines in humanitarian crises, 2015-2019: A review of practice.
Vaccine. 2022 Mar 24. pii: S0264-410X(22)00335.
PubMed Abstract available

VOORMAN A, Lyons H, Bennette C, Kovacs S, et al
Analysis of population immunity to poliovirus following cessation of trivalent oral polio vaccine.
Vaccine. 2022 Mar 23. pii: S0264-410X(22)00277.
PubMed Abstract available

LIU X, Yu W, Yin Z, Rodewald L, et al
Vaccine events raising public concern and associated immunization program policy and practice changes, China, 2005-2021.
Vaccine. 2022 Mar 23. pii: S0264-410X(22)00334.
PubMed Abstract available

ABDEL-QADER DH, Hazza Alkhatatbeh I, Hayajneh W, Annab H, et al
IgA nephropathy in a pediatric patient after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine.
Vaccine. 2022 Mar 23. pii: S0264-410X(22)00265.
PubMed

SNIDER CJ, Boualam L, Tallis G, Takashima Y, et al
Concurrent outbreaks of circulating vaccine-derived poliovirus types 1 and 2 affecting the Republic of the Philippines and Malaysia, 2019-2021.
Vaccine. 2022 Mar 22. pii: S0264-410X(22)00145.
PubMed Abstract available

MALTEZOU HC, Medic S, Cassimos DC, Effraimidou E, et al
Decreasing routine vaccination rates in children in the COVID-19 era.
Vaccine. 2022 Mar 22. pii: S0264-410X(22)00333.
PubMed

FANO V, Crielesi A, Coviello E, Fabiani M, et al
Effectiveness of the Comirnaty and the Vaxzevria vaccines in preventing SARS-CoV-2 infection among residents in Lazio region (Italy).
Vaccine. 2022 Mar 22. pii: S0264-410X(22)00208.
PubMed Abstract available

FERDINANDS JM, Patel M
Influence of disease attenuation on relative influenza vaccine effectiveness by vaccine type.
Vaccine. 2022 Mar 21. pii: S0264-410X(22)00274.
PubMed Abstract available

JIAN-BIN L, Lau EYH, Chan DKC
Why do Hong Kong parents have low intention to vaccinate their children against COVID-19? testing health belief model and theory of planned behavior in a large-scale survey.
Vaccine. 2022 Mar 21. pii: S0264-410X(22)00340.
PubMed Abstract available

YUEN WLP, Loh SYJ, Wang DB
SIRVA (Shoulder Injury Related to Vaccine Administration) following mRNA COVID-19 Vaccination: Case discussion and literature review.
Vaccine. 2022 Mar 21. pii: S0264-410X(22)00337.
PubMed Abstract available

ZERBO O, Modaressi S, Goddard K, Lewis E, et al
Safety of measles and pertussis-containing vaccines in children with autism spectrum disorders.
Vaccine. 2022 Mar 18. pii: S0264-410X(22)00331.
PubMed Abstract available

CALLAGHAN T, Washburn D, Goidel K, Nuzhath T, et al
Imperfect messengers? An analysis of vaccine confidence among primary care physicians.
Vaccine. 2022 Mar 18. pii: S0264-410X(22)00302.
PubMed Abstract available

ESPOSITO S, Nauta J, Lapini G, Montomoli E, et al
Efficacy and safety of a quadrivalent influenza vaccine in children aged 6-35 months: A global, multiseasonal, controlled, randomized Phase III study.
Vaccine. 2022 Mar 18. pii: S0264-410X(22)00263.
PubMed Abstract available

BILGIN H, Marku M, Yilmaz SS, Karahasan Yagci A, et al
The effect of immunization with inactivated SARS-CoV-2 vaccine (CoronaVac) and/or SARS-CoV-2 infection on antibody levels, plasmablasts, long-lived-plasma-cells, and IFN-gamma release by natural killer cells.
Vaccine. 2022 Mar 18. pii: S0264-410X(22)00264.
PubMed Abstract available

GRUHN S, Witte J, Greiner W, Damm O, et al
Epidemiology and economic burden of meningococcal disease in Germany: A systematic review.
Vaccine. 2022;40:1932-1947.
PubMed Abstract available

WANG H, Ypma E, Nicolay U
Managing multiplicity in clinical vaccine studies - A case study using a gatekeeping testing strategy.
Vaccine. 2022 Mar 17. pii: S0264-410X(22)00244.
PubMed Abstract available

GRAFFIGNA G, Palamenghi L, Barello S, Boccia S, et al
Erratum to ""Cultivating" acceptance of a COVID-19 vaccination program: Lessons from Italy" [Vaccine 38(48) (2020) 7585-7586].
Vaccine. 2022 Mar 17. pii: S0264-410X(22)00295.
PubMed

BATOOL R, Yousafzai MT, Qureshi S, Ali M, et al
Corrigendum to "Effectiveness of typhoid conjugate vaccine against culture-confirmed typhoid in a peri-urban setting in Karachi: A case-control study". [Vaccine 39 (2021) 5858-5865].
Vaccine. 2022 Mar 17. pii: S0264-410X(22)00294.
PubMed

MACKLIN G, Peak C, Eisenhawer M, Kurji F, et al
Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experience.
Vaccine. 2022 Mar 17. pii: S0264-410X(22)00195.
PubMed Abstract available

SADIGH K, Fox G, Khetsuriani N, Gao H, et al
Policy and practice of checking vaccination status at school in 2018, a global overview.
Vaccine. 2022 Mar 17. pii: S0264-410X(22)00266.
PubMed Abstract available

GAO Z, Chen L, Song T, Pan X, et al
A candidate multi-epitope vaccine against porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae induces robust humoral and cellular response in mice.
Vaccine. 2022 Mar 17. pii: S0264-410X(22)00296.
PubMed Abstract available

GUL A, Doskaya M, Can H, Karakavuk M, et al
Immunogenicity of a xenogeneic multi-epitope HER2(+) breast cancer DNA vaccine targeting the dendritic cell restricted antigen-uptake receptor DEC205.
Vaccine. 2022 Mar 16. pii: S0264-410X(22)00279.
PubMed Abstract available

BEESLAAR J, Mather S, Absalon J, Eiden JJ, et al
Safety data from the MenB-FHbp clinical development program in healthy individuals aged 10 years and older.
Vaccine. 2022;40:1872-1878.
PubMed Abstract available

KHETSURIANI N, Zaika O, Slobodianyk L, Scobie HM, et al
Diphtheria and tetanus seroepidemiology among children in Ukraine, 2017.
Vaccine. 2022;40:1810-1820.
PubMed Abstract available

CAMARA J, Gonzalez-Diaz A, Barrabeig I, Fernandez-Huerta M, et al
SARS-CoV-2 outbreak in a nursing home after vaccination with BNT162b2: A role for the quantification of circulating antibodies.
Vaccine. 2022 Mar 15. pii: S0264-410X(22)00303.
PubMed Abstract available

ROTOLO B, Dube E, Vivion M, MacDonald SE, et al
Hesitancy towards COVID-19 vaccines on social media in Canada.
Vaccine. 2022 Mar 15. pii: S0264-410X(22)00301.
PubMed Abstract available

MOSCARDINO U, Musso P, Inguglia C, Ceccon C, et al
Sociodemographic and psychological correlates of COVID-19 vaccine hesitancy and resistance in the young adult population in Italy.
Vaccine. 2022 Mar 14. pii: S0264-410X(22)00293.
PubMed Abstract available

MORGA A, Kimura T, Feng Q, Rozario N, et al
Compliance to Advisory Committee on Immunization Practices recommendations for pneumococcal vaccination.
Vaccine. 2022 Mar 12. pii: S0264-410X(22)00269.
PubMed Abstract available

LAMORI J, Feng X, Pericone CD, Mesa-Frias M, et al
Real-world evidence on adherence and completion of the two-dose recombinant zoster vaccine and associated factors in U.S. adults, 2017-2021.
Vaccine. 2022 Mar 12. pii: S0264-410X(22)00268.
PubMed Abstract available

HUANG HJ, Yang M, Chen HW, Wang S, et al
A novel chimeric dengue vaccine candidate composed of consensus envelope protein domain III fused to C-terminal-modified NS1 protein.
Vaccine. 2022 Mar 11. pii: S0264-410X(22)00225.
PubMed Abstract available

GU YOON J, Jang AY, Ja Kim M, Bin Seo Y, et al
Persistent serotype 3 and 19A invasive pneumococcal diseases in adults in vaccine era: Serotype-dependent difference in ceftriaxone susceptibility.
Vaccine. 2022 Mar 10. pii: S0264-410X(22)00267.
PubMed Abstract available

KAKATSAKI I, Vergadi E, Paraskakis E, Galanakis E, et al
Attitudes of junior healthcare professionals towards mandatory vaccination.
Vaccine. 2022 Mar 10. pii: S0264-410X(22)00275.
PubMed Abstract available

HARUTYUNYAN V, Quddus A, Pallansch M, Zipursky S, et al
Global oral poliovirus vaccine stockpile management as an essential preparedness and response mechanism for type 2 poliovirus outbreaks following global oral poliovirus vaccine type 2 withdrawal.
Vaccine. 2022 Mar 10. pii: S0264-410X(22)00204.
PubMed Abstract available

VAN DEN HOOGEN LL, Smits G, van Hagen CCE, Wong D, et al
Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?
Vaccine. 2022 Mar 9. pii: S0264-410X(22)00272.
PubMed Abstract available

THOMAS CM, Searle K, Galvan A, Liebman AK, et al
Healthcare worker perspectives on COVID-19 vaccines: Implications for increasing vaccine acceptance among healthcare workers and patients.
Vaccine. 2022 Mar 9. pii: S0264-410X(22)00276.
PubMed Abstract available

WILKINSON K, Righolt CH, Kwong JC, Schwartz KL, et al
Corrigendum to "A nested case-control study measuring pertussis vaccine effectiveness and duration of protection in Manitoba, Canada, 1992-2015: A Canadian Immunization Research Network Study" [Vaccine 37(48) (2019) 7132-7137].
Vaccine. 2022 Mar 7. pii: S0264-410X(22)00240.
PubMed

YUEN VWH
Political attitudes and efficacy of health expert communication on the support for COVID-19 vaccination program: Findings from a survey in Hong Kong.
Vaccine. 2022 Mar 7. pii: S0264-410X(22)00261.
PubMed Abstract available

BANSAL P, Raj A, Mani Shukla D, Sunder N, et al
COVID-19 vaccine preferences in India.
Vaccine. 2022 Mar 7. pii: S0264-410X(22)00241.
PubMed Abstract available

ULRICH AK, Sundaram ME, Basta NE
Supporting individual vaccine decision-making: A role for vaccination counselors.
Vaccine. 2022 Mar 4. pii: S0264-410X(22)00135.
PubMed

MASCHERINI M, Nivakoski S
Social media use and vaccine hesitancy in the European Union.
Vaccine. 2022 Mar 3. pii: S0264-410X(22)00206.
PubMed Abstract available

KLUMPP M, Monfared IG, Vollmer S
Public opinion on global distribution of COVID-19 vaccines: Evidence from two nationally representative surveys in Germany and the United States.
Vaccine. 2022 Mar 3. pii: S0264-410X(22)00259.
PubMed Abstract available

COULAUD PJ, Ablona A, Bolduc N, Fast D, et al
COVID-19 vaccine intention among young adults: Comparative results from a cross-sectional study in Canada and France.
Vaccine. 2022 Mar 3. pii: S0264-410X(22)00260.
PubMed Abstract available

ROBERTSON LJ, Price R, Moore JS, Curry G, et al
IgG antibody production and persistence to 6 months following SARS-CoV-2 vaccination: A Northern Ireland observational study.
Vaccine. 2022 Mar 3. pii: S0264-410X(22)00262.
PubMed Abstract available

KREPS SE, Kriner DL
How do COVID-19 vaccine mandates affect attitudes toward the vaccine and participation in mandate-affected activities? Evidence from the United States.
Vaccine. 2022 Mar 2. pii: S0264-410X(22)00258.
PubMed Abstract available

WONDIMU A, Postma MJ, van Hulst M
Cost-effectiveness analysis of quadrivalent and nonavalent human papillomavirus vaccines in Ethiopia.
Vaccine. 2022 Mar 2. pii: S0264-410X(22)00245.
PubMed Abstract available

YU M, Yao X, Liu G, Wu J, et al
Barriers and facilitators to uptake and promotion of influenza vaccination among health care workers in the community in Beijing, China: A qualitative study.
Vaccine. 2022 Mar 2. pii: S0264-410X(22)00207.
PubMed Abstract available

POINTON L, Howe AS, Hobbs M, Paynter J, et al
Evidence of suboptimal maternal vaccination coverage in pregnant New Zealand women and increasing inequity over time: A nationwide retrospective cohort study.
Vaccine. 2022 Mar 2. pii: S0264-410X(22)00243.
PubMed Abstract available

LAI FTT, Leung MTY, Chan EWW, Huang L, et al
Self-reported reactogenicity of CoronaVac (Sinovac) compared with Comirnaty (Pfizer-BioNTech): A prospective cohort study with intensive monitoring.
Vaccine. 2022;40:1390-1396.
PubMed Abstract available

DENNY L
HPV vaccine introduction and implementation in LMICs.
Vaccine. 2022 Mar 1. pii: S0264-410X(22)00227.
PubMed

GU J, Dor A, Li K, Broniatowski DA, et al
The impact of Facebook's vaccine misinformation policy on user endorsements of vaccine content: An interrupted time series analysis.
Vaccine. 2022 Mar 1. pii: S0264-410X(22)00209.
PubMed Abstract available

SEXSON TEJTEL SK, Munoz FM, Al-Ammouri I, Savorgnan F, et al
Myocarditis and pericarditis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
Vaccine. 2022;40:1499-1511.
PubMed Abstract available

MOURA C, Truche P, Sousa Salgado L, Meireles T, et al
The impact of COVID-19 on routine pediatric vaccination delivery in Brazil.
Vaccine. 2022 Mar 1. pii: S0264-410X(22)00242.
PubMed Abstract available

February 2022

SINGH JA, Kochhar S, Wolff J, Atuire C, et al
WHO guidance on COVID-19 vaccine trial designs in the context of authorized COVID-19 vaccines and expanding global access: Ethical considerations.
Vaccine. 2022 Feb 28. pii: S0264-410X(22)00175.
PubMed Abstract available

MCANDREW T, Cambeiro J, Besiroglu T
Aggregating human judgment probabilistic predictions of the safety, efficacy, and timing of a COVID-19 vaccine.
Vaccine. 2022 Feb 28. pii: S0264-410X(22)00200.
PubMed Abstract available

LAU YL, Fan Leung T, Sirvan Cetin B, Cagri Dinleyici E, et al
Safety and reactogenicity of a liquid formulation of human rotavirus vaccine (porcine circovirus-free): A phase III, observer-blind, randomized, multi-country study.
Vaccine. 2022 Feb 26. pii: S0264-410X(22)00218.
PubMed Abstract available

SALIOU P, Duteil Q, Plotkin SA, Gentilini M, et al
The scourge of vaccine falsification.
Vaccine. 2022 Feb 26. pii: S0264-410X(22)00119.
PubMed Abstract available

SCHAFER W, Reinders T, Schink T
Second dose of measles-mumps-rubella-varicella vaccine (MMRV) and the risk of febrile convulsions.
Vaccine. 2022 Feb 26. pii: S0264-410X(22)00222.
PubMed Abstract available

DANIELS V, Saxena K, Patterson-Lomba O, Gomez-Lievano A, et al
Modeling the health and economic implications of adopting a 1-dose 9-valent human papillomavirus vaccination regimen in a high-income country setting: An analysis in the United Kingdom.
Vaccine. 2022 Feb 26. pii: S0264-410X(22)00220.
PubMed Abstract available

KAGEYAMA T, Tanaka S, Etori K, Hattori K, et al
Immunological features that associate with the strength of antibody responses to BNT162b2 mRNA vaccine against SARS-CoV-2.
Vaccine. 2022 Feb 25. pii: S0264-410X(22)00192.
PubMed Abstract available

MULLER KE, Dohos D, Sipos Z, Kiss S, et al
Immune response to influenza and pneumococcal vaccines in adults with inflammatory bowel disease: A systematic review and meta-analysis of 1429 patients.
Vaccine. 2022 Feb 25. pii: S0264-410X(22)00163.
PubMed Abstract available

MCGOLDRICK M, Gastineau T, Wilkinson D, Campa C, et al
How to accelerate the supply of vaccines to all populations worldwide? Part II: Initial industry lessons learned and detailed technical reflections leveraging the COVID-19 situation.
Vaccine. 2022;40:1223-1230.
PubMed Abstract available

MCGOLDRICK M, Gastineau T, Wilkinson D, Campa C, et al
How to accelerate the supply of vaccines to all populations worldwide? Part I: Initial industry lessons learned and practical overarching proposals leveraging the COVID-19 situation.
Vaccine. 2022;40:1215-1222.
PubMed Abstract available

DIXON MG, Tapia MD, Wannemuehler K, Luce R, et al
Measles susceptibility in maternal-infant dyads-Bamako, Mali.
Vaccine. 2022;40:1316-1322.
PubMed Abstract available

HAO F, Shao W
Understanding the influence of political orientation, social network, and economic recovery on COVID-19 vaccine uptake among Americans.
Vaccine. 2022 Feb 22. pii: S0264-410X(22)00219.
PubMed Abstract available

NIE J, Sun Y, Feng K, Huang L, et al
The efficient development of a novel recombinant adenovirus zoster vaccine perfusion production process.
Vaccine. 2022 Feb 22. pii: S0264-410X(22)00159.
PubMed Abstract available

EL-HENEIDY A, Grimwood K, Lambert SB, Sarna M, et al
Association between vaccination status, symptom identification and healthcare use: Implications for test negative design observational studies.
Vaccine. 2022 Feb 22. pii: S0264-410X(22)00198.
PubMed Abstract available

ABBATECOLA AM, Incalzi RA, Malara A, Palmieri A, et al
Monitoring COVID-19 vaccine use in Italian long term care centers: The GeroCovid VAX study.
Vaccine. 2022 Feb 22. pii: S0264-410X(22)00217.
PubMed Abstract available

CHOOI WH, Ng PW, Hussain Z, Ming LC, et al
Vaccine contamination: Causes and control.
Vaccine. 2022 Feb 21. pii: S0264-410X(22)00169.
PubMed

TAWINPRAI K, Siripongboonsitti T, Porntharukchareon T, Wittayasak K, et al
Immunogenicity and safety of an intradermal fractional third dose of ChAdOx1 nCoV-19/AZD1222 vaccine compared with those of a standard intramuscular third dose in volunteers who previously received two doses of CoronaVac: A randomized controlled trial
Vaccine. 2022 Feb 21. pii: S0264-410X(22)00143.
PubMed Abstract available

ISMAIL ALHOSANI F, Eduardo Stanciole A, Aden B, Timoshkin A, et al
Impact of the Sinopharm's BBIBP-CorV vaccine in preventing hospital admissions and death in infected vaccinees: Results from a retrospective study in the emirate of Abu Dhabi, United Arab Emirates (UAE).
Vaccine. 2022 Feb 19. pii: S0264-410X(22)00174.
PubMed Abstract available

FILIA A, Rota MC, Grossi A, Martinelli D, et al
Are vaccine shortages a relevant public health issue in Europe? Results from a survey conducted in the framework of the EU Joint Action on Vaccination.
Vaccine. 2022 Feb 19. pii: S0264-410X(22)00187.
PubMed Abstract available

WINTER T, Riordan BC, Scarf D, Jose PE, et al
Conspiracy beliefs and distrust of science predicts reluctance of vaccine uptake of politically right-wing citizens.
Vaccine. 2022 Feb 18. pii: S0264-410X(22)00074.
PubMed Abstract available

STANDAERT B, Strens D, Raes M, Benninghoff B, et al
Explaining the formation of a plateau in rotavirus vaccine impact on rotavirus hospitalisations in Belgium.
Vaccine. 2022 Feb 18. pii: S0264-410X(22)00199.
PubMed Abstract available

LEE GY, Inthasorn P, Laowahutanont P, Lawpoolsri S, et al
Long-term effectiveness of human papillomavirus vaccines among adult women: A real-world scenario.
Vaccine. 2022 Feb 18. pii: S0264-410X(22)00188.
PubMed Abstract available

SCHMALING KB
Couples and COVID-19 vaccination: Frequency and reasons for discordance.
Vaccine. 2022 Feb 18. pii: S0264-410X(22)00202.
PubMed Abstract available

TRUMP BD, Golan MS, Keisler JM, Cegan JC, et al
Vaccine supply chain: Resilience-by-design and resilience-by-intervention.
Vaccine. 2022 Feb 17. pii: S0264-410X(22)00172.
PubMed

HENSCHKE N, Bergman H, Hungerford D, Cunliffe NA, et al
The efficacy and safety of rotavirus vaccines in countries in Africa and Asia with high child mortality.
Vaccine. 2022 Feb 17. pii: S0264-410X(22)00125.
PubMed Abstract available

KASSTAN B, Mounier-Jack S, Letley L, Gaskell KM, et al
Localising vaccination services: Qualitative insights on public health and minority group collaborations to co-deliver coronavirus vaccines.
Vaccine. 2022 Feb 17. pii: S0264-410X(22)00201.
PubMed Abstract available

MERKLEY E, Loewen PJ
The correlates and dynamics of COVID-19 vaccine-specific hesitancy.
Vaccine. 2022 Feb 17. pii: S0264-410X(22)00168.
PubMed Abstract available

LAZO L, Bequet-Romero M, Lemos G, Musacchio A, et al
A recombinant SARS-CoV-2 receptor-binding domain expressed in an engineered fungal strain of Thermothelomyces heterothallica induces a functional immune response in mice.
Vaccine. 2022;40:1162-1169.
PubMed Abstract available

JOG P, Memon IA, Thisyakorn U, Hozbor D, et al
Pertussis in Asia: Recent country-specific data and recommendations.
Vaccine. 2022;40:1170-1179.
PubMed Abstract available

STEFANIZZI P, Larocca AMV, Martinelli A, Soldano S, et al
Immune response to one dose of BNT162b2 mRNA Covid-19 vaccine followed by SARS-CoV-2 infection: An Italian prospective observational study.
Vaccine. 2022 Feb 16. pii: S0264-410X(22)00124.
PubMed Abstract available

KALASKA B, Miklosz J, Swieton J, Jakimczuk A, et al
The effect of ChAdOx1 nCov-19 vaccine on arterial thrombosis development and platelet aggregation in female rats.
Vaccine. 2022 Feb 16. pii: S0264-410X(22)00173.
PubMed Abstract available

BUCKLEY A, Lager K
Efficacy of an inactivated Senecavirus A vaccine in weaned pigs and mature sows.
Vaccine. 2022 Feb 16. pii: S0264-410X(22)00142.
PubMed Abstract available

ANUGULRUENGKITT S, Angsuwatcharakon P, Puthanakit T, Bunjoungmanee P, et al
Seroprevalence of mumps among children and adolescents in Thailand, 2020.
Vaccine. 2022;40:1061-1064.
PubMed Abstract available

HUSKA B, Kubinec C, Sadarangani M, Ulanova M, et al
Seroprevalence of IgG and IgM antibodies to Haemophilus influenzae type a in Canadian children.
Vaccine. 2022;40:1128-1134.
PubMed Abstract available

ARAKELIAN T, Oosterhuis K, Tondini E, Los M, et al
Pyroptosis-inducing active caspase-1 as a genetic adjuvant in anti-cancer DNA vaccination.
Vaccine. 2022 Feb 15. pii: S0264-410X(22)00162.
PubMed Abstract available

SALEH OA, Halperin O
Influenza virus vaccine compliance among pregnant women during the COVID-19 pandemic (pre-vaccine era) in Israel and future intention to uptake BNT162b2 mRNA COVID-19 vaccine.
Vaccine. 2022 Feb 15. pii: S0264-410X(22)00160.
PubMed Abstract available

HIDLE A, Brennan T, Garon J, An Q, et al
Cost of human papillomavirus vaccine delivery at district and health facility levels in Zimbabwe: A school-based vaccination program targeting multiple cohorts.
Vaccine. 2022 Feb 15. pii: S0264-410X(22)00047.
PubMed Abstract available

QUITIAN LM, Rodriguez-Martinez CE, Sossa-Briceno MP, Cortes JA, et al
Disease burden and vaccination priorities in Colombia.
Vaccine. 2022 Feb 15. pii: S0264-410X(22)00029.
PubMed Abstract available

TANI N, Chong Y, Kurata Y, Gondo K, et al
Relation of fever intensity and antipyretic use with specific antibody response after two doses of the BNT162b2 mRNA vaccine.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00158.
PubMed Abstract available

AMMETER T, Lang P, Czock A
Overview of the influenza vaccination activities and legal frameworks in 26 Swiss cantons during the influenza season 2019/20.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00132.
PubMed Abstract available

MUCHIRI SK, Muthee R, Kiarie H, Sitienei J, et al
Unmet need for COVID-19 vaccination coverage in Kenya.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00167.
PubMed Abstract available

GAFFNEY KK, Jana Broadhurst M, Brett-Major DM
Mumps to COVID-19: Vaccinated persons remain vulnerable when community uptake is low.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00193.
PubMed Abstract available

YAMAMOTO S, Fukunaga A, Tanaka A, Takeuchi JS, et al
Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00196.
PubMed Abstract available

UWAMINO Y, Yokoyama T, Shimura T, Nishimura T, et al
The effect of the E484K mutation of SARS-CoV-2 on the neutralizing activity of antibodies from BNT162b2 vaccinated individuals.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00191.
PubMed Abstract available

GAO F, An C, Bian L, Wang Y, et al
Establishment of the first Chinese national standard for protein subunit SARS-CoV-2 vaccine.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00194.
PubMed Abstract available

CHAN IL, Mowson R, Alonso JP, Roberti J, et al
Promoting immunization equity in Latin America and the Caribbean: Case studies, lessons learned, and their implication for COVID-19 vaccine equity.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00197.
PubMed Abstract available

CHRYSI P, Stella M, Marios K, Despo C, et al
Exploring vaccination coverage and attitudes of health care workers towards influenza vaccine in Cyprus.
Vaccine. 2022 Feb 12. pii: S0264-410X(22)00141.
PubMed Abstract available

HELLER O, Chun Y, Shlomo Y, Gewirtz-Meydan A, et al
Public perceptions and the willingness to get vaccinated against COVID-19: Lessons from Israel.
Vaccine. 2022 Feb 11. pii: S0264-410X(22)00165.
PubMed Abstract available

KOCHHAR S, Barreira D, Beattie P, Cavaleri M, et al
Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case.
Vaccine. 2022 Feb 11. pii: S0264-410X(21)01395.
PubMed Abstract available

DIETRICH LG, Luthy A, Lucas Ramanathan P, Baldesberger N, et al
Healthcare professional and professional stakeholders' perspectives on vaccine mandates in Switzerland: A mixed-methods study.
Vaccine. 2022 Feb 11. pii: S0264-410X(22)00007.
PubMed Abstract available

TIBBELS NJ, Dosso A, Fordham C, Benie W, et al
"On the last day of the last month, I will go": A qualitative exploration of COVID-19 vaccine confidence among Ivoirian adults.
Vaccine. 2022 Feb 11. pii: S0264-410X(22)00166.
PubMed Abstract available

KAPLONEK P, Yao L, Reppe K, Voss F, et al
A semisynthetic glycoconjugate provides expanded cross-serotype protection against Streptococcus pneumoniae.
Vaccine. 2022;40:1038-1046.
PubMed Abstract available

ABHILASH KPP, Mathiyalagan P, Krishnaraj VRK, Selvan S, et al
Impact of prior vaccination with Covishield(TM) and Covaxin(R) on mortality among symptomatic COVID-19 patients during the second wave of the pandemic in South India during April and May 2021: a cohort study.
Vaccine. 2022 Feb 10. pii: S0264-410X(22)00157.
PubMed Abstract available

DEBELLUT F, Mkisi R, Masoo V, Chisema M, et al
Projecting the cost of introducing typhoid conjugate vaccine (TCV) in the national immunization program in Malawi using a standardized costing framework.
Vaccine. 2022 Feb 10. pii: S0264-410X(22)00139.
PubMed Abstract available

COLE JW, M H Chen A, McGuire K, Berman S, et al
Motivational interviewing and vaccine acceptance in children: The MOTIVE study.
Vaccine. 2022 Feb 10. pii: S0264-410X(22)00114.
PubMed Abstract available

PAOLINO KM, Regules JA, Moon JE, Ruck RC, et al
Safety and immunogenicity of a plant-derived recombinant protective antigen (rPA)-based vaccine against Bacillus anthracis: A Phase 1 dose-escalation study in healthy adults.
Vaccine. 2022 Feb 10. pii: S0264-410X(22)00093.
PubMed Abstract available

BERGMANN ESTEVES S, Moreira Santos C, Ferreira Salgado F, Paldes Goncales A, et al
Efficacy of commercially available vaccines against canine leptospirosis: A systematic review and meta-analysis.
Vaccine. 2022 Feb 10. pii: S0264-410X(22)00144.
PubMed Abstract available

DREYER N, Reynolds MW, Albert L, Brinkley E, et al
How frequent are acute reactions to COVID-19 vaccination and who is at risk?
Vaccine. 2022 Feb 9. pii: S0264-410X(22)00103.
PubMed Abstract available

PRAMOD S, Govindan D, Ramasubramani P, Kar SS, et al
Effectiveness of Covishield vaccine in preventing Covid-19 - A test-negative case-control study.
Vaccine. 2022 Feb 9. pii: S0264-410X(22)00138.
PubMed Abstract available

DE LUCA C, Schachner A, Heidl S, Hess M, et al
Vaccination with a fowl adenovirus chimeric fiber protein (crecFib-4/11) simultaneously protects chickens against hepatitis-hydropericardium syndrome (HHS) and inclusion body hepatitis (IBH).
Vaccine. 2022 Feb 9. pii: S0264-410X(22)00116.
PubMed Abstract available

SCHALTZ-BUCHHOLZER F, Toldi G
The association between parental and neonatal BCG vaccination and neonatal T helper 17 cell expansion.
Vaccine. 2022 Feb 9. pii: S0264-410X(22)00128.
PubMed Abstract available

CARLOW DA, Lai JCY, Kollmann TR, Sadarangani M, et al
Cutaneous CpG adjuvant conditioning to enhance vaccine responses.
Vaccine. 2022 Feb 8. pii: S0264-410X(21)01668.
PubMed Abstract available

MASUDA T, Murakami K, Sugiura K, Sakui S, et al
A phase 1/2 randomised placebo-controlled study of the COVID-19 vaccine mRNA-1273 in healthy Japanese adults: An interim report.
Vaccine. 2022 Feb 8. pii: S0264-410X(22)00164.
PubMed Abstract available

PEREZ-RODRIGUEZ S, de la Caridad Rodriguez-Gonzalez M, Ochoa-Azze R, Climent-Ruiz Y, et al
A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: Safety, reactogenicity and immunogenicity.
Vaccine. 2022 Feb 8. pii: S0264-410X(22)00161.
PubMed Abstract available

LADHANI SN, Campbell H, Amin-Chowdhury Z, Lucidarme J, et al
Timing of meningococcal vaccination with 4CMenB (Bexsero(R)) in children with invasive meningococcal group B (MenB) disease in England.
Vaccine. 2022 Feb 8. pii: S0264-410X(21)01618.
PubMed Abstract available

CORNISH MJ, Hedrick JA, Gabrielsen AA, Johnson AD, et al
Safety and immunogenicity of an investigational quadrivalent meningococcal tetanus toxoid conjugate vaccine (MenACYW-TT) co-administered with routine pediatric vaccines in infants and toddlers: A Phase II study.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00096.
PubMed Abstract available

DENG JZ, Lancaster C, Winters MA, Phillips KM, et al
Multi-attribute characterization of pneumococcal conjugate vaccine by Size-exclusion chromatography coupled with UV-MALS-RI detections.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00076.
PubMed Abstract available

WALKER B, Anderson A, Stoecker C, Shao Y, et al
COVID-19 and Routine Childhood and Adolescent Immunizations: Evidence from Louisiana Medicaid.
Vaccine. 2022;40:837-840.
PubMed Abstract available

CRUVINEL E, P Richter K, S Scheuermann T, M Machado N, et al
The impact of COVID-19 on income and employment and willingness to become vaccinated among African Americans enrolled in a smoking cessation randomized trial.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00120.
PubMed Abstract available

MEWHIRTER J, Sagir M, Sanders R
Towards a predictive model of COVID-19 vaccine hesitancy among American adults.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00134.
PubMed Abstract available

DOMNICH A, Orsi A, Sticchi L, Panatto D, et al
Effect of the 2020/21 season influenza vaccine on SARS-CoV-2 infection in a cohort of Italian healthcare workers.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00137.
PubMed Abstract available

BELLOS I, Karageorgiou V, Viskin D
Myocarditis following mRNA Covid-19 vaccination: A pooled analysis.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00140.
PubMed Abstract available

SPRENGHOLZ P, Korn L, Eitze S, Felgendreff L, et al
Attitude toward a mandatory COVID-19 vaccination policy and its determinants: Evidence from serial cross-sectional surveys conducted throughout the pandemic in Germany.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00130.
PubMed Abstract available

WONODI C, Obi-Jeff C, Adewumi F, Keluo-Udeke SC, et al
Conspiracy theories and misinformation about COVID-19 in Nigeria: Implications for vaccine demand generation communications.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00126.
PubMed Abstract available

WALKER J, Paul P, Dooling K, Oliver S, et al
Modeling strategies for the allocation of SARS-CoV-2 vaccines in the United States.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00136.
PubMed Abstract available

HU S, Logan N, Puenpa J, Wanlapakorn N, et al
Evaluation of the effect of maternally derived antibody on response to MMR vaccine in Thai infants.
Vaccine. 2022 Feb 5. pii: S0264-410X(22)00095.
PubMed Abstract available

AKGUN O, Kayaalp GK, Demirkan FG, Cakmak F, et al
Exploring the attitudes, concerns, and knowledge regarding COVID-19 vaccine by the parents of children with rheumatic disease: Cross-sectional online survey.
Vaccine. 2022 Feb 4. pii: S0264-410X(22)00117.
PubMed Abstract available

NONVIGNON J, Owusu R, Asare B, Adjagba A, et al
Estimating the cost of COVID-19 vaccine deployment and introduction in Ghana using the CVIC tool.
Vaccine. 2022 Feb 4. pii: S0264-410X(22)00070.
PubMed Abstract available

OLIANI F, Savoia A, Gallo G, Tiwana N, et al
Italy's rollout of COVID-19 vaccinations: The crucial contribution of the first experimental mass vaccination site in Lombardy.
Vaccine. 2022 Feb 3. pii: S0264-410X(22)00115.
PubMed Abstract available

GORSE GJ, Grimes S, Buck H, Mulla H, et al
MAS-1, a novel water-in-oil adjuvant/delivery system, with reduced seasonal influenza vaccine hemagglutinin dose may enhance potency, durability and cross-reactivity of antibody responses in the elderly.
Vaccine. 2022 Feb 3. pii: S0264-410X(22)00059.
PubMed Abstract available

IRVING SA, Groom HC, Dandamudi P, Daley MF, et al
A decade of data: Adolescent vaccination in the vaccine safety datalink, 2007 through 2016.
Vaccine. 2022 Feb 3. pii: S0264-410X(22)00091.
PubMed Abstract available

TAKESHITA K, Ishiwada N, Takeuchi N, Ohkusu M, et al
Immunogenicity and safety of routine 13-valent pneumococcal conjugate vaccination outside recommended age range in patients with hematological malignancies and solid tumors.
Vaccine. 2022 Feb 3. pii: S0264-410X(22)00102.
PubMed Abstract available

GORSE GJ, Grimes S, Buck H, Mulla H, et al
A phase 1 dose-sparing, randomized clinical trial of seasonal trivalent inactivated influenza vaccine combined with MAS-1, a novel water-in-oil adjuvant/delivery system.
Vaccine. 2022 Feb 3. pii: S0264-410X(22)00058.
PubMed Abstract available

ELLITHORPE ME, Alade F, Adams RB, Nowak GJ, et al
Looking ahead: Caregivers' COVID-19 vaccination intention for children 5 years old and younger using the health belief model.
Vaccine. 2022 Feb 1. pii: S0264-410X(22)00097.
PubMed Abstract available

HEYERDAHL LW, Vray M, Lana B, Tvardik N, et al
Conditionality of COVID-19 vaccine acceptance in European countries.
Vaccine. 2022 Feb 1. pii: S0264-410X(22)00099.
PubMed Abstract available

SHAW J, Anderson KB, Fabi RE, Thompson CA, et al
COVID-19 vaccination intention and behavior in a large, diverse, U.S. refugee population.
Vaccine. 2022 Feb 1. pii: S0264-410X(22)00100.
PubMed Abstract available

YOUSAF M, Hassan Raza S, Mahmood N, Core R, et al
Immunity debt or vaccination crisis? A multi-method evidence on vaccine acceptance and media framing for emerging COVID-19 variants.
Vaccine. 2022 Feb 1. pii: S0264-410X(22)00101.
PubMed Abstract available

January 2022

YANG YL, Kim J, Jeong Y, Jang YS, et al
Intranasal immunization with a Middle East respiratory syndrome-coronavirus antigen conjugated to the M-cell targeting ligand Co4B enhances antigen-specific mucosal and systemic immunity and protects against infection.
Vaccine. 2022;40:714-725.
PubMed Abstract available

JANSSEN YF, Feitsma EA, Boersma HH, Alleva DG, et al
Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452.
Vaccine. 2022 Jan 31. pii: S0264-410X(22)00077.
PubMed Abstract available

PANWAR K, Godi A, Cocuzza CE, Andrews N, et al
Binding antibody levels to vaccine (HPV6/11/16/18) and non-vaccine (HPV31/33/45/52/58) HPV antigens up to 7 years following immunization with either Cervarix(R) or Gardasil(R) vaccine.
Vaccine. 2022 Jan 31. pii: S0264-410X(22)00075.
PubMed Abstract available

SANDMANN FG, van Leeuwen E, Bernard-Stoecklin S, Casado I, et al
Health and economic impact of seasonal influenza mass vaccination strategies in European settings: A mathematical modelling and cost-effectiveness analysis.
Vaccine. 2022 Jan 31. pii: S0264-410X(22)00039.
PubMed Abstract available

PITTET LF, Cox L, Freyne B, Germano S, et al
Hepatitis B vaccine co-administration influences the heterologous effects of neonatal BCG vaccination in a sex-differential manner.
Vaccine. 2022 Jan 29. pii: S0264-410X(22)00020.
PubMed Abstract available

MORGAN C, Giattas MR, Holroyd T, Pfitzer A, et al
Integration of other services with human papillomavirus vaccination; lessons from earlier in the life course highlight the need for new policy and implementation evidence.
Vaccine. 2022 Jan 29. pii: S0264-410X(21)01674.
PubMed Abstract available

SHERIDAN S, McIntyre P, Liu B, Fathima P, et al
Pertussis burden and acellular pertussis vaccine effectiveness in high risk children.
Vaccine. 2022 Jan 28. pii: S0264-410X(21)01322.
PubMed Abstract available

MSUSA KP, Rogalski-Salter T, Mandi H, Clemens R, et al
Critical success factors for conducting human challenge trials for vaccine development in low- and middle-income countries.
Vaccine. 2022 Jan 28. pii: S0264-410X(22)00072.
PubMed Abstract available

KANTELE A, Rombo L, Vene S, Kundi M, et al
Three-dose versus four-dose primary schedules for tick-borne encephalitis (TBE) vaccine FSME-immun for those aged 50 years or older: A single-centre, open-label, randomized controlled trial.
Vaccine. 2022 Jan 28. pii: S0264-410X(22)00048.
PubMed Abstract available

KALNIN KV, Plitnik T, Kishko M, Huang D, et al
Pan-SARS neutralizing responses after third boost vaccination in non-human primate immunogenicity model.
Vaccine. 2022 Jan 28. pii: S0264-410X(22)00045.
PubMed Abstract available

WHITE AA, Neelon B, Martin RH, Cartmell KB, et al
Spatial patterns of HPV and Tdap vaccine dose administration and the association of health department clinic access in Georgia counties.
Vaccine. 2022 Jan 28. pii: S0264-410X(21)01647.
PubMed Abstract available

DING H, Huang J, Ngai CH, Sun Q, et al
The cost-effectiveness of starting 23-valent pneumococcal polysaccharide vaccine and influenza vaccination at 50 vs. 65 years: A comparative modelling study.
Vaccine. 2022 Jan 28. pii: S0264-410X(22)00057.
PubMed Abstract available

STEPPERT P, Mosor M, Stanek L, Burgstaller D, et al
A scalable, integrated downstream process for production of a recombinant measles virus-vectored vaccine.
Vaccine. 2022 Jan 27. pii: S0264-410X(22)00019.
PubMed Abstract available

HE Q, Xiao J, Liu M, Li Z, et al
Immunogenicity of meningococcal polysaccharide conjugate vaccine as a replacement for meningococcal polysaccharide vaccine in children in Guangzhou, China.
Vaccine. 2022 Jan 27. pii: S0264-410X(21)01200.
PubMed Abstract available

JAFFE AE, Graupensperger S, Blayney JA, Duckworth JC, et al
The role of perceived social norms in college student vaccine hesitancy: Implications for COVID-19 prevention strategies.
Vaccine. 2022 Jan 26. pii: S0264-410X(22)00073.
PubMed Abstract available

KARAFILLAKIS E, Peretti-Watel P, Verger P, Chantler T, et al
'I trust them because my mum trusts them': Exploring the role of trust in HPV vaccination decision-making among adolescent girls and their mothers in France.
Vaccine. 2022 Jan 25. pii: S0264-410X(22)00046.
PubMed Abstract available

IANNINO F, Uriza PJ, Duarte CM, Pepe MV, et al
Development of a Salmonella-based oral vaccine to control intestinal colonization of Shiga-toxin-producing Escherichia coli (STEC) in animals.
Vaccine. 2022 Jan 24. pii: S0264-410X(22)00056.
PubMed Abstract available

OGUTI B, Ali A, Andrews N, Barug D, et al
The half-life of maternal transplacental antibodies against diphtheria, tetanus, and pertussis in infants: an individual participant data meta-analysis.
Vaccine. 2022;40:450-458.
PubMed Abstract available

ZINTGRAFF J, Gagetti P, Napoli D, Sanchez Eluchans N, et al
Invasive Streptococcus pneumoniae isolates from pediatric population in Argentina for the period 2006-2019. Temporal progression of serotypes distribution and antibiotic resistance.
Vaccine. 2022;40:459-470.
PubMed Abstract available

BLUNCK BN, Aideyan L, Ye X, Avadhanula V, et al
Antibody responses of healthy adults to the p27 peptide of respiratory syncytial virus fusion protein.
Vaccine. 2022;40:536-543.
PubMed Abstract available

KIMOTO T
Development of a safe and effective novel synthetic mucosal adjuvant SF-10 derived from physiological metabolic pathways and function of human pulmonary surfactant.
Vaccine. 2022;40:544-553.
PubMed Abstract available

TANGUAY M, Boutin M, Laumaea A, Salaciak M, et al
B-cell cytopenia and time to last B-cell-depleting therapy predict response to SARS-COV-2 vaccines in patients with lymphoproliferative disorders.
Vaccine. 2022 Jan 24. pii: S0264-410X(22)00071.
PubMed Abstract available

TRICOU V, Gottardo R, Egan MA, Clement F, et al
Characterization of the cell-mediated immune response to Takeda's live-attenuated tetravalent dengue vaccine in adolescents participating in a phase 2 randomized controlled trial conducted in a dengue-endemic setting.
Vaccine. 2022 Jan 22. pii: S0264-410X(22)00040.
PubMed Abstract available

HIDALGO-RUIZ M, Mejia-Lopez S, Perez-Serrano RM, Zaldivar-Lelo de Larrea G, et al
Babesia bovis AMA-1, MSA-2c and RAP-1 contain conserved B and T-cell epitopes, which generate neutralizing antibodies and a long-lasting Th1 immune response in vaccinated cattle.
Vaccine. 2022 Jan 22. pii: S0264-410X(22)00049.
PubMed Abstract available

GHASWALLA PK, Bengtson LGS, Marshall GS, Buikema AR, et al
Corrigendum to 'Meningococcal vaccination in patients with newly diagnosed asplenia in the United States' [Vaccine 39 (2021) 272-281].
Vaccine. 2022 Jan 22. pii: S0264-410X(21)00994.
PubMed

TRENT MJ, Salmon DA, MacIntyre CR
Predictors of pneumococcal vaccination among Australian adults at high risk of pneumococcal disease.
Vaccine. 2022 Jan 22. pii: S0264-410X(22)00026.
PubMed Abstract available

STEBBINGS R, Armour G, Pettis V, Goodman J, et al
AZD1222 (ChAdOx1 nCov-19): A Single-Dose biodistribution study in mice.
Vaccine. 2022;40:192-195.
PubMed Abstract available

DRAZAN D, Czajka H, Maguire JD, Pregaldien JL, et al
A phase 3 study to assess the immunogenicity, safety, and tolerability of MenB-FHbp administered as a 2-dose schedule in adolescents and young adults.
Vaccine. 2022;40:351-358.
PubMed Abstract available

RUSTANDI RR, Xu Q
Reactivity characterization of bromoacetyl derivatized polyribosylribitol polysaccharide in Haemophilus influenzae type b for PedvaxHIB(R) by NMR spectroscopy.
Vaccine. 2022;40:187-191.
PubMed Abstract available

TUN ZM, Ring Z, Tam CC
Factors associated with maternal tetanus vaccination in Myanmar: An analysis of demographic and health survey data.
Vaccine. 2022 Jan 20. pii: S0264-410X(22)00042.
PubMed Abstract available

LIU F, Feng C, Xu S, Wu Q, et al
An AAV vaccine targeting the RBD of the SARS-CoV-2 S protein induces effective neutralizing antibody titers in mice and canines.
Vaccine. 2022 Jan 20. pii: S0264-410X(22)00054.
PubMed Abstract available

LIAO Q, Cowling BJ, Xiao J, Yuan J, et al
Priming with social benefit information of vaccination to increase acceptance of COVID-19 vaccines.
Vaccine. 2022 Jan 20. pii: S0264-410X(22)00055.
PubMed Abstract available

LI LL, Zheng C, La J, Do NV, et al
Impact of prior SARS-CoV-2 infection on incidence of hospitalization and adverse events following mRNA SARS-CoV-2 vaccination: A nationwide, retrospective cohort study.
Vaccine. 2022 Jan 19. pii: S0264-410X(22)00051.
PubMed Abstract available

PITCOVSKI J, Gruzdev N, Abzach A, Katz C, et al
Oral subunit SARS-CoV-2 vaccine induces systemic neutralizing IgG, IgA and cellular immune responses and can boost neutralizing antibody responses primed by an injected vaccine.
Vaccine. 2022 Jan 19. pii: S0264-410X(22)00050.
PubMed Abstract available

ZHU D, Lv M, Bai Y, Wu J, et al
Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in Beijing: A modeling analysis.
Vaccine. 2022 Jan 19. pii: S0264-410X(22)00024.
PubMed Abstract available

PASSARETTI CL, Priem JS, Agner TG, McCurdy L, et al
Reducing the rates of household transmission: The impact of COVID-19 vaccination in healthcare workers with a known household exposure.
Vaccine. 2022 Jan 19. pii: S0264-410X(22)00044.
PubMed Abstract available

TUSE D, Malm M, Tamminen K, Diessner A, et al
Safety and immunogenicity studies in animal models support clinical development of a bivalent norovirus-like particle vaccine produced in plants.
Vaccine. 2022 Jan 18. pii: S0264-410X(22)00022.
PubMed Abstract available

ROLFES L, Harmark L, Kant A, van Balveren L, et al
COVID-19 vaccine reactogenicity - A cohort event monitoring study in the Netherlands using patient reported outcomes.
Vaccine. 2022 Jan 17. pii: S0264-410X(22)00028.
PubMed Abstract available

OHFUJI S, Tanaka T, Nakano T, Kase T, et al
Annual trends in adverse events following mumps vaccination in Japan: A retrospective study.
Vaccine. 2022 Jan 17. pii: S0264-410X(22)00023.
PubMed Abstract available

BEDSTON S, Akbari A, Jarvis CI, Lowthian E, et al
COVID-19 vaccine uptake, effectiveness, and waning in 82,959 health care workers: A national prospective cohort study in Wales.
Vaccine. 2022 Jan 15. pii: S0264-410X(21)01535.
PubMed Abstract available

TANAKA M, Okubo R, Hoshi SL, Ishikawa N, et al
Cost-effectiveness of pertussis booster vaccination for preschool children in Japan.
Vaccine. 2022 Jan 13. pii: S0264-410X(22)00003.
PubMed Abstract available

SIMON JK, Staerke NB, Hemming-Harlo M, Layle S, et al
Lot-to-lot consistency, safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in healthy adults aged >/=50 years: A randomized phase 3 trial (PNEU-TRUE).
Vaccine. 2022 Jan 13. pii: S0264-410X(21)01675.
PubMed Abstract available

MALTER KB, Tugel ME, Gil-Rodriguez M, Guardia G, et al
Variability in non-core vaccination rates of dogs and cats in veterinary clinics across the United States.
Vaccine. 2022 Jan 13. pii: S0264-410X(22)00006.
PubMed Abstract available

WARNER EL, Barbati JL, Duncan KL, Yan K, et al
Vaccine misinformation types and properties in Russian troll tweets.
Vaccine. 2022 Jan 13. pii: S0264-410X(21)01648.
PubMed Abstract available

MOYO P, Bosco E, Bardenheier BH, Rivera-Hernandez M, et al
Variation in influenza vaccine assessment, receipt, and refusal by the concentration of Medicare Advantage enrollees in U.S. nursing homes.
Vaccine. 2022 Jan 13. pii: S0264-410X(21)01688.
PubMed Abstract available

WONG WHS, Leung D, Chua GT, Duque JSR, et al
Adolescents' attitudes to the COVID-19 vaccination.
Vaccine. 2022 Jan 12. pii: S0264-410X(22)00025.
PubMed Abstract available

WOO EJ, Moro PL
Postmarketing safety surveillance of high-dose quadrivalent influenza vaccine: Reports to the Vaccine Adverse Event Reporting System.
Vaccine. 2022 Jan 11. pii: S0264-410X(22)00001.
PubMed Abstract available

SHIMIZU S, Tanaka R, Itoh E, Maekawa-Matsuura M, et al
Performance and usability evaluation of novel intradermal injection device Immucise and reanalysis of intradermal administration trials of influenza vaccine for the elderly.
Vaccine. 2022 Jan 11. pii: S0264-410X(21)01669.
PubMed Abstract available

BLYTH DM, Liang Z, Williams M, Murray CK, et al
Immune interference revisited: Impact of live-attenuated influenza vaccine prior to yellow fever vaccination.
Vaccine. 2022 Jan 11. pii: S0264-410X(21)01637.
PubMed Abstract available

DANIEL CL, Williams J, Legg R, McGowen C, et al
Factors associated with COVID-19 vaccination intentions among adults in the deep South.
Vaccine. 2022 Jan 10. pii: S0264-410X(21)01667.
PubMed Abstract available

PENG KW, Carey T, Lech P, Vandergaast R, et al
Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine.
Vaccine. 2022 Jan 10. pii: S0264-410X(21)01671.
PubMed Abstract available

OMER I, Rosenberg A, Sefty H, Pando R, et al
Lineage-matched versus mismatched influenza B vaccine effectiveness following seasons of marginal influenza B circulation.
Vaccine. 2022 Jan 8. pii: S0264-410X(21)01664.
PubMed Abstract available

VADLAMUDI NK, Patrick DM, Rose C, Sadatsafavi M, et al
A population-based analysis to determine the impact of the 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in British Columbia, Canada.
Vaccine. 2022 Jan 7. pii: S0264-410X(21)01673.
PubMed Abstract available

FOO D, Sarna M, Pereira G, Moore HC, et al
Longitudinal, population-based cohort study of prenatal influenza vaccination and influenza infection in childhood.
Vaccine. 2022 Jan 7. pii: S0264-410X(21)01556.
PubMed Abstract available

UWAMINO Y, Kurafuji T, Sato Y, Tomita Y, et al
Young age, female sex, and presence of systemic adverse reactions are associated with high post-vaccination antibody titer after two doses of BNT162b2 mRNA SARS-CoV-2 vaccination: An observational study of 646 Japanese healthcare workers and universit
Vaccine. 2022 Jan 7. pii: S0264-410X(22)00002.
PubMed Abstract available

HSIAO A, Hansen J, Nunley KV, Lewis N, et al
Safety of recombinant quadrivalent influenza vaccine compared to inactivated influenza vaccine in Chinese adults: An observational study.
Vaccine. 2022 Jan 6. pii: S0264-410X(21)01641.
PubMed Abstract available

EUSER S, Kroese FM, Derks M, de Bruin M, et al
Understanding COVID-19 vaccination willingness among youth: A survey study in the Netherlands.
Vaccine. 2022 Jan 5. pii: S0264-410X(21)01670.
PubMed Abstract available

HUANG Z, Ji M, Ren J, Sun X, et al
Effect of the framing of HPV vaccination on parents' willingness to accept an HPV vaccine.
Vaccine. 2022 Jan 4. pii: S0264-410X(21)01659.
PubMed Abstract available

GLADSTONE RA, Siira L, Brynildsrud OB, Vestrheim DF, et al
International links between Streptococcus pneumoniae vaccine serotype 4 sequence type (ST) 801 in Northern European shipyard outbreaks of invasive pneumococcal disease.
Vaccine. 2022 Jan 4. pii: S0264-410X(21)01377.
PubMed Abstract available

LEDLIE S, Ricci C, Pan C, Rojas A, et al
Yellow fever vaccine usage in the United States and risk of neurotropic and viscerotropic disease: A retrospective cohort study using three healthcare databases.
Vaccine. 2022 Jan 4. pii: S0264-410X(21)01655.
PubMed Abstract available

VILLENA R, Valenzuela MT, Bastias M, Santolaya ME, et al
Invasive meningococcal disease in Chile seven years after ACWY conjugate vaccine introduction.
Vaccine. 2022 Jan 4. pii: S0264-410X(21)01549.
PubMed Abstract available

PENLINGTON M, Goulet P, Metcalfe B
Improving knowledge and trust in vaccines: A survey-based assessment of the potential of the European Union Clinical Trial Regulation No 536/2014 plain language summary to increase health literacy.
Vaccine. 2022 Jan 4. pii: S0264-410X(21)01653.
PubMed Abstract available

ZHANG J, Ji Y, Wang Z, Jia Y, et al
Effective improvements to the live-attenuated Newcastle disease virus vaccine by polyethylenimine-based biomimetic silicification.
Vaccine. 2022 Jan 3. pii: S0264-410X(21)01662.
PubMed Abstract available

KUZNETSOVA A, Ceregido MA, Jourquin A, Campora L, et al
Fourteen years of the Pregnancy Registry on maternal immunisation with a reduced-antigen-content tetanus-diphtheria-acellular pertussis (Tdap) vaccine.
Vaccine. 2022 Jan 3. pii: S0264-410X(21)01658.
PubMed Abstract available

OHM M, Knol MJ, Vos ERA, Bogaard MJM, et al
Seroprevalence of meningococcal ACWY antibodies across the population in the Netherlands: Two consecutive surveys in 2016/17 and 2020.
Vaccine. 2022;40:59-66.
PubMed Abstract available

KUJAWSKI SA, Yao L, Wang HE, Carias C, et al
Impact of the COVID-19 pandemic on pediatric and adolescent vaccinations and well child visits in the United States: A database analysis.
Vaccine. 2022 Jan 1. pii: S0264-410X(21)01672.
PubMed Abstract available

December 2021

PASCHALL AV, Ozdilek A, Briner SL, Brindley MA, et al
Modulation of immunosuppressant drug treatment to improve SARS-CoV-2 vaccine efficacy in mice.
Vaccine. 2021 Dec 31. pii: S0264-410X(21)01666.
PubMed Abstract available

GROOM HC, Crane B, Naleway AL, Weintraub E, et al
Monitoring vaccine safety using the vaccine safety Datalink: Assessing capacity to integrate data from Immunization Information systems.
Vaccine. 2021 Dec 31. pii: S0264-410X(21)01656.
PubMed Abstract available

LUBLIN A, Katz C, Gruzdev N, Yadid I, et al
Protection against avian coronavirus conferred by oral vaccination with live bacteria secreting LTB-fused viral proteins.
Vaccine. 2021 Dec 30. pii: S0264-410X(21)01661.
PubMed Abstract available

SAELAND E, van der Fits L, Bolder R, Heemskerk-van der Meer M, et al
Immunogenicity and protective efficacy of adenoviral and subunit RSV vaccines based on stabilized prefusion F protein in pre-clinical models.
Vaccine. 2021 Dec 29. pii: S0264-410X(21)01651.
PubMed Abstract available

FAINGELERNT Y, Dagan R, Givon-Lavi N, van der Beek BA, et al
The impact of the pneumococcal conjugate vaccines on the incidence of community-acquired alveolar pneumonia in premature compared with in term-born infants.
Vaccine. 2021 Dec 29. pii: S0264-410X(21)01636.
PubMed Abstract available

ASOGWA OA, de Hoog MLA, Bruijning-Verhagen PCJI
Impact of 7-valent versus 10-valent pneumococcal conjugate vaccines on primary care consultations across various age groups in the Netherlands, 5 years after the switch: A time-series analysis.
Vaccine. 2021 Dec 27. pii: S0264-410X(21)01533.
PubMed Abstract available

REIS LR, Costa-Rocha IAD, Campi-Azevedo AC, Peruhype-Magalhaes V, et al
Exploratory study of humoral and cellular immunity to 17DD Yellow Fever vaccination in children and adults residents of areas without circulation of Yellow Fever Virus.
Vaccine. 2021 Dec 27. pii: S0264-410X(21)01638.
PubMed Abstract available

KUSI KA, Ofori EA, Akyea-Mensah K, Kyei-Baafour E, et al
Towards large-scale identification of HLA-restricted T cell epitopes from four vaccine candidate antigens in a malaria endemic community in Ghana.
Vaccine. 2021 Dec 27. pii: S0264-410X(21)01650.
PubMed Abstract available

CHOWDHURY F, Akter A, Bhuiyan TR, Tauheed I, et al
A non-inferiority trial comparing two killed, whole cell, oral cholera vaccines (Cholvax vs. Shanchol) in Dhaka, Bangladesh.
Vaccine. 2021 Dec 27. pii: S0264-410X(21)01623.
PubMed Abstract available

SHUKLA S, Fressin F, Un M, Coetzer H, et al
Optimizing vaccine distribution via mobile clinics: a case study on COVID-19 vaccine distribution to long-term care facilities.
Vaccine. 2021 Dec 27. pii: S0264-410X(21)01657.
PubMed Abstract available

RIBEIRO SP, De Moura Mattaraia VG, Almeida RR, Valentine EJG, et al
A promiscuous T cell epitope-based HIV vaccine providing redundant population coverage of the HLA class II elicits broad, polyfunctional T cell responses in nonhuman primates.
Vaccine. 2021 Dec 24. pii: S0264-410X(21)01550.
PubMed Abstract available

DE KOFF EM, van Houten MA, de Heij F, Berbers GAM, et al
Salivary antibody responses to ten-valent pneumococcal conjugate vaccination following two different immunization schedules in a healthy birth cohort.
Vaccine. 2021 Dec 24. pii: S0264-410X(21)01622.
PubMed Abstract available

FREEMAN RE, Thaker J, Daley MF, Glanz JM, et al
Vaccine timeliness and prevalence of undervaccination patterns in children ages 0-19 months, U.S., National immunization Survey-Child 2017.
Vaccine. 2021 Dec 24. pii: S0264-410X(21)01645.
PubMed Abstract available

JUNE CHOE Y, Yi S, Hwang I, Kim J, et al
Safety and effectiveness of BNT162b2 mRNA Covid-19 vaccine in adolescents.
Vaccine. 2021 Dec 24. pii: S0264-410X(21)01654.
PubMed Abstract available

THOMAS SJ, Perez JL, Lockhart SP, Hariharan S, et al
Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial.
Vaccine. 2021 Dec 24. pii: S0264-410X(21)01652.
PubMed Abstract available

LACY J, Tessier E, Andrews N, White J, et al
Impact of an accelerated measles-mumps-rubella (MMR) vaccine schedule on vaccine coverage: An ecological study among London children, 2012-2018.
Vaccine. 2021 Dec 23. pii: S0264-410X(21)01619.
PubMed Abstract available

BRENNAN T, Hidle A, Doshi RH, An Q, et al
Cost of human papillomavirus vaccine delivery in a single-age cohort, routine-based vaccination program in Senegal.
Vaccine. 2021 Dec 23. pii: S0264-410X(21)01531.
PubMed Abstract available

RAHIM S, Ahmad Z, Abdul-Ghafar J
The polio vaccination story of Pakistan.
Vaccine. 2021 Dec 23. pii: S0264-410X(21)01595.
PubMed Abstract available

FERNANDES C, Alves J, Rodrigues A, Azevedo J, et al
Epidemiological impact of the human papillomavirus vaccination program on genital warts in Portugal: A retrospective, chart review study.
Vaccine. 2021 Dec 22. pii: S0264-410X(21)01544.
PubMed Abstract available

KIM HJ, Yun HJ, Kim J, Kym S, et al
Antibody response to second dose of the BNT162b2 mRNA vaccine in the first 12 weeks in South Korea: A prospective longitudinal study.
Vaccine. 2021 Dec 22. pii: S0264-410X(21)01620.
PubMed Abstract available

ROMAIN-SCELLE N, Elias C, Vanhems P
COVID-19 vaccine is correlated with favourable epidemiological indicators in the Auvergne-Rhone-Alpes region (France): An ecological study.
Vaccine. 2021 Dec 22. pii: S0264-410X(21)01644.
PubMed Abstract available

MANOMAIPIBOON A, Phumisantiphong U, Maneerit J, Chalearmchai Y, et al
Immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 with 12-dose vials: An interim analysis.
Vaccine. 2021 Dec 22. pii: S0264-410X(21)01632.
PubMed Abstract available

KENNEDY RB, Ovsyannikova IG, Haralambieva IH, Grill DE, et al
Proteomic assessment of humoral immune responses in smallpox vaccine recipients.
Vaccine. 2021 Dec 21. pii: S0264-410X(21)01642.
PubMed Abstract available

PORTH JM, Wagner AL, Treleaven E, Fleischer NL, et al
Childhood vaccination timeliness following maternal migration to an informal urban settlement in Kenya.
Vaccine. 2021 Dec 21. pii: S0264-410X(21)01625.
PubMed Abstract available

TADAKUMA K, Maruyama T, Mori K, Fujiki N, et al
Effectiveness of seasonal influenza vaccine in adult Japanese workers, 2017-2020.
Vaccine. 2021 Dec 21. pii: S0264-410X(21)01624.
PubMed Abstract available

ERBER W, Khan F, Zavadska D, Freimane Z, et al
Effectiveness of TBE vaccination in southern Germany and Latvia.
Vaccine. 2021 Dec 21. pii: S0264-410X(21)01639.
PubMed Abstract available

PETERSEN MB, Jorgensen F, Lindholt MF
Did the European suspension of the AstraZeneca vaccine decrease vaccine acceptance during the COVID-19 pandemic?
Vaccine. 2021 Dec 21. pii: S0264-410X(21)01631.
PubMed Abstract available

WILLIAMS KV, Zhai B, Alcorn JF, Patricia Nowalk M, et al
A randomized controlled trial of antibody response to 2019-20 cell-based inactivated and egg-based live attenuated influenza vaccines in children and young adults.
Vaccine. 2021 Dec 21. pii: S0264-410X(21)01643.
PubMed Abstract available

SHAPIRO GK, Gottfredson N, Leask J, Wiley K, et al
COVID-19 and missed or delayed vaccination in 26 middle- and high-income countries: An observational survey.
Vaccine. 2021 Dec 21. pii: S0264-410X(21)01649.
PubMed Abstract available

BLANCO S, Salome Konigheim B, Diaz A, Spinsanti L, et al
Evaluation of the Gam-COVID-Vac and vaccine-induced neutralizing response against SARS-CoV-2 lineage P.1 variant in an Argentinean cohort.
Vaccine. 2021 Dec 20. pii: S0264-410X(21)01634.
PubMed Abstract available

NASREEN S, Wang J, Kwong JC, Crowcroft NS, et al
Population-based incidence of invasive pneumococcal disease in children and adults in Ontario and British Columbia, 2002-2018: A Canadian Immunization Research Network (CIRN) study.
Vaccine. 2021;39:7545-7553.
PubMed Abstract available

IVANOVA-MARKOVA Y, Gonzalez-Dominguez A, Hidalgo A, Sanchez R, et al
Cost of illness of invasive meningococcal disease caused by serogroup B Neisseria meningitidis in Spain.
Vaccine. 2021;39:7646-7654.
PubMed Abstract available

RANADE D, Jena R, Sancheti S, Deore V, et al
Rapid, high throughput protein estimation method for saponin and alhydrogel adjuvanted R21 VLP Malaria vaccine based on intrinsic fluorescence.
Vaccine. 2021 Dec 18. pii: S0264-410X(21)01627.
PubMed Abstract available

HERRING WL, Zhang Y, Shinde V, Stoddard J, et al
Clinical and economic outcomes associated with respiratory syncytial virus vaccination in older adults in the United States.
Vaccine. 2021 Dec 18. pii: S0264-410X(21)01609.
PubMed Abstract available

POUKKA E, Baum U, Palmu AA, Lehtonen TO, et al
Cohort study of Covid-19 vaccine effectiveness among healthcare workers in Finland, December 2020 - October 2021.
Vaccine. 2021 Dec 18. pii: S0264-410X(21)01640.
PubMed Abstract available

WIDGREN K, Tomba GS, Leung KY, Giesecke J, et al
Modelling varicella vaccination - What does a lack of surge in herpes zoster incidence tell us about exogenous boosting?
Vaccine. 2021 Dec 17. pii: S0264-410X(21)01537.
PubMed Abstract available

CHUNG NH, Chen YC, Yang SJ, Lin YC, et al
Induction of Th1 and Th2 in the protection against SARS-CoV-2 through mucosal delivery of an adenovirus vaccine expressing an engineered spike protein.
Vaccine. 2021 Dec 17. pii: S0264-410X(21)01635.
PubMed Abstract available

CARLSON SJ, McKenzie L, Roberts L, Blyth CC, et al
Does a major change to a COVID-19 vaccine program alter vaccine intention? A qualitative investigation.
Vaccine. 2021 Dec 16. pii: S0264-410X(21)01629.
PubMed Abstract available

GOLDBLATT D, Fiore-Gartland A, Johnson M, Hunt A, et al
Towards a population-based threshold of protection for COVID-19 vaccines.
Vaccine. 2021 Dec 15. pii: S0264-410X(21)01615.
PubMed Abstract available

YU Y, Jia W, Lau MMC, Lau JTF, et al
Levels and factors derived from the Health Action Process Approach of behavioral intentions to take up COVID-19 vaccination: A random population-based study.
Vaccine. 2021 Dec 15. pii: S0264-410X(21)01628.
PubMed Abstract available

CHEN X, Wang H
On the rise of the new B.1.1.529 variant: Five dimensions of access to a COVID-19 vaccine.
Vaccine. 2021 Dec 14. pii: S0264-410X(21)01596.
PubMed Abstract available

ALMOHAYA AM, Alsubie H, Alqarni B, Alzayad B, et al
Acute unsolicited adverse events following BNT162b2 vaccine in Saudi Arabia, a real-world data.
Vaccine. 2021 Dec 13. pii: S0264-410X(21)01610.
PubMed Abstract available

KURANI S, MacLaughlin KL, Jacobson RM, St Sauver JL, et al
Socioeconomic disadvantage and human papillomavirus (HPV) vaccination uptake.
Vaccine. 2021 Dec 13. pii: S0264-410X(21)01611.
PubMed Abstract available

BOTTON J, Dray-Spira R, Baricault B, Drouin J, et al
Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines.
Vaccine. 2021 Dec 11. pii: S0264-410X(21)01617.
PubMed Abstract available

COSSU D, Ruberto S, Yokoyama K, Hattori N, et al
Efficacy of BCG vaccine in animal models of neurological disorders.
Vaccine. 2021 Dec 11. pii: S0264-410X(21)01613.
PubMed Abstract available

LUTRICK K, Groom H, Fowlkes AL, Groover KD, et al
COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers.
Vaccine. 2021 Dec 11. pii: S0264-410X(21)01593.
PubMed Abstract available

HSIEH YL, Rak S, SteelFisher GK, Bauhoff S, et al
Effect of the suspension of the J&J COVID-19 vaccine on vaccine hesitancy in the United States.
Vaccine. 2021 Dec 11. pii: S0264-410X(21)01559.
PubMed Abstract available

OLIVEIRA-SILVA J, Reis T, Lopes C, Batista-Silva R, et al
Humoral response to the SARS-CoV-2 BNT162b2 mRNA vaccine: Real-world data from a large cohort of healthcare workers.
Vaccine. 2021 Dec 11. pii: S0264-410X(21)01621.
PubMed Abstract available

ZHAO AR, Bishai DM
Public health spending, primary care, and perceived risk promoted vaccination against H1N1.
Vaccine. 2021 Dec 10. pii: S0264-410X(21)01538.
PubMed Abstract available

KATZ MA, Harlev EB, Chazan B, Chowers M, et al
Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI).
Vaccine. 2021 Dec 10. pii: S0264-410X(21)01580.
PubMed Abstract available

AVILA-AGUERO ML, Camacho-Badilla K, Ulloa-Gutierrez R, Espinal-Tejada C, et al
Epidemiology of pertussis in Costa Rica and the impact of vaccination: A 58-year experience (1961-2018).
Vaccine. 2021 Dec 10. pii: S0264-410X(21)01552.
PubMed Abstract available

KADKHODA K
Post RNA-based COVID vaccines myocarditis: Proposed mechanisms.
Vaccine. 2021 Dec 9. pii: S0264-410X(21)01594.
PubMed

ZHAO H, Li Y, Wang Z
Adverse event of Sinovac Coronavirus vaccine: Deafness.
Vaccine. 2021 Dec 9. pii: S0264-410X(21)01576.
PubMed Abstract available

HOOK SA, Hansen AP, Niesobecki SA, Meek JI, et al
Evaluating public acceptability of a potential Lyme disease vaccine using a population-based, cross-sectional survey in high incidence areas of the United States.
Vaccine. 2021 Dec 8. pii: S0264-410X(21)01540.
PubMed Abstract available

PEPIN J, Labbe AC, Carignan A, Parent ME, et al
Does BCG provide long-term protection against SARS-CoV-2 infection? A case-control study in Quebec, Canada.
Vaccine. 2021;39:7300-7307.
PubMed Abstract available

VON REYN CF
BCG versus rBCG: What is the way forward?
Vaccine. 2021;39:7319-7320.
PubMed

VAN HOOIJ A, van den Eeden SJF, Khatun M, Soren S, et al
BCG-induced immunity profiles in household contacts of leprosy patients differentiate between protection and disease.
Vaccine. 2021;39:7230-7237.
PubMed Abstract available

HEIJMENBERG I, Husain A, Sathkumara HD, Muruganandah V, et al
ESX-5-targeted export of ESAT-6 in BCG combines enhanced immunogenicity & efficacy against murine tuberculosis with low virulence and reduced persistence.
Vaccine. 2021;39:7265-7276.
PubMed Abstract available

KOWALEWICZ-KULBAT M, Locht C
BCG for the prevention and treatment of allergic asthma.
Vaccine. 2021;39:7341-7352.
PubMed Abstract available

LENNON RP, Block R Jr, Schneider EC, Zephrin L, et al
Underserved population acceptance of combination influenza-COVID-19 booster vaccines.
Vaccine. 2021 Dec 7. pii: S0264-410X(21)01597.
PubMed Abstract available

MA J, Casadei E, Bruce TJ, Sepahi A, et al
Long-term efficacy of nasal vaccination against enteric red mouth (ERM) disease and infectious hematopoietic necrosis (IHN) in juvenile rainbow trout (Oncorhynchus mykiss).
Vaccine. 2021 Dec 7. pii: S0264-410X(21)01551.
PubMed Abstract available

MARGOLIS MA, Brewer NT, Boynton MH, Lafata JE, et al
Provider response and follow-up to parental declination of HPV vaccination.
Vaccine. 2021 Dec 6. pii: S0264-410X(21)01529.
PubMed Abstract available

PEREZ-VILAR S, Dores GM, Marquez PL, Ng CS, et al
Safety surveillance of meningococcal group B vaccine (Bexsero(R)), Vaccine Adverse Event Reporting System, 2015-2018.
Vaccine. 2021 Dec 6. pii: S0264-410X(21)01545.
PubMed Abstract available

SULIS G, Basta NE, Wolfson C, Kirkland SA, et al
Influenza vaccination uptake among Canadian adults before and during the COVID-19 pandemic: An analysis of the Canadian Longitudinal study on Aging (CLSA).
Vaccine. 2021 Dec 4. pii: S0264-410X(21)01579.
PubMed Abstract available

RAW RK, Rees J, Kelly CA, Wroe C, et al
Prior COVID-19 infection is associated with increased Adverse Events (AEs) after the first, but not the second, dose of the BNT162b2/Pfizer vaccine.
Vaccine. 2021 Dec 4. pii: S0264-410X(21)01577.
PubMed Abstract available

BRONSTEIN MV, Kummerfeld E, MacDonald A 3rd, Vinogradov S, et al
Willingness to vaccinate against SARS-CoV-2: The role of reasoning biases and conspiracist ideation.
Vaccine. 2021 Dec 4. pii: S0264-410X(21)01553.
PubMed Abstract available

FACK C, Wood R, Hatherill M, Cobelens F, et al
The impact of a change in infant BCG vaccination policy on adolescent TB incidence rates: A South African population-level cohort study.
Vaccine. 2021 Dec 3. pii: S0264-410X(21)01488.
PubMed Abstract available

NGUYEN AT, Arnold BF, Kennedy CJ, Mishra K, et al
Evaluation of a city-wide school-located influenza vaccination program in Oakland, California with respect to race and ethnicity: A matched cohort study.
Vaccine. 2021 Dec 3. pii: S0264-410X(21)01547.
PubMed Abstract available

IZAK M, Stoyanov E, Dezuraev K, Shinar E, et al
Correlation of Anti-SARS-CoV-2 S1-specificIgG antibody levels and adverse events following vaccination with BNT162b2 mRNA COVID-19 vaccine in healthcare workers.
Vaccine. 2021 Dec 3. pii: S0264-410X(21)01557.
PubMed Abstract available

HERZBERG J, Vollmer T, Fischer B, Becher H, et al
SARS-CoV-2-antibody response in health care workers after vaccination or natural infection in a longitudinal observational study.
Vaccine. 2021 Dec 3. pii: S0264-410X(21)01555.
PubMed Abstract available

YORSAENG R, Suntronwong N, Phowatthanasathian H, Assawakosri S, et al
Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults.
Vaccine. 2021 Dec 3. pii: S0264-410X(21)01560.
PubMed Abstract available

HELLE F, Moyet J, Demey B, Francois C, et al
Humoral anti-SARS-CoV-2 immune response after two doses of Comirnaty vaccine in nursing home residents by previous infection status.
Vaccine. 2021 Dec 3. pii: S0264-410X(21)01558.
PubMed Abstract available

LI S, Chen W, Shen Y, Xia J, et al
Molecular characterization of infectious bronchitis virus in Southwestern China for the protective efficacy evaluation of four live vaccine strains.
Vaccine. 2021 Dec 2. pii: S0264-410X(21)01546.
PubMed Abstract available

DUONG CH, Mueller JE, Tubert-Bitter P, Escolano S, et al
Estimation of mid-and long-term benefits and hypothetical risk of Guillain-Barre syndrome after human papillomavirus vaccination among boys in France: A simulation study.
Vaccine. 2021 Dec 2. pii: S0264-410X(21)01502.
PubMed Abstract available

WANG CH, Kung WJ, Lee CH, Lee CF, et al
High rates of colonization and antimicrobial resistance of group B streptococcus highlight the need for vaccination even after implementation of guidelines for intrapartum antibiotic prophylaxis.
Vaccine. 2021 Dec 2. pii: S0264-410X(21)01543.
PubMed Abstract available

MUNOZ-QUILES C, Lopez-Lacort M, Diez-Domingo J, Rodrigo-Casares V, et al
Human papillomavirus vaccines effectiveness to prevent genital warts: A population-based study using health system integrated databases, 2009-2017.
Vaccine. 2021 Dec 2. pii: S0264-410X(21)01536.
PubMed Abstract available

NEWALL AT, Beutels P, Tuffaha HW, Hall PS, et al
How can early stage economic evaluation help guide research for future vaccines?
Vaccine. 2021 Dec 2. pii: S0264-410X(21)01462.
PubMed

PRICE J, Mooney J, Bain C, Bawa JT, et al
National stakeholder preferences for next-generation rotavirus vaccines: Results from a six-country study.
Vaccine. 2021 Dec 2. pii: S0264-410X(21)01443.
PubMed Abstract available

VALCKX S, Crevecoeur J, Verelst F, Vranckx M, et al
Individual factors influencing COVID-19 vaccine acceptance in between and during pandemic waves (July-December 2020).
Vaccine. 2021 Dec 1. pii: S0264-410X(21)01414.
PubMed Abstract available

EZE P, Aniebo CL, Agu UJ, Agu SA, et al
Validity of maternal recall for estimating childhood vaccination coverage - Evidence from Nigeria.
Vaccine. 2021 Dec 1. pii: S0264-410X(21)01534.
PubMed Abstract available

WIRTZ C, Mohamed Y, Engel D, Sidibe A, et al
Integrating HPV vaccination programs with enhanced cervical cancer screening and treatment, a systematic review.
Vaccine. 2021 Dec 1. pii: S0264-410X(21)01447.
PubMed Abstract available

November 2021

ATTWELL K, Rizzi M, McKenzie L, Carlson SJ, et al
COVID-19 vaccine Mandates: An Australian attitudinal study.
Vaccine. 2021 Nov 30. pii: S0264-410X(21)01530.
PubMed Abstract available

SUGISHITA Y, Sugawara T
Effectiveness and cost-effectiveness of influenza vaccination for elderly people.
Vaccine. 2021 Nov 29. pii: S0264-410X(21)01257.
PubMed Abstract available

PORRAS C, Sampson JN, Herrero R, Gail MH, et al
Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trial.
Vaccine. 2021 Nov 29. pii: S0264-410X(21)01486.
PubMed Abstract available

ZOU X, He J, Zheng J, Liang M, et al
Evaluation of effectiveness, safety and cost-benefit of the 23- valent pneumococcal capsular polysaccharide vaccine for HIV-Infected patients.
Vaccine. 2021 Nov 29. pii: S0264-410X(21)01532.
PubMed Abstract available

LAURENZ M, von Eiff C, Borchert K, Jacob C, et al
Vaccination rates and adherence in premature infants before and after pneumococcal conjugate vaccine schedule change for term infants - A claims database analysis in Germany.
Vaccine. 2021 Nov 28. pii: S0264-410X(21)01437.
PubMed Abstract available

LI H, Monslow MA, Freed DC, Chang D, et al
Novel adjuvants enhance immune responses elicited by a replication-defective human cytomegalovirus vaccine in nonhuman primates.
Vaccine. 2021 Nov 28. pii: S0264-410X(21)01416.
PubMed Abstract available

MALTEZOU HC, Anastassopoulou C, Hatziantoniou S, Poland GA, et al
Anaphylaxis rates associated with COVID-19 vaccines are comparable to those of other vaccines.
Vaccine. 2021 Nov 27. pii: S0264-410X(21)01539.
PubMed Abstract available

CASTRO F, Pascale JM, Slocum Hewitt I, Calvo A, et al
Mass vaccination campaign during the 2016 influenza outbreak in Panama: Challenges and implications for COVID-19 vaccination efforts.
Vaccine. 2021 Nov 27. pii: S0264-410X(21)01504.
PubMed

SCHMITZ M, Luminet O, Klein O, Morbee S, et al
Predicting vaccine uptake during COVID-19 crisis: A motivational approach.
Vaccine. 2021 Nov 27. pii: S0264-410X(21)01542.
PubMed Abstract available

JIN P, Sun F, Liu Q, Wang Q, et al
An oral vaccine based on chitosan/aluminum adjuvant induces both local and systemic immune responses in turbot (Scophthalmus maximus).
Vaccine. 2021 Nov 26. pii: S0264-410X(21)01396.
PubMed Abstract available

GULPINAR G, Uzun MB
Examining community pharmacists' intention to provide pharmacist-driven vaccination services: A structural equation modelling.
Vaccine. 2021 Nov 26. pii: S0264-410X(21)01499.
PubMed Abstract available

ROBERTSON JS, Loizides U, Adisa A, Lopez de la Rica Manjavacas A, et al
International Nonproprietary Names (INN) for novel vaccine substances: A matter of safety.
Vaccine. 2021 Nov 26. pii: S0264-410X(21)01528.
PubMed Abstract available

ENGEL D, Afeli ADJ, Morgan C, Zeck W, et al
Promoting adolescent health through integrated human papillomavirus vaccination programs: The experience of Togo.
Vaccine. 2021 Nov 26. pii: S0264-410X(21)01466.
PubMed Abstract available

AHMED S, Dorin F, Satter SM, Sarker AR, et al
The economic burden of rotavirus hospitalization among children < 5 years of age in selected hospitals in Bangladesh.
Vaccine. 2021;39:7082-7090.
PubMed Abstract available

CANNON K, Elder C, Young M, Scott DA, et al
A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults >/=65 years of age with different prior pneumococcal vaccination.
Vaccine. 2021 Nov 25. pii: S0264-410X(21)01352.
PubMed Abstract available

KLEINWAKS G, Schmit V, Morrison J
Considering human challenge trials for tuberculosis vaccine development.
Vaccine. 2021 Nov 25. pii: S0264-410X(21)01469.
PubMed Abstract available

URUENA A, Badano MN, Bare P, Gonzalez J, et al
Humoral and cellular immune memory response 12 years following single dose vaccination against hepatitis A in Argentinian children.
Vaccine. 2021 Nov 24. pii: S0264-410X(21)01482.
PubMed Abstract available

BUCHMAN TG, Simpson SQ, Sciarretta KL, Finne KP, et al
Seasonal influenza vaccination is associated with reduced risk of death among Medicare beneficiaries().
Vaccine. 2021 Nov 23. pii: S0264-410X(21)01461.
PubMed Abstract available

BETTENCOURT PJG, Joosten SA, Lindestam Arlehamn CS, Behr MA, et al
100 years of the Bacillus Calmette-Guerin vaccine.
Vaccine. 2021 Nov 22. pii: S0264-410X(21)01483.
PubMed

SUN P, Jani V, Johnson A, Cheng Y, et al
T cell and memory B cell responses in tetravalent DNA, tetravalent inactivated and tetravalent live-attenuated prime-boost dengue vaccines in rhesus macaques.
Vaccine. 2021 Nov 22. pii: S0264-410X(21)01325.
PubMed Abstract available

DINC HO, Saltoglu N, Can G, Balkan II, et al
Inactive SARS-CoV-2 vaccine generates high antibody responses in healthcare workers with and without prior infection.
Vaccine. 2021 Nov 22. pii: S0264-410X(21)01507.
PubMed Abstract available

LENTZEN MP, Huebenthal V, Kaiser R, Kreppel M, et al
A retrospective analysis of social media posts pertaining to COVID-19 vaccination side effects.
Vaccine. 2021 Nov 22. pii: S0264-410X(21)01526.
PubMed Abstract available

AREGA SM, Knobel DL, Toka FN, Conan A, et al
Non-specific effects of veterinary vaccines: a systematic review.
Vaccine. 2021 Nov 20. pii: S0264-410X(21)01479.
PubMed Abstract available

HARA M, Koshida R, Nakano T
Parents' views on mumps, mumps vaccine, and the factors associated with vaccination in Japan.
Vaccine. 2021 Nov 20. pii: S0264-410X(21)01449.
PubMed Abstract available

YE K, Shi D, Zhang Z, Bian L, et al
A chemiluminescence immunoassay for precise automatic quality control of glycoprotein in human rabies vaccine.
Vaccine. 2021 Nov 20. pii: S0264-410X(21)01393.
PubMed Abstract available

LIN C, Tu P, Terry TC
Moving the needle on racial disparity: COVID-19 vaccine trust and hesitancy.
Vaccine. 2021 Nov 20. pii: S0264-410X(21)01444.
PubMed Abstract available

CHEN T, Dai M, Xia S
Perceived facilitators and barriers to intentions of receiving the COVID-19 vaccines among elderly Chinese adults.
Vaccine. 2021 Nov 19. pii: S0264-410X(21)01484.
PubMed Abstract available

CAMBON L, Schwarzinger M, Alla F
Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world's most vaccine-hesitant countries.
Vaccine. 2021 Nov 19. pii: S0264-410X(21)01467.
PubMed Abstract available

MUSCATELLO DJ, Nazareno AL, Turner RM, Newall AT, et al
Influenza-associated mortality in Australia, 2010 through 2019: High modelled estimates in 2017.
Vaccine. 2021 Nov 19. pii: S0264-410X(21)01464.
PubMed Abstract available

BELLIZZI S, Aidyralieva C, Al-Shaikh A, Muthu N, et al
Inclusiveness of prisons in COVID-19 vaccination deployment: Evidence from Jordan.
Vaccine. 2021 Nov 18. pii: S0264-410X(21)01468.
PubMed

ORTEGA-SANCHEZ IR, Mott JA, Kittikraisak W, Khanthamaly V, et al
Cost-effectiveness of seasonal influenza vaccination in pregnant women, healthcare workers and adults >= 60 years of age in Lao People's Democratic Republic.
Vaccine. 2021 Nov 18. pii: S0264-410X(21)01445.
PubMed Abstract available

IRVING SA, Ball SW, Booth SM, Regan AK, et al
A multi-country investigation of influenza vaccine coverage in pregnant individuals, 2010-2016.
Vaccine. 2021 Nov 18. pii: S0264-410X(21)01463.
PubMed Abstract available

HAFNER-GIESSAUF H, Horn S, Schwantzer G, Sprenger-Mahr H, et al
Cholecalciferol supplementation to improve the hepatitis B vaccination response in hemodialysis patients: A first randomized open label pilot study (DeVitaHep).
Vaccine. 2021 Nov 18. pii: S0264-410X(21)01474.
PubMed Abstract available

BLAIN AE, Reese HE, Marjuki H, Topaz N, et al
Serogroup A, C, W, and Y meningococcal disease in persons previously vaccinated with a serogroup ACWY meningococcal vaccine - United States, 2014-2018.
Vaccine. 2021 Nov 18. pii: S0264-410X(21)01480.
PubMed Abstract available

WANG W, Wang Y, Wang Y, Yan F, et al
Vaccine bidding, procurement and distribution management practices in mainland China: A nationwide study.
Vaccine. 2021 Nov 18. pii: S0264-410X(21)01465.
PubMed Abstract available

NGUYEN KH, Anneser E, Toppo A, Allen JD, et al
Disparities in national and state estimates of COVID-19 vaccination receipt and intent to vaccinate by race/ethnicity, income, and age group among adults >/= 18 years, United States.
Vaccine. 2021 Nov 18. pii: S0264-410X(21)01485.
PubMed Abstract available

KITRO A, Sirikul W, Piankusol C, Rirermsoonthorn P, et al
Acceptance, attitude, and factors affecting the intention to accept COVID-19 vaccine among Thai people and expatriates living in Thailand.
Vaccine. 2021 Nov 17. pii: S0264-410X(21)01476.
PubMed Abstract available

JEAN BAPTISTE AE, Bawa S, Oteri AJ, Dieng B, et al
Nationwide measles supplementary immunization activities to increase immunity levels in Nigeria.
Vaccine. 2021;39 Suppl 3:C1-C2.
PubMed

KORAVE J, Bawa S, Ageda B, Ucho A, et al
Internal displacement; an impediment to the successful implementation of planned measles supplemental activities in Nigeria, a case study of Benue State.
Vaccine. 2021;39 Suppl 3:C76-C81.
PubMed Abstract available

HOFF NA, Bratcher A, Mukadi P, Ahuka S, et al
Increasing Ebola transmission behaviors 6 months post-vaccination: Comparing vaccinated and unvaccinated populations near 2018 Mbandaka Ebola outbreak in the Democratic Republic of Congo.
Vaccine. 2021 Nov 16. pii: S0264-410X(21)01404.
PubMed Abstract available

VOSS G, Jacquet JM, Tornieporth N, Kampmann B, et al
Meeting report: CEPI consultation on accelerating access to novel vaccines against emerging infectious diseases for pregnant and lactating women, London, 12-13 February 2020.
Vaccine. 2021 Nov 16. pii: S0264-410X(21)01382.
PubMed Abstract available

VOHRA P, Chintoan-Uta C, Bremner A, Mauri M, et al
Evaluation of a Campylobacter jejuni N-glycan-ExoA glycoconjugate vaccine to reduce C. jejuni colonisation in chickens.
Vaccine. 2021 Nov 16. pii: S0264-410X(21)01434.
PubMed Abstract available

LIANG Q, Li H, Chang X, Zhang H, et al
A phase 3 clinical trial of MINHAI PCV13 in Chinese children aged from 7 months to 5 years old.
Vaccine. 2021;39:6947-6955.
PubMed Abstract available

BRAKEL KA, Binjawadagi B, French-Kim K, Watts M, et al
Coexpression of respiratory syncytial virus (RSV) fusion (F) protein and attachment glycoprotein (G) in a vesicular stomatitis virus (VSV) vector system provides synergistic effects against RSV infection in a cotton rat model.
Vaccine. 2021;39:6817-6828.
PubMed Abstract available

BOBO FT, Asante A, Woldie M, Dawson A, et al
Child vaccination in sub-Saharan Africa: Increasing coverage addresses inequalities.
Vaccine. 2021 Nov 15. pii: S0264-410X(21)01439.
PubMed Abstract available

ESPARZA J, Damaso CR
Searching for the origin of the smallpox vaccine: Edward Jenner and his little-known horsepox hypothesis.
Vaccine. 2021 Nov 15. pii: S0264-410X(21)01441.
PubMed

AMEND KL, Turnbull B, Zhou L, Marks MA, et al
Vaccine initiation and 3-dose series completion of 4vHPV vaccine among US insured males 2012-2016.
Vaccine. 2021 Nov 15. pii: S0264-410X(21)01403.
PubMed Abstract available

SILAS J, Jones A, Weiss-Cohen L, Ayton P, et al
The seductive allure of technical language and its effect on covid-19 vaccine beliefs and intentions.
Vaccine. 2021 Nov 15. pii: S0264-410X(21)01472.
PubMed Abstract available

MURPHY RP, Taaffe C, Ahern E, McMahon G, et al
A meta-analysis of influenza vaccination following correspondence: Considerations for COVID-19.
Vaccine. 2021 Nov 15. pii: S0264-410X(21)01470.
PubMed Abstract available

ROGERS JH, Cox SN, Hughes JP, Link AC, et al
Trends in COVID-19 vaccination intent and factors associated with deliberation and reluctance among adult homeless shelter residents and staff, 1 November 2020 to 28 February 2021 - King County, Washington.
Vaccine. 2021 Nov 15. pii: S0264-410X(21)01471.
PubMed Abstract available

CHOKEPHAIBULKIT K, Puthanakit T, Bhat N, Mansouri S, et al
A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age.
Vaccine. 2021 Nov 14. pii: S0264-410X(21)01425.
PubMed Abstract available

BURKE RM, Shih S, Hsiung CA, Yen C, et al
Impact of rotavirus vaccination on rotavirus hospitalizations in Taiwanese children.
Vaccine. 2021 Nov 14. pii: S0264-410X(21)01397.
PubMed Abstract available

REESE HE, McNamara LA, Vianzon V, Blain A, et al
Serogroup B meningococcal disease in persons previously vaccinated with a serogroup B meningococcal vaccine - United States, 2014-2019.
Vaccine. 2021 Nov 13. pii: S0264-410X(21)01438.
PubMed Abstract available

ROSENTHAL S, Cummings CL
Influence of rapid COVID-19 vaccine development on vaccine hesitancy.
Vaccine. 2021 Nov 13. pii: S0264-410X(21)01448.
PubMed Abstract available

HARMON SHE, Faour DE, MacDonald NE
Mandatory immunization and vaccine injury support programs: A survey of 28 GNN countries.
Vaccine. 2021 Nov 12. pii: S0264-410X(21)01390.
PubMed Abstract available

CHHABRIA S, Stanford FC
A long shot: The importance of needle length in vaccinating patients with obesity against COVID-19.
Vaccine. 2021 Nov 11. pii: S0264-410X(21)01442.
PubMed

VIZCARRA P, Haemmerle J, Velasco H, Velasco T, et al
BNT162b2 mRNA COVID-19 vaccine Reactogenicity: The key role of immunity.
Vaccine. 2021 Nov 11. pii: S0264-410X(21)01417.
PubMed Abstract available

AW R, Ashik MR, Islam AAZM, Khan I, et al
Production and purification of an active CRM197 in Pichia pastoris and its immunological characterization using a Vi-typhoid antigen vaccine.
Vaccine. 2021 Nov 10. pii: S0264-410X(21)01432.
PubMed Abstract available

COLOMBATTI OLIVIERI MA, Moyano RD, Mon ML, Gravisaco MJ, et al
Evaluation of a virulent strain of Mycobacterium avium subsp. Paratuberculosis used as a heat-killed vaccine.
Vaccine. 2021 Nov 10. pii: S0264-410X(21)01433.
PubMed Abstract available

MCLEAN HQ, Levine MZ, King JP, Flannery B, et al
Serologic response to sequential vaccination with enhanced influenza vaccines: Open label randomized trial among adults aged 65-74 years.
Vaccine. 2021 Nov 10. pii: S0264-410X(21)01415.
PubMed Abstract available

BABUADZE GG, Echanove J, Lamarre C, deLaVega MA, et al
A novel DNA platform designed for vaccine use with high transgene expression and immunogenicity.
Vaccine. 2021 Nov 10. pii: S0264-410X(21)01315.
PubMed Abstract available

RODRIGUES CMC, Plotkin SA
The influence of interval between doses on response to vaccines.
Vaccine. 2021 Nov 10. pii: S0264-410X(21)01381.
PubMed

RADWAN NF, Abu-Sheasha GA, Bedwani RN, Yassine OG, et al
Vaccine wastage and cost saving after multi-dose vial policy implementation in Egypt: A success story.
Vaccine. 2021 Nov 9. pii: S0264-410X(21)01400.
PubMed Abstract available

SHAH SFA, Ginossar T, Bentley JM, Zimet G, et al
Using the Theory of Planned behavior to identify correlates of HPV vaccination uptake among college students attending a rural university in Alabama.
Vaccine. 2021 Nov 9. pii: S0264-410X(21)01431.
PubMed Abstract available

SVENNERHOLM AM, Qadri F, Lundgren A, Kaim J, et al
Induction of mucosal and systemic immune responses against the common O78 antigen of an oral inactivated ETEC vaccine in Bangladeshi children and infants.
Vaccine. 2021 Nov 9. pii: S0264-410X(21)01389.
PubMed Abstract available

THULUVA S, Matur R, Tsa K, Gv SR, et al
A single blind randomized phase 3 study to evaluate safety and immunogenicity of inactivated hepatitis A vaccine (HAPIBEV(TM)) in 1-15 years-old healthy hepatitis A vaccine-naive children.
Vaccine. 2021 Nov 8. pii: S0264-410X(21)01326.
PubMed Abstract available

HOSANGADI D, Martin EK, Watson M, Bruns R, et al
Supporting use of thermostable vaccines during public health emergencies: Considerations and recommendations for the future.
Vaccine. 2021 Nov 8. pii: S0264-410X(21)01398.
PubMed

MCKINNON B, Quach C, Dube E, Tuong Nguyen C, et al
Social inequalities in COVID-19 vaccine acceptance and uptake for children and adolescents in Montreal, Canada.
Vaccine. 2021 Nov 8. pii: S0264-410X(21)01426.
PubMed Abstract available

WU K, Choi A, Koch M, Elbashir S, et al
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice.
Vaccine. 2021 Nov 8. pii: S0264-410X(21)01435.
PubMed Abstract available

VILLANUEVA-UY MET, Lam HY, Aldaba JG, Uy TMZ, et al
Cost-effectiveness of rotavirus vaccination in the Philippines: A modeling study.
Vaccine. 2021 Nov 6. pii: S0264-410X(21)01290.
PubMed Abstract available

CUEVAS-JUAREZ E, Pando-Robles V, Palomares LA
Flavivirus vaccines: Virus-like particles and single-round infectious particles as promising alternatives.
Vaccine. 2021 Nov 6. pii: S0264-410X(21)01383.
PubMed Abstract available

SHARUN K, Tiwari R, Saied AA, Dhama K, et al
SARS-CoV-2 vaccine for domestic and captive animals: An effort to counter COVID-19 pandemic at the human-animal interface.
Vaccine. 2021 Nov 6. pii: S0264-410X(21)01386.
PubMed Abstract available

GOODE JR, Cook P, Cuttino S, Gatewood SBS, et al
Early experience with COVID-19 vaccine in a Federally-Qualified Healthcare Center for the homeless.
Vaccine. 2021 Nov 6. pii: S0264-410X(21)01388.
PubMed

DE HAAS TDJ, Yeung KHT, Hutubessy R, van der Putten IM, et al
Programme costs for introducing age/gestation-based universal influenza vaccine schedules for young children and pregnant women in Hong Kong.
Vaccine. 2021;39:6762-6780.
PubMed Abstract available

LAU CL, Mayfield HJ, Sinclair JE, Brown SJ, et al
Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework.
Vaccine. 2021 Nov 4. pii: S0264-410X(21)01428.
PubMed Abstract available

SANZ-ROJO S, Jimenez-Garcia R, Lopez-de-Andres A, de Miguel-Diez J, et al
Influenza vaccination uptake among high-risk target groups and health care workers in Spain and change from 2017 to 2020.
Vaccine. 2021 Nov 3. pii: S0264-410X(21)01392.
PubMed Abstract available

VASUDEVAN L, Ostermann J, Wang Y, Harrison SE, et al
Predictors of HPV vaccination in the southern US: A survey of caregivers from 13 states.
Vaccine. 2021 Nov 3. pii: S0264-410X(21)01356.
PubMed Abstract available

RIBERA-CANO A, Dupont M, Houze-Cerfon CH, Houze-Cerfon V, et al
Evaluation of a prototype decontamination mobile unit (UMDEO) for COVID-19 vaccination: A cross-sectional survey in France.
Vaccine. 2021 Nov 3. pii: S0264-410X(21)01429.
PubMed Abstract available

MIYA TV, Groome MJ, de Assis Rosa D
TLR genetic variation is associated with Rotavirus-specific IgA seroconversion in South African Black infants after two doses of Rotarix vaccine.
Vaccine. 2021 Nov 2. pii: S0264-410X(21)01384.
PubMed Abstract available

PIERRON A, Bozon F, Berceanu A, Fontan J, et al
Vaccination coverage in hematological patients undergoing chemotherapy: Should we move towards personalized vaccination?
Vaccine. 2021 Nov 2. pii: S0264-410X(21)01369.
PubMed Abstract available

MALTEZOU HC
Vaccination of healthcare personnel in the COVID-19 era: A call for actions.
Vaccine. 2021 Nov 2. pii: S0264-410X(21)01427.
PubMed

CASSONE A, Cauda R
Multicomponent vaccines to fight SARS-CoV-2 variants of concern.
Vaccine. 2021 Nov 1. pii: S0264-410X(21)01402.
PubMed

WAGNER A, Jasinska J, Tomosel E, Zielinski CC, et al
Absent antibody production following COVID19 vaccination with mRNA in patients under immunosuppressive treatments.
Vaccine. 2021 Nov 1. pii: S0264-410X(21)01401.
PubMed Abstract available

October 2021

LIU H, Zhou C, An J, Song Y, et al
Development of recombinant COVID-19 vaccine based on CHO-produced, prefusion spike trimer and alum/CpG adjuvants.
Vaccine. 2021 Oct 30. pii: S0264-410X(21)01399.
PubMed Abstract available

MALTEZOU HC, Panagopoulos P, Sourri F, Giannouchos TV, et al
COVID-19 vaccination significantly reduces morbidity and absenteeism among healthcare personnel: A prospective multicenter study.
Vaccine. 2021 Oct 30. pii: S0264-410X(21)01387.
PubMed Abstract available

KHOURY J, Najjar-Debbiny R, Hanna A, Jabbour A, et al
COVID-19 vaccine - Long term immune decline and breakthrough infections.
Vaccine. 2021 Oct 30. pii: S0264-410X(21)01370.
PubMed Abstract available

GORDON SF, Clothier HJ, Morgan H, Buttery JP, et al
Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia.
Vaccine. 2021 Oct 29. pii: S0264-410X(21)01350.
PubMed Abstract available

GARCIA-GRIMSHAW M, Ceballos-Liceaga SE, Michel-Chavez A, Garcia-Alanis M, et al
Transient sensory symptoms among first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine: A case-control study.
Vaccine. 2021 Oct 29. pii: S0264-410X(21)01391.
PubMed Abstract available

MAZUR A, Benitez S, Chuffart-Finsterwald S, La Rotta R, et al
COVAX no fault compensation program for COVID-19 vaccine injuries in 92 low and middle income countries.
Vaccine. 2021 Oct 28. pii: S0264-410X(21)01380.
PubMed

MARTIN S, Vanderslott S
"Any idea how fast 'It's just a mask!' can turn into 'It's just a vaccine!'": From mask mandates to vaccine mandates during the COVID-19 pandemic.
Vaccine. 2021 Oct 28. pii: S0264-410X(21)01351.
PubMed Abstract available

NOWALK MP, D'Agostino HEA, Zimmerman RK, Saul SG, et al
Agreement among sources of adult influenza vaccination in the age of immunization information systems.
Vaccine. 2021 Oct 26. pii: S0264-410X(21)01372.
PubMed Abstract available

JEON S, Kelly M, Yun J, Lee B, et al
Scalable production and immunogenicity of a cholera conjugate vaccine.
Vaccine. 2021 Oct 26. pii: S0264-410X(21)01312.
PubMed Abstract available

CAPPOZZO F, Dal Zotto A, Scollo M, Bernardini D, et al
dTap vaccination uptake during pregnancy: Pregnant women-focused and health professionals-focused predictors in the Veneto Region (Italy).
Vaccine. 2021 Oct 25. pii: S0264-410X(21)01321.
PubMed Abstract available

HUANG J, Bai Y, Ding H, Wang B, et al
Acceptance of pneumococcal vaccination in older adults: A general population-based survey.
Vaccine. 2021 Oct 25. pii: S0264-410X(21)01344.
PubMed Abstract available

CHANTHAVANICH P, Versage E, Van Twuijver E, Hohenboken M, et al
Antibody responses against heterologous A/H5N1 strains for an MF59-adjuvanted cell culture-derived A/H5N1 (aH5N1c) influenza vaccine in healthy pediatric subjects.
Vaccine. 2021 Oct 25. pii: S0264-410X(21)01317.
PubMed Abstract available

OLANIPEKUN T, Abe T, Effoe V, Westney G, et al
Changes in COVID-19 vaccine acceptance rate among recovered critically Ill patients: A 12-month follow-up study.
Vaccine. 2021 Oct 25. pii: S0264-410X(21)01324.
PubMed Abstract available

OPRIESSNIG T, Rawal G, McKeen L, Filippsen Favaro P, et al
Evaluation of the intranasal route for porcine reproductive and respiratory disease modified-live virus vaccination.
Vaccine. 2021 Oct 24. pii: S0264-410X(21)01353.
PubMed Abstract available

LOEB M, Russell ML, Kelly-Stradiotto C, Fuller N, et al
Adjuvanted trivalent influenza vaccine versus quadrivalent inactivated influenza vaccine in Hutterite Children: A randomized clinical trial.
Vaccine. 2021 Oct 23. pii: S0264-410X(21)01355.
PubMed Abstract available

MYAT TW, Thu HM, Tate JE, Burnett E, et al
Rotavirus infection among children under five years of age hospitalized with acute gastroenteritis in Myanmar during 2018-2020 - Multicentre surveillance before rotavirus vaccine introduction.
Vaccine. 2021 Oct 23. pii: S0264-410X(21)01323.
PubMed Abstract available

FAN X, Li X, Wan K, Zhao X, et al
Construction and immunogenicity of a T cell epitope-based subunit vaccine candidate against Mycobacterium tuberculosis.
Vaccine. 2021 Oct 23. pii: S0264-410X(21)01354.
PubMed Abstract available

SHACHOR-MEYOUHAS Y, Hussein K, Szwarcwort-Cohen M, Weissman A, et al
Single BNT162b2 vaccine dose produces seroconversion in under 60 s cohort.
Vaccine. 2021 Oct 23. pii: S0264-410X(21)01327.
PubMed Abstract available

TRAN VN, Nguyen HA, Le TTA, Truong TT, et al
Factors influencing adverse events following immunization with AZD1222 in Vietnamese adults during first half of 2021.
Vaccine. 2021;39:6485-6491.
PubMed Abstract available

ANDRADE G
Covid-19 vaccine hesitancy, conspiracist beliefs, paranoid ideation and perceived ethnic discrimination in a sample of University students in Venezuela.
Vaccine. 2021 Oct 22. pii: S0264-410X(21)01371.
PubMed Abstract available

SHUBITZ LF, Robb EJ, Powell DA, Bowen RA, et al
Deltacps1 vaccine protects dogs against experimentally induced coccidioidomycosis.
Vaccine. 2021 Oct 22. pii: S0264-410X(21)01349.
PubMed Abstract available

VAN BEEK LF, Langereis JD, van den Berg van Saparoea HB, Gillard J, et al
Intranasal vaccination with protein bodies elicit strong protection against Streptococcus pneumoniae colonization.
Vaccine. 2021 Oct 22. pii: S0264-410X(21)01313.
PubMed Abstract available

DAR SA, Kole S, Shin SM, Jeong HJ, et al
Comparative study on antigen persistence and immunoprotective efficacy of intramuscular and intraperitoneal injections of squalene - aluminium hydroxide (Sq + Al) adjuvanted viral hemorrhagic septicaemia virus vaccine in olive flounder (Paralichthys o
Vaccine. 2021 Oct 22. pii: S0264-410X(21)01345.
PubMed Abstract available

ABU-RAYA B, Maertens K, Munoz FM, Zimmermann P, et al
Factors affecting antibody responses to immunizations in infants born to women immunized against pertussis in pregnancy and unimmunized women: Individual-Participant Data Meta-analysis.
Vaccine. 2021;39:6545-6552.
PubMed Abstract available

FAN S, Li D, Zhao H, Yu L, et al
Ameliorated immunity elicited by intradermal inoculation in individuals vaccinated with inactivated SARS-CoV-2 vaccine.
Vaccine. 2021 Oct 22. pii: S0264-410X(21)01375.
PubMed Abstract available

MAKOVITZKI A, Lerer E, Kafri Y, Adar Y, et al
Evaluation of a downstream process for the recovery and concentration of a Cell-Culture-Derived rVSV-Spike COVID-19 vaccine candidate.
Vaccine. 2021 Oct 22. pii: S0264-410X(21)01376.
PubMed Abstract available

WANG J, Wagner AL, Chen Y, Jaime E, et al
Would COVID-19 vaccination willingness increase if mobile technologies prohibit unvaccinated individuals from public spaces? A nationwide discrete choice experiment from China.
Vaccine. 2021 Oct 22. pii: S0264-410X(21)01340.
PubMed Abstract available

JAMES EK, Bokemper SE, Gerber AS, Omer SB, et al
Persuasive messaging to increase COVID-19 vaccine uptake intentions.
Vaccine. 2021 Oct 22. pii: S0264-410X(21)01368.
PubMed Abstract available

NETANEL C, Ben-Aharon O, Ben-Ari Z, Chodick G, et al
Evaluation of a universal hepatitis B vaccination program and antenatal screening for hepatitis B surface antigen: Results from a real-world study 2015-2016.
Vaccine. 2021 Oct 20. pii: S0264-410X(21)01287.
PubMed Abstract available

DANKWA EA, Donnelly CA, Brouwer AF, Zhao R, et al
Estimating vaccination threshold and impact in the 2017-2019 hepatitis A virus outbreak among persons experiencing homelessness or who use drugs in Louisville, Kentucky, United states.
Vaccine. 2021 Oct 19. pii: S0264-410X(21)01308.
PubMed Abstract available

KIM D, Pekgun P, Yildirim I, Keskinocak P, et al
Resource allocation for different types of vaccines against COVID-19: Tradeoffs and synergies between efficacy and reach.
Vaccine. 2021 Oct 18. pii: S0264-410X(21)01346.
PubMed Abstract available

DANG TKNS, Rivero Cabrera R, Yeung KHT, van der Putten IM, et al
Feasibility of age- and gestation-based routine universal influenza vaccines schedules for children aged 6 months - 2 years and pregnant women.
Vaccine. 2021 Oct 18. pii: S0264-410X(21)01291.
PubMed Abstract available

CHEN AT, Stacey HD, Marzok A, Singh P, et al
Effect of inactivated influenza vaccination on human coronavirus infection: Secondary analysis of a randomized trial in Hutterite colonies.
Vaccine. 2021 Oct 18. pii: S0264-410X(21)01341.
PubMed Abstract available

MAKI Y, Kashiwagi S, Kimizuka Y
Laser vaccine adjuvants: Light-augmented immune responses.
Vaccine. 2021 Oct 16. pii: S0264-410X(21)01233.
PubMed Abstract available

CHAPIN-BARDALES J, Myers T, Gee J, Shay DK, et al
Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system.
Vaccine. 2021 Oct 16. pii: S0264-410X(21)01339.
PubMed Abstract available

ALI SAHRAIAN M, Ghadiri F, Azimi A, Naser Moghadasi A, et al
Adverse events reported by Iranian patients with multiple sclerosis after the first dose of Sinopharm BBIBP-CorV.
Vaccine. 2021;39:6347-6350.
PubMed Abstract available

AYAZ S, Dibben O, Chapman D
Presence of defective viral genes in H1N1 live attenuated influenza vaccine strains is not associated with reduced human cell fitness or vaccine effectiveness.
Vaccine. 2021 Oct 15. pii: S0264-410X(21)01320.
PubMed Abstract available

SILVER MC, Neumann PJ, Ma S, Kim DD, et al
Frequency and impact of the inclusion of broader measures of value in economic evaluations of vaccines.
Vaccine. 2021 Oct 13. pii: S0264-410X(21)01285.
PubMed Abstract available

MOGHNIEH R, Mekdashi R, El-Hassan S, Abdallah D, et al
Immunogenicity and reactogenicity of BNT162b2 booster in BBIBP-CorV-vaccinated individuals compared with homologous BNT162b2 vaccination: Results of a pilot prospective cohort study from Lebanon.
Vaccine. 2021 Oct 13. pii: S0264-410X(21)01314.
PubMed Abstract available

LALWANI SK, Ramanan PV, Sapru A, Sundaram B, et al
Safety and immunogenicity of a multidose vial formulation of 13-valent pneumococcal conjugate vaccine administered with routine pediatric vaccines in healthy infants in India: A phase 4, randomized, open-label study.
Vaccine. 2021 Oct 13. pii: S0264-410X(21)01208.
PubMed Abstract available

BUUS M, da Silva I, Nielsen S, Thysen SM, et al
Coverage and factors associated with receiving campaign polio vaccines in an urban population in Guinea-Bissau.
Vaccine. 2021 Oct 12. pii: S0264-410X(21)01150.
PubMed Abstract available

PARK WJ, Yoon YK, Kim Y, Park JS, et al
Development of a bivalent conjugate vaccine candidate against rotaviral diarrhea and tuberculosis using polysaccharide from Mycobacterium tuberculosis conjugated to DeltaVP8* protein from rotavirus.
Vaccine. 2021 Oct 9. pii: S0264-410X(21)01282.
PubMed Abstract available

MCNAY LA, Arnoczy G, Martell M, Mock P, et al
Community-based hospitals: New partners for government-sponsored clinical research during public health emergencies.
Vaccine. 2021;39:6183-6185.
PubMed Abstract available

HART P, Farrar J
The influenza vaccines roadmap - A better future through improved influenza vaccines.
Vaccine. 2021 Oct 8. pii: S0264-410X(21)01286.
PubMed

VERBERK JDM, van Dongen JAP, van de Kassteele J, Andrews NJ, et al
Impact analysis of rotavirus vaccination in various geographic regions in Western Europe.
Vaccine. 2021 Oct 8. pii: S0264-410X(21)01262.
PubMed Abstract available

BRYDEN GM, Rockloff M, Browne M, Unsworth C, et al
Effect of contamination and purity priming on attitudes to vaccination and other health interventions: A randomised controlled experiment.
Vaccine. 2021 Oct 8. pii: S0264-410X(21)01278.
PubMed Abstract available

VANDERMEULEN C, Leroux-Roels I, Vandeleur J, Staniscia T, et al
A new fully liquid presentation of MenACWY-CRM conjugate vaccine: Results from a multicentre, randomised, controlled, observer-blind study.
Vaccine. 2021 Oct 8. pii: S0264-410X(21)01283.
PubMed Abstract available

FU LY, Torres R, Caleb S, Cheng YI, et al
Vaccination coverage among young homeless children compared to US national immunization survey data.
Vaccine. 2021 Oct 8. pii: S0264-410X(21)01288.
PubMed Abstract available

MOTTELSON A, Vandeweerdt C, Atchapero M, Luong T, et al
A self-administered virtual reality intervention increases COVID-19 vaccination intention.
Vaccine. 2021 Oct 8. pii: S0264-410X(21)01311.
PubMed Abstract available

HUMBLE RM, Sell H, Dube E, MacDonald NE, et al
Canadian parents' perceptions of COVID-19 vaccination and intention to vaccinate their children: Results from a cross-sectional national survey.
Vaccine. 2021 Oct 8. pii: S0264-410X(21)01309.
PubMed Abstract available

BYRNE T, Patel P, Shrotri M, Beale S, et al
Trends, patterns and psychological influences on COVID-19 vaccination intention: Findings from a large prospective community cohort study in England and Wales (Virus Watch).
Vaccine. 2021 Oct 8. pii: S0264-410X(21)01281.
PubMed Abstract available

CLEMENTS JD, Gorman GH, Waters CN, Lane HC, et al
Tackling the burden of mumps in the military: A report of the Defense Health Board.
Vaccine. 2021;39:6186-6188.
PubMed

MAHAPATRA SR, Dey J, Kaur T, Sarangi R, et al
Immunoinformatics and molecular docking studies reveal a novel Multi-Epitope peptide vaccine against pneumonia infection.
Vaccine. 2021;39:6221-6237.
PubMed Abstract available

SCHNEIDER JC, Chen HC, Bautista E, Retallack D, et al
Safety and immunogenicity of Px563L, a recombinant anthrax vaccine candidate, in a two-dose regimen for post-exposure prophylaxis in healthy adults.
Vaccine. 2021;39:6333-6339.
PubMed Abstract available

WANG J, Wu QS, Lu J, Ni YH, et al
Low vaccination coverage of pneumococcal conjugate vaccines (PCVs) in Shanghai, China: A database analysis based on birth cohorts from 2012 to 2020.
Vaccine. 2021;39:6189-6194.
PubMed Abstract available

ABAYNEH T, Getachew B, Gelaye E, Traxler R, et al
Viability evaluation of freeze dried and suspension anthrax spore vaccine formulations stored at different temperatures.
Vaccine. 2021;39:6245-6249.
PubMed Abstract available

MULLER-PEBODY B, Sinnathamby MA, Warburton F, Rooney G, et al
Impact of the childhood influenza vaccine programme on antibiotic prescribing rates in primary care in England.
Vaccine. 2021 Oct 6. pii: S0264-410X(21)01284.
PubMed Abstract available

GIERSING B, Shah N, Kristensen D, Amorij JP, et al
Strategies for vaccine-product innovation: Creating an enabling environment for product development to uptake in low- and middle-income countries.
Vaccine. 2021 Oct 6. pii: S0264-410X(21)00996.
PubMed Abstract available

REIDENBERG BE, Hirsch K, Costello CM, Russo M, et al
Drive through COVID19 vaccination for developmentally disabled persons.
Vaccine. 2021 Oct 6. pii: S0264-410X(21)01279.
PubMed

MUKHERJEE N, Julian E, Torrelles JB, Svatek RS, et al
Effects of Mycobacterium bovis Calmette et Guerin (BCG) in oncotherapy: Bladder cancer and beyond.
Vaccine. 2021 Oct 6. pii: S0264-410X(21)01256.
PubMed Abstract available

ALLEVA DG, Delpero AR, Scully MM, Murikipudi S, et al
Development of an IgG-Fc fusion COVID-19 subunit vaccine, AKS-452.
Vaccine. 2021 Oct 5. pii: S0264-410X(21)01294.
PubMed Abstract available

LAZAROS G, Anastassopoulou C, Hatziantoniou S, Kalos T, et al
A case series of acute pericarditis following COVID-19 vaccination in the context of recent reports from Europe and the United States.
Vaccine. 2021 Oct 5. pii: S0264-410X(21)01295.
PubMed Abstract available

DRAPER M, Stergiopoulos S
Shingles vaccination uptake in Massachusetts adults aged 50 years and older.
Vaccine. 2021 Oct 5. pii: S0264-410X(21)01223.
PubMed Abstract available

BRUCE YU Y, Taraban MB, Briggs KT
All vials are not the same: Potential role of vaccine quality in vaccine adverse reactions.
Vaccine. 2021 Oct 5. pii: S0264-410X(21)01280.
PubMed

VADREVU KM, Raju D, Rani S, Reddy S, et al
Persisting antibody responses to Vi polysaccharide-tetanus toxoid conjugate (Typbar TCV(R)) vaccine up to 7years following primary vaccination of children<2years of age with, or without, a booster vaccination.
Vaccine. 2021 Oct 5. pii: S0264-410X(21)00966.
PubMed Abstract available

CORCORAN KE, Scheitle CP, DiGregorio BD
Christian nationalism and COVID-19 vaccine hesitancy and uptake.
Vaccine. 2021 Oct 2. pii: S0264-410X(21)01289.
PubMed Abstract available

SRICHAN P, Thohinung U, Kodyee S, Apidechkul T, et al
Vaccine serocoverage under the expanded program on immunization among hill tribe children in Thailand: A cross-sectional study.
Vaccine. 2021 Oct 1. pii: S0264-410X(21)01264.
PubMed Abstract available

RANE MS, Rohani P, Halloran ME
Durability of protection after 5 doses of acellular pertussis vaccine among 5-9 year old children in King County, Washington.
Vaccine. 2021;39:6144-6150.
PubMed Abstract available

BHAT S, Caldera F, Farraye FA
Standardizing shared vaccination responsibilities among specialists to improve vaccination rates of immunosuppressed patients.
Vaccine. 2021;39:6015-6016.
PubMed

KNUF M, Haas H, Garcia-Corbeira P, Turriani E, et al
Hexavalent vaccines: What can we learn from head-to-head studies?
Vaccine. 2021;39:6025-6036.
PubMed Abstract available

YOSHIKAWA T
Third-generation smallpox vaccine strain-based recombinant vaccines for viral hemorrhagic fevers.
Vaccine. 2021;39:6174-6181.
PubMed Abstract available

PARADOWSKA-STANKIEWICZ I, Rumik A, Bogusz J, Zbrzezniak J, et al
Duration of protection against Bordetella pertussis infection elicited by whole-cell and acellular vaccine priming in Polish children and adolescents.
Vaccine. 2021;39:6067-6073.
PubMed Abstract available

FUJISAWA S, Murata S, Takehara M, Aoyama J, et al
In vitro characterization of adipocyte plasma membrane-associated protein from poultry red mites, Dermanyssus gallinae, as a vaccine antigen for chickens.
Vaccine. 2021;39:6057-6066.
PubMed Abstract available

KUNITOKI K, Funato M, Mitsunami M, Kinoshita T, et al
Access to HPV vaccination in Japan: Increasing social trust to regain vaccine confidence.
Vaccine. 2021;39:6104-6110.
PubMed Abstract available

SISNOWSKI J, Vujovich-Dunn C, Gidding H, Brotherton J, et al
Differences in school factors associated with adolescent HPV vaccination initiation and completion coverage in three Australian states.
Vaccine. 2021;39:6117-6126.
PubMed Abstract available

BOZORGI A, Fahimnia B
Micro array patch (MAP) for the delivery of thermostable vaccines in Australia: A cost/benefit analysis.
Vaccine. 2021;39:6166-6173.
PubMed Abstract available

BOZORGI A, Fahimnia B
Transforming the vaccine supply chain in Australia: Opportunities and challenges.
Vaccine. 2021;39:6157-6165.
PubMed Abstract available

MALTEZOU HC, Effraimidou E, Cassimos DC, Medic S, et al
Vaccination programs for pregnant women in Europe, 2021.
Vaccine. 2021;39:6137-6143.
PubMed Abstract available

September 2021

NIEUWENHUIZEN NE, Zyla J, Zedler U, Bandermann S, et al
Weaker protection against tuberculosis in BCG-vaccinated male 129 S2 mice compared to females.
Vaccine. 2021 Sep 30. pii: S0264-410X(21)01230.
PubMed Abstract available

LEWIS G, Lazzaro T, Crawford NW
Recurrent lipoatrophy following multiple vaccinations: A case study.
Vaccine. 2021 Sep 30. pii: S0264-410X(21)01237.
PubMed

KHAIMOVA R, Fischetti B, Cope R, Berkowitz L, et al
Serological response with Heplisav-B(R) in prior Hepatitis B vaccine non-responders living with HIV.
Vaccine. 2021 Sep 29. pii: S0264-410X(21)01251.
PubMed Abstract available

FRANCIS-OLIVIERO F, Bozoki S, Micsik A, Kieny MP, et al
Research priorities to increase vaccination coverage in Europe (EU joint action on vaccination).
Vaccine. 2021 Sep 28. pii: S0264-410X(21)01224.
PubMed Abstract available

YACOUB MR, Cucca V, Asperti C, Ramirez GA, et al
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine.
Vaccine. 2021 Sep 28. pii: S0264-410X(21)01239.
PubMed Abstract available

ROMANO CJ, Hall C, Khodr ZG, Bukowinski AT, et al
History of pandemic H1N1-containing influenza vaccination and risk for spontaneous abortion and birth defects.
Vaccine. 2021 Sep 28. pii: S0264-410X(21)01171.
PubMed Abstract available

HOFMEISTER MG, Weng MK, Thoroughman D, Thomasson ED, et al
Prevalence of indications for adult hepatitis A vaccination among hepatitis A outbreak-associated cases, Three US States, 2016-2019.
Vaccine. 2021 Sep 28. pii: S0264-410X(21)01254.
PubMed Abstract available

MOON JE, Greenleaf ME, Regules JA, Debois M, et al
A phase IIA extension study evaluating the effect of booster vaccination with a fractional dose of RTS,S/AS01E in a controlled human malaria infection challenge.
Vaccine. 2021 Sep 27. pii: S0264-410X(21)01203.
PubMed Abstract available

CASEY RM, Adrien N, Badiane O, Diallo A, et al
National introduction of HPV vaccination in Senegal-Successes, challenges, and lessons learned.
Vaccine. 2021 Sep 27. pii: S0264-410X(21)01075.
PubMed Abstract available

SINGH AK, Srikrishna G, Bivalacqua TJ, Bishai WR, et al
Recombinant BCGs for tuberculosis and bladder cancer.
Vaccine. 2021 Sep 27. pii: S0264-410X(21)01231.
PubMed Abstract available

VIEIRA REZENDE RP, Braz AS, Guimaraes MFB, Ribeiro SLE, et al
Characteristics associated with COVID-19 vaccine hesitancy: A nationwide survey of 1000 patients with immune-mediated inflammatory diseases.
Vaccine. 2021 Sep 25. pii: S0264-410X(21)01260.
PubMed Abstract available

BLEICHER I, Kadour-Peero E, Sagi-Dain L, Sagi S, et al
Early exploration of COVID-19 vaccination safety and effectiveness during pregnancy: interim descriptive data from a prospective observational study.
Vaccine. 2021 Sep 25. pii: S0264-410X(21)01234.
PubMed Abstract available

SHEVZOV-ZEBRUN N, Caplan A
Parental consent for vaccination of minors against COVID-19.
Vaccine. 2021 Sep 25. pii: S0264-410X(21)01250.
PubMed

FISHER KA, Nguyen N, Crawford S, Fouayzi H, et al
Preferences for COVID-19 vaccination information and location: Associations with vaccine hesitancy, race and ethnicity.
Vaccine. 2021 Sep 25. pii: S0264-410X(21)01261.
PubMed Abstract available

MOLODECKY NA, Jafari H, Safdar RM, Ahmed JA, et al
Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemic.
Vaccine. 2021 Sep 25. pii: S0264-410X(21)01228.
PubMed Abstract available

ZENG W, Cui Y, Jarawan E, Avila C, et al
Optimizing immunization schedules in endemic cholera regions: cost-effectiveness assessment of vaccination strategies for cholera control in Bangladesh.
Vaccine. 2021 Sep 24. pii: S0264-410X(21)01235.
PubMed Abstract available

AKSNES BN, Walldorf JA, Nkwenkeu SF, Zoma RL, et al
Vaccination information, motivations, and barriers in the context of meningococcal serogroup A conjugate vaccine introduction: A qualitative assessment among caregivers in Burkina Faso, 2018.
Vaccine. 2021 Sep 24. pii: S0264-410X(21)01229.
PubMed Abstract available

FADLYANA E, Rusmil K, Tarigan R, Rahmadi AR, et al
A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18-59 years: An interim analysis in Indonesia.
Vaccine. 2021 Sep 24. pii: S0264-410X(21)01255.
PubMed Abstract available

SINGH AK, Phatak SR, Singh R, Bhattacharjee K, et al
Antibody response after first and second-dose of ChAdOx1-nCOV (Covishield(TM)(R)) and BBV-152 (Covaxin(TM)(R)) among health care workers in India: The final results of cross-sectional coronavirus vaccine-induced antibody titre (COVAT) study.
Vaccine. 2021 Sep 24. pii: S0264-410X(21)01258.
PubMed Abstract available

FOWLER A, Sampson M, Remaley AT, Chackerian B, et al
A VLP-based vaccine targeting ANGPTL3 lowers plasma triglycerides in mice.
Vaccine. 2021;39:5780-5786.
PubMed Abstract available

NOWAK SA, Gidengil CA, Parker AM, Matthews LJ, et al
Association among trust in health care providers, friends, and family, and vaccine hesitancy.
Vaccine. 2021;39:5737-5740.
PubMed Abstract available

MALO JA, Ware RS, Lambert SB
Estimating the risk of recurrent invasive pneumococcal disease in Australia, 1991-2016.
Vaccine. 2021;39:5748-5756.
PubMed Abstract available

KARAFILLAKIS E, Peretti-Watel P, Verger P, Chantler T, et al
The role of maturity in adolescent decision-making around HPV vaccination in France.
Vaccine. 2021;39:5741-5747.
PubMed Abstract available

LAWRENCE J, Kitchin N, Anderson AS, Pride MW, et al
Safety and immunogenicity of different Clostridioides (Clostridium) difficile vaccine formulations in two early phase randomized studies of healthy adults aged 50-85 years.
Vaccine. 2021;39:5991-6003.
PubMed Abstract available

KOTLER L, Greenberg D, Givon-Lavi N, van der Beek BA, et al
Decline in pneumococcal nasopharyngeal carriage in children 6-23 months with respiratory illnesses following pneumococcal conjugate vaccine implementation.
Vaccine. 2021;39:5757-5761.
PubMed Abstract available

AZAM JM, Saitta B, Bonner K, Ferrari MJ, et al
Modelling the relative benefits of using the measles vaccine outside cold chain for outbreak response.
Vaccine. 2021;39:5845-5853.
PubMed Abstract available

YUN KW, Rhie K, Kang JH, Kim KH, et al
Emergence of serotype 10A-ST11189 among pediatric invasive pneumococcal diseases, South Korea, 2014-2019.
Vaccine. 2021;39:5787-5793.
PubMed Abstract available

CAMPBELL JD, Pasetti MF, Oot L, Adam Z, et al
Linked vaccination coverage surveys plus serosurveys among Ethiopian toddlers undertaken three years apart to compare coverage and serologic evidence of protection in districts implementing the RED-QI approach.
Vaccine. 2021;39:5802-5813.
PubMed Abstract available

BAQUI AH, Koffi AK, McCollum ED, Roy AD, et al
Impact of national introduction of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in Bangladesh: Case-control and time-trend studies.
Vaccine. 2021;39:5794-5801.
PubMed Abstract available

PRELOG M, Almanzar G, Stern R, Robrade K, et al
Humoral and cellular immune response to tick-borne-encephalitis (TBE) vaccination depends on booster doses in patients with Juvenile Idiopathic Arthritis (JIA).
Vaccine. 2021;39:5918-5927.
PubMed Abstract available

SILCOCK R, Moghimi A, Perrett K, Crawford N, et al
Subcutaneous nodule at the vaccine injection site - A case of mistaken identity.
Vaccine. 2021;39:6013-6014.
PubMed

MARCHI S, Remarque EJ, Viviani S, Rizzo C, et al
Measles immunity over two decades in two large Italian Regions: How far is the elimination goal?
Vaccine. 2021;39:5928-5933.
PubMed Abstract available

HUANG XX, Bose AS, Gupta BP, Rai P, et al
Vaccine preventable diseases surveillance in Nepal: How much does it cost?
Vaccine. 2021;39:5982-5990.
PubMed Abstract available

BEDFORD H, Firman N, Waller J, Marlow L, et al
Which young women are not being vaccinated against HPV? Cross-sectional analysis of a UK national cohort study.
Vaccine. 2021;39:5934-5939.
PubMed Abstract available

YAMAZAKI Y, Ikeda M, Imada T, Furuno K, et al
A phase 3, multicenter, single-arm, open-label study to assess the safety, tolerability, and immunogenicity of a single dose of 13-valent pneumococcal conjugate vaccine in Japanese participants aged 6-64 years who are considered to be at increased ris
Vaccine. 2021 Sep 23. pii: S0264-410X(21)01168.
PubMed Abstract available

MOORE KA, Ostrowsky JT, Kraigsley AM, Mehr AJ, et al
A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future.
Vaccine. 2021 Sep 23. pii: S0264-410X(21)01028.
PubMed Abstract available

CHOWDHURY F, Akter A, Rahman Bhuiyan T, Tauheed I, et al
A non-inferiority trial comparing two recombinant vaccines (Hepa-B vs. Engerix-B) for hepatitis B among adults in Dhaka, Bangladesh.
Vaccine. 2021 Sep 21. pii: S0264-410X(21)01222.
PubMed Abstract available

MELGAARD A, Krogsgaard LW, Randrup T, Plana-Ripoll O, et al
Pre-vaccination vulnerability and suspected adverse events following HPV vaccination. A case-control study nested in the Danish national birth cohort.
Vaccine. 2021 Sep 21. pii: S0264-410X(21)01232.
PubMed Abstract available

LIU CH, Huang WT, Chie WC, Arnold Chan K, et al
Safety surveillance of varicella vaccine using tree-temporal scan analysis.
Vaccine. 2021 Sep 21. pii: S0264-410X(21)01226.
PubMed Abstract available

GIESE H, Neth H, Gaissmaier W
Determinants of information diffusion in online communication on vaccination: The benefits of visual displays.
Vaccine. 2021 Sep 21. pii: S0264-410X(21)01195.
PubMed Abstract available

ANGSUWATCHARAKON P, Puthanakit T, Bunjoungmanee P, Anugulruengkitt S, et al
High seroprevalence of rubella in Thai children with a 2-dose MMR national immunization policy.
Vaccine. 2021 Sep 20. pii: S0264-410X(21)01127.
PubMed Abstract available

MANSUY JM, Sagna AS, Laurent M, Izopet J, et al
COVID-19 diagnosis in a Senegalese company: A model for COVID-19 vaccination?
Vaccine. 2021 Sep 17. pii: S0264-410X(21)01227.
PubMed

ELBASHA EH, Choi Y, Daniels V, Goveia MG, et al
Cost-effectiveness of routine catch-up hepatitis a vaccination in the United States: Dynamic transmission modeling study.
Vaccine. 2021 Sep 17. pii: S0264-410X(21)01147.
PubMed Abstract available

MOSINA L, Kulper-Schiek W, Jacques-Carroll L, Earnshaw A, et al
Supporting National Immunization Technical Advisory Groups in the WHO European Region in developing national COVID-19 vaccination recommendations through online communication platform.
Vaccine. 2021 Sep 16. pii: S0264-410X(21)01225.
PubMed Abstract available

PRESTON KB, Wong TAS, To A, Tashiro TE, et al
Single-vial filovirus glycoprotein vaccines: Biophysical characteristics and immunogenicity after co-lyophilization with adjuvant.
Vaccine. 2021;39:5650-5657.
PubMed Abstract available

LI L, Hessell AJ, Kong XP, Haigwood NL, et al
A large repertoire of B cell lineages targeting one cluster of epitopes in a vaccinated rhesus macaque.
Vaccine. 2021;39:5607-5614.
PubMed Abstract available

DECKER MD, Garman PM, Hughes H, Yacovone MA, et al
Enhanced safety surveillance study of ACAM2000 smallpox vaccine among US military service members.
Vaccine. 2021;39:5541-5547.
PubMed Abstract available

KUROKAWA N, Robinson MK, Bernard C, Kawaguchi Y, et al
Safety and immunogenicity of a plant-derived rotavirus-like particle vaccine in adults, toddlers and infants.
Vaccine. 2021;39:5513-5523.
PubMed Abstract available

GOLDEN AR, Adam HJ, Baxter M, Martin I, et al
Whole genome characterization of Streptococcus pneumoniae from respiratory and blood cultures collected from Canadian hospitals before and after PCV-13 implementation in Canada: Focus on serotypes 22F and 33F from CANWARD 2007-2018.
Vaccine. 2021;39:5474-5483.
PubMed Abstract available

MORAIS E, El Mouaddin N, Schuurman S, De A, et al
Landscape assessment for gender neutral human papillomavirus vaccination recommendations including head and neck cancer burden data.
Vaccine. 2021;39:5461-5473.
PubMed Abstract available

MORIKAWA Y, Sakakibara H, Kimiya T, Obonai T, et al
Live attenuated vaccine efficacy six months after intravenous immunoglobulin therapy for Kawasaki disease.
Vaccine. 2021;39:5680-5687.
PubMed Abstract available

ODUWOLE EO, Mahomed H, Laurenzi CA, Larson HJ, et al
Point-of-care vaccinators' perceptions of vaccine hesitancy drivers: A qualitative study from the cape metropolitan district, South Africa.
Vaccine. 2021;39:5506-5512.
PubMed Abstract available

YSEBAERT C, Castado C, Mortier MC, Rioux S, et al
UspA2 is a cross-protective Moraxella catarrhalis vaccine antigen.
Vaccine. 2021;39:5641-5649.
PubMed Abstract available

NIKOLAY B, Ribeiro Dos Santos G, Lipsitch M, Rahman M, et al
Assessing the feasibility of Nipah vaccine efficacy trials based on previous outbreaks in Bangladesh.
Vaccine. 2021;39:5600-5606.
PubMed Abstract available

JUNG Y, Min JY, Kim HJ, Min KB, et al
Disparities in infant mortality from all-infectious, vaccine-preventable, and non-vaccine preventable diseases in relation to parental education.
Vaccine. 2021;39:5658-5665.
PubMed Abstract available

VENEGAS-VARGAS C, Taylor LP, Foss DL, Godbee TK, et al
Cellular and humoral immunity following vaccination with two different PCV2 vaccines (containing PCV2a or PCV2a/PCV2b) and challenge with virulent PCV2d.
Vaccine. 2021;39:5615-5625.
PubMed Abstract available

ZHANG N, Zheng T, Chen Y, Zhu H, et al
Coxsackievirus B5 virus-like particle vaccine exhibits greater immunogenicity and immunoprotection than its inactivated counterpart in mice.
Vaccine. 2021;39:5699-5705.
PubMed Abstract available

KARAFILLAKIS E, Paterson P, Larson HJ
'My primary purpose is to protect the unborn child': Understanding pregnant women's perceptions of maternal vaccination and vaccine trials in Europe.
Vaccine. 2021;39:5673-5679.
PubMed Abstract available

KOHL-HECKL WK, Schroter M, Dobos G, Cramer H, et al
Complementary medicine use and flu vaccination - A nationally representative survey of US adults.
Vaccine. 2021;39:5635-5640.
PubMed Abstract available

NACIUTE M, Kiwitt T, Kemp RA, Hook S, et al
Bacteria biohybrid oral vaccines for colorectal cancer treatment reduce tumor growth and increase immune infiltration.
Vaccine. 2021;39:5589-5599.
PubMed Abstract available

JIANG Y, Li X, Yu L, Tong W, et al
Immune efficacy of a candidate porcine reproductive and respiratory syndrome vaccine rHN-NP49 administered by a Needle-free intradermal delivery system in comparison with intramuscular injection.
Vaccine. 2021;39:5557-5562.
PubMed Abstract available

HASSAN AS, Perera DJ, Ward BJ, Ndao M, et al
Therapeutic activity of a Salmonella-vectored Schistosoma mansoni vaccine in a mouse model of chronic infection.
Vaccine. 2021;39:5580-5588.
PubMed Abstract available

RODRIGUES DE OLIVEIRA N, Jorge S, Andrade Colares Maia M, Thurow Bunde T, et al
Protective efficacy of whole-cell inactivated Leptospira vaccines made using virulent or avirulent strains in a hamster model.
Vaccine. 2021;39:5626-5634.
PubMed Abstract available

KIM DY, Kang YM, Cho HK, Park SJ, et al
Development of a recombinant H9N2 influenza vaccine candidate against the Y280 lineage field virus and its protective efficacy.
Vaccine. 2021 Sep 14. pii: S0264-410X(21)01149.
PubMed Abstract available

SULIMAN DM, Nawaz FA, Mohanan P, Modber MAKA, et al
UAE efforts in promoting COVID-19 vaccination and building vaccine confidence.
Vaccine. 2021 Sep 7. pii: S0264-410X(21)01194.
PubMed Abstract available

SCHLEISS MR, John CC, Permar SR
Children are the key to the Endgame: A case for routine pediatric COVID vaccination.
Vaccine. 2021;39:5333-5336.
PubMed

WEBSTER H, Valencia S, Kumar A, Chan C, et al
Pre-existing immunity to cytomegalovirus in macaques influences human CMV vaccine responses in preclinical models.
Vaccine. 2021;39:5358-5367.
PubMed Abstract available

IWAMOTO M, Hickman CJ, Colley H, Arciuolo RJ, et al
Measles infection in persons with secondary vaccine failure, New York City, 2018-19.
Vaccine. 2021;39:5346-5350.
PubMed Abstract available

STAPLES JN, Nelamangala SL, Morris S, Wells K, et al
Exploring socio-demographic and geospatial variation in human papillomavirus vaccination uptake in Virginia.
Vaccine. 2021;39:5385-5390.
PubMed Abstract available

GOUD R, Thompson D, Welsh K, Lu M, et al
ICD-10 anaphylaxis algorithm and the estimate of vaccine-attributable anaphylaxis incidence in Medicare.
Vaccine. 2021;39:5368-5375.
PubMed Abstract available

KRISTINSDOTTIR I, Haraldsson A, Love A, Asgeirsdottir TL, et al
Burden of rotavirus disease in young children in Iceland - Time to vaccinate?
Vaccine. 2021;39:5422-5427.
PubMed Abstract available

BRITTON KJ, Pickering JL, Pomat WS, de Gier C, et al
Lack of effectiveness of 13-valent pneumococcal conjugate vaccination against pneumococcal carriage density in Papua New Guinean infants.
Vaccine. 2021;39:5401-5409.
PubMed Abstract available

BORGHI L, Riva E
Was Aldo Castellani the inventor of combined and polyvalent vaccines?
Vaccine. 2021;39:5442-5446.
PubMed Abstract available

ELDRIDGE JH, Egan MA, Matassov D, Hamm S, et al
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for a soluble glycoprotein vaccine to prevent disease caused by Nipah or Hendra viruses.
Vaccine. 2021;39:5436-5441.
PubMed Abstract available

MCCLAIN JB, Chuang A, Reid C, Moore SM, et al
Rabies virus neutralizing activity, pharmacokinetics, and safety of the monoclonal antibody mixture SYN023 in combination with rabies vaccination: Results of a phase 2, randomized, blinded, controlled trial.
Vaccine. 2021 Sep 2. pii: S0264-410X(21)01114.
PubMed Abstract available

August 2021

CANTARELLI P, Belle N, Quattrone F
Nudging influenza vaccination among health care workers.
Vaccine. 2021 Aug 31. pii: S0264-410X(21)01073.
PubMed Abstract available

YLADE M, Agrupis KA, Daag JV, Crisostomo MV, et al
Effectiveness of a single-dose mass dengue vaccination in Cebu, Philippines: A case-control study.
Vaccine. 2021;39:5318-5325.
PubMed Abstract available

MILLER CN, Kemp TJ, Abrahamsen M, Isaacs-Soriano K, et al
Increases in HPV-16/18 antibody avidity and HPV-specific memory B-cell response in mid-adult aged men post-dose three of the quadrivalent HPV vaccine.
Vaccine. 2021;39:5295-5301.
PubMed Abstract available

WILSON R
HPV vaccine acceptance in West Africa: A systematic literature review.
Vaccine. 2021;39:5277-5284.
PubMed Abstract available

CHHATWAL J, Sapru A, Sundaram B, Shenoy B, et al
A phase 4 study of the safety of the 13-valent pneumococcal conjugate vaccine in children 6 to 17 years of age in India.
Vaccine. 2021;39:5313-5317.
PubMed Abstract available

O'LORCAIN P, Cotter S, Walsh C
Influenza vaccine uptake among healthcare workers and residents in public health care facilities in Ireland over nine influenza seasons (2011-2012 to 2019-2020).
Vaccine. 2021 Aug 27. pii: S0264-410X(21)00987.
PubMed Abstract available

GORANDER S, Honda-Okubo Y, Backstrom M, Baldwin J, et al
A truncated glycoprotein G vaccine formulated with Advax-CpG adjuvant provides protection of mice against genital herpes simplex virus 2 infection.
Vaccine. 2021 Aug 26. pii: S0264-410X(21)01098.
PubMed Abstract available

LEWIN BJ, Rodriguez J, Yang SJ, Tartof SY, et al
Predictors of hepatitis A immunity in adults in California in order to better utilize hepatitis A vaccine.
Vaccine. 2021 Aug 25. pii: S0264-410X(21)01104.
PubMed Abstract available

LAMM DL, Morales A
A BCG success story: From prevention of tuberculosis to optimal bladder cancer treatment.
Vaccine. 2021 Aug 17. pii: S0264-410X(21)01046.
PubMed Abstract available

WANG R, Chen K, Wang Y, Liu C, et al
Booster immunization improves the generation of T follicular helper (Tfh) cells specific to hepatitis B surface antigen (HBsAg) after prenatal HBsAg exposure.
Vaccine. 2021 Aug 16. pii: S0264-410X(21)01040.
PubMed Abstract available

PALLADINO G, Ferrari A, Music N, Settembre EC, et al
Improved immunologic responses to heterologous influenza strains in children with low preexisting antibody response vaccinated with MF59-adjuvanted influenza vaccine.
Vaccine. 2021 Aug 12. pii: S0264-410X(21)01041.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.